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Abstract 
 
Ionic Liquids New Technologies 
Monika Gurbisz 
 
Novel methylimidazolium and pyridinium ionic liquids (ILs), derivatives of 3,4-dimethoxy-
3,4-methylenedioxy- and 3,4-dihydroxy- mandelic acid, have been synthesised to serve as 
low-toxic and biodegradable solvents for catalytic asymmetric reactions. These ILs were 
prepared with three types of counteranion (halide, OctOSO3−, NTf2−) via a simple 3-5 step 
scalable synthetic route. The stability of the prepared ILs on aqueous conditions was 
studied. Although of the prepared ILs were chiral, they were obtained as racemic mixtures. 
Various methods were attempted to obtain ILs in the optically pure form and with the use 
of a chiral auxiliary approach, a diastereomerically enriched IL was obtained. Further 
synthetic work involved the optimisation and large scale (40-120 g) preparation of known 
achiral and chiral ILs. Both optically pure and achiral ILs were obtained in a 3-4 step 
synthesis, without the need for chromatographic purification. Preliminary ecotoxicological 
assessment of novel ILs was carried out; including, antimicrobial and antifungal screening 
as well as biodegradation studies. The majority of the ILs tested proved to be of low 
toxicity towards microorganisms and two ILs proved to be non-toxic towards bacteria at 
concentration as high as 100 mM. In the biodegradation test of halide ILs, one IL was 
found to pass the test (66 %) and for the remaining ILs values between 13–52 % were 
reached in the 28 day test. Selected ILs were tested as solvents in asymmetric reactions 
with chiral catalysts. With the use of organic co-solvents, very good eantioselectivities, 
short reaction times and catalyst recycling were achieved. In the presence of the novel ILs, 
derivatives of 3,4-disubstituted mandelic acids, asymmetric hydrogenation of the enamide 
double bond, together with aromatic ring reduction, was achieved at very mild conditions.  
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1.1 ILs General Information 
Ionic Liquids (ILs) are salts of low melting point (typically below 100 oC),1 consisting of 
an organic cation and relatively weakly coordinating2,3 inorganic anion1. Currently ILs are 
being considered as “green” replacement for volatile organic solvents.4,5 The most common 
classes of cations are derivatives of 1-methylimidazolium, pyridinium, pyrrolidinium, 
piperidinium, quaternary ammonium and quaternary phosphonium, where the majority 
have not been obtained by protonation of the nucleophile, but rather via alkylation of the 
nitrogen atom (Figure 1.1).6 Typical anions include: halides (Br−, Cl−), tetrafluoroborate 
(BF4−), hexafluorophosphate (PF6−), octylsulfate (OctOSO3−) and  
bis(trifluoromethanesulphonyl)imide (NTf2−), although many others, such as acetate 
(CH3COO−), nitrate (NO3−), phosphonate (PO4−), triflate (CF3SO3−), camphorsulfonate7 or 
saccharinate8 have also been prepared (Figure 1.1).6 1,3-Dialkylimidazolium ILs with 
various anions (e.g. Figure 1.2)  belong to the group of most studied ILs.  
 
Cations: 
N N
N
N
N P
N
 
Anions: 
Cl−, Br−, OctOSO3−, NO3−, CH3COO−, MeSO3−, MeOSO3−, EtOSO3−, CF3COO−,  
 
F
B
F F
F
P
F
F F
F
F
F N
C
N
C
N
S
NF3C
O O
S
O O
CF3
S
O
O
O
 
         BF4−        PF6−           NTf2−     N(CN)2−   OTs− 
 
Figure 1.1 Common cations and anions present in the ILs’ structure 
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NNNN
BF4 PF6
 
        [emim][BF4]                [bmim][PF6] 
 
NN
NTf2
 
     [omim][NTf2] 
Figure 1.2 1,3-Dialkylimidazolium ILs 
 
Although the area of ILs research  has flourished in the last decade, IL’s history dates back 
to end of the nineteen century, when the first examples of ILs were isolated and identified.1 
Considerable interest in ILs, (called also molten salts, fused salts, liquid salts, ionic fluids, 
liquid organic salts)3 was roused in the 1950s, when haloaluminate ILs, as a binary 
mixtures of 1,3-dialkylimidazolium halides and inorganic salts (e.g aluminium chloride) 
were prepared to serve as electrolytes for batteries.1 Haloaluminate ILs, now called “first 
generation ILs”,4 due to their good thermal stability (over 300 oC),1 wide electrochemical 
window 1 and very high electric conductivity found applications in electrochemistry.1 Those 
“first generation ILs” proved to also be useful in organic synthesis, but had a serious 
drawback - they were highly reactive in the presence of even small amounts of water and 
emitted corrosive hydrochloric acid. Rigorous anhydrous conditions were required if the 
ILs were applied in the synthesis.3,9 In 1992 Zawrotko and Wilkes reported the successful 
synthesis of various ILs with greater stability to hydrolysis (at least at room temperature) 
with anions, such as PF6−, BF4−, SO42−, NO3− , CH3COO−.1,9 Several years later the list of 
known, stable ILs was further expanded, when Fuller et al. introduced more anions (e.g. 
CF3SO3−, CN−, OTs−).10 Salts with these more stable anions are now called “second 
generation” ILs and most of the work towards applying ILs as solvents and catalysts in 
organic synthesis involves this class of compounds.4 About a decade ago “task-specific 
ionic liquids” (TSIL) emerged, in which either the cation or anion is designed to actively 
participate in a reaction (often as a catalyst).11,12 Concurrently, the first examples of 
optically pure, chiral ILs (CILs), were also prepared in this phase of IL development.13 
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1.1.1 Unique properties of ILs  
ILs have garnered great interest due to their unusual properties and potential applications in 
green chemistry. Typically ILs have a low melting point, negligible vapor pressure, high 
polarity, high thermal stability, and a broad electrochemical window.2,14 Furthermore, they 
are able to dissolve many organic, inorganic and organometallic compounds and are often 
immiscible with non-polar organic solvents.14  
The presence of large, unsymmetrical cations and anions results in charge diffusion, 
observed in ILs, which contributes to low melting points of ILs. Usually ILs melt below 
100 oC, and many are liquids at room temperature (so called room temp. RTILs).15,16 As a 
result of their ionic character, ILs have a negligible vapor pressure and are non-
flammable.14 ILs often contain weakly coordinating anions (e.g. BF4−, PF6−), therefore they 
are polar, yet non-coordinating solvents.2 ILs polarity and thus miscibility depends mainly 
on the type of anion or cation present and it may be rapidly adjusted by the anion exchange 
process.2 For example, imidazolium NTf2− ILs are in general hydrophobic, whereas the 
corresponding imidazolium halide ILs are hydrophilic or even hygroscopic.17 
The type of cation also has some impact on ILs polarity,2 for example [emim][BF4] has 
very good water solubility, while [omim][BF4] forms a biphasic system with water.18 This 
is an important feature of ILs, that their properties (such as melting point, viscosity, 
polarity) can be easily tuned by simple changes in their structure, therefore ILs are often 
called “designer solvents”.13,16 ILs also exhibit good thermal stability (e.g. [emim][BF4]; up 
to 300 oC, [emim][NTf2]; 400 oC) and have good gas solubility (e.g. H2, CO, O2).2 This 
wide range of favourable properties makes ILs good candidates as solvents for organic 
reactions, especially catalytic processes, where metal catalysts can be immobilised, 
recycled and products easily extracted or distilled off.2 ILs have ability to accelerate 
catalytic reactions, improve stability of catalysts and enhance reaction selectivity.14 It is 
postulated that ILs positive effect in catalytic processes stems from their ability to form a 
more active catalytic species (e.g. via anion exchange into less coordinating anion, resulting 
in enhanced Lewis acidity of the catalyst), to stabilize reactive intermediates (e.g. 
stabilization of vinyl cationic intermediates, arenium intermediates, anionic oxygen 
radicals) and stabilize transition states (e.g. ambiphilic “electrophile-nucleophile” dual 
activation role).14  
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1.2 Applications of ILs 
ILs found enormous applications as solvents, catalysts, reagents, additives or support 
phases in various areas of chemistry, including electrochemistry, organic synthesis, 
biochemistry and analytical sciences (Table 1.1).17  
 
Table 1.1 Applications of ILs in various areas of science17 
 
 
 
Electrochemistry: 
Electrolyte in batteries 
Metal plating 
Solar panels 
Fuel cells 
Electro-optic 
Ion propulsion 
 
Engineering: 
Coatings 
Lubricants 
Plasticisers 
Dispersing agents 
Compatibilisers 
 
Analytics: 
Matrixes for mass spectrometry 
Gas chromatography columns 
Stationary phases for HPLC  
 
 
Physical chemistry: 
Refractive index 
Thermodynamics 
Binary and ternary systems 
 
 
ILs Applications: 
Solvents and catalysts: 
Synthesis 
Catalysis 
Microwave chemistry 
Nanochemistry  
Multiphasic reactions 
 
Biological uses: 
Biomass processing 
Drug delivery  
Biocides 
Personal care 
Embalming 
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The widest range of applications for ILs has been in the field of synthetic chemistry, where 
they have been used as solvents and catalysts in C-C, C-O, C-N, C-S, and C-halogen bond 
forming reactions, as well as oxidation and reduction reaction processes (Table 1.2).  
ILs with non-coordinating anions such as BF4−, PF6−, and NTf2−, became popular as 
solvents or co-solvents in enzymatic reactions.19 It has been reported that enzymes 
effectively become immobilised in the IL, where they can exhibit higher activity, stability 
and selectivity than in common organic solvents. Enzyme-catalyzed transesterification, 
alcoholysis, ammoniolysis, hydrolysis, epoxidation, resolution, oxidation, reduction and 
deracemisation in ILs have all been reported.19 Extraction and dissolution processes with 
use of ILs also gained significant interest. Task specific ILs with thioether, thiourea and 
urea functionality incorporated into cation structure were applied to extract heavy metals 
(e.g. Hg2+, Cd 2+).20 Phosphoramide-functionalized ILs have also been shown to be efficient 
in the removal of various actinides (Am3+, UO2+, Pu4+) from aqueous solutions. Amine 
functionalised TSILs have proved to be excellent solvents for CO2 capture, in which the gas 
is reversibly bound as an ammonium carbamate salt and the whole system can be recycled 
upon heating.20 ILs with strongly hydrogen-bonding anions such as chloride, are effective 
in dissolving cellulose.21 Successful processes have also been carried out in ILs on an 
industrial scale.17 BASF successfully replaced the toxic gas, phosgene, with a solution of 
HCl in an IL in their process for the chlorination of butane-1,4-diol. The Eastman Chemical 
Company also used phosphonium IL to run process of isomerisation of 3,4-epoxybut-1-ene 
to 2,5-dihydrofuran. The French company IFP applied first generation, chloroaluminate(III) 
ILs as solvents for nickel-catalysed dimerisation reactions. IFP reported that the IL-
immobilised catalyst exhibited higher activity and selectivity than in the neat reaction and 
the product could easily be separated from the biphasic mixture. The Air Products company 
has applied ILs to safe storage and transport of reactive gases. One such reactive species is 
BF3, which can be complexed to [bmim][BF4], transported at sub-atmospheric pressure and 
finally can be  released from IL under vacuum.17  
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Table 1.2 ILs Applications as solvents and catalysts in synthetic chemistry21 
 
C-C bond forming reactions 
Friedel–Crafts reaction 
Diels–Alder reaction 
Knoevenagel condensation  
Aldol condensation reaction 
Baylis–Hillman reaction 
Alkylation reactions 
Wittig reaction 
Heck reaction 
Coupling of aryl halides  
Stille, Negishi and Trost–Tsuji 
reactions 
Rosenmund–Von Braun reaction 
Hydroformylation  
Alkoxycarbonylation  
Olefin metathesis 
Michael addition reactions  
Dimerisation and polymerisation 
reactions 
Cyclopropanation of styrene 
 
Carbon–oxygen bond-forming 
reactions 
O-Acetylation of alcohols and 
carbohydrates  
Glycosylation 
Acylation of nucleosides 
Esterification of aliphatic acids 
with olefins 
Carbon–sulphur bond-forming 
reactions  
Conversion of oxiranes into 
thiiranes  
Transthioacetylation of acetals  
Conjugate addition of thiols to α,β-
unsaturated ketones  
 
Carbon–halogen bond-forming 
reactions  
Fluorination by nucleophilic 
substitution 
Fluorination by electrophilic 
substitution 
Bromination of alkynes 
 
Hydrogenation 
Catalytic Hydrogenation 
Transfer Hydrogenation 
Oxidation and reduction 
reactions 
Oxidation of alcohols, aldehydes, 
oximes, thiols 
Epoxidation of olefins 
Asymmetric dihydroxylation of 
olefins  
Oxidative carbonylation of amines 
Carbon–nitrogen bond-forming 
reactions  
Synthesis of symmetrical urea 
derivatives with CO2 
Synthesis of aryl amines 
Synthesis of α-aminonitriles  
Synthesis of homoallylic amines  
 
ILs in organic chemistry: 
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1.2.1 Chiral ILs 
Asymmetric reactions, including Michael addition, aldol reaction, Baylis-Hillman, Diels-
Alder and hydrogenation reaction with chiral ILs as solvents or catalysts gained significant 
interest.  
Starting from (S)-proline, Luo and co-workers have synthesized the first, highly successful 
chiral ionic liquid, applied as catalyst in asymmetric Michael addition (Figure 1.3).22 In the 
reaction, catalyst (IL I, 15 mmol%) and additive (TFA, 5 mmol%), were used on neat 
conditions (ketone used in 20 eq. excess). A broad range of ketone and aldehyde donors 
with nitrostyrene acceptors were tested, resulting in products with high yields (up to 100 
%), excellent diastereoselectivity (syn:anti up to 99:1) and enantioselectivity (up to 99 % 
ee). Catalyst I was easily recycled by precipitation with diethyl ether and up to four cycles 
with good selectivity were maintained, however with decreasing activity and selectivity. 
Introduction of either a hydroxyl group or an aprotic substituent at the 2-position of the 
imidazolium ring did not improve catalyst performance. In the tested reactions ILs with Br− 
and BF4− anions turned out to be better catalysts than IL with PF6− anion. Control reactions 
with (S)-proline and 1-[(2S)-pyrrolidin-2-ylmethyl]-1H-imidazole as catalysts demonstrated 
that IL I exhibits significant advantages over related uncharged catalysts in terms of 
activity and selectivity.22 
O
Ph
NO2+
O Ph
NO2
15 mol% cat.
5 mol% TFA
       RT
N
H
NN Bu
BF4
100 % yield, 99:1 d.r., 99 % ee
I
 
Figure 1.3 Michael addition catalysed by chiral IL I 
 
Pyridinium analogue of IL I were prepared by Ni and Headley and used as a catalyst in the 
same Michael reaction (Figure 1.3).23  Excellent yields (74-99 %), diastereoselectivities 
(95:5 up to 99:1) and enantioselectivities (up to 99 % ee) were obtained under neat 
conditions with 15 mmol% of catalyst and 5 mmol% additive (TFA). IL with anions such 
as Cl− and BF4− again proved more efficient catalysts than the IL with PF6− or NTf2− anions. 
Other analogues of I, with thioimidazolium24,25 triazolium26 or isoquinolium27 cation 
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instead of butylimidazolium, were also prepared and proved highly effective in the above 
reaction.  
Luo et al. have also successfully applied another proline derivative, benzimidazolium IL II 
for the desymetrization of prochiral ketones via Michael addition to nitroolefines (Figure 
1.4).28 Catalyst (IL II, 15 mmol%) and additive (salicylic acid, 5 mmol%), were used in the 
reaction. A broad range of 4-substituted cyclohexanones and nitrostyrenes were tested 
affording Michael adducts with good to excellent yield (61-99 %), diastereoselectivity 
(4:1–10:1) and enantioselectivities (93-99 % ee). Similarly as in the case of I, catalyst II 
could be recycled up to four times, however with a marked decrease of activity.  
O
Ar
NO2+
O Ar
NO2
15 mol% cat.
5 mol% 
    RT
N
H
NN Bu
Br
99 % yield, 10:1 d.r., 97 % ee
R
R = Me, Et, t-Bu, Ph, N3, SAc
O Ar
NO2
+
R R
OH
COOH
II
 
Figure 1.4 Michael addition catalysed by chiral IL 
 
Zlotin et al. synthesised IL III as a catalyst for the aldol reaction between cyclohexane and 
benzaldehyde. Using 30 mol% IL, the aldolisation took place with excellent ee (> 99 %) 
and diastereoselectivity (d.r. 97:3) (Figure 1.5).29 Various cycloalkanones and aromatic 
aldehydes were screened with good results and up to five recycles were possible, retaining 
good activity and selectivity. 
O
CHO
+
O OH
30 mol% cat.
 20 oC, 10 h
      water
>99 % conv.,  97:3 d.r., >99 % ee
N NC12H25 O
O
N
H
O
OH
PF6
4
III
 
Figure 1.5 Aldol reaction catalysed by chiral IL 
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In 2006, Leitner et al. reported the highest asymmetric induction yet obtained with a chiral 
solvent as the only source of chirality.30 The authors prepared a methyltrioctylammonium 
IL with a dimalatoborate anion IV as the source of chirality, and tested the IL as a solvent 
for the aza-Baylis-Hillman reaction (Figure 1.6). Methyl vinyl ketone was reacted with an  
N-tosyl imine in the presence of PPh3 as a nucleophilic catalyst and good enantioselectivity 
(84 % ee) with a modest conversion (39 %) was achieved with IL IV as the solvent. 
Formation of a zwitterionic intermediate and its stabilisation by the IL via electrostatic 
interactions and hydrogen bonding have been postulated to explain the asymmetric 
induction.30  
N
Ts
Br
O
+
NH
Br
O
Ts
RT, 24 h
10 mol % PPh3
39 % conv., 84 % ee
COOH
O
OO OO
O
B N
C8H17
C8H17
C8H17
IV
COOH
 
Figure 1.6 Aza-Baylis-Hillman reaction in chiral IL as solvent 
 
Pegot, Vo-Thanh et al. have successfully used chiral (1R, 2S)-N-methylephedrine derived 
IL V as a catalyst in a related asymmetric Baylis-Hillman reaction (Figure 1.7).31 In the 
neat reaction of benzaldehyde with methyl acrylate in the presence of 1 eq. of 1,4-
diazabicyclo[2.2.2]octane (DABCO) and 50 mol% (1R,2S)-N-methylephedrinium IL V, the 
product  was obtained in 76% yield and 20% ee. However, upon increasing the IL V in the 
reaction to 3 eq., a significant improvement in enantioselectivity, to 44 % ee was obtained 
with moderate yield (60 %). An analogue of V with an acetyl protected hydroxyl group was 
also prepared, but in this case a significant decrease in enantioselectivity to 6% ee was 
observed, demonstrating the importance of the unprotected hydroxyl group for chirality 
transfer. A control experiment with N-methylephedrine as the catalyst also resulted in 
decreased enantioselectivity (9 % ee), but with improved yield (75 %). 
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Figure 1.7 Baylis-Hillman reaction catalysed by chiral IL 
 
Doherty et al. investigated an imidazolium-tagged bis(oxazoline) IL VI as a chiral ligand in 
the copper-catalysed Diels-Alder reaction of N-acryloyloxazolidinone and cyclopentadiene 
(Figure 1.8).32 10 mol% of IL VI was used with a second, achiral IL, [emim][NTf2] as the 
solvent. The Diels-Alder adduct was obtained with very high enantioselectivity (95 % ee), 
good diastereoselectivity (endo:exo ratio, 7.3:1), and outstanding reaction rate (2 min). A 
control experiment carried out in CH2Cl2 resulted in a decrease in enantioselectivity to 16 
% ee, with an increased reaction time of 1 h. Recycling up to ten cycles was possible 
without loss of activity or stereoselectivity. Experiments with uncharged bis(oxazoline) 
ligand were carried out, but due to its leaching into organic phase recycling it was 
inefficient.32 Zhou et al. prepared modified, C2 symmetrical version of VI and an improved 
diastereoselectivities (9:1 ratio) and enantioselectivities (97 % ee) were obtained in the 
same reaction (Figure 1.8).33 The catalytic system could be recycled 20 times without loss 
of activity. 
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Figure 1.8 Diels-Alder reaction catalysed by chiral IL 
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Garvilov and Reetz have prepared ILs VII and VIII, which incorporate established chiral 
phosphorus ligands within an imidazolium side-chain (Figure 1.9).34 ILs VII and VIII were 
tested in rhodium-catalyzed asymmetric hydrogenation reactions of functionalised olefins, 
and good enantioselectivities (96 % ee) were obtained.34 
N
N
P
O
BF4
N
N
O
O
P O
BF4
N
N
 
    VII    VIII 
Figure 1.9 Chiral ILs applied in asymmetric hydrogenation reaction 
 
The same strategy was used by Feng et al., who synthesized IL IX which incorporates 
Josiphos ligand (Figure 1.10).35 Using this catalyst in a biphasic system, Feng achieved  
excellent conversions (100 %) and enantioselectivities (up to 99 % ee) in the asymmetric 
hydrogenation of methyl acetamidoacrylate and dimethyl itaconate.35 
 
O
H
N N N
Fe
Ph
H
NTf2  
          IX 
Figure 1.10 Chiral IL applied in asymmetric hydrogenation reaction 
 
1.3 ILs reactivity 
Although ILs are considered as inert, non-coordinating and chemically and thermally stable 
solvents, reports regarding cation and anion reactivity have been published.36,37,38 Some of 
the transformations are undesirable, leading to decomposition of ILs, such as BF4− and PF6− 
anions’ hydrolysis, while others such as carbene formation may be beneficial and are 
responsible for catalytic activity of certain ILs.38,39,40   
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ILs' cation reactivity is a result of relatively high acidity of the H2 proton of 
methylimidazolium core, with pKa of 21-24 (measured in water and DMSO).37 This acidity 
steams from the methylimidazolium electronic structure, where the positive charge is 
delocalised by resonance over both nitrogen atoms and, to slightly smaller degree, over a 
C2 atom (Figure 1.10).41 C2 is electron deficient and C4 and C5, equally sharing C=C 
bond, are neutral. According to Hunt et al. electron delocalization occurs over the entire 
ring, but it is the most significant among N1C2N3 atoms (Figure 1.10).41  
N NN
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N
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Figure 1.11 Resonance structures of 1,3-dialkylimidazolium IL cation 
 
Acidity of H2 protons have been demonstrated in experiments of Olofson et al., where in 
1,3-dialkylimidazolium ILs, on mildly basic condition (pD = 8.92) a rapid exchange of H2 
with deuterium has been observed (t1/2 4.5 min).42 According to Handy and Okello, 
substitution of the C2 position by a methyl group, e.g. [bdmim][Cl] (1-butyl-2,3-
dimethylimidazolium chloride), improves IL stability, however it is not sufficient to ensure 
complete inertness and a slow exchange of protons of the methyl group, is still occurring in 
the presence of triethylamine (0.2 M in D2O, k = 0.04 × 10-3 min-1).43  In another study 
rapid deuterium exchange (50 % in 1 h) occurred in [bmim][PF6] (0.1 M) placed in a 
CD3OD:D2O 1:1 mixture. In the same test [bdmim][PF6] produced less than 10% deuterium 
exchange at C2 methyl group at room temperature over one week. Jurcik showed that C2 
substitution by phenyl ring results in ILs stable in even strongly basic conditions.44 Baylis-
Hillman reaction catalysed by DABCO and alkylation with Grigniard reagent were 
successfully carried out in such C2-phenyl substituted ILs.44 Another approach to obtain 
less reactive ILs was presented by Handy et al., who has shown that type of anion present 
in ILs, also influences proton H2 lability.43 When a deuterium exchange reaction was 
carried out without a base, the process occurred spontaneously in [bmim][N(CN)2] (0.2 M 
in D2O, k = 4.1 × 10-2 min-1), but [bmim][BF4] with non-basic and weekly coordinating 
anion was inert to such process within 72 h.43  
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In the presence of base 1,3-dialkyl substituted imidazolium ILs may form N-heterocyclic 
carbenes. That leads to undesired by-products formation in reactions such as Baylis-
Hillman,43,45 Horner–Wadsworth–Emmons,38 Knoevenagel and Claisen–Schmidt 
condensation38. Aggarwal isolated and characterized a by-product of the aldehyde addition 
to C2 position of an IL in the Baylis-Hillman reaction.45 Formation of carbenes was also 
observed in palladium catalyzed Heck reaction, where from [bmim][Br] and Pd(OAc)2, a 
mixture of carbene-metal complexes was obtained.39 However in the Heck reaction, those 
complexes were beneficial to the reaction, probably acting as catalysts.38,39,40 Another 
undesirable reaction of ILs’ cation, which has been observed, is chemically or thermally 
induced dealkylation. Ermenger et al. observed decomposition of branched ILs, occurring 
during their microwave induced synthesis on solvent free conditions.46 Ermenger postulated 
a dealkylation process, similar to a Hofmann elimination was taking place.46 Dullius et al. 
successfully applied [bmim][BF4] in palladium catalysed hydrodimerisation of 1,3-
butadiene.47 However upon addition of water to the reaction mixture, dealkylation of IL, 
probably in the process of β-elimination,  took place.47 Decomposition of ILs via reversed 
Menschutkin reaction was also found by Oxley et al. on ultrasonic conditions.48 
Chloromethane, chlorobutane and imidazole decomposition products were detected upon 
[bmim][Cl] sonification at 135 oC.38,48  
ILs reactivity may be also due to anion hydrolysis, as have been observed in the case of 
anions, such as BF4−, PF6− or MeOSO3−. Although PF6− anions have received more 
attention, considering their hydrolysis and HF formation, BF4− were shown to be much 
more prone to such process.49 Cho et al. have studied anion influence on [bmim][A] (A = 
SbF6−, PF6−, BF4−) toxicity towards algae and as part of the study a fluoride release, 
resulting from anion hydrolysis, was investigated.50 Authors found that at room temperature 
hydrolysis of [bmim][SbF6] (7.0 mM) was instantaneous (F−content after 9 days 600 mg/L), 
[bmim][PF6] was stable towards hydrolysis and moderate decomposition was taking place 
in case of [bmim] [BF4] (F− content over 100 mg/L after 9 days).50 Freire et al. have studied 
the thermal (25 oC-100 oC) and chemical (pH 3-12) stability of [bmim] and [omim] with 
BF4− and PF6− anions in water-methanol mixture. It was found that ILs with PF6− anion 
were stable in moderate conditions (even in the 3-year old sample), but hydrolysis was 
taking place in acidic environment (pH of 3.0) or at high temperature (70 oC and 100 oC).18 
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Those findings were confirmed by other studies.51,52 ILs with BF4− anion were undergoing 
hydrolysis on all of the conditions tested, even at room temperature.18 Hydrolysis was 
shown to increase with longer alkyl chain length on the methylimidazole core, which 
authors postulated is a result of weakened cation anion interactions, favouring water anion 
interaction. Hydrolysis of PF6− anion to F− and to PO43− in the presence of acid was also 
observed.53,54 Decomposition of PF6− to F−, PO4− and various fluorophosphates (e.g. 
F5POH−) was found to occur in the presence of metal complexes.55,56 Referring to their 
unpublished results Wasserscheid et al. reported methylsulfate and ethylsulfate anions are 
undergoing significant hydrolysis at 80 oC resulting in hydrogen sulfate and alcohol 
release.57  
 
1.4 Principles of green chemistry 
Most of the processes involving chemicals risk negative impact on the environment58 and 
human health. This risk can be expressed by formula (1): 
                                              Risk = Hazard × Exposure                                                  (1)                              
Traditionally, attempts to eliminate risk focused on reducing the exposure, through 
controlling of circumstantial factors, such as use, handling, treatment, and disposal of 
chemicals. The pursuit of green chemistry is to eliminate risk by minimizing the hazard, 
through controlling of intrinsic factors, such as selection of chemicals with reduced toxicity 
and the design of reaction pathways that eliminate by-products or ensure that they are 
benign (so called 'benign by design').58  
In the late 1980’s the term “sustainable development” appeared, which stems from the 
philosophy of “Meeting the needs of the present generation without compromising the 
ability of future generations to meet their own needs.”59 Chemistry can contribute to the  
sustainable development by substitution of fossil resources—oil, coal and natural gas by 
renewable raw materials, by recycling chemicals, lowering materials and energy 
consumption and by preventing chemicals bio-accumulation in the environment.60  
Sustainable development and hazard elimination both became the core of the green 
chemistry. Sheldon introduced a definition: “Green chemistry efficiently utilizes 
(preferably renewable) raw materials, eliminates waste and avoids the use of toxic and/or 
hazardous reagents and solvents in the manufacture and application of chemical products.59 
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This definition has been detailed by Anastas and Warren, who introduced twelve principles 
of green chemistry.58 To quantitatively assessed environmental impact of a chemical 
process, terms E factor and atom economy (or efficiency) have been also introduced. 
E(nviromental) factor expresses the number of kg of waste per kg of product and atom 
economy indicates the percentage of substrate atoms present in the product.59  
 
1.4.1 ILs and green chemistry 
Nowadays green chemistry research can be divided into 3 main areas: alternative 
feedstocks, alternative solvents and alternative synthetic pathways.58 Ionic liquids alongside 
supercritical fluids (e.g. CO2, H2O), fluorous solvents, renewable solvents and water are 
currently being tested as alternative solvents.2,16a,16b ILs, due to their unusual physico-
chemical properties, also offer the possibility for alternative synthetic pathways.  
Ionic liquids obtained the label ‘green solvents’ primarily based on their low to negligible 
vapour pressure, which as compared with other VOCs, significantly reduced the exposure 
and thus environmental and health risks.16a,16b Over time it became apparent ILs meet other 
green chemistry requirements.61 ILs are excellent solvents for catalytic reactions, including 
enzymatic processes, where catalysts and solvents can be immobilised and recycled.2,14 In 
ILs, increased reaction rates and better selectivity than in conventional solvents can be 
achieved, leading to waste and energy requirement minimization.2,4,14 Due to ease of 
biphasic systems formation and negligible vapour pressure, product separation can be 
facilitated in the presence of Ils.2 However at the moment ILs probably can not be yet 
considered as “green solvents”, due to their often not environmentally friendly synthetic 
methods, and not fully understood toxicity and  environmental fate. 
 
1.5 ILs synthesis   
ILs typically are synthesized by quaternisation of amine or phosphine by an alkylating 
agent,62 in the presence of an aprotic solvent.63 Anion exchange reactions via anion 
methathesis, acid-base neutralisation or by use of anion exchange resin are subsequently 
carried out if necessary (Scheme 1.1).62 Commonly used nitrogen-containing compounds 
are 1-methylimidazole, 1-butylimidazole, 1,2- dimethylimidazole, pyridine, alkyl amines, 
pyrrolidine, piperidine. Alkyl halides, especially bromides and chlorides are the most 
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common alkylating reagents, however other reagents such as alkyl triflates, tosylates,62 
dialkyl sulphates,64 carbonates,65 phosphates,66 or oxonium salts67 have also been used.  
 
NN
Cl
NN Cl
+
NN
BF4
NaBF4 + NaCl
 
Scheme 1.1 Example of ILs synthesis. 
 
A quaternisation reaction is a highly atom efficient process, where both substrates are 
converted into products and no by-products are being formed.68 However hazardous 
chemicals and VOCs, including chlorinated solvents, are often used in the synthesis.63,69,70 
ILs may require purification by solvent washes, since an excess of alkylating agent is 
typically used in the synthesis. Upon anion exchange reactions stoichiometric amounts of 
inorganic salts or acids are generated. Rakita classified the hazard associated with 
[bmim][PF6] synthesis and pointed out that toxic (HPF6), irritant (chlorobutane) and 
corrosive (1-methylimidazole, HPF6) chemicals are involved.69 ILs synthesis also may be 
not energetically efficient, as it may involve several hours (8-72 h) of refluxing.71 
Preparation of alkylating agents and heterocyclic amines often also proceed through many 
synthetic steps and involve hazardous chemicals.70 Therefore many efforts are underway to 
obtain ILs via short, more efficient, solvent free routes.68 Ideally starting materials should 
be non-toxic, renewable and not expensive.72  
 
1.5.1 ILs green synthetic methods 
Sartori et al. have prepared series of RTILs by alkylation of respective amines, phosphines 
and amine heterocycles with alkyl triflates on solvent free conditions.68 Hexane addition 
was necessary in case of solid ILs. Reactions were carried out at 0 oC to RT and were 
completed within 0.5-24 h. Excess of alkylating reagents were removed under vacuum and 
near quantitative yields were achieved.68 Zhao et al. prepared N-ethylpyridinium bromide 
on neat conditions. An excess of alkylating reagent was used and after 24 h of heating at 29 
oC, [epy][Br] as white crystals was obtained at 97 % yield. IL was filtered and 
recrystallised.73  
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Shen et al. found that the solvent free synthesis of 1,3-dialkylimidazolium halide ILs leads 
to coloured impurities, interfering with analytical applications of the final products.74 
Therefore the synthesis of [bmim][Br] and [hmim][Br] was carried out in water as a solvent 
and as a result clear, transparent products, without appreciable absorption in the visible 
region were obtained with yields up to 98 % ([bmim][Br], 24 h, at 70 oC, 2.5 eq. of 
bromobutane and 91 % yield at 1.2 eq. of bromobutane).74  
Solvent free, microwave technology was first applied to 1,3-dialkylimidazolium halide ILs 
synthesis and anion metathesis process by Varma et al.75 ILs [Bmim][Br] and [bmim][Cl] 
were prepared in an unmodified household microwave with an open vessel in 86 % yield 
(1.2 eq. of alkylating agent) and 76 % yield (2 eq. of alkylating agent) respectively, within 
less than 2 min of uncontinueous irradiation (intermittent heating and mixing).75 Products 
were washed with diethyl ether and dried. It was observed that at elevated power levels or 
extended reaction times, evaporation of alkyl halide and partial decomposition/charring of 
the ionic liquid occurs.75 Anion methathesis into BF4− was also carried out in less than 5 
min, with yields 88-92 %.76 First generation ILs could be also obtained by this technology 
in quantitive yields.75 Khadilkar and Rebeiro reported microwave assisted synthesis of ILs 
in a safer, sealed vessel and they were also able to greatly reduce synthesis time, from 22 h 
to 24 min for [bmim][Cl] (91 % yield, at 150 oC) and from 72 h to 1h in the case of 
[bpy][Cl] (66 % yield, programmed 180 to 200 oC).77 Products were purified by washings 
with ethyl acetate, filtration and drying. At 200 °C of continuous irradiation the [bpy][Cl] 
was formed in quantitative yield; however, the product obtained was partially tarnished.77  
Vo-Thanh have studied microwave assisted synthesis of (1R, 2S)-N-methylephedrine 
derived ILs (e.g. IL V, Figure 1.7), where halide IL preparation and anion methathesis 
(BF4−, PF6−, OTf−) were carried out in one pot reaction. Yields of 51-91 % were achieved 
within 10-120 min, however chromatographic purification was necessary.78 
Bazureau et al. have prepared series of PEG derived ILs within 30 min with 73-95 % 
yields.71 Impressive reduction of the reaction time from 14 days (98 %, 80 oC) to 45 min 
(86 %, 130 oC) was achieved by Bica et al. in their microwave synthesis of 
methylimidazolium (1S)-(+)-camphorsulfonic acid derived ILs.79 IL with a borneol unit 
was prepared with a 91 % yield (105 min, 150 oC), where presence of anhydrous ethyl 
acetate proved to be beneficial for purity of the product.79  
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1.5.2 ILs from biorenewable sources 
Another means of achieving greener ILs synthesis is a careful choice of non-toxic, 
renewable starting materials. One of the first ILs coming from renewable sources were ILs 
based on naturally occurring ammonium salt - choline chloride.80 ILs (e.g. IL X) were 
prepared, as eutectic mixtures of choline and zinc chloride, upon heating of both 
compounds at 150 oC, until colourless liquid was obtained (Figure 1.11). Various molar 
ratios of both compounds were used and significantly lower melting points, than pure 
choline chloride (m.p. 302 oC), were achieved (e.g. 1:2 ratio, m.p. 25 oC) (Figure 1.12). ILs 
as a mixture of choline chloride, zinc and tin chlorides exhibited similarly low melting 
points (e.g. 1:1:1 ratio, 21-23 oC).80 Those choline ILs are stable to moisture, however their 
high viscosity is one of the drawbacks. An even lower melting point was reached when IL 
XI as mixture of choline chloride and urea (1:2 ratio, 12 oC) was prepared.81  
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Figure 1.12 Choline based ILs 
 
Choline IL XII with (S)-proline counteranion was prepared by Hu et al. and was applied in 
direct aldol reactions (Figure 1.12).82 In the first synthetic step choline chloride was 
converted into choline hydroxide and next the hydroxide salt was neutralised with proline 
(Figure 1.13).82 Recently Yu et al. reported  preparation of a series of compounds via a 
similar method, where various naphthenic acids (e.g. cyclohexane carboxylic acid, benzoic 
acid, salicylic acid, IL XIII, deoxycholic acid, lithocholic acid, IL XIV) were used for 
choline hydroxide neutralization (Figure 1.13).83 The remarkable advantage of such ILs are 
their biodegradation properties, where except choline 2-naphthoxyacetate and choline 
anthracene-9-carboxylate, all of the ILs pass the biodegradation test (60-83 % in a closed-
bottle test (OECD 301D)).83  
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Figure 1.13 ILs with cations and anions from renewable sources 
 
Naturally occurring acids, such as lactic and tartaric acids have drawn the attention of many 
researchers as potential sources of ILs, especially that besides their benign character they 
are also chiral. Seddon prepared [bmim] with (S)-lactate anion via a simple anion exchange 
reaction between [bmim][Cl] and sodium lactate and applied such IL as a solvent for Diels-
Alder reaction.13 ILs with cations derived from (S)-(+)-lactic acid, IL XV,84 (2R,3R)-(+)-
tartaric acid, IL XVI85 and (1S,2S,5S)-(–)-myrtanol, IL XVII,85 were also prepared by 
alkylation of 1-methylimidazole with respective triflates or tosylates (Figures 1.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 21
                                        
COOEt
OTf N
COOEt
N
TfO
1-methylimidazole
 
XV 
OTs
OTs
O
O
OTs
1-methylimidazole
N
N
O
O
N
N
N
N
TsO
TsO
TsO
XVI
XVII
1-methylimidazole
 
Figure 1.14 ILs from renewable sources 
 
Bao et al. also prepared ILs with cations derived from (2R,3R)-(+)-tartaric acid, IL XVIII 
(Scheme 1.2), however via a lengthy six-step synthesis.86 In one of the steps, a nucleophilic 
substitution of tosylate by bromide, [bmim][Br] was used as solvent/reactant (Scheme 1.2). 
Very similar route was applied for and (S)-(+)-lactic acid derived IL and those ILs found 
application in asymmetric Michael addition.86 
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Scheme 1.2 Chiral IL derived from tartaric acid 
 
IL IV with anion consisting of chiral (S)-(−)-malic acid, complexed to borane, associated 
with methyltrioctylammonium cation (from commercially available Aliquat 336) was 
prepared by Leitner et al. and was very successfully applied to an aza-Baylis-Hillman 
reaction (Scheme 1.3, Figure 1.6).30 Chiral IL IV was synthesized by heating the mixture of 
boric acid, sodium hydroxide and malic acid with subsequent sodium ion exchange with 
methyltrioctylammonium chloride (Scheme 1.3).30  
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Scheme 1.3 Synthesis of chiral ILs with maloborate anion 
 
Significant number of amino acid derived ILs was also synthesized. Ohno et al. have 
prepared ILs with anions based on 20 natural amino acids (e.g. IL XIX) via simple 
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neutralization of aqueous solution of [emim][OH] with 20 unmodified natural amino acids 
(Figure 1.15). Amino acids ILs with various cations, such as ammonium, pyrolidinium, 
pyridinium were also synthesized.87,88 
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        XIX 
Figure 1.15 Preparation of ILs with amino acid anion 
 
Ammonium ILs XX with high melting points were prepared by acidification of amino acids 
and subsequent water evaporation.87,89 The same procedure carried out on esterified amino 
acids and followed by anion exchange reactions led to numerous RTILs XXI (Figure 
1.16).87,89 
H2N COOH H3N COOH
H3N COOR
HX
ROH HCl
MYCl
H3N COOR
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X
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X = Cl−, NO3−, BF4−, PF6−, CF3COO−, SO42− 
M = Ag+, Na+, K+, Li+ 
Y = NO3−, BF4−, PF6−, CH3COO−, NTf2−, SCN−, CH3CHOHCOO− 
Figure 1.16 Amino acid derived ILs 
 
Following the work of Davis et al. who prepared ILs with saccharinate and acesulphamate 
anions (e.g. [bmim][ace], [chol][sac]),8 synthesis of “fully green” ILs comprising of amino 
acids ester as a cation and nitrate XXII or saccharinate XXIII as anion was carried out by 
Kou et al. (Figure 1.17).72 ILs XXII and XXIII are oils at RT or solids with m.p. below 
100 oC and were applied in Diels-Alder reactions.72 
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Figure 1.17 ILs with nitrate and saccharinate anion 
 
Except the cases where amino acids were used in their unmodified form, they were also 
applied as substrates to construct heterocycle moiety of IL. Wasserscheid et al. carried out a 
three step synthesis of oxazoline IL, starting from L-valine and followed by an anion 
exchange process.90 In the first step L-valine was reduced to valinol and the obtained 
alcohol was reacted with sulphuric acid to yield oxazoline, which was further alkylated to 
afford IL XXIV. The oxazoline IL, however was unstable and was undergoing hydrolysis 
under aqueous conditions.90 Similar synthetic route, with one additional step of 
sulfurization with P2S5, allowed Gaumont et al. to prepare stable ILs, derivative of L-
phenylalanine.87 The 4,5-dihydrothiazolium IL was applied in Stetter reaction and 
Mukaiyama aldolization.87  
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R = Me, n-Pentyl        XXIV 
Scheme 1.4 Synthesis of oxazoline ILs 
 
Bao et al. prepared various N-substituted imidazole, starting from L-alanine, L-leucine and 
L-valine.91 Amino acids were first condensed with aldehydes under basic conditions to form 
an N-substituted imidazole ring. In the next step carboxylate group was esterified and 
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subsequently reduced with LiAlH4. Final ILs were obtained by N-alkylation of imidazole 
with bromoethane (e.g. XXV) (Scheme 1.5). These ILs have remarkably low melting points 
ranging from 5 oC to 16 oC.91  
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Scheme 1.5 Amino acid derived ILs 
 
L-Valine was also applied by Guillemin et al. as building block to prepare 4,5-
dihydroxyimidazole and subsequently an IL.92 First N-Boc-L-valine was reacted with t-
butylaniline. That step was followed by Boc-deprotection under acidic conditions and the 
subsequent reduction of the amide functional group. The obtained diamine was converted 
into hydrochloride salt and treated with trimethylorthoformate to afford 4,5-
dihydroimidazole, which was subsequently alkylated (e.g. IL XXVI)(Scheme 1.6). ILs 
XXVI poses chiral recognition ability.92 
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R = C8H17, (CH2)2OH, (CH2)3OH, (CH2)8OH, X = NTf2−, PF6−   
Scheme 1.6 4,5-Dihydroimidazolium ILs 
Luo et al. prepared IL I, highly efficient as catalysts, derived from the amino acid (S)-
proline (Scheme 1.7).22,93 In the first step carboxylic acid of proline was reduced to alcohol. 
Next amine was protected by Boc anhydride and alcohol was converted into a tosyl group, 
which subsequently was used to alkylate imidazole. Next imidazole was again alkylated 
with butyl bromide. In the last step amine was deprotected and an anion metathesis was 
carried out (Scheme 1.7). Proline derived ILs (e.g. IL I) proved to be excellent catalysts in 
Michael additions and aldol reactions (Figure 1.3).22,93 
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Scheme 1.7 Preparation of (S)-proline derived ILs 
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Except choline, chiral organic acids and amino acids, many other compounds, such as 
chiral alkohols, amines and even sugars found application in ILs synthesis. Wasserscheid et 
al. has prepared chiral ILs starting from (1R, 2S)-ephedrine, via methylation reactions, 
followed by anion exchange process.90 Ephedrinium IL XXVII (Figure 1.18) was 
successfully applied as stationary phase in gas chromatography. Vo-Thanh synthesised 
similar (1R, 2S)-N-methylephedrine derived IL V, which proved to be very effective in the 
Baylis-Hillman reaction (Figure 1.7).31  
HO
NMe3
NTf2
 
             XXVII 
Figure 1.18 (1R, 2S)-ephedrine derived ammonium IL 
 
Handy et al. prepared two classes of ILs based on (−)-nicotine.16 Pyridinium IL XXVIII 
was obtained by alkylation with hexyl iodide in acetonitrile. Pyrrolidinium IL XXIX was 
prepared by a similar reaction, however upon the prior protection of pyridine with benzyl 
bromide. Both of the ILs XXVIII and XXIX were used as acylation catalysts and after 
washings with a solution of sodium hydroxide they could be recycled (Figure 1.19).16  
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Figure 1.19 (−)-Nicotine derived ILs 
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Later on Scammells et al. have prepared ILs based on nicotinic acid via acid esterification 
and subsequent N-alkylation of pyridine.94 Those nicotinic ILs XXX were one of the first 
reported examples of biodegradable ILs (Figure 1.20). 
N
R
O
OBu
X
 
XXX 
R = Me, Bu      
X = I−, OctOSO3−, NTf2− 
Figure 1.20 Nicotnic acid derived ILs 
 
(1R,2S,5R)-(–)-Menthol derived ILs were obtained by alkylation of 1-methylimidazole with 
chloromethyl menthyl ether (e.g. IL XXXI, Figure 1.21).95,96 Those ILs were applied to 
enantioselective photodimerisation reactions. Ionic liquids with anions7,85 or cations,79 
derived from (1S)-(+)-camphorsulfonic acid were prepared and applied in Diels-Alder 
reactions.  
O Cl O NNR3
R3
R2
R1
Cl
 
            XXXI 
R1 = CH3, C2H5, R2 = CH3, C2H5, R3 = C2H5, i-C3H7, C4H9, C6H13, C7H15, C8H17, C9H19, C10H21, C11H23, C12H25, CH2Ph  
Figure 1.21 Menthol based ammonium ILs 
 
Sugars also found applications in IL synthesis, either upon convertion into ammonium salt 
or as a building block for preparation of substituted imidazole core. Chiappe et al. reported 
a preparation of ammonium and sulphonium ILs, starting from protected deoxy sugars after 
converting a primary hydroxy group into triflate and the subsequent alkylation of 
triethylamine or various sulfides.97 Handy et al. prepared 4-hydroxymethylene imidazolium 
IL XXXII, derivative of fructose.98 The first 4-hydroxymethylene imidazole was 
synthesised from fructose in one step, which was followed by alkylation of both nitrogen 
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atoms to yield IL (Scheme 1.8). This fructose derived IL XXXII, with various 
counteranions, found application as a solvent in a Heck reaction.98  
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Scheme 1.8 Preparation of fructose derived IL 
 
1.6 IL toxicity towards diverse organisms 
The broad range of possible applications of ILs, especially as solvents on the industrial 
scales, results in a high probability of environmental contamination.99 Therefore ILs' 
ecotoxicity, possible distribution and behavior in the environment, need to be well 
understood. Many of the known ILs are water soluble and in the event of release to the 
environment, a significant risk of water contamination exists.5 Moreover as shown by 
Gorman-Lewis and Fein, the IL [bmim][Cl] is minimally absorbed by common geological 
surfaces, thus spillage of ILs may result in facile transport to groundwater systems.100 
Recently, many studies regarding ILs’ toxicity have been carried out, involving various 
organisms and complexity levels (Figure 1.22). The effect of ILs on the enzymes, bacteria, 
fungi, algae, cell lines, plants, invertebrates and vertebrates have been investigated.5  
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Figure 1.22 Example of ILs studied. 
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1.6.1 Algae 
Cho et al. investigated the effect of ILs on algae Pseudokirchneriella subcapitata over a 96 
h exposure time. EC50 values representing the IL concentration, at 50 % growth inhibition, 
were determined. 1-Octyl-3-methylmidazolium bromide exhibited the most toxic effect (the 
lowest EC50 values) and 1-butyl-3-methylpyrrolidinium bromide was the least toxic: 
[omim][Br] (38.2 µM)> [hmim][Br] (0.29 mM)> [bmim][Br] (1.0 mM)> [pmim][Br] (1.4 
mM)> [tbuA][Br] (2.2 mM)> [bmpy][Br] (4.9 mM)> [bmpyrol][Br] (12.3 mM).101,102 In 
further tests, the authors established the effect of anion on IL toxicity. For a 96 h assay the 
following order was found: [bmim][SbF6] (135 µM)> [bmim][PF6] (1.3 mM)> 
[bmim][BF4] (2.5 mM)> [bmim][Br] (2.1 mM)> [bmim][OctOSO3] (2.2 mM)> [bmim][Cl] 
(2.9 mM). In addition, the effect of various inorganic salts (e.g. KSbF6; 162 µM, NaPF6; 1.7 
mM, NaBF4; 4.5 mM, NaCl; 125.9 mM) on the algae was tested.50 For 1-butyl-3-
methylimidazolium ILs, with anions of relatively low-toxic salts (e.g. NaCl or NaBF4), the 
toxic effect can be attributed to the cation. However, in case of ILs such as [bmim][SbF6], 
the anions of highly toxic salts determine overall IL toxicity. Polar organic solvents were 
also tested and were found to be less toxic than the majority of the ILs screened (methanol; 
708 mM, 2-propanol; 195 mM, DMF; 23 mM).50  
Wells and Coombe tested a range of ILs against the same algae (over 48 h), however, much 
stronger toxic effects were established; which might be due to the different protocols 
applied. The following EC50 values and toxicty order were found: [C12mim][Cl] (0.004 
µM)> [C16mim][Cl] (0.012 µM)> [C18mim][Cl] (0.035 µM)> [bmim][PF6] (158 µM)> 
[bpy][Cl] (170 µM)> [bmim][Cl] (220 µM).103 Pretti et al. tested the toxicity of various ILs  
against algae P. subcapitata and the following order was found: Ammoeng 130 (1.4 µM)> 
[bpy][NTf2] (16.9 µM)> [bmim][NTf2] (63.2 µM)> [chol][PF6] (151.6 µM). Ventura et al. 
tested the toxicity of [pmim][NTf2] towards freshwater microalgae P. subcapitata and C. 
vulgaris and obtained EC50 values of 40 µM and 28 µM, respectively.105 Stolte and Matzke 
tested the effects of ILs towards algae Scenedesmus vacuolatus and identified the following 
toxicity order: [C10mim][Cl] (0.0003 µM)> [omim][Cl] (0.002 µM)> [C14mim][Cl] (0.003 
µM)> [C16/C18mim][Cl] (0.01 µM)> [hmim][Cl] (1.2 µM)> [bmim][Cl] (180 µM)> 
[bpy][Cl] (390 µM)> [emim][Cl] (603 µM)> [bmpip][Cl] (1.9 mM)> [mpyrol][Cl] (2.3 
mM)> [bedmA][Cl], [bmmor][Cl] (10.0 mM).106 Toxicity order was also established for 1-
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butyl-3-methylimidazolium ILs with various anions: [bmim][NTf2] (50µM)> 
[bmim][OctOSO3] (60 µM) > [bmim][BF4] (130 µM)> [bmim][Cl] (140 µM).107  
 
1.6.2 Invertebrates 
Wells and Coombe investigated the toxicity of ILs towards Daphnia magna upon 48 h 
exposure. EC50 values (concentration at which 50 % of the organisms are either 
immobilized or killed) were determined and the following toxicity order was found: 
[C18mim][Cl] (0.005 µM)> [C16mim][Cl] (0.01 µM)> [C12mim][Cl] (0.015 µM)> 
[bmim][Cl] (37 µM)> [bmim][PF6] (84 µM)> [bPy][Cl] (0.12 mM).103  
Pretti et al. found that the toxicity of ILs towards D. magna decreases in the following 
order: Ammoeng 130 (0.9 µM)> [bpy][NTf2] (4.2 µM)> [bmim][NTf2] (45.1 µM)> 
[bmpy][NTf2] (88.0 µM).104 Nockemann et al. determined EC50 values for 48 h exposure of 
D. magna to choline ILs and found relatively low toxicities for choline saccharinate (4.3 
mM) and choline acesulfamate (5.2 mM).108 Luo et al. found that the presence of 
[omim][Br] had negative effect on reproductivity and development of D. magna. The 
authors also determined LC50 values, the concentration at which lethal effect is observed, 
for 24 and 48 h of exposure to be of 7.2 µM and of 3.4 µM, respectively.109 The same LC50 
value after 48 h exposure were determined by Yu et al. for [omim][Br], and the toxicity 
order for several other ILs were established: [C12mim][Br] (0.15 µM)> [C10mim][Br] (0.5 
µM)> [omim][Br] (3.5 µM)> [hmim][Br] (11.4 µM)> [bmim][Br] (70.0 µM).110  
Bernot et al. determined the anion infuence on ILs toxicity towards D. magna over 48 h and 
found decreasing toxicity in following order: [bmim][Br] (37 µM)> [bmim][BF4] (47 µM)> 
[bmim][PF6] (70 µM)> [bmim][Cl] (85 µM). D. magna was more tolerant to inorganic 
salts: NaBF4 (43.4 mM)> NaPF6 (55.6 mM). The authors observed a negative effect of ILs 
on the reproductivity of the tested organisms.111 Costello et al. investigated the effect of ILs 
on zebra mussels (Dreissena polymorpha); LC50 values and toxicity order were established, 
for methylimidazolium ILs: [omim][Br]> (79 µM)> [hmim][Br] (0.43 mM)> bmim][Br] 
(5.9 mM) and for pyridinium ILs: [ompy][Br] (75 µM)> [hmpy][Br] (0.56 mM)> 
[bmpy][Br] (3.9 mM).112 Bernot et al. tested toxicity of ILs towards the freshwater snail 
Physa acuta. Toxicity rank and LC50 values were determined: [ompy][Br] (3.5 µM)> 
[omim][Br] (29.8 µM)> [hmim][Br] (0.23 mM)> [bmim][PF6] (0.43 mM)> [hmpy][Br] 
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(0.87 mM)> [bmim][Br] (1.0 mM)> [bmpy][Br] (1.4 mM)> [tbuA][Br] (1.8 mM). It was 
found that the snails’ movement and grazing was impaired upon IL exposure.113   
 
1.6.3 Vertebrates 
Li et al. investigated the 96 h toxicity of [omim][[Br] towards embryonic frog Rana 
nigromaculata. Organism mortality was found to be dependent on the embroynic 
development stage, and LD50 values were found to be in the range of 0.15 – 0.31 mM. 
Morphological malformations were observed in the tested organisms.114 Bailey et al. 
reported adverse effects of ILs on mice upon exposure to [bmim][Cl] (113-225 mg kg−1d−1), 
including malformation, dose dependent morbidity and prenatal mortality.115 The toxic 
effect of [bmim][Cl] towards mice and rats was studied by Landry et al. Acute oral LD50 
was found to be 550 mg/kg. Upon dermal exposure of the animals towards ILs, skin and 
eye irritation occurred, however, the toxic effect was found to be dependent on the solvent 
used for administration.116 Sipes et al. investigated [bmim][Cl] and [bpy][Cl] metabolism in 
mice and rats, upon sub-lethal dose administration. Both ILs were quickly absorbed by the 
animals, even after dermal exposure. Urinary excretion of the parent ILs was a major 
elimination path, and the rate of removal was found to be dependent on route of 
application. Tissue disposition and metabolism were negligible.117,118  
 
1.6.4 IL toxicity patterns 
On each of the tested levels very similar toxicity patterns were observed. The most typical 
trend, valid for all of the organisms tested, is of increased toxicity with longer alkyl chain at 
the heterocycle core.5,101,110-113 In some cases, however, a cutoff effect was observed, where 
further increase in alkyl chain length did not increased toxicity.103,106 
In general, ILs with highly liphophilic anions (e.g. NTf2−, PF6−) were more toxic than 
hydrophilic anions (halide, BF4−).50,107 However type of anion present in ILs was shown to 
be less significant than cation’s structure. Studies demonstrating liphophilicity and toxicity 
correlation have been published.106,119 In some cases ILs derived from aromatic amines 
were more toxic than ILs derived from nonaromatic compounds.106,108 
The mechanism of ILs toxicity is not known, but few potential modes of action, including 
disruption of cell membrane, enzyme inhibition and structural DNA damage have been 
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proposed.113,120 The long alkyl chains of corresponding ILs may intercalate into 
phospholipid bilayer, which is a major component of biological membranes. That may lead 
to membrane-bound protein disruption and subsequently to cell narcosis.120,121 IL induced 
superoxide radicals and subsequent peroxidation of membrane lipids was also suggested as 
mechanism of cell damage by Yu et al.110 Several enzymes, including acetylcholinesterase, 
AMP deaminase and antioxidant enzymes were shown to be effected by ILs 
presence.5,107,122    
1.7 ILs Biodegradation 
The importance of biodegradability is highlighted as one of the 12 principles of Green 
chemistry: “Chemical products should be designed so that at the end of their function they 
do not persist in the environment and break down into innocuous degradation products.”58 
Though present at non-toxic concentrations, persistent non-biodegradable chemicals may 
still accumulate in organisms, resulting in toxic or chronic toxic effects.123  Therefore, not 
only should toxicity be considered during ecotoxicological assessment or the design of new 
chemicals, but also biodegradability. 
Biodegradation can be defined as a natural process involving the collective effort of 
different microorganisms breaking down complex organic molecules into biomass or 
inorganic compounds, such as carbon dioxide and water. 12 Primary biodegradation refers to 
the alteration in the chemical structure of a substance, brought about by biological action, 
resulting in the loss of a specific property of that substance.124,125 Ultimate biodegradation 
represents the level of degradation achieved when the test compound is totally utilized by 
microorganisms resulting in the production of carbon dioxide, water, mineral salts and new 
microbial cellular constituents (biomass).124,125 Biodegradation of an organic compound 
arises from either growth or cometabolism processes.126 In growth processes, an organic 
compound is used as a sole source of energy, and is ultimately mineralized. For this to be 
possible the compound must first be converted into one of the intermediates of the central 
metabolism system. After initial oxidation, the compound is degraded by the peripheral 
system into the respective intermediates, which are finally converted into biomass. The 
process of cometabolism is defined as the metabolism of an organic compound in the 
presence of a growth substrate which is used as the primary energy source. In this manner, 
an organic compound is oxidized, without any nutritional benefits to the microorganism. 
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However, the resulting product may still function as a substrate for other organisms in a 
mixed culture environment. 
Many bacteria and fungi strains have the ability to biodegradate organic pollutants, 
however, only mixed microbial communities have potential to degrade complex mixtures of 
organic compounds. Single bacteria can degrade only a limited number of organic 
compounds. The most versatile species are able to use ~ 100 different organic compounds. 
Some of the the most efficient degradative organisms are the gram-negative rods 
Pseudomonas putida and fluorescens; the Comamonas species Burkholderia and 
Xanthomonas; and the gram-positive species Rhodococci and Coryneform.126 In the 
biodegradation process two classes of enzymes, oxidoreductases and hydrolases, are 
employed; the former of which are responsible for the key processes of oxidation. Among 
oxidoreductases, the enzymes oxygenases, laccases and peroxidases play the most 
significant role.127,128        
Biodegradability of an organic compound depends on two main factors; namely, the 
compound's structure and environmental conditions. Considering these two factors, 
potential reasons for compound recalcitrance to biodegradation were identified (Table 
1.3).129,130 
Table 1.3 Possible reason for resistance of a substance to microbial degradation129,130 
 
 
 
 
 
 
 
 
 
 
 
 
 
Environment: 
> Appropriate microorganisms do not exist or are not present in the environment 
> There are inadequate nutrients for the microbial population 
> The temperature, pH or pO2 is too low or too high; ionic conditions are unsuitable 
> Concentration of the substrate is too high or too low 
> The substrate is adsorbed or covalently attached to clays, etc., or is physically inaccessible 
> The substrate is not accessible to attack because is too large and/or insoluble  
Molecule: 
> The substrate: 
─ is not transported into the cell 
─ is not a substrate for available enzymes 
─ is not an inducer for appropriate enzymes or transport systems 
─ does not give a rise to products that can integrate into normal metabolism 
─ is converted into products that are toxic or interfere with normal metabolism 
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Focusing on compound's structure, Boethling et al. also pointed out which structural 
features are unfavorable and should be avoided in the design of biodegradable compounds, 
the so called “Rules of Thumb”.129 The structural patterns which may cause compound’s 
recalcitrance include: halogens, especially chlorine and fluorine and especially if there are 
more than three in a small molecule; chain branching if extensive (quaternary carbon is 
especially problematic); tertiary amine, nitro, nitroso, azo, and arylamino groups; 
polycyclic residues (such as in polycyclic aromatic hydrocarbons), especially with more 
than three fused rings; heterocyclic residues, for example, imidazole; and aliphatic ether 
bonds (except in ethoxylates).129 
Biodegradation of a compound can be evaluated via number of available standard methods. 
Depending on the method, the parameters measured may include: the dissolved organic 
carbon (Die-Away test, 301 A); the dissolved oxygen (Closed bottle test: 301 D); the CO2 
evolution (CO2 evolution test: 301 B, CO2 headspace test: ISO 14593), and the oxygen 
consumption (Manometric respirometry test: 301 F, MITI test: 301 C). The level of primary 
biodegradation is determined by the decrease of concentration of the parent compound.124   
The importance of information regarding the biodegradation of ionic liquids was 
highlighted by a recent theoretical study, which suggested that the cation 
methylimidazolium is unlikely to biodegrade and it may persist in the environment.131 The 
common 1,3-dialkylimidazolium ILs were shown to be not biodegradable in standard tests, 
as reported by Gathergood and Scammells ([bmim][X], X = Br−, BF4−, PF6−, NTf2−)132,133, 
by Wells and Coombe ([bmim][Cl], [bmim][PF6], [C12mim][Cl], [C16mim][Cl], 
[C18mim][Cl])103, by Docherty and Kulpa ([bmim][Br])134, by Stolte ([emim][Cl], 
[bmim][Cl])135 and by Romero ([bmim][Cl], [hmim][X], [omim][X], X = Cl−, PF6−)136. 1-
methylimidazole was also shown to be recalcitrant to biodegradation.135 However the ILs 
[hmim][Br] and [omim][Br], which posses longer alkyl chains, showed partial 
biodegradation (54 % and 41 % respectively)134 and two other studies99,135  reported 100 % 
of primary biodegradation of [omim][Cl] (complete removal of parent compound).  
The presence of the anion octylsulphate in the structure ILs, and introduction of various 
functional groups such as esters, hydroxyl or carboxyl groups, was shown to be beneficial 
for IL biodegradability.132,133,135,137   
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In contrast with the early biodegradation results, Esquivel-Viveros et al. have shown 
significant primary biodegradation of [bmim][PF6] by the fungi strain Fusarium.138 Pham et 
al. indicated products of [bmim][Br] primary biodegradation by activated sludge, however, 
the level of degradation was not revealed.140 Abrusci et al. reported high levels of 
biodegradation (32 - 90 %) of various 1,3-dialkylimidazolium ILs ([emim][X], [bmim][X], 
[hmim][X], [omim][X], X = Br−, Cl− BF4−, PF6−, NTf2−) by Sphingomonas paucimobilis, 
although at an unusualy high temperature (45 oC).140 Only one species of organism was 
applied in the studies of Esquivel-Viveros and Abrusci, reflecting a limited representation 
of the behavior ILs in the environment.138,140 Aside from the report of Abrusci, suggesting 
heterocyclic core biodegradation,140 there are no other studies or analytical data supporting 
methylimidazolium cation biodegradation.  
Pyridinium ILs with short alkyl chain are recalcitrant to biodegradation (e.g. [epy][Cl], 
[bpy][Cl], [bdmpy][Cl]135, [bpy][Cl]103, [bmpy][Br]134. In general, however, pyridinium ILs 
showed more facile biodegradation. A study by Docherty and Kulpa showed that 
[ompy][Br] and [hmpy][Br] were completely mineralized in DOC tests, although only after 
slightly extended time period in the latter case.134 Grabinska-Sota and Kalka demonstrated 
partial biodegradation of pyridinium ILs, including [C12py][Cl].141 In both of these studies, 
removal of pyridinium ring during the test was confirmed by 1H NMR data.134,141 Zhang et 
al. demonstrated biodegradation of [epy][BF4] and [epy][CF3COO] by a single 
microorganism strain and identified the respective products.142,143  According to the study 
biodegradation of only the alkyl chain occurred in the presence of Pseudomonas 
fluorescens143 and Corynebacterium species were able to also degrade pyridinium ring142 
(Scheme 1.9). The proposed biodegradation pathway is in agreement with one of the well-
known decomposition pathways for pyridine containing compounds.144 
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Scheme 1.9 Proposed IL biodegradation pathway.144 
 
1.8 Conclusions  
An overview of various ILs properties has been presented. ILs possess very interesting 
properties and an impressive range of applications in many areas of chemistry. However, 
due to their occasionally high toxicity, frequently low biodegradability, and often multistep, 
syntheses, ILs (especially “second generation” examples) cannot yet be viewed as “green 
solvents”. Accumulated toxicity data show that ILs are more toxic than common organic 
solvents and ILs with long alkyl chains can even exhibit toxic effects at nM concentrations. 
Only a few of the ILs tested to date have been shown to pass OECD tests of 
biodegradability. Therefore, especially in the case of 1,3-dialkylimidazolium ILs, a risk of 
becoming persistent organic pollutants exists. In second generation ILs there is also a 
dichotomy between toxicity and biodegradation requirements, since ILs with short alkyl 
chains exhibit the lowest toxicity, but are most recalcitrant towards biodegradation. 
Conversely, ILs with alkyl chains of at least eight carbons, which are biodegradable, exhibit 
the highest toxicity towards all of the organisms tested. However, a new family of ILs 
which are derived from natural compounds have recently emerged. These naturally-derived 
ILs (e.g. from choline) have the potential to combine low toxicity and biodegradability and 
could offer a solution to the environmental concerns over ILs. It is expected that naturally-
derived ILs, from biorenewable sources, designed according to the principles of green 
chemistry will become increasingly important over the next decade.    
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2.1 Aim of the study 
The aim of this study was to prepare a library of novel chiral ILs of low toxicity and good 
biodegradability, which would find applications in asymmetric synthesis. Our strategy was 
to prepare pyridinium and methylimidazolium ILs from simple disubstituted mandelic acids 
(e.g. 3,4-dimethoxy, 3,4-methylenedioxy- and 3,4-dihydroxymandelic acid), via a direct 
and scalable synthetic route. Two classes of chiral IL were identified as targets. Firstly, ILs 
with a heterocycle (pyridine or 1-methylimidazole) linked directly to the chiral centre 
(Figure 2.1) and secondly those with an acetoxy linker between the chiral centre and the 
heterocycle (Figure 2.2). After racemic synthesis of the ILs, methods of obtaining 
enantiomerically enriched ILs were investigated, including diastereomer separation of 
chiral ester derivatives (with subsequent hydrolysis and re-esterification), enzymatic 
hydrolysis of esters, and heterocycle alkylation via chiral auxiliary methods. Scaling up the 
synthesis of both achiral and chiral ILs with an ultimate view to applications in industrial 
hydrogenation reactions was also investigated. 
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Figure 2.1 Example of IL with a heterocycle            Figure 2.2 Example of IL with an     
at the chiral centre                        acetoxy linker 
                       
2.2 Synthesis of ILs without a linker from (RS)-3,4-dimethoxy- and (RS)-3,4-
methylenedioxymandelic acids 
2.2.1 Synthetic Strategy 
A small library of methylimidazolium and pyridinium ILs, derived from 3,4-dimethoxy-, 
3,4-methylenedioxy- and 3,4-dihydroxymandelic acids, containing three representative 
counteranion types (halide [Cl− or Br−], OctOSO3−, NTf2− , Figure 2.3) was prepared. All of 
the ILs were synthesised starting from 1,2-disubstituted benzenes and glyoxylic acid. 
Similar synthetic method was used for the preparation of 3,4-dimethoxy- and 3,4-
methylenedioxymandelic acid derived ILs 1(a–c)–6(a–c,d), while a slightly different route, 
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involving a “one pot” reaction was used in the case of ILs 7a and 8a (based on 3,4-
dihydroxymandelic acid, Figure 2.3).   
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     6d Br−  
Figure 2.3 Library of ILs with a heterocycle directly linked to the chiral centre 
 
The first step in the synthesis was an acid catalysed electrophilic substitution reaction 
between 1,2-dimethoxybenzene or 1,2-methylenedioxybenzene and glyoxylic acid. The 
resulting disubstituted mandelic acids 9 and 10 (Figure 2.4) were esterified 11–13 (Figure 
2.5) and then chlorinated or brominated α- to the carbonyl group 14–17 (Figure 2.6). The 
chlorinated or brominated compounds were subsequently used to N-alkylate 1-
methylimidazole or pyridine to form an ionic liquid 1a–8a, 6d (Figure 2.3). In each case an 
additional step of anion metathesis was required in order to obtain the corresponding 
octylsulfate and bistriflimide ILs 1b–6b, and 1c–6c (Figure 2.3, Scheme 2.1). ILs based on 
3,4-dihydroxymandelic acid (18), were prepared via an alternative synthesis in which 
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methyl 3,4-dihydroxymandelate (19) was converted into ILs 7a and 8a, without isolation of 
the intermediate chloride (Figure 2.7) .   
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Figure 2.4 3,4-Dimethoxy- and 3,4-methylenedioxymandelic acids, (9) and (10) 
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Figure 2.5 3,4-Dimethoxy- and 3,4-methylenedioxymandelic acids esters 11–13 
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Figure 2.6 α-Chlorinated and brominated esters 14–17 
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Figure 2.7 3,4-Dihydroxymandelic acid (18) and methyl ester (19) 
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Scheme 2.1 Synthetic route to ILs 1a and 1b 
 
2.2.2 (RS)-3,4-Dimethoxy- and (RS)-3,4-methylenedioxymandelic acids 
Synthesis of racemic 3,4-dimethoxymandelic acid (9) was carried out via electrophilic 
aromatic substitution of 1,2-dimethoxybenzene by glyoxylic acid, in the presence of 
catalytic concentrated sulfuric acid (Figure 2.8). The literature procedure1 was modified by 
initially stirring the glyoxylic acid and sulfuric acid for 10 min. before commencing 
dropwise addition of 1,2-dimethoxybenzene over 70 min. at between −10 oC and −4 oC. A 
purification step was also introduced.  
MeO
OMe
OO
OH
H2SO4
−4 oC
+
63 % MeO
OMe
OH
O
OH
 
                     9 
Figure 2.8 Preparation of (RS)-3,4-dimethoxymandelic acid 9 
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Purification of the crude product was required to remove unreacted 1,2-dimethoxybenzene 
and 1,1-bis(3,4-dimethoxyphenyl)acetic acid (Figure 2.9), the by-product of a second 
electrophilic aromatic substitution at glyoxylic acid.1 Toluene washes of the aqueous 
reaction phase, followed by extraction with ethyl acetate were necessary to purify the 
product. The purification was facilitated by carrying out the extraction at 85 oC, which 
improved phase separation and decreased the volume of toluene required. After drying the 
product in vacuo a yellow oil was obtained, which crystallised on standing. Alternatively, 
the product could be isolated as a pale yellow solid after removing traces of water by 
azeotroping the product with ten portions of toluene. By this method, 9 was obtained in a 
moderate yield of 63 % (Figure 2.8). 
OMe
OHO
OMe
MeO
OMe
 
Figure 2.9 By-product in the synthesis of (RS)-3,4-dimethoxymandelic acid1 
 
Formation of 9, via electrophilic substitution at para position of 1,2-dimethoxybenzene 
occurred due to the ortho/para directing effect of the methoxy groups.2 Although ortho-
substitution would also be possible, it is disfavored by steric hindrance and thus only the 
para product 9 was observed. Substitution at the C3, C5 and C6 positions (Figure 2.10) of 
the aromatic ring was confirmed by 1H NMR, (Figure 2.11) in which long-range coupling 
of the aromatic protons, resulting in characteristic splitting patterns was observed. Three 
aromatic protons were observed in the spectrum, with two of the signals appearing as 
doublets and one as a doublet of doublets. The signal of proton H4 is a doublet with a small 
coupling constant of 2.0 Hz, resulting from a meta coupling with H8 (Figure 2.11). 
Similarly, proton H7 appears as a doublet, but with a larger coupling constant, J = 8.2 Hz, 
resulting from an ortho coupling with H8. The signal observed for H8 is a doublet of 
doublets with J = 8.2 Hz and 2.0 Hz, from ortho coupling to H7 and meta coupling to H4.  
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9
 
Figure 2.10 Numbering system for (RS)-3,4-dimethoxymandelic acid (9) 
 
Figure 2.11 Signal splitting for aromatic protons in the 1H NMR spectrum of (RS)-3,4-
dimethoxymandelic acid (9) 
 
3,4-Methylenedioxymandelic acid (10) was prepared in 76 % yield, again by the 
reaction of 1,2-methylenedioxybenzene with glyoxylic acid, catalysed by concentrated 
sulfuric acid (Figure 2.12).   
OO
OH
H2SO4
−10 oC
+
O
O
76%
OH
O
OH
O
O
 
            10 
Figure 2.12 Electrophilic substitution of 1,2-methylenedioxybenzene with glyoxylic acid. 
 
Preparation of 10 was carried out by combining two reported procedures, one for the 
reaction3 and one for the work up.4 The synthesis of 10 was more robust than that of 9 and 
the crude product was readily obtained as a crystalline material. The same extraction used 
for 9, followed by recrystallisation from chloroform:ethanol (50:11)5 proved to be an 
effective means of purification.     
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In common with 3,4-dimethoxymandelic acid (9), product formation occurred via 
electrophilic substitution of 1,2-methylenedioxybenzene with glyoxylic acid. Substitution 
para to the methylenedioxy group was confirmed by 1H NMR.  
 
2.2.3 Esters of (RS)-3,4-dimethoxy- and (RS)-3,4-methylenedioxymandelic acid 
Methyl and butyl esters of 3,4-dimethoxymandelic acid (11) and (12) and the methyl ester 
of 3,4-methylenedioxymandelic acid (13) were formed via Fischer esterification in the 
presence of thionyl chloride in either methanol or butanol, at room temperature (Figure 
2.13). Reaction of thionyl chloride with the solvent alcohol generates HCl in situ and acid 
catalyzed esterification occurs.  
MeO
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       9          11 
Figure 2.13 Preparation of (RS)-methyl 3,4-dimethoxymandelate (11) 
 
Syntheses of 11, 12 and 13 were carried out via a modification of the reported procedure.6 
The original procedure for the synthesis of esters of mandelic acid, such as 11 and 12 
required refluxing of an alcoholic solution of mandelic acid in the presence of thionyl 
chloride. However, when the same conditions were used for 3,4-dimethoxymandelic acid 9, 
ether formation at the benzylic position accompanied the desired esterification (Figure 
2.14). Hence, during the synthesis of 11, methyl 2-(3,4-dimethoxyphenyl)-2-
methoxyacetate (20) was obtained as the major product.  
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        9     11                                  20 
      Figure 2.14 Fischer esterification of 9 under reflux in methanol 
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Similarly, esterification in the presence of butanol afforded butyl 2-(3,4-dimethoxyphenyl)-
2-butoxyacetate as the major product (Figure 2.15). Analysis of the crude reaction mixture 
by 1H NMR spectroscopy indicated a 2:1 ratio of by-product to the desired ester 12.  
MeO
OMe
OBu
COOBu
 
Figure 2.15 (RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-butoxyacetate 
 
Formation of by-products with the ether bonds can be explained by the ease of formation of 
a benzylic carbocation, mesomerically stabilized by one of the two electron-donating 
methoxy substituents on the ring (Schemes 2.2, 2.3). The benzylic cation may undergo 
nucleophilic attack by methanol, leading to etheryfication. 
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Scheme 2.2 Formation of by-product 20 during esterification 
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Scheme 2.3 Carbocation stabilization by an electron donating para-methoxy group 
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In order to minimize ether formation, the reaction was carried out at RT and the quantity of 
thionyl chloride reduced to 1.5 equivalents, affording the desired esters 11 and 12 as major 
products. Methyl 3,4-dimethoxymandelate (11) was purified by column chromatography 
and isolated as a yellow oil in 69 % yield. Crude butyl 3,4-dimethoxymandelate (12) was 
azeotroped ten times with hexane to remove butanol and then purified by column 
chromatography, again resulting in isolation of a yellow oil, but in 80 % yield. 
In the case of methyl methylenedioxymandelate (13), only 0.5 equivalents of thionyl 
chloride were necessary for completion of the reaction and product 13 was obtained in 
excellent yield (93 %) as white crystals without the need for further purification (Figure 
2.16). 
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       10              13 
Figure 2.16 Esterification of (RS) 3,4-methylenedioxymandelate (10) 
 
2.2.4 α-Halogenated esters derived from (RS)-3,4-dimethoxy- and (RS)-3,4-
methylenedioxymandelic acid 
α-Chlorinated or brominated esters 14–17 were synthesised from the respective α-
hydroxyesters 11, 12 and 13  using thionyl chloride or thionyl bromide as the halogenating 
agent, according to a general procedure (Figure 2.17).7 
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                                                          11            14 
Figure 2.17 Chlorination of (RS)-methyl 3,4-dimethoxymandelate (11) 
 
Methyl 2-chloro-(3,4-dimethoxyphenyl)acetate (14) was obtained as a colourless oil in 58 
% yield after column chromatography. The only significant by-product of the reaction, 
triethylammonium chloride, was removed by water washing of the reaction mixture. A high 
purity of α-chloroester 14 was essential for synthesis of the final IL and chromatography 
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was necessary to remove traces of minor impurities present. Product 14 was obtained in 
moderate yield (58 %), we postulate as a result of hydrolysis of 14 to the starting material, 
methyl 3,4-dimethoxymandelate (11) during purification. 
Formation of 14 probably occurs via an alkyl chlorosulfite intermediate, as does the  
chlorination of benzylic alcohols with thionyl chloride in the presence of pyridine (Figure 
2.18).8 However, the latter reaction is an SN2 type process, with inversion of configuration,8 
while in the case of 14, an SN1 mechanism is highly likely, due to benzylic cation 
stabilisation.  
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           11               14 
Figure 2.18 SN2 mechanism for chlorination of 11 
 
Formation of 14 was confirmed by NMR spectroscopy and GCMS analysis. LCMS 
analysis was not possible due to rapid hydrolysis of 14 to 11. However, the molecular ion 
for 14 was observable by GCMS.  The same general procedure and purification steps were 
used to synthesize butyl 2-chloro-(3,4-dimethoxyphenyl)acetate (15), methyl 2-chloro-2-
(3,4-methylenedioxyphenyl) acetate (16) and methyl 2-bromo-2-(3,4-
methylenedioxyphenyl) acetate (17), for which yields of 78 %, 65 % and 68 %, respectively 
were obtained (Figure 2.19).   
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                                             15                                  16                                  17 
Figure 2.19 Structures of α-halogenated esters 
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2.2.5 Methylimidazolium ILs with halide counteranion 
Ionic liquids with chloride counteranions (1a, 3a and 5a) were synthesised via N-alkylation 
of 1-methylimidazole by the respective α-chlorinated esters (14, 15 or 16) in diethyl ether 
(Figure 2.20).  
MeO
OMe
Cl
O
OMe diethyl ether
−15 oC, N2 atm.
1-methylimidazole
MeO
OMe
N
O
OMe
N
Cl
89 %
 
          14                   1a 
Figure 2.20 N-alkylation of 1-methylimidazole by 14 
 
 
Synthesis of 1a was carried out according to the general procedure,6,13 using a slight excess 
of 2-chloro-2-(3,4-dimethoxyphenyl)acetate (14) (1.2 equivalents). Excess 14 was required 
because the use of stoichiometric chloride resulted in an incomplete reaction, in which IL 
1a was contaminated with 1-methylimidazole, which proved difficult to remove.  
After stirring for 24 h, IL 1a precipitated as a white powder, which was collected by 
filtration. Further concentration of the filtrate afforded more IL, indicating that either an 
increase in temperature or a higher concentration might improve the efficiency of the 
reaction. Further purification of the IL was carried out by dissolving 1a in dichloromethane 
and then extracting with water. Ionic liquid 1a was hygroscopic, and either repeated co-
evaporation with chloroform at room temperature or drying under high vacuum for 48 h 
was necessary to remove traces of water. When dry, IL 1a was isolated as a white 
crystalline powder in 89 % yield, with respect to 1-methylimidazole. However, on standing 
at RT over the time IL 1a showed additional peaks in the 1H NMR indicating 
decomposition, thus a stability study was carried out, as described in Chapter 3.0 (Section 
3.2).  
Ionic liquid synthesis is a Menschutkin reaction,9 whereby two neutral species react with 
each other to form an ionic product (Figure 2.21). Although this quaternisation at nitrogen 
is typically an SN2 process,9,10,11 according to a study by Yoh et al., highly activated 
benzylic bromides react via simultaneous SN1 and SN2 mechanisms.12  
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           14                       1a 
Figure 2.21 Formation of IL 1a9 
 
IL 1a was characterized by spectroscopic data, with 1H and 13C assignments based on 
COSY, DEPT, HMQC and HMBC experiments.17 In the 1H NMR spectrum of IL 1a, 
(Figure 2.22) the most deshielded signal was assigned to H12, from the methine group 
between the two imidazolium nitrogen atoms (Figure 2.23).  The signal for H12 varied in 
chemical shift from 10.5 to 11.0 ppm, depending on both IL concentration, and the water 
content of the sample. In CDCl3, this signal provides a good indication of the type of 
counteranion present in the IL, shifting to 9.3–9.6 ppm in case of OctOSO3− ILs and to 8.8–
8.9 ppm in case of NTf2− ILs. Proton H12 gives a singlet signal in the spectrum, but each of 
remaining two methylimidazolium protons (H13 and H14) are split into triplets, with the 
same coupling constants (J value of 1.6 Hz) (Figure 2.24). Closer examination of H12 
singlet reveals that line width corresponds to the width of triplets (like H13 or H14).18 The 
splitting pattern is a result of coupling between all of the aromatic protons in the 
methylimidazolium ring. Benzylic proton H2 is represented by a singlet in the aromatic 
range (7.42 ppm) (Figure 2.24). Also this signal H2 is sensitive to the type of counteranion 
present and shifts to 6.6 ppm in case of OctOSO3− anion and to 6.3-6.4 ppm in case of 
NTf2− anion. Aromatic protons in the 3,4-dimethoxyphenyl ring also couple to each other, 
resulting in two doublets for H4 (J = 2.2 Hz) and H7 (J = 8.4 Hz) and a doublet of doublets 
for H8 (J = 2.2, 8.4 Hz, Figure 2.24). The four methyl groups, H9, H10, H11 and H15 
appear as singlets between 3.8 and 4.0 ppm (Figure 2.23). In the 13C and DEPT spectra all 
signals were assigned to the respective carbon atoms (Figure 2.25). The DEPT spectrum 
(Figure 2.26) confirmed the absence of CH2 groups, as all the signals pointed in the same 
direction (upwards, representing CH and CH3 groups), whilst methylene groups would have 
pointed downwards. The quaternary carbon signals, including carbonyl carbon (C1, C3, C5, 
C6) are suppressed in the spectrum.  
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Figure 2.22 Structure of IL 1a 
 
Figure 2.23 1H NMR spectrum of IL 1a in CDCl3 
 
 
Figure 2.24 Aromatic region of the 1H NMR spectrum of IL 1a 
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Figure 2.25 13C NMR spectrum of IL 1a in CDCl3 
 
 
Figure 2.26 DEPT spectrum of IL 1a in CDCl3 
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Butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetate, chloride salt 3a was 
prepared via alkylation of 1-methylimidazole by 15, according to the general procedure 
(Figure 2.27).6,13 Upon stirring for 24 hours product 3a as a white powder was collected by 
filtration. The remainder of the organic phase was refluxed for 4 h in order to ensure that 
the reaction had gone to completion. A further amount of precipitate was obtained, and both 
solids were combined. Finally, product 3a was washed with diethyl ether to remove traces 
of starting material. A moderate yield of 82 % was obtained.  
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       15            3a 
         Figure 2.27 Preparation of chloride IL 3a  
 
Methyl 2-(3,4-methylenedioxyphenyl)-2-(3-methylimidazolium) acetate, chloride salt 5a 
was prepared by reaction of methyl 2-chloro-2-(3,4-methylenedioxyphenyl) acetate (16) 
with 1-methylimidazole in diethyl ether (Figure 2.28). After stirring the reaction mixture 
for 48 h the starting material 16 was still present and thus the reaction was refluxed for a 
further 24 h. This proved sufficient for completion of the reaction and the precipitated 
product 5a was collected in nearly quantitative yield (96 %) after diethyl ether washings. 
Ionic liquid 5a was hygroscopic and at least 48 h drying under high vacuum was necessary 
to remove traces of water.  
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            16            5a 
    Figure 2.28 Preparation of IL 5a 
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2.2.6 Pyridinium ILs with halide counteranion 
Methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt (2a) was prepared via 
N-alkylation of pyridine by methyl 2-chloro-2-(3,4-dimethoxyphenyl)acetate (14), 
according to a modification of the usual procedure (Figure 2.29).6,14 Completion of the 
reaction at room temperature was not possible within 48 h and thus refluxing of the reaction 
mixture was attempted. Refluxing in diethyl ether, THF or toluene was investigated, but no 
improvement in conversion was recorded. However, the use of an excess of pyridine (1.8–
2.5 equivalents) and refluxing for 24 h in diethyl ether proved sufficient to complete the 
reaction. Using this method, an inconvenient additional step of co-evaporating the reaction 
mixture with toluene was necessary to remove excess pyridine. Next, neat reactions were 
carried out, at various temperatures and ratios of the substrates. A neat reaction run at 50 oC 
was stopped within 2 h, as the reaction mixture solidified, however starting materials were 
still present. An excess of pyridine (1.5–2.0 equivalents) facilitated stirring of the reaction 
mixture and led to completion of the reaction, however this method remained inefficient 
due to contamination of the IL with pyridine. Finally, a lower temperature of 35 oC and a 
ratio of 14 to pyridine of 1.0: 0.9 were established as the optimum conditions for the neat 
reaction. Under these optimized conditions, the reaction reached completion overnight and 
repeated washing of the solid product with diethyl ether, afforded 2a as a yellow powder. 
Even then, a small peak at around 4.35 ppm in the 1H NMR indicated the presence of an 
impurity in the final product. Neither partitioning between water and CH2Cl2, nor column 
chromatography or recrystallization of the product proved successful in purifying the 
material. However, refluxing the crude product in acetone removed the impurity, giving the 
final product 2a as a white powder in 61 % yield.   
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                 14           2a 
         Figure 2.29 Synthesis of pyridinium IL 2a 
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Butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt (4a) was prepared by N-
alkylation of pyridine with butyl 2-chloro-2-(3, 4-dimethoxyphenyl)acetate (15), according 
to the same procedure as for IL 2a (Figure 2.30).14 The reaction mixture was stirred at 35 
oC until it solidified and then the product was washed with diethyl ether to yield 4a as a 
white powder.  
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Figure 2.30 Synthesis of pyridinium IL 4a 
 
NMR spectra were recorded and signals were assigned to the respective protons and 
carbons (Figures 2.31–2.38). At the lowest field of 1H NMR spectrum three multiplets 
representing the five pyridinium protons H15–H19 were identified (Figure 2.33). Similarly 
to methylimidazolium ILs, in CDCl3 the signal from protons H15 and H19, next to the 
quaternary nitrogen atom, varies in chemical shift depending on the anion present. In the 
case of halide ILs, these protons resonate in the range of 9.4–9.6 ppm. However, with an 
OctOSO3− anion, the signal for H15 and H19 shifts to between 9.0 and 9.1 ppm, whereas 
with NTf2− it can be found at 8.8–8.9 ppm. Similarly, with the chloride counteranion the 
singlet from benzylic proton H2, is located at 8.0 ppm (Figure 2.33), but shifts to 7.3–7.4 
ppm with OctOSO3− and to 6.8–6.9 ppm for NTf2−. Aromatic protons H4, H7 and H8 
exhibit the same splitting pattern previously described for 3,4-disubstituted mandelic acid 
derivatives (e.g. 1a) and are represented by two doublets and one doublet of doublets with J 
values of 8.4 and 1.6 Hz. In the region of 4.0 ppm, the two nonequivalent, diastereotopic 
protons H11 (CH2) of the butyl ester chain appear as two doublets of triplets (Figure 2.35). 
Each H11 proton exhibits a geminal coupling (J = 10.8 Hz), but also couples with the two 
vicinal protons H12, resulting in further splitting (J = 6.8 Hz) of the signal into a doublet of 
triplets. The singlet at 3.62 ppm corresponds to the two methoxy groups H9 and H10 on the 
aromatic ring (Figure 2.32) which appear together. The remaining butyl ester protons H12–
H14 resonate in the region 1.38–0.57 ppm (Figure 2.36). The first of these signals, H12 
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(CH2), appears as a multiplet at 1.38–1.30 ppm, while the next, a triplet of quartets is a 
result of vicinal coupling of protons H13 (CH2) with H12 (CH2) and H14 (CH3), with the 
same J value of 7.4 Hz. The last signal corresponds to protons H14 (CH3), and it is a triplet 
with a J value of 7.4 Hz. It was possible to assign most of the 13C signals to the respective 
carbon atoms by carrying out additional DEPT, HMQC and HMBC experiments. Due to 
their close proximity (Figure 2.37), the signals for quaternary aromatics C5/C6 and also 
C9/C10 could not be assigned unambiguously, even by HMBC. Furthermore, the ortho-
pyridinium carbon atoms C15 and C19 proved to be magnetically indistinguishable and 
resonated as one signal at 144.68 ppm (Figures 2.37, 2.38). The same proved to be the case 
for the meta-pyridinium carbon atoms C16 and C18 which appeared at 137.07 ppm 
(Figures 2.37, 2.38).  
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Figure 2.31 Structure of IL 4a 
 
Figure 2.32 1H NMR spectrum of IL 4a in CDCl3 
 
 
Figure 2.33 Pyridinium proton signals in the 1H NMR spectrum of IL 4a 
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Figure 2.34 Aromatic proton signals of IL 4a 
 
Figure 2.35 H11 protons signals in the 1H NMR spectrum of IL 4a 
 
 
Figure 2.36 Butyl ester protons H12–H14 signals in the 1H NMR of IL 4a 
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Figure 2.37 13C NMR spectrum of IL 4a in CDCl3 
 
 
Figure 2.38 DEPT spectrum of IL 4a in CDCl3 
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Ionic liquid 6a was prepared by N-alkylation of pyridine with methyl 2-chloro-2-(3,4-
methylenedioxyphenyl)acetate (16), according to the same procedure used for IL 2a (Figure 
2.39). The reaction mixture was stirred at 35 oC until it solidified and then the product was 
washed with diethyl ether to yield 6a as a white powder.    
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Figure 2.39 Preparation of pyridinium IL 6a 
 
Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, bromide salt (6d) was 
prepared by reaction of methyl 2-bromo-2-(3,4-methylenedioxyphenyl) acetate 17 with 
pyridine in diethyl ether (Figure 2.40). The reaction was carried out according to the 
general procedure used for the synthesis of 5a. After stirring the reaction mixture for 48 h, 
starting material 17 was still present and thus the reaction was refluxed for 8 h, followed by 
overnight stirring. This was sufficient for completion of the reaction and the precipitated 
product 6d was isolated in good yield (79 %).  
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    17       6d 
Figure 2.40 Preparation of pyridinium ionic liquid 6d 
 
Due to its lower nucleophilicity compared with 1-methylimidazole, N-alkylation of 
pyridine required more forcing conditions. Only with the superior leaving group, bromide2 
could the synthesis of ILs, e.g. 6d be implemented under the same conditions as for 
methylimidazolium ILs. 
 
 
 69
2.2.7 ILs with OctOSO3− counteranion  
Six ILs 1b–6b with the octylsulfate counteranion were prepared according to the general 
procedure (Figure 2.3).6,13 Anion exchange reactions were carried out between chloride ILs 
1a–6a and sodium octylsulfate in water (Figure 2.40). After completion of the process, 
reaction mixtures were evaporated, dissolved in dichloromethane and washed with a small 
amount of water to remove sodium chloride. Low to moderate yields (42–66 %) of ILs with 
methyl ester side chains 1b, 2b, 5b, 6b were probably a result of losses during aqueous 
extraction due to their partial water solubility. By contrast, ILs with butyl ester side chains 
3b and 4b were isolated in good yields (88 and 90 %). All octylsulfate ILs 1b–6b were oils 
at room temperature.  
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            1a              1b 
Figure 2.41 Preparation of IL 1b 
 
 
Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, octylsulfate salt (6b) (Figure 
2.42) was prepared in 59 % yield from chloride IL 6a by anion exchange. NMR spectra 
were recorded and signals were assigned to the respective hydrogen and carbon atoms 
(Figures 2.42–2.50). Three multiplets at the lowest field of the 1H NMR spectra were 
assigned to pyridinium protons H11–H15 (Figure 2.44). The benzylic proton, H2 was 
assigned to the singlet at 7.31 ppm (Figure 2.43). Aromatic protons H4, H7 and H8 from 
the 3,4-methylenedioxyphenyl ring in 6a exhibit similar long range coupling to those 
already described for analogous compounds (Figure 2.45). However, in this case the signal 
for the aromatic proton H4 appears as a broad singlet and the J splitting by H8 cannot be 
clearly discerned because the signal for H4 closely overlaps the doublet of doublets from 
H8 (Figure 2.45). The two diastereotopic protons H9 from the methylenedioxy group (-
OCH2O-), appear as an AB system, consisting of two doublets (Figure 2.46). These protons 
are magnetically non-equivalent and couple to each other with a small geminal coupling 
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constant of 1.4 Hz. The singlet at 3.80 ppm corresponds to the methyl ester group H10 
(Figure 2.47). All the remaining signals in the spectrum can be attributed to protons from 
the octylsulfate anion. Protons H16 from the methylene group, α- to the sulfate  
(-CH2OSO3−) appear as a triplet at 3.98 ppm, with a coupling constant of 6.5 Hz (Figure 
2.47). The methylene group β- to the sulfate, H17, resonates between 1.61-1.53 ppm, and is 
split by vicinal protons H16 and H18 resulting in a multiplet (Figure 2.48). The signal in 
the range 1.28–1.24 ppm appears as a multiplet, corresponding to the two protons H18, and 
overlaps with multiplets from the eight protons H19–H22 (Figure 2.48). The highest field 
signal in the spectrum is a triplet at 0.79 ppm, representing the terminal methyl group, H23, 
which couples to the H22 methylene with a J value of 6.8 Hz (Figure 2.48). 
13C signals were assigned to respective carbon atoms using DEPT, HMQC and HMBC 
experiments. Due to signal proximity, differentiation between C21 and C22 and also 
between C17, C19 and C20 was not possible (Figures 2.49, 2.50). 
Chemical shifts (ppm) of the carbon signals of octylsulfate anion were found to be different 
than expected from their position in the hydrocarbon chain and their proximity to electron 
withdrawing sulfate group (Figures 2.42, 2.49). This is the case for all OctOSO3 ILs 1b–6b 
and can be observed most clearly for IL 1b (see Section 2.8 of this chapter), where the 
order of carbon signals in the spectrum is as followed: C16, C21/C22, C17, C19, C20, C18, 
C21/C22, C23. For example the signal for C21/C22 at 31.66 ppm, between the signals of 
C16 and C17 (67.64 ppm and  29.39 ppm respectively), suggests that carbon C21/C22 is 
experiencing an electron withdrawing environment similar to C16 and C17, however 
C21/C22 is localized near the end of the alkyl chain. Similar effect, attributed to the 
presence of gamma substituents, was observed in long chain alkanes or polymers.19,20  
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Figure 2.42 Structure of IL 6b 
 
Figure 2.43 1H NMR spectrum of IL 6b with OctOSO3− counteranion in CDCl3 
 
Figure 2.44 Pyridinium proton signals in the 1H NMR of IL 6b 
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Figure 2.45 Aromatic proton signals in the 1H NMR spectrum of IL 6b 
 
Figure 2.46 Methylenedioxy group proton signals in the 1H NMR spectrum of IL 6b 
 
 
Figure 2.47 Protons H16 and H10 signals in the 1H NMR spectrum of IL 6b. 
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Figure 2.48 Octylsulfate chain protons signals in the 1H NMR spectrum of IL 6b 
 
 
Figure 2.49 13C NMR spectrum of IL 6b in CDCl3 
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Figure 2.50 DEPT spectrum of IL 6b in CDCl3 
 
2.2.8 ILs with NTf2− counteranion  
Six ILs 1c–6c with the bistriflimide counteranion were prepared according to the general 
procedure (Figure 2.51).6,13 Anion exchange reactions were carried out between halide ILs 
1a–5a, 6d and lithium bistriflimide in water. After completion of the process, water-
insoluble products (1c, 2c, 4c–6c) were filtered or decanted (3c) and washed with water to 
remove lithium chloride or bromide. Moderate to good yields (67–92 %) were obtained. 
Methylimidazolium IL 3c with a butyl ester side chain was an oil at room temperature, but 
the remaining ILs 1c, 2c, 4c–6c were solids at RT. As expected, the more symmetrical 
pyridinium ILs 2c, 4c, 6c had higher melting points than the corresponding 
methylimidazolium ILs 1c, 3c, 5c.  
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Figure 2.51 Preparation of IL 1c 
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Figure 2.52 Structure of IL 1c 
 
Figure 2.53 1H NMR spectrum of IL 1c in CDCl3 
 
Figure 2.54 Splitting patterns for aromatic protons in the 1H NMR spectrum of IL 1c 
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Figure 2.55 Signals from methyl groups in 1H NMR spectrum of IL 1c 
 
 
Figure 2.56 13C NMR spectrum of IL 1c in CDCl3 
 
In the 1H NMR spectra of IL 1c all methylimidazolium protons are represented by singlets, 
with two of them, H13 and H14 (at 7.297 and 7.293 ppm) overlapping (Figure 2.53). 
Aromatic protons from the 3,4-dimethoxyphenyl ring overlap, but a characteristic splitting 
pattern of two doublets and a doublet of doublets can be identified (Figure 2.54). All of the 
remaining signals are singlets (Figures 2.53, 2.55). In the 13C NMR, a quartet representing 
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two equivalent carbons (CF3 groups) of the NTf2 anion can be observed at 120.02 ppm 
(Figure 2.56) as a result of carbon-fluorine coupling with J value of 319.2 Hz.  
 
2.3 Synthesis of ILs without a linker from (RS)-3,4-dihydroxymandelic acid 
2.3.1 (RS)-3,4-Dihydroxymandelic acid 
3,4-Dihydroxymandelic acid (18) was prepared by the reaction of catechol (1,2-
dihydroxybenzene) with glyoxylic acid according to a reported procedure (Figure 2.57).15 
The crude product was extracted with ethyl acetate and filtered through Celite (to clear the 
emulsion). The product was then recrystallised from the same solvent or from t-butyl 
methyl ether according to another reported procedure.16 Occasionally, the product did not 
precipitate and it was used, as crude material in the next synthetic step.  
HO
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60 oC
+
36 %
 
                            18 
Figure 2.57 Preparation of (RS)-3,4-dihydroxymandelic acid (18) 
 
In contrast to the previous disubstituted mandelic acid analogues, 9 and 10, which were 
prepared by an acid-catalysed reaction, synthesis of 18 was carried out under basic 
conditions in the presence of 1.8 equivalents of NaOH and was catalyzed by Al2O3.15   
The surface of Al2O3 catalysts consist of Lewis acidic aluminium atoms in various 
coordination states and Lewis basic oxygen atoms.21 The Al atoms may be coordinated by 
hydroxide ions, generated by dissociation of water. The oxygen atoms and hydroxyls of the 
alumina surface may themselves coordinate to protons generated by dissociation of water, 
as well as by undissociated water molecules.21 Despite a great deal of interest in alumina 
catalysis, the exact bulk structure and nature of the surface sites are still not well 
understood, due to the complexity of the surface.21 In the above aromatic substitution 
reaction catalytic processes may occur via
 
coordination of the carbonyl group of glyoxylic 
acid to Al2O3 and activation of this group for nucleophilic attack. However the exact 
mechanism is not known.  
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2.3.2 (RS)-3,4-Dihydroxymandelic acid methyl ester 
Synthesis of methyl 3,4-dihydroxymandelate (19) was carried out according to the reported 
procedure, by acidic esterification of 18 in methanol, catalysed by PTSA (Figure 2.58).16 
Washing the crude product with t-butyl methyl ether did not result in sufficiently pure ester, 
so column chromatography was carried out, eluting with either dichloromethane:methanol 
(90:10) or  hexane:ethyl acetate (50:50) as the mobile phase. Further purification by stirring 
with t-butyl methyl ether and filtering the solid gave product 19 in 46 % yield. 
Alternatively 19 could be obtained in high purity and in the same yield after 
chromatographic purifications on silica, first with hexane:ethyl acetate (50:50), then a 
second flash column chromatography using hexane:ethyl acetate (60:40).  
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     18                19 
Figure 2.58 Preparation of (RS)-methyl 3,4-dihydroxymandelate 19 
 
2.3.3 (RS)-3,4-dihydroxymandelic acid derived halide ILs 
 
The synthesis of methyl 2-(3,4-dihydroxyphenyl)-2-(3-methylimidazolium)acetate, chloride 
salt (7a) was attempted via the standard route in which the α-chlorinated ester is reacted 
with 1-methylimidazole. For synthesis of the required α-chlorinated ester, methyl 2-chloro-
2-(3,4-dihydroxyphenyl)acetate, the routine procedure with thionyl chloride and 
triethylamine as well as an alternative method, using 4M HCl in dioxane were investigated. 
However, in both cases purification of the product was difficult and yields were low, 
probably due to hydrolysis of the α-chlorinated ester to the starting material 19. Therefore 
synthesis of ILs via a “one pot” reaction was carried out, wherein the α-chlorinated ester 
was formed in situ and not isolated (Figure 2.59). Following formation of the α-chloro 
intermediate, 1-methylimidazole was added, affording IL 7a. The chlorination was carried 
out in dichloromethane, with thionyl chloride as the chlorinating agent. 1-Methylimidazole 
was used as both a base for the chlorination, and a nucleophile for alkylation and a second 
equivalent was required in order to form IL 7a. The crude product contained 1-
methylimidazolium hydrochloride as an impurity, together with a small amount of starting 
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material. Due to the similar polarity of IL 7a and the by-product, 1-methylimidazolium 
hydrochloride, purification of IL 7a was difficult and column chromatography was carried 
out twice in order to obtain pure 7a. Mobile phases were chosen for gradient elution, first 
dichloromethane:methanol (98:2.0, increasing in polarity to 90:10) and then (90:10 to 
80:20). However, the synthesis of IL 7a was not very reproducible and yields varied within 
the range 14–65 %.  
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       19                                       7a 
 
Figure 2.59 Preparation of IL 7a 
 
Alternative bases for the synthesis were also investigated in order to facilitate the 
purification process. When 1 equivalent of pyridine was added as a base, followed by 1 
equivalent of 1-methylimidazole, pyridinium IL 8a was formed contaminated with 
methylimidazolium hydrochloride (1:0.2 ratio). This result can be explained by the fact that 
pyridine is a weaker base and so 1-methylimidazole is protonated preferentially, allowing 
pyridine to act as the nucleophile. Next, the solid-supported base (Amberlyst-A21) was 
investigated, but did not improve the reaction outcome and starting material (40 %) was 
returned, with a poor conversion to IL 7a (24 %), accompanied by methylimidazolium 
hydrochloride in a ratio of ~1:1.5. Sodium bicarbonate and Al2O3 were also tested as bases, 
however, no reaction took place in either case, even using an excess of base.  
Similarly, methyl 2-(3,4-dihydroxyphenyl)-2-pyridinium acetate, chloride salt (8a) was 
prepared from 19 via in situ procedure, but using both pyridine and thionyl chloride in a 
slight excess (1.15 equivalents) for efficient chlorination. (Figure 2.60).  
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Figure 2.60 Preparation of IL 8a 
 
After stirring overnight, the second 1.15 equivalents of pyridine, required for alkylation 
was added. The reaction was left to continue overnight again, after which IL 8a was 
collected by filtration, and isolated as a white precipitate. The majority of the by-product, 
pyridinium hydrochloride did not precipitate, but remained dissolved in the 
dichloromethane. However 8a remained contaminated with a small amount of pyridinium 
hydrochloride (10–20 mol%). Purification of 8a by washing, or refluxing with 
dichloromethane did not remove the by-product entirely. Column chromatography with 
CH2Cl2:MeOH (90:10) and MeOH (100 %) as the mobile phase resulted in a more impure 
product, indicating that degradation of 8a was occurring on silica. Neither washing nor 
refluxing the product with acetone or acetonitrile, nor recrystallisation from methanol were 
successful in obtaining pure IL. However, first dissolving the product in water and then 
washing with dichloromethane was successful and the pure IL was obtained in moderate 
yield (41 %). 
In order to facilitate purification, a variety of alternative bases were also investigated. 
These included a solid-supported base (Amberlyst-A21), a highly lipophilic base 
(trioctylamine), and also 1-butylimidazole, but no satisfactory results were obtained. With 
trioctylamine as the base, the corresponding hydrochloride by-product was very soluble in 
dichloromethane and it did not contaminate the final IL. However, the product 8a was still 
contaminated by traces of pyridinium hydrochloride and starting material 19. When 1-
butylimidazole was used as the base, the product was formed, but was accompanied by 
traces of pyridinium and butylimidazolium hydrochloride salts.  
1H NMR for 8a was recorded in D2O (Figures 2.61, 2.62). Multiplets representing 
hydrogens from the pyridinium ring are shifted most downfield 8.64–7.63 ppm. In the 
region 6.80–6.60 ppm the characteristic two doublets and a doublet of doublets correspond 
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to the three aromatic protons H4, H7 and H8. Benzylic proton H2 gives a singlet in the 
same range at 6.68 ppm. The singlet from the protons H9 of the methyl ester resonates at 
3.68 ppm. The 13C spectrum was also recorded in D2O and it was possible to assign all of 
the signals to the respective carbons without ambiguity (Figure 2.63).  
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Figure 2.61 Structure of IL 8a 
               
Figure 2.62 1H NMR spectrum of IL 8a in D2O 
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Figure 2.63 13C NMR spectrum of IL 8a in D2O 
 
An ion exchange reaction was carried out to obtain ILs 7(b,c) and 8(b,c) with octylsulfate 
and bistriflimide counteranions. However impure products were obtained upon the 
reactions and purification was not successful. An exchange process, involving treatment of 
the 3,4-dihydroxymandelic acid-derived pyridinium chloride IL, 8a, with OctOSO3Na to 
obtain OctOSO3− IL 8b was carried out in water according to the standard procedure. The 
brown oil obtained was separated from the reaction mixture and the remaining aqueous 
phase was extracted with ethyl acetate. However, the same 1H NMR spectra were obtained 
from the oil and ethyl acetate phases, and both contained the impurity in the pyridinium 
region of the spectra (originally observed in 8a). The products were combined and 
chromatographed, eluting with ethyl acetate, but the impurity was still present. IL 8b was 
than extracted with water, which removed the impurity, but gave a product with an excess 
of octyl chain signals in the 1H NMR.  
Similarly, the synthesis of pyridinium IL 8c, containing the NTf2− counteranion was carried 
out from 8a according to the standard method, but impure product was again obtained. 
Purification by extraction between water and dichloromethane was attempted, but was not 
successful. 
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2.4 Synthesis of ILs with acetoxy linker, derived from (RS)-3,4-dimethoxy- and (RS)-
3,4-methylenedioxymandelic acid 
2.4.1 Synthetic strategy 
Eight ILs, derived from 3,4-dimethoxy- and 3,4-methylenedioxymandelic acids (9), (10) 
with an acetoxy linker between the chiral centre and the heterocyclic ring were synthesised 
(Figure 2.64). The synthetic route was similar to that used for ILs 1a−8a. Substituted 
mandelic acids 9 and 10 were again prepared by electrophilic aromatic substitution, and 
then esterified to give 11 and 13. However, in this case subsequent reaction with 
bromoacetyl bromide gave α-bromo esters 25-27, which were treated with either 1-
methylimidazole or pyridine to form acetoxy-linked ILs 21a−24a (Figure 2.65, Scheme 
2.4). Acetoxy-linked ILs 21a−24a have the advantage that resolution of the racemate might 
be carried out early in the synthesis, e.g. at the stage of the mandelic acid derivatives 9 and 
10. This is possible because acylation with bromoacetyl bromide and final alkylation do not 
involve substitution at the chiral centre. Hence, IL formation would not incur the same risk 
of racemisation via SN1 processes encountered in the synthesis of ILs 1a−8a in which 
halogenation and alkylation take place at the chiral centre.  
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Figure 2.64 ILs with acetoxy linker 
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Figure 2.65 α-Bromo esters 25-27 for preparing ILs with acetoxy linker 
 
bromoacetyl bromide,
CH2Cl2, 0 oC to RT
OO
OH
OH
O
OH
H2SO4
  −9 oC
+
OH
O
OMe
SOCl2
RT
O
O
OMe
diethyl ether
−15 oC, N2 atm.
1-methylimidazole
water, RT
NaOctOSO3
OctOSO3
O
O
O
O
O
O
O
O
O
Br
O
O
OMe
O
O
O
N
N
Br
O
O
OMe
O
O
O
N
N
MeOH
10
1327
23a 23b
 
 
Scheme 2.4 Synthetic route to ILs 23a and 23b with acetoxy linker 
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2.4.2 α-Bromo esters 
α-Bromo ester 25 was obtained by reaction of methyl 3,4-dimethoxymandelate (11) with 
bromoacetyl bromide, catalysed by Al2O3 (Figure 2.66) according to the general 
procedure.22
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Figure 2.66 Preparation of α-bromo ester 25 
 
Although the reaction was carried out neat, toluene was required to wash the product from 
the sodium bicarbonate used for filtration. A mixture of product 25 and a by-product, 
tentatively identified as methyl 2-bromo-2-(3,4-dimethoxyphenyl)acetate (28) (Figure 2.67) 
were formed in a ratio of 1.0:0.7 (estimated by 1H NMR on a crude sample). 
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          11                                  25         28 
Figure 2.67 Esterification of 11 
 
The low isolated yield of 27 % for 25 may be due to poor product recovery of the crude 
ester from solid sodium bicarbonate. Alternatively, losses may have been incurred during 
chromatography, owing to the very similar polarities of the two products.  
In the bromoacetylation reaction, catalytic processes may occur via
 
coordination of the 
carbonyl group of bromoacetyl bromide to Al2O3 and activation of this group for 
nucleophilic attack, although the mechanism is not known with certainty.  
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Synthesis of butyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (26) was carried 
out by two methods. In the first procedure, the reaction was catalysed by Al2O322 and 
similarly as in the last example (Figure 2.67), a mixture of 26 and the by-product, 29 was 
obtained with a low yield of 26 (25 %). The by-product was tentatively assigned as butyl 2-
bromo-(3,4-dimethoxyphenyl)acetate (29) (Figure 2.68). Secondly, the synthesis was 
carried out according to a known procedure, where bromoacetyl bromide and triethylamine 
were used.13,23 Again, a mixture of 26 and 29 was formed and a low yield (23 %) of 26 was 
obtained. 
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Figure 2.68 O-bromoacetylation of 12 catalyzed by Al2O3 
 
α-Bromo ester 27 was prepared by the reaction of methyl 3,4-methylenedioxymandelate 
(13) and bromoacetyl bromide in the presence of potassium carbonate as a base, according 
to the general procedure (Figure 2.69).24 Product 27 was obtained in good yield (69 %) and 
no by-products were formed. The only drawback to this method was a difficulty in driving 
the reaction to completion and so addition of an extra equivalent of both reagents was 
necessary during the synthesis. 
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Figure 2.69 Preparation of α-bromo ester 27 
 
Base catalysed bromoacetylation is postulated to occur according to the general mechanism 
of nucleophilic substitution, through a tetrahedral intermediate (Figure 2.70).2 
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Figure 2.70 Mechanism of bromoacetylation 
 
2.4.3 Acetoxy-linked ILs with bromide counteranion 
Bromide IL with an acetoxy linker 21a was prepared via N-alkylation of 1-methylimidazole      
by methyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (25) (Figure 2.71), 
according to the general procedure.6,13 Product 21a was obtained in 61 % yield, together 
with minor impurities. However this ionic liquid proved to be very unstable, as indicated by 
the appearance of new peaks in the NMR spectra over a short period of time.  
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Figure 2.71 Preparation of ionic liquid with acetoxy linker 21a 
 
Purification of IL 21a was attempted, either by repeated washing with diethyl ether or 
column chromatography. However, neither method proved successful, and after 
chromatography, methyl 3,4-dimethoxymandelate (11) was obtained as the major product 
after purification. The same compound (11) was identified as an impurity in the crude 
product by 1H NMR, suggesting that hydrolysis of IL 21a occurs readily. Due to the 
instability of 21a only 1H NMR spectra were recorded. Further studies regarding the 
stability of ILs with an acetoxy linker were carried out and will be described in Chapter 3.0 
(Section 3.2). 
Similar problems were encountered during the synthesis of butyl 2-(3,4-dimethoxyphenyl)-
2-[2-(3-methylimidazolium) acetoxy]acetate, bromide salt (22a). Compound 22a was 
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prepared in 93 % yield by the reaction of butyl 2-(2-bromoacetoxy)-2-(3,4-
dimethoxyphenyl)acetate (20) with 1-methylimidazole in diethyl ether (Figure 2.72). 
Efforts to purify the product 22a by column chromatography failed, leading to formation of 
butyl 3,4-dimethoxymandelate (12). Purification of 22a by partition between water and 
ethyl acetate afforded pure material. However, in the 1H NMR spectrum, additional peaks 
appeared over a short period of time, indicating further decomposition. It is possible that 
hydrolysis of 22a, leading to formation of butyl 3,4-dimethoxymandelate 12 and 1-
methylimidazolium hydrochloride salt may have taken place. LCMS analysis of the sample 
of IL 22a revealed the presence of a major peak with m/z corresponding to the ionic liquid 
cation (M+ 391.0), as well as a smaller peak corresponding to butyl 3,4-
dimethoxymandelate (12) (251.0, 291.0). Complete characterization of 22a was not 
possible because of the instability of this IL. Further studies regarding the stability of ILs 
with an acetoxy linker are discussed in Chapter 3.0 (Section 3.2). 
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Figure 2.72 Preparation of IL 22a with acetoxy linker 
 
Synthesis of methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) acetoxy] 
acetate, bromide salt (23a) was carried out by N-alkylation of 1-methylimidazole with 2-(2-
bromoacetoxy)-2-(3,4-methylenedioxyphenyl)acetate (27) (Figure 2.73).6,13 
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Figure 2.73 Preparation of IL 23a with acetoxy linker 
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Unexpectedly, even the presence of moisture in the diethyl ether used to wash traces of 
starting material from 23a led to side-chain hydrolysis, as was the case with ILs 21a and 
22a. However, the use of freshly distilled diethyl ether, with minimal exposure to air, 
followed by removal of solvent at room temperature (with chloroform co-evaporation) 
under high vacuum resulted in pure IL 23a in 63 % yield. The pure sample of 23a was then 
stored in a freezer at −20 °C. NMR spectra were recorded and all signals were assigned to 
the respective atoms. The most deshielded proton H13 appears as a broad singlet and each 
of the remaining two protons H14 and H15 appear as triplets with coupling constant J = 1.8 
Hz (Figure 2.76). Splitting of the aromatic protons via long range coupling can also be 
observed. Protons H4 and H7 are represented by doublets and H8 by a doublet of doublets 
(Figure 2.77). Diastereotopic protons from the methylenedioxy group resonate as an AB 
system consisting of two doublets with a small coupling constant (J = 1.6 Hz) (Figure 
2.78). The remaining protons, H10, H12, and H16 appear as singlets. Protons H12 are also 
diastereotopic, but they appear as broad singlet. However in other similar compounds (e.g. 
21a, 22a and 24a) protons H12 can be observed as an AB system consisting of two 
doublets with a large coupling constant of 17.4-17.9 Hz (Experimental 2.8). It was possible 
to assign most of the carbon signals for 23a to the respective atoms (Figures 2.79, 2.80).  
 
 
 
 
 
 
 
 
 
 90
7
6
5
4
3
8 2
O
1
O
O
Br
O
9
O
11
12
O
N
10
15
14
N13
16
23a
 
Figure 2.74 Structure of methylimidazolium IL 23a with acetoxy linker 
 
Figure 2.75 1H NMR spectrum of IL 23a in CD3CN 
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Figure 2.76 1H NMR spectrum of IL 23a,      Figure 2.77 1H NMR spectrum of IL 23a,  
methylimidazolium protons H14 and H15     aromatic protons H4, H7 and H8 
 
Figure 2.78 1H NMR spectrum of IL 23a, protons H9 and H12 
 
 
 92
 
Figure 2.79 13C NMR spectrum of IL 23a in CD3CN 
 
 
Figure 2.80 DEPT spectrum of IL 23a in CD3CN 
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Pyridinium IL 24a was prepared by reaction of methyl 2-(2-bromoacetoxy)-2-(3,4-
methylenedioxyphenyl)acetate (27) with pyridine in diethyl ether (Figure 2.81). 
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Figure 2.81 Preparation of pyridinium IL 24a with acetoxy linker 
 
Product 24a was obtained according to the general procedure, followed by refluxing the 
reaction mixture.6,13 The desired compound was prepared in excellent yield (90 %) after 
repeated washings with distilled diethyl ether. As with 23a, it was essential that exposure to 
air was minimised, and that solvent was not evaporated at above room temperature, to 
obtain product 24a in high purity. IL 24a was then recrystallised from chloroform.  
 
2.4.4 Acetoxy-linked ILs with OctOSO3− counteranion 
IL 23b was prepared via anion exchange between IL 23a and sodium octylsulfate, in water 
according to the general procedure.6,13 After the usual work up, 23b still contained 
impurities, probably as a result of hydrolysis during evaporation of the final product from 
water at 50 oC. However, the IL was dissolved in dichloromethane and then purified by 
extracting with water. Organic solvent was removed and IL 23b was further washed with 
diethyl ether to give pure 23b in 55 % yield. A similar procedure was used for the 
preparation and purification of 24b, which was obtained in 45 % yield. Both ILs 23b and 
24b were oils at room temperature. 
 
2.4.5 Acetoxy-linked ILs with NTf2− counteranion 
ILs 23c and 24c were prepared from the respective bromide ILs 23a and 24a via anion 
exchange with lithium bis(trifluoromethane)sulfonimide in water, according to the general 
procedure (Figure 2.82).6,13 Washing of the products with distilled water was sufficient to 
obtain IL 23c and IL 24c as pure materials in 76 % and 78 % yield respectively.   
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Figure 2.82 Preparation of IL 24c with NTf2 counteranion 
 
2.5 Chiral resolution 
2.5.1 Preparation of enantiomerically pure compounds 
Enantiomerically pure compounds can be obtained via either synthetic methods or 
resolution, according to three main approaches.25 One of these approaches involves the 
exploitation of enantiomerically pure starting materials from “the chiral pool” for the 
synthesis of the desired product. In the second method, prochiral substrates are used and 
asymmetric synthetic techniques are applied. A third approach, resolution of a racemate, 
uses either kinetic, crystallisation, or chromatographic methods to distinguish the two 
enantiomers. Resolution of both diastereomers and enantiomers can be achieved by 
chromatographic separation, but in the case of enantiomers, chiral stationary phases must 
be used. Crystallisation can be carried out on either a mixture of enantiomers (direct 
preferential crystallisation) or diastereomers (diastereomeric salts crystallisation).  
Kinetic resolution is a process whereby two enantiomers are transformed into a product at 
different rates and involves either biocatalysis (by an enzyme or microorganism) or 
chemocatalysis (by a chiral acid, base or metal complex).25 In an ideal case 50 % yield can 
be obtained, in which one of the enantiomers is converted into the product and the other can 
be recovered unchanged.26 Among enzymes, lipases are the most frequently used in 
resolution processes, because of their stability and versatility across a broad range of 
substrates. Lipases also have the advantage of compatibility with organic solvents25,27and 
can catalyse a wide variety of reactions, including hydrolysis, esterification, 
transesterification and amidation.28 Yadav et al. studied hydrolysis of (RS)-methyl 
mandelate catalysed by Novozyme 435,27 a solid-supported lipase and found that (R)-(−) 
mandelic acid was obtained in 84 % ee and 30 % conversion after 4 h.27 Hydrolytic 
resolution of (RS)-2,2,2-trifluoroethyl α-chlorophenylacetate by various lipase enzymes 
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was investigated by Wen et al.29 The hydrolysis product, (R)-α-chlorophenylacetic acid was 
isolated in 10 % ee with catalysis by Novozyme 435.26 Enzymatic resolution of (RS)-
methyl mandelate was also carried out on a preparative scale by Queiroz via selective 
acetylation.28 The substrate was treated with the acetylating agent, vinyl acetate and a 
Pseudomonas species lipase catalyst, to give (S)-O-acetyl methyl mandelate and (R)-methyl 
mandelate in excellent optical purity (both 99 % ee and 50 % yield) after 96 h.28 
In favourable cases, a kinetic resolution process can be converted into a dynamic kinetic 
resolution (DKR), in which 100 % yield can be obtained.26 This is achieved by introducing 
a racemisation step, in which the slower reacting enantiomer in the kinetic resolution is 
converted into the opposite one. DKR can be carried out either by enzymatic or chemical 
procedures (chiral catalyst, chiral auxiliary), or by tandem approaches, involving both 
methods.26 
Lee et al. have applied a dynamic kinetic resolution process to the nucleophilic substitution 
of α-bromo esters by alkyl amines.30 (S)-Methyl mandelate was used as a chiral auxiliary 
and the respective diastereomeric α-bromo esters (α-RS, S configuration) were reacted with 
the amine in the presence of TBAI and DIEA. α-Amino esters were obtained in up to 81 % 
yield and 97:3 dr (Scheme 2.5). 30 
Br
Ph
O
O
COOMe
Ph
Br
Ph
O
O
COOMe
Ph
Bn2N
Ph
O
O
COOMe
Ph
Bn2N
Ph
Bn2NH
TBAI
DIEA
LiAlH4
97:3 dr 97:3 er
OH
 
Scheme 2.5 Preparation of (R)-2-dibenzylamino-2-phenylethanol by chiral auxiliary/DKR 
method30 
   
 
 
 96
2.5.2 Strategy for enantiomerically pure ILs synthesis 
All ILs in the small library derived from 3,4-dimethoxy-, 3,4-methylenedioxy- and 3,4-
dihydroxymandelic acids (9, 10 and 18 respectively) were synthesised as racemic mixtures 
(Figures 2.3 and 2.64). After the synthesis, attempts were made to obtain the 
enantiomerically pure ILs via chiral resolution methods. Due to the lower stability of ILs 
with an acetoxy linker, only the resolution of ILs without the linker was attempted. Several 
approaches were investigated, including chromatographic separation of diastereoisomers, 
enzymatic resolution, and chiral auxiliary methods. The first two methods were carried out 
on the final IL in order to preclude the possibility of racemisation in subsequent steps. The 
chiral auxiliary method was implemented over the final two steps of IL synthesis.   
 
2.5.3 Synthesis of diastereomers 
In order to obtain enantiomerically pure ILs by the formation of diastereomers, a second 
chiral centre was temporarily introduced into the molecule, via derivatisation with a chiral 
auxiliary. Due to the different physicochemical properties of the resulting diastereomers, it 
was anticipated that they might be separated by column chromatography. The newly 
introduced chiral auxiliary might then be removed, to give the desired IL as a single 
enantiomer.   
In the case of our ILs, a second chiral centre was introduced by esterification of the IL with 
a chiral alcohol. For that purpose ILs containing a free carboxylic acid group 30c−32c were 
first prepared via base-catalysed hydrolysis. Subsequent esterification with a chiral alcohol 
gave the corresponding diastereomeric chiral esters.  
Halide ILs 1a and 2a were hydrolysed by KOH in methanol, followed by acidic work-up 
with HCl, according to a general procedure.36 However, purification of the hydrolysed ILs 
was difficult, due to the similar polarities of the product and by-product (KCl). Next, ILs 
1c, 5c and 6c with the NTf2 counteranion were hydrolysed (Figure 2.83). Due to their high 
hydrophobicity, the respective products were easily purified by extracting the products 
from the aqueous phase with dichloromethane. Products 30c−32c were obtained in good 
yields (80–93 %).  
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Figure 2.83 Hydrolysis of IL 1c 
 
Subsequently carboxylic acid, 30c was esterified with (S)-1-phenylbutanol in the presence 
of DCC and DMAP (Figure 2.84) according to a general procedure.38 The desired mixture 
of diastereoisomeric esters 33c [(R,S) and (S,S) configuration] was obtained, as confirmed 
by NMR (Figure 2.86, 2.82)  
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Figure 2.84 Preparation of IL 33c as a mixture of two diastereomers 
 
From a consideration of the integrations in the 1H NMR spectrum of ILs 33c, it is apparent 
that one of the diastereomers is present in a slight excess (1.0:0.87). This indicates that 
some degree of chiral resolution is occurring during esterification, with one of the 
diastereomers being formed more rapidly by kinetic resolution. Next, efforts were made to 
separate the two diastereomers by column chromatography. Chromatographic separation 
was attempted twice, with different mobile phases, however resolution of the two 
diastereomers was not successful. Two more diastereomeric ILs (methylimidazolium and 
pyridinium ILs) from (S)-1-phenylethanol were prepared, however their separation was also 
not possible.  
One of the reasons that column chromatography was not a suitable method for diastereomer 
separation, may be that the ILs have a high affinity to silica gel, which results in low Rf 
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values over a variety of mobile phases and “tailing” of the compounds’ bands. While 
introduction of the lipophilic chiral alcohol into the ester of the IL was expected to increase 
the Rf, the effect was not significant in the examples described above.     
Esterification of 30c in the presence of the coupling agent, DCC and a DMAP catalyst 
occurred according to the conventionally accepted mechanism (Figure 2.85).31,32 In this 
reaction DCC reacts with the carboxylic acid, to form an O-acylisourea intermediate, which 
is an activated carboxylic acid. Next, the acyl transfer catalyst, DMAP reacts with the O-
acylisourea, leading to formation of an acylpyridinium cation. The highly electrophilic 
acylpyridinium cation then reacts with the alcohol, to give the desired ester.   
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Figure 2.85 Esterification of 30c in the presence of DCC and DMAP31,32 
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Figure 2.86 Structure of ILs 33c 
 
Figure 2.87 1H NMR spectrum of IL 33c in CDCl3 
 
2.5.4 Enzymatic resolution 
Formation of enantiomerically pure ILs was also attempted via enzymatic methods by the 
use of Novozym 435 (component B of the lipase from Candida antarctica immobilized on 
a macroporous polyacrylate resin). Two types of enantioselective enzymatic reactions were 
carried out: enzymatic hydrolysis and acetylation. In the first method selective hydrolysis 
of only one enantiomer or diastereomer was the objective. ILs 34c and 35c which contain 
fluorinated activated esters, were prepared, to decrease the reversibility of the reaction 
(Figures 2.88, 2.91).25 Enantiomerically pure (S)-(−)-1,1,1-trifluoro-2-octanol and achiral 
2,2,2-trifluoroethanol were used to synthesise the respective esters 34c and 35c.  
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Synthesis of 1-(trifluoromethyl)heptyl ester 34c was carried out by esterification of 2-(3,4-
dimethoxyphenyl)-2-(3-methylimidazolium) acetic acid, NTf2 salt (30c) with (S)-(−)-1,1,1-
trifluoro-2-octanol, catalysed by DMAP, in the presence of n-propylphosphonic anhydride 
(T3P) according to a general procedure.33 As a work up, only water washings of the organic 
layer were required, resulting in the pure 34c in a moderate yield of 59 %. The product was 
obtained as a mixture of two diastereomers in a 1:1 ratio, which was determined by 1H 
NMR (Figures 2.88, 2.89). The 19F NMR spectrum of 34c was also recorded and one 
singlet for the fluorine atoms of the NTf2− anion and two doublets at slightly different shifts, 
corresponding to the two diastereomers, were observed. Fluorine splitting (J = 7.5 Hz) is 
due to CF3 coupling with the proton at the neighbouring chiral centre. 
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Figure 2.88 Structure of IL 34c 
 
Figure 2.89 1H NMR spectrum of IL 34c in CDCl3 
 
The mechanism of esterification with T3P as the coupling reagent and DMAP as a catalyst 
in the presence of TEA has not been investigated, but we postulate that it occurs via a 
mixed anhydride mechanism. (Figure 2.90).34  
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Figure 2.90 Mechanism of esterification in the presence of T3P and DMAP34 
 
Synthesis of 2,2,2-trifluoroethyl ester 35c was carried out by esterification of 2-(3,4-
dimethoxyphenyl)-2-(3-methylimidazolium)acetic acid, NTf2 salt (30c) with 2,2,2-
trifluoroethanol. In common with ester 34c, water washings of the organic layer were 
sufficient for product purification and 35c was obtained in a moderate yield of 55 % 
(Figure 2.91, 2.87). In the 1H NMR spectrum, diastereotopic protons H11 are represented 
by two sets of doublets of quartets, which are the result of geminal H11 coupling (J = 12.6 
Hz) and vicinal coupling to fluorine (J = 8.2 Hz, Figures 2.91, 2.92). The 19F NMR 
spectrum of 35c was also recorded, in which one singlet from the fluorine atoms of the 
NTf2 anion was observed, as well as a triplet (J = 7.5 Hz) from splitting of the CF3 fluorine 
signal by the two protons at the neighbouring carbon.  
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Figure 2.91 Structure of IL 35c 
 
Figure 2.92 1H NMR spectrum of IL 35c in CDCl3 
 
Hydrolysis of both esters 34c and 35c catalysed by Novozyme 435 was investigated. 
Reaction did not occur when water-saturated isooctane was used as the solvent at 45 oC, 
even after an extended reaction time of 7 days. Next, a biphasic mixture of phosphate 
buffer (pH 7.4), hexane and methanol was used as the reaction medium at 37 oC and under 
these conditions 35 % hydrolysis of 34c and 82 % of 35c occurred. However, from the 1H 
NMR and 19F NMR spectra of 34c, it seemed likely that both diastereomers were 
undergoing the process at the same rate, as their ratio remained unchanged after the 
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reaction. This result suggested that the enzyme was not participating in the hydrolysis 
reaction. Confirmation for this conclusion came when blank reactions for 34c and 35c 
without the enzyme were carried out and found that in both cases IL hydrolysis had 
occurred.  
Apart from hydrolysis, an enzymatic acylation was also attempted, in which esterification 
of the alcohol group of methyl 3,4-methylenedioxymandelate (13) by vinyl acetate was the 
goal. The objective was that kinetic resolution by selective acylation of one of the 
enantiomers of 13 should take place. Novozyme 435 was used as the catalyst, with hexane 
as a solvent, but after 7 days no change in the starting material 13 was observed.  
Although enzymatic reactions are very useful in asymmetric synthesis and resolution, 
yielding enantiomerically pure products with excellent enantioselectivity, even on a large 
scale, their limited substrate range is often a problem.25,28 Further research, using a panel of 
various enzymes will be necessary to achieve a successful enzymatic kinetic resolution with 
these ILs.  
 
2.5.5 Chiral auxiliary method 
Preparation of enantiomerically pure ILs was also attempted using a chiral auxiliary and 
TBAI as a catalyst to achieve dynamic kinetic resolution. For that purpose the synthetic 
route to the ILs was slightly modified, introducing a halogenation step before esterification 
(Scheme 2.6). During esterification an enantiomerically pure mandelate ester chiral 
auxiliary was introduced, resulting in a mixture of two diastereomers (Scheme 2.6). In the 
final synthetic step (displacement of bromide by 1-methylimidazole) the auxiliary induced 
some degree of stereocontrol over nucleophilic attack at the original chiral centre of the 
substrate. Further improvement in the optical purity is possible by a concurrent  dynamic 
kinetic resolution process, whereby the more hindered bromide (and less reactive) 
diastereomer is inverted by catalytic tetrabutylammonium iodide prior to final product 
formation.This DKR process means that in theory a single diastereomeric IL could be 
formed. 
(S)-(+)-Methyl mandelate (45) was used as the chiral auxiliary and 2-bromo-2-(3,4-
methylenedioxyphenyl)acetic acid (36) was esterified by 45 in the presence of DMAP and 
T3P (Scheme 2.6). In the following step IL 38a was prepared from 37 and 1-
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methylimidazole. TBAI was added in the IL-forming step, to epimerise starting material 
and induce DKR.  
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Scheme 2.6 Synthetic route to IL 38a 
 
2-Bromo-2-(3,4-methylenedioxyphenyl)acetic acid (36) was prepared by bromination of 
alcohol group of 10 via a biphasic reaction using HBr aq. in DCM according to a reported 
method.37 Product 36 was obtained in near quantitative yield without the need for 
purification. Next, 36 was esterified with (S)-(+) methyl mandelate (45) in the presence of 
DMAP and T3P according to the previous general procedure.33 Column chromatography 
was conducted twice to remove residual (S)-(+) methyl mandelate (45). Product 37 was 
obtained as a mixture of two diastereoisomers in a 1:1 ratio and with a combined yield of 
42 %. In the 1H NMR spectrum both of the diastereomers could be distinguished, as their 
chemical shifts were slightly different (Figures 2.93−2.95).  
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Figure 2.93 Structure of 37 
 
Figure 2.94 1H NMR spectrum of 37 in CDCl3 
 
 
Figure 2.95 Signals of aromatic protons in the 1H NMR spectrum of 37 
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Preparation of IL 38a according to the general procedure was attempted.30 Analogously to 
the reported procedure, α-bromo ester 37, 1-methylimidazole and TBAI were used to 
attempt N-alkylation with concomitant DKR. However the desired IL 38a was not formed 
and a by-product, tentatively assigned as α-ketoester 39 (based on 1H and 13C NMR) was 
the main product of the reaction (Figure 2.96).   
O
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39 
Figure 2.96 Proposed structure of by-product 39 
 
Next, the reaction was carried out without TBAI and using only 0.5 equivalents of 1-
methylimidazole. In this reaction the desired IL, 38a was obtained as a mixture of two 
diastereomers, one of which was present in excess (1:0.76). Purification of the product 
mixture was attempted by extraction with distilled water, however this process was 
inefficient and so anion exchange reaction was carried to give the less hydrophilic NTf2 IL, 
38c which was extracted with dichloromethane and then purified by column 
chromatography.  
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Figure 2.97 Preparation of 38c by anion exchange 
 
IL 38c was obtained in 26 % yield and in a diastereomeric ratio of 1.0:0.67 (20 % de) ((R, 
S) and (S, S) configuration) (Figure 2.97). In both the 1H NMR and 13C NMR spectra, an 
excess of one of the diastereomers was evident from the peak integrations (Figures 
2.98−2.100). 
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Figure 2.98 Structure of IL 38c 
 
Figure 2.99 1H NMR spectrum of NTf2 IL 38c in CDCl3 
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Figure 2.100 Aromatic region in the 1H NMR spectrum of IL 38c in CDCl3 
The remaining bromide IL 38a which was extracted with water (albeit inefficiently, as it 
tended to partition between water and DCM), was evaporated under reduced pressure at 50 
oC and the pure IL was isolated as a mixture of two diastereoisomers. However, after 
extraction, the two diastereoisomers were found to be present in a 1.0:1.0 ratio (i.e. 0 % de) 
(Figures 2.102−2.103). This result indicated that epimerisation was occurring at the chiral 
centre (benzylic position) of 38a, upon evaporating the IL from water at 50 oC. 
Epimerisation of 38a may occur under basic or occasionally, acidic conditions. As will be 
postulated in the next chapter (Section 3.2.3), the halide ILs may exhibit acidic properties 
in the presence of water. Therefore we propose that acid-catalysed ester tautomerisation is a 
plausible explanation for the epimerisation of 38a (Figure 2.101).39  
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Figure 2.101 Acid-catalysed epimerization of 38a 
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Figure 2.102 Structure of IL 38a 
 
Figure 2.103 1H NMR spectrum of bromide
 
IL 38a in CDCl3 
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Figure 2.104 Aromatic region in the 1H NMR spectrum of bromide
 
IL 38a in CDCl3 
 
2.6 Preparation of ILs on a large scale as solvents for catalytic hydrogenation 
2.6.1 Synthetic strategy 
Chiral, enantiomerically pure ILs and achiral ILs were needed in large quantities (40 – 120 
g) to be used as solvents for asymmetric hydrogenation reactions (see Chapter 4.0). 
Enantiomerically pure ILs with an acetoxy linker, derived from (S)- and (R)-mandelic acids 
and (S)- 2-methylpiperidine were prepared (Figure 2.105). Synthesis of achiral ILs starting 
from pentanol and di(ethylene glycol) n-butyl ether was also carried out.  
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Figure 2.105 ILs prepared as solvents for hydrogenation reactions 
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ILs derived from both (S)- and (R)-mandelic acid were prepared according to the same 
route previously described for acetoxy linked ILs 23c and 24c. However, in the case of ILs 
40c and 41c, enantiomerically pure starting materials were used (Scheme 2.7). 
Enantiomerically pure (S)- and (R)-mandelic acids are known to be prone to racemisation 
under basic conditions and so a test was performed to determine whether such a process 
was occurring during IL synthesis. In the original procedure used in our group, 
bromoacetylation is promoted by a base (Scheme 2.7) and so two methods for preparing α-
bromo ester 46 (either using K2CO3 or Al2O3) were compared, determing the degree of 
racemisation in each case.  
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Scheme 2.7 Synthetic route to (S)-(+)-methyl mandelate based ionic liquid
 
40c 
 
2.6.2 Determination of optical purity of ILs prepared by two methods 
Methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) was prepared from (S)-(+)-methyl 
mandelate (45) and bromoacetyl bromide by two methods; A, with use of K2CO3 and B, 
with use of Al2O3 (Scheme 2.8).24,22 Next, both compounds 46 were hydrolysed to give (S)-
(+)-methyl mandelate (45) and optical purity was determined by reacting both esters 45 
with (S)-(−)-camphanoyl chloride according to a general procedure.35 Diastereomer 
formation in the camphanate ester, evident by 1H NMR, would indicate racemisation of the 
original mandelate ester. Racemic (RS)-methyl mandelate was also reacted with (S)-(−)-
camphanoyl chloride for comparison purposes.  
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Scheme 2.8 Determination of enantiomeric purity of bromo ester 46 by use of (S)-(−)- 
camphanoyl chloride  
 
According to method A, 46 was prepared under heterogeneous basic conditions using 
potassium carbonate and bromoacetyl bromide. In method B, 46 was obtained after mixing 
of 45 with Al2O3, followed by addition of bromoacetyl bromide. In the next step both 
samples of (S)-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) prepared by methods 
A and B were individually transesterified under acidic conditions. The transesterification 
involved treating a solution of the ester in methanol with thionyl chloride and refluxing for 
3 h to afford 45. In each case (S)-(+)-methyl mandelate (45) was purified by column 
chromatography and then reacted with (S)-(−)-camphanoyl chloride to give methyl 
(2S,1’S)-2-phenyl-2-(3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane) 
carbonyloxy)acetate (47) (Scheme 2.7). Racemic (RS)-methyl mandelate was also reacted 
with (S)-(−)-camphanoyl chloride to give methyl (2RS,1’S)-2-phenyl-2-(3-oxo-4,7,7-
trimethyl-2-oxabicyclo[2.2.1]heptane) carbonyloxy)acetate (48). 
In the 1H NMR spectrum of 48 doubling of some of the signals occurs indicating the 
presence of two diastereomers (2R,1’S and 2S,1’S configuration). This can be observed 
clearly for benzylic proton (H2) where the two signals at 6.00 and 6.03 ppm are visible 
(Figure 2.106).  
For camphanate esters 47 starting from (S)-(+)-methyl mandelate 45, in either the pathway 
involving K2CO3 (method A), or Al2O3 (method B), a single set of signals in the 1H NMR 
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spectrum of the camphanate ester indicated only the presence of the (2S,1’S) diastereomer. 
However, careful analysis of the expanded region at around 6.00 ppm revealed that via 
either method A (Figure 2.107) or B (Figure 2.108), two very small signals (at 6.012 and 
6.006 ppm) accompany the major peak (at 6.033 ppm). A comparison with chemical shifts 
of the camphanate ester from the racemic sample indicated that the second minor peak 
comes from the (2R,1’S) diastereomer and is the result of a racemisation process. This 
conclusion was confirmed by spiking the sample with  a 1:1 mixture of diastereomers 48, 
which caused an increase in the integration of the second minor peak (at 6.006) (Figures 
2.109 and 2.110). The integration ratio of the main peak at 6.033 ppm to the small peak at 
6.006 ppm is about 0.98:0.02 for samples prepared by both methods (Figures 2.107, 2.108). 
It may therefore be concluded that racemisation is taking place at a very low level (approx. 
2 %) during reactions A and B.  
 
Figure 2.106 Protons α to the ester group in 48 obtained by the reaction of racemic methyl 
mandelate with (S)-(−)-camphanoyl chloride 
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Figure 2.107 Method A: Signal H2 of   Figure 2.108 Method B: Signal H2 of   
benzylic proton of 47                                                 benzylic proton of 47 
                   
Figure 2.109 Method A: Sample spiked   Figure 2.110 Method B: Sample spiked   
with 48      with 48  
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2.6.3 Large scale synthesis of mandelic acid derived ILs 
 (S)-(+)-Methyl mandelate derived IL 40c was prepared on a large scale (45.5 g, 79.90 
mmol) according to the literature procedure6 in an overall yield of 87 % (Scheme 2.7). 
Accordingly, in the first step of the synthesis, (S)-(+)-methyl mandelate (45) was prepared 
in good yield (80 %), according to the reported procedure.6 Next, 45 was esterified using 
bromoacetyl bromide to give 46 (Scheme 2.6). As was described in Section 2.6.2, two 
methods of esterification were tested to ensure that no racemisation of the starting material 
45 was taking place. The conclusion was drawn that both of the methods can be used to 
obtain enantiomerically pure material, as only negligible to very low levels of racemisation 
take place during this step. However both of the methods present some drawbacks. In 
method A, an additional equivalent of bromoacetyl bromide and potassium carbonate must 
be added during the synthesis to achieve a good conversion. Even then, a trace of starting 
material 45 (~2 %) still remained in the reaction mixture. In the case of synthesis by 
method B, 1H NMR indicated formation of the minor by-product 2-bromo-2-phenyl acetate 
(also ~2 %). Ultimately, the choice of method was based on the scale of the reaction and 
the nature of the impurities. Hence, when the synthesis of 40c was carried out on a 45 g 
scale, method A was preferred, because large-scale column chromatography can be 
avoided. Traces of the residual starting material, (S)-(+)-methyl mandelate 45 do not 
interfere with alkylation of 1-methylimidazole by 46, and are readily removed from the 
final IL by washing with diethyl ether. Method B is less suitable, because chromatography 
is required to remove the impurity, 2-bromo-2-phenyl acetate, which also reacts with 1-
methylimidazole to form an IL, and would be detrimental to the purity of the final product. 
Method A was routinely employed, using potassium carbonate as a heterogeneous base to 
give (S)-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) in 87 % yield. Next (S)-(+)-
methyl 2-phenyl-2-[2-(3-methylimidazolium)acetoxy]acetate, bromide salt 40a was 
prepared in 86 % yield by reacting 46 with 1-methylimidazole. In the final ion exchange 
step, following the general procedure (Scheme 2.7), NTf2 IL 40c was isolated in an 
excellent yield of 95 %. 
(R)-(−)-Methyl mandelate derived IL
 
41c was prepared following the reported procedures 
used for 40c.6 (R)-(−)-Methyl mandelate (49) was prepared from (R)-(−)-mandelic acid and 
thionyl chloride / methanol in 90 % yield. Ester 49 was reacted with bromoacetyl bromide 
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and potassium carbonate to afford 50 in 72 % yield. (R)-(−)-Methyl 2-phenyl-2-[2-(3-
methylimidazolium)acetoxy]acetate, bromide salt 41a was obtained in 60 % yield via N-
alkylation of 1-methylimidazole by 50. NTf2 IL 41c was prepared in 78 % yield by anion 
exchange with LiNTf2.  
 
2.6.4 Synthesis of achiral ILs  
Pentanol-derived NTf2 IL 43c was prepared on a large scale (72.7 g, 148.12 mmol) in 87 % 
overall yield over three synthetic steps (Scheme 2.9). IL 43c has previously been 
synthesised in our group using triethylamine as a base in the acylation step. However, this 
time the intermediate pentyl 2-bromoacetate (51) was prepared according to an improved 
procedure, using sodium carbonate as a heterogeneous base.13,24 The advantage of this 
method was that pure pentyl 2-bromoacetate was obtained directly, without the distillation 
or column chromatography required in the case of method with triethylamine.  
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Scheme 2.9 Synthetic route to IL 43c 
 
NTf2 IL 44c, derived from di(ethylene glycol) n-butyl ether was prepared on a large scale 
(121.4 g, 214.7 mmol) in 88 % overall yield via the synthetic steps depicted in Scheme 
2.10. Synthesis of 44c was previously carried out in our group using triethylamine as the 
base in the first step. However, on this scale the intermediate 2-(2-butoxyethoxy)ethyl 2-
bromoacetate 52 was again prepared by the improved method using sodium carbonate, 
rather than triethylamine.13,23  
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Scheme 2.10 Synthetic route to ionic liquid 44c 
 
2.6.5 Synthesis of amide ILs  
Based on the results of the asymmetric hydrogenation study (see Chapter 4.0), a chiral 
piperidinyl IL 42c, was identified as a target. IL 42c was prepared over three steps, in an 
overall yield of 72 % (Scheme 2.11). 
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Scheme 2.11 Synthetic route to amide ionic liquid 42c 
 
In the first step, α-bromoamide 53 was synthesised by bromoacetylation of (S)-2-
methylpiperidine in 76 % yield, according to the general procedure, without the need for 
chromatographic purification.24 Next 1-methylimidazole was N-alkylated by the 
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intermediate α-bromo amide 53 to give bromide IL 42a in 76 % yield. Anion exchange was 
carried out with LiNTf2, affording IL 42c in 64 % yield.    
1H NMR spectra recorded for 53, 42a and 42c revealed that the amides exist as a mixture of 
rotamers. Based on relative integrations, peaks corresponding to both the rotamers were 
identified. Geminal couplings between the methylene protons α- to the amide group, give 
an AB system at 5.1–5.7 ppm, apparent in 42a and 42c with J values of 16.4 and 11.0 Hz, 
respectively.  
 
2.7 Conclusions 
Novel methylimidazolium and pyridinium ILs derived from disubstituted mandelic acids 
(3,4-dimethoxy, 3,4-methylenedioxy- and 3,4-dihydroxymandelic acid) with three types of 
counteranion (halide, OctOSO3−, NTf2−) were prepared from simple starting materials. Two 
classes of IL were synthesised, one with a cationic heterocycle linked directly to the chiral 
centre and another with an acetoxy linker between the heterocycle and the chiral centre 
(Figures 2.1, 2.2).  
For examples 1a−6a, which lack an acetoxy linker, the same synthetic scheme was 
followed as for ILs derived from 3,4-dimethoxy and 3,4-methylenedioxymandelic acids (9 
and 10). However, ILs 7a and 8a, derived from 3,4-dihydroxymandelic acid (18) were 
prepared by a shorter route, in which two steps were combined in a “one pot” reaction 
(Scheme 2.3). ILs based on 3,4-dimethoxy and 3,4-methylenedioxymandelic acids (9) and 
(10) were obtained in either four (halide) or five synthetic steps (OctOSO3−, NTf2−). The 
highest yields (82-96 %) were achieved for imidazolium halides, but relatively good yields 
(61-80 %) were also recorded for pyridinium halide ILs. More variable yields were 
obtained for OctOSO3− and NTf2−  ILs, ranging from 46-90 % for the octylsulfates to 67-92 
% for ditriflimides. After optimisation, all of the synthetic steps were very efficient and in a 
routine IL synthesis, column chromatography was only necessary for the purification of α-
haloesters 14-17. During the alkylation step in the synthesis of pyridinium ILs, difficulties 
were encountered in achieving complete conversion, and therefore neat reactions were 
introduced.  
Halide ILs 7a and 8a, derived from 3,4-dihydroxymandelic acid (18), were prepared in 
three steps, whereby the α-haloester was formed in situ and was not isolated. However, 
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purification of the ILs 7a and 8a was more difficult than for 1a−6a. Also yields at each 
synthetic step were lower for the 7a and 8a ILs than for ILs 1a−6a, derived from 3,4-
dimethoxy and 3,4-methylenedioxymandelic acids, 9 and 10. Nevertheless, ILs 7a and 8a 
were synthesised in moderate yields of 65 and 41 %, respectively. Attempts to prepare 
OctOSO3− and NTf2− ILs with the methyl 3,4-dihydroxymandelate core (19) were not 
successful.  
Synthesis of ILs with an acetoxy linker 21a−24a was also achieved, but this class of ILs 
proved unstable towards hydrolysis. Hydrolytic decomposition was even observed during 
their synthesis if moisture was not rigorously excluded (Scheme 2.4). ILs 21a and 22a 
derived from 3,4-dimethoxymandelic acid (9) were prepared, although full characterisation 
was not possible because of IL instability towards hydrolysis. Similar problems were 
encountered with ILs derived from 3,4-methylenedioxymandelic acid (10). However, both 
methyl 3,4-methylenedioxymandelate methylimidazolium, 23a and pyridinium, 24a ILs  
were finally synthesised in a pure form and ion exchange was carried out to give the 
corresponding OctOSO3− and  NTf2− salts. Stability studies on both classes of IL, with the 
acetoxy linker and without, were carried out, as described in Chapter 3.0.  
All of the novel ILs contain stereocentres, but were prepared in racemic form. Obtaining 
chiral ILs in enantiomerically pure form was one of the aims of this project and was 
attempted via various methods of chiral resolution. To achieve this objective, ILs 1c, 5c and 
6c were hydrolysed and then diastereomeric ILs 33c and 34c were prepared by 
esterification with an enantiomerically pure chiral alcohol. However, attempts at resolution 
by chromatographic separation of the diastereomers of 33c or by enzymatic hydrolysis of 
either 34c, 35c or 13 proved unsuccessful. However, substrate control by a chiral auxiliary 
during 1-methylimidazole alkylation confirmed that asymmetric induction is possible 
during IL synthesis. This method resulted in isolation of a diastereomerically enriched NTf2 
IL 38c with a de of 20 %. However, further research towards this objective is necessary, 
since complete epimerisation of bromide IL 38a occurred upon evaporation from water.  
As part of the synthetic part of the project, a large-scale synthesis of known achiral and 
enantiomerically pure chiral ILs was also completed (Figure 2.105). ILs in quantities of 40-
120 g were required for hydrogenation experiments with an industrial collaborator. ILs 
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40a,c and 41a,c derived from enantiomerically pure (S)- and (R)-mandelic acids were 
prepared, after first establishing that racemisation had not taken place during the synthesis.  
An example of an enantiomerically pure amide IL, 42a was also synthesised, and practical 
large scale syntheses of achiral ILs 43a,c and 44a,c from pentanol and di(ethylene glycol) 
n-butyl ether were developed. In the case of achiral ILs and ILs derived from mandelic 
acid, the known synthetic route was scaled up and modified to prevent by-product 
formation and thus avoid inconvenient chromatographic purification.  
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2.8 Experimental section 
Materials and methods: 
Chemicals 
All chemicals were purchased from Sigma-Aldrich, with the exception of LiNTf2, which 
was purchased from Solvionic. Organic solvents, 1-methylimidazole and triethylamine 
were dried over molecular sieves and distilled before use. Riedel de Haen silica gel 
was used for flash and thin layer chromatography. 
NMR Analysis 
All NMR analysis was carried out on a Bruker 400 MHz spectrometer, operating at 400 
MHz for 1 H NMR and 100 MHz for 13C NMR or on a Bruker 600 MHz spectrometer, 
operating at 600 MHz for 1H NMR and 150 MHz for 13C NMR. All spectra were recorded 
in deuterated chloroform, acetonitrile, water, methanol or DMSO. Chemical shifts are 
measured in parts per million (ppm) and coupling constants (J) are measured in Hertz (Hz). 
Splitting patterns are noted as follows: s: singlet; d: doublet; t: triplet; q: quartet; dd: 
doublet of doublets; tt: triplet of triplets; tq: triplet of quartets; br: broad 
LC/MS 
Liquid chromatography mass spectrometry was recorded on an Agilent Technologies 1200 
Series Liquid 252 Chromatography system, with a Agilent Technologies 6110 Mass 
Spectrometer (Quadrupole G6110A). 
HPLC 
High performance liquid chromatography was recorded on Waters TOG-407 system with 
Waters 2487 (dual λ absorbance detector). 
GCMS 
Gas chromatography mass spectrometry analysis was carried out on a Hewlett Packard HP 
6890 Series GC System and a Hewlett Packard 5973 Mass Selective Detector. Column: 
CP-Cyclodextrin-β -2,3,6-M-19. Column temp.: 150 oC isocratic, Flow: 1.0 mL/min, Split 
ratio: 100:1.    
IR analysis 
All IR analysis was carried out on a Perkin Elmer 100 FT-IR spectrometer with ATR. 
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Optical Rotation 
All optical rotation measurements were carried out on a Perkin Elmer 343 Polarimeter in 
chloroform or methanol at 25 ºC. 
 
Melting point 
All melting point measurements (uncorrected) were carried out on a Griffin melting point 
apparatus and values are expressed in degrees Celsius (ºC). 
 
Synthesis of ILs without a linker from (RS)-3,4-dimethoxy- and (RS)-3,4-
methylenedioxymandelic acids 
(RS)-3,4-Dimethoxymandelic acid (9)1,16,40 
7
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A flask was charged with glyoxylic acid (50 % aq. solution, 4.90 mL, 43.86 mmol) and at 
−4 oC conc. sulfuric acid (3.20 mL, 60.08 mmol) was added. The mixture was stirred for 10 
min and then 1,2-dimethoxybenzene (5.588 g, 40.45 mmol) was then added dropwise over 
70 min  at −4 oC. After stirring for an additional 2.5 h at −4 oC water (8 mL) was added, 
followed by 30 % aquoues NaOH (10.80 mL, 12.80 g, 96.00 mmol). The reaction mixture 
was washed with toluene (6 × 30 mL) and extracted with ethyl acetate (6 x 30 mL). The 
organic phase was dried over anhydrous MgSO4, filtered and concentrated under reduced 
pressure to give the title compound 9 as a pale yellow solid in 63 % yield (5.426 g, 25.57 
mmol). 
Product characterization: 
Molecular formula: C10H12O5 
Molecular weight: 212.2 g/mol  
1H NMR (400 MHz, CDCl3, δ): 6.94 (dd, J = 8.2, 2.0 Hz, 1H, H8), 6.92 (d, J = 2.0 Hz, 1H, 
H4) 6.80 (d, J = 8.2 Hz, 1H, H7), 5.15 (s, 1H, H2), 3.83 (s, 3H, H9/H10), 3.82 (s, 3H, 
H9/H10) 
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1H NMR (400 MHz, DMSO-d6, δ): 12.59 (s, 1H, COOH), 7.00-6.89 (m, 3H, H4, H7,  H8), 
4.94 (s, 1H, H2), 3.74 (s, 6H, H9, H10)  
13C NMR (100 MHz, CDCl3, δ): 177.54 (COO, C1), 149.59 (ArC, C5/C6), 149.34 (ArC, 
C5/C6), 130.26 (ArC, C3), 119.61 (ArCH, C8), 111.36 (ArCH, C7), 109.84 (ArCH, C4), 
73.74 (CHOH, C2), 56.17(OCH3, C9/C10), 56.16 (OCH3, C9/C10) 
IR (neat) νmax: 3392, 2943, 2842, 1727, 1709, 1596, 1516, 1465, 1421, 1213, 1140, 1066, 
1017 cm-1 
m.p.: 97-99 oC [lit. m.p.: 105-106 oC]40 
Compound prepared with a modification of the reported procedure1 
1H, 13C NMR, IR in agreement with literature1,16 
 
(RS)-3,4-Methylenedioxymandelic acid (10)3,4,5 
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A flask was charged with glyoxylic acid monohydrate (2.209 g, 24.01 mmol), water (2.23 
mL) and at −10 oC conc. sulfuric acid (2.50 mL, 47.00 mmol) was added dropwise to the 
stirred mixture. After 10 min, 1,2-(methylenedioxy)benzene (2.697 g, 22.10 mmol) was 
added dropwise over 2 h at −10 oC. The reaction mixture was allowed to warm to room 
temperature and stirring continued for an additional 29 h. Water (8 mL) was then added, the 
mixture was stirred further for 10 min and white crystals were filtered.  
The crystals were then dissolved in 30 mL of water, 10 mL of toluene was added and 
mixture was heated to 85 oC. Two more washings with toluene were carried out and 
product was extracted into ethyl acetate (8 × 25 mL). The organic phase was dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure to give the title 
compound 10 as a white solid in 76 % yield (3.306 g, 16.87 mmol).  
Product characterization: 
Molecular formula: C9H8O5 
Molecular weight: 196.2 g/mol 
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1H NMR (400 MHz, d6-DMSO, δ): 6.94 (d, 1H, J = 1.6 Hz, H4), 6.90 (dd, J = 8.0, 1.6 Hz, 
1H, H8), 6.86 (d, J = 8.0 Hz, 1 H, H7), 5.99 (d, part A of an AB system, J = 1.4 Hz, 1H, 
H9), 5.98 (d, part B of an AB system, J = 1.4 Hz, 1H, H9), 4.94 (s, 1H, H2) 
13C NMR (100 MHz, DMSO-d6, δ): 174.13 (COO, C1), 147.05 (ArC, C5/C6), 146.68 
(ArC, C5/C6), 134.09 (ArC, C3), 120.11 (ArCH, C7/C8), 107.85 (ArCH, C7/C8), 106.96 
(ArCH, C4), 100.90 (OCH2O, C9), 72.02 (HCOH, C2)  
IR (neat) νmax: 3446, 3412, 2941, 2907, 1714, 1501, 1485, 1444, 1245, 1196, 1067, 1044 
cm-1 
Compound prepared according to the reported procedures3,4  
1H in agreement with literature5 
(RS)-Methyl 3,4-dimethoxymandelate (11)1,41 
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To a stirred solution of 3,4-dimethoxymandelic acid (9) (4.080 g, 19.23 mmol) in methanol 
(15 mL) was added thionyl chloride (2.00 mL, 27.41 mmol) dropwise at room temperature. 
After stirring for 2.5 h the reaction was quenched with water (10 mL) and the product was 
extracted with CH2Cl2 (4 × 25 mL). The combined extracts were washed with saturated 
aqueous sodium bicarbonate (3 × 15 mL), dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The resulting ester was purified by column 
chromatography (SiO2, CH2Cl2:EtOAc 88:12) to give the title compound 11 as a yellow oil 
in 69 % yield (3.012 g, 13.32 mmol). 
Product characterization: 
Molecular formula: C11H14O5 
Molecular weight: 226.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 6.94-6.91 (m, 2H, H4, H8), 6.82 (d, J = 8.0 Hz, 1H, H7), 
5.10 (s, 1H, H2), 3.85 (s, 3H, H9/H10), 3.84 (s, 3H, H9/H10), 3.73 (s, 3H, H11) 
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13C NMR (100 MHz, CDCl3, δ): 174.47 (COO, C1), 149.45 (ArC, C5/C6), 149.36 (ArC, 
C5/C6), 131.04 (ArC, C3), 119.49 (ArCH, C8), 111.28 (ArCH, C7), 109.73 (ArCH, C4), 
72.95 (CHOH, C2), 56.15 (OCH3, C9/C10), 56.13 (OCH3, C9/C10), 53.21 (OCH3, C11) 
ESI-MS (70 eV) m/z: 249.0 (M + Na+), 209.0 (M - OH) 
IR (neat) νmax:  3462, 2951, 2839, 1734, 1594, 1513, 1463, 1454, 1441, 1420, 1258, 1232, 
1138, 1076, 1021 cm-1 
GCMS(EI) m/e: 226.1 (M+, 29 %), 227.0 (3), 139 (66), 167 (100) 
1H, 13C NMR, IR in agreement with literature1,41 
 
 (RS)-Butyl 3,4-dimethoxymandelate (12) 
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To a solution of 3,4-dimethoxymandelic acid (9) (7.501 g, 35.35 mmol) in butanol (15 mL) 
was added thionyl chloride (3.60 mL, 49.34 mmol) dropwise at room temperature. After 
stirring for 2 h, the reaction was quenched with water (50 mL) and the product was 
extracted with CH2Cl2 (8 × 25 mL). The combined extracts were washed with aqueoues 
saturated sodium bicarbonate (3 × 15 mL), dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The resulting oil was azeotroped with ten portions of 
hexane to give the title compound 12 as yellow oil in 80 % yield (7.601 g, 28.33 mmol). 
Product characterization: 
Molecular formula: C14H20O5 
Molecular weight: 268.3 g/mol 
1H NMR (400 MHz, CDCl3, δ): 6.92 (dd, J = 8.0, 2.0 Hz, H8), 6.90 (d, J = 2.0 Hz, 1H, H4), 
6.80 (d, J = 8.0 Hz, 1H, H7), 5.07 (d, J = 5.0 Hz 1H, H2), 4.13 (dt, J
 
 = 10.8, 6.8 Hz 1H, 
H11), 4.10 (dt, J = 10.8, 6.8 Hz 1H, H11), 3.830 (s, 3H, H9), 3.825 (s, 3H, H10), 3.61 (d, J 
= 5.0 Hz 1H, OH) 1.56-1.49 (m, 2H, H12), 1.21 (tq, J = 8.5, 7.4 Hz, 2H, H13), 0.82 (t, J = 
7.4 Hz, 3H, H14)  
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13C NMR (100 MHz, CDCl3, δ): 173.86 (COO, C1), 149.01 (ArC, C5/C6), 148.97 (ArC, 
C5/C6), 131.00 (ArC, C3), 119.10 (ArCH, C8), 110.89 (ArCH, C7), 109.32 (ArCH, C4), 
72.64 (CH, C2), 65.87 (OCH2, C11), 55.87 (OCH3, C9/C10), 55.81 (OCH3, C9/C10), 30.41 
(CH2, C12), 18.86 (CH2, C13), 13.55 (CH3, C14)  
IR (neat) νmax: 3465, 2960, 1731, 1514, 1260, 1235, 1139, 1080, 1024, 803, 764 cm-1 
GCMS(EI) m/e: 268.1 (M+, 15 %), 269.1 (2), 139 (50), 167 (100) 
 
(RS)-Methyl 3,4-methylenedioxymandelate (13)42 
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To a stirred solution of 3,4-methylenedioxymandelic acid (10) (3.896 g, 19.88 mmol) in 
methanol (40 mL) was added thionyl chloride (0.73 mL, 9.94 mmol) dropwise at room 
temperature. After stirring for 1.5 h the reaction was quenched with water and the product 
was extracted with CH2Cl2 (5 × 25 mL). The combined extracts were washed with saturated 
aqueous sodium bicarbonate (3 × 15 mL), dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to give the title compound 13 as white crystals in 93 
% yield (3.871 g, 18.43 mmol).   
Product characterization: 
Molecular formula: C10H10O5 
Molecular weight: 210.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 6.90-6.88 (m, 2H, H4, H7), 6.79 (dd, J = 7.2, 1.2 Hz, 1H, 
H8), 5.97 (s, 2H, H9), 5.08 (s, 1H, H2), 3.77 (s, 3H, H10). 
13C NMR (100 MHz, CDCl3, δ): 174.43 (COO, C1), 148.19 (ArC, C5/C6), 148.08 (ArC, 
C5/C6), 132.35 (ArC, C3), 120.72 (ArCH, C4/C8), 108.59 (ArCH, C7), 107.29 (ArCH, 
C4/C8), 101.53 (OCH2O, C9), 72.92 (CHOH, C2), 53.37 (OCH3, C10) 
IR (neat) νmax: 3442, 2952, 2913, 1733, 1487, 1436, 1234, 1203, 1174, 1083, 1032 cm-1 
GCMS(EI) m/e: 210.0 (M+, 28 %), 211.0 (3), 93 (73), 65 (38), 151 (100) 
1H with agreement with literature data42 
m.p.: 88-89 oC [lit.: 93-95 oC]42 
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(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-methoxyacetate (20) 
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To a stirred solution of 3,4-dimethoxymandelic acid (9) (3.084 g, 14.53 mmol) in methanol 
(20 mL) was added thionyl chloride (2 mL, 27.41 mmol) dropwise and the reaction mixture 
was refluxed for 2 h. The reaction was quenched with water and extracted with CH2Cl2 (4 × 
25 mL). The combined extracts were dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The resulting crude product was purified by column 
chromatography (SiO2, CH2Cl2:EtOAc 95:5) to give the title compound 20 as a yellow oil 
in 13 % yield (0.445 g, 1.85 mmol). 
Product characterization: 
Molecular formula: C12H16O5 
Molecular weight: 240.3 g/mol 
1H NMR (400 MHz, CDCl3, δ): 6.99-6.97 (m, 2H, H4, H8), 6.85 (d, J = 8.0 Hz, H7) 4.72 
(s,1H, H2), 3.90 (s, 3H, H9/H10), 3.88 (s, 3H, H9/H10), 3.73 (s, 3H, H11), 3.40 (s, 3H, 
H12) 
13C NMR (100 MHz, CDCl3, δ): 171.54(COO, C1), 149.58 (ArC, C5/C6), 149.37 (ArC, 
C5/C6), 128.65 (ArC, C3), 120.35 (ArCH, C4/C8), 111.08 (ArCH, C7), 109.82 (ArCH, 
C4/C8), 82.37 (CH, C2), 57.23 (OCH3, C12), 56.07 (OCH3, C9/C10), 56.04 (OCH3, 
C9/C10), 52.51 (OCH3, C11) 
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(RS)-Methyl 2-chloro-2-(3, 4-dimethoxyphenyl)acetate (14) 
7
6
5
4
3
8
O
O
2
Cl
1
O
O
10
9
11
 
To a stirred solution of methyl 3,4-dimethoxymandelate (11) (4.569 g, 20.20 mmol) in 
CH2Cl2 (40 mL) at 0 oC was added thionyl chloride (1.48 mL, 20.28 mmol) dropwise, 
followed by TEA (2.81 mL, 20.23 mmol) also added dropwise and the reaction mixture 
was allowed to warm to room temperature. After stirring for 1 h the reaction mixture was 
washed with distilled water (3 × 10 mL). The organic phase was dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. The resulting oil was purified by 
column chromatography (SiO2, hexane:EtOAc, 80:20) to give the title compound 14 as a 
colourless oil in 58 % yield (2.859 g, 11.68 mmol).  
 
Product characterization: 
Molecular formula: C11H13ClO4 
Molecular weight: 244.7 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.02 (d, J = 2.0 Hz, 1H, H4), 6.99 (dd, J = 8.2, 2.0 Hz, 1H, 
H8), 6.81 (d, J = 8.2 Hz, 1H, H7), 5.31 (s, 1H, H2), 3.88 (s, 3H, H9/H10), 3.86 (s, 3H, 
H9/H10), 3.75 (s, 3H, H11) 
13C NMR (100 MHz, CDCl3, δ): 169.23 (COO, C1), 150.20 (ArC, C5/C6), 149.52 (ArC, 
C5/C6), 128.23 (ArC, C3), 121.02 (ArCH, C8), 111.14 (ArCH, C7), 110.96 (ArCH, C4), 
59.25 (CH, C2), 56.22 (OCH3, C9/C10), 56.18 (OCH3, C9/C10), 53.53 (OCH3, C11) 
IR (neat) νmax: 2956, 2839, 1751, 1514, 1261, 1139, 1023, 760, 722 cm-1 
GCMS(EI) m/e: 244.0 (M+, 29 %), 246.0 (10), 209 (53), 187 (33), 185 (100) 
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(RS)-Butyl 2-chloro-(3, 4-dimethoxyphenyl)acetate (15) 
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To a stirred solution of butyl 3,4-dimethoxymandelate (12) (3.018 g, 11.26 mmol) in 
CH2Cl2 (50 mL) at 0 oC was added thionyl chloride (0.82 mL, 11.26 mmol) dropwise, 
followed by TEA (1.56 mL, 11.26 mmol) also added dropwise and the reaction mixture 
was allowed to warm to room temperature. After stirring for 4 h the reaction mixture was 
washed with distilled water (3 × 20 mL). The organic phase was dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. The resulting oil was purified by 
column chromatography (SiO2, CH2Cl2) to give the title compound 15 as a colorless oil in 
78 % yield (2.513 g, 8.77 mmol).  
Product characterization: 
Molecular formula: C14H19ClO4 
Molecular weight : 286.8 g/mol
 
1H NMR (400 MHz, CDCl3, δ): 7.04 (d, J = 2.2 Hz, 1H, H4), 7.01 (dd, J  = 8.3, 2.2 Hz, 1H, 
H8), 6.82 (d, J = 8.3 Hz, 1H, H7), 5.30 (s, 1H, H2), 4.19 (dt, J
 
 = 10.8, 6.7 Hz, 1H, H11), 
4.13 (dt, J
 
 = 10.8, 6.7 Hz, 1H, H11), 3.89 (s, 3H, H9/H10), 3.88 (s, 3H, H9/H10), 1.60 (tt, J 
= 7.5, 6.5 Hz, 2H, H12), 1.31 (tq, J = 7.5, 7.5 Hz, 2H, H13), 0.88 (t, J = 7.4 Hz, 3H, H14) 
13C NMR (100 MHz, CDCl3, δ): 168.79 (COO, C1), 150.02 (ArC, C5/C6), 149.37 (ArC, 
C5/C6), 128.35 (ArC, C3), 120.98 (ArCH, C8), 110.97(ArCH, C4), 110.80 (ArCH, C7), 
66.44 (OCH2, C11), 59.45 (CH, C2), 56.11 (OCH3, C9, C10), 30.58 (CH2, C12), 19.13 
(CH2, C13), 13.81 (CH3, C14)  
IR (neat) νmax: 2960, 2936, 1747, 1604, 1593, 1514, 1463, 1421, 1261, 1246, 1152, 1140, 
1024, 912, 730 cm-1 
GCMS(EI) m/e: 286.1 (M+, 20 %), 288.0 (7), 187 (33), 151 (46), 185 (100) 
 
 
 
 131
(RS)-Methyl 2-chloro-2-(3,4-methylenedioxyphenyl) acetate (16) 
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To a stirred solution of methyl 3,4-methylenedioxymandelate (13) (3.155 g, 15.03 mmol) in 
CH2Cl2 (50 mL) at 0 oC was added thionyl chloride (1.10 mL, 15.03 mmol) dropwise, 
followed by  TEA (2.10 mL, 15.03 mmol) also added dropwise and the reaction mixture 
was allowed to warm to room temperature. After stirring for 1 h the reaction mixture was 
washed with distilled water (4 ×15 mL). The organic phase was dried over anhydrous 
MgSO4, filtrated and concentrated under reduced pressure. The resulting oil was purified by 
column chromatography (SiO2, CH2Cl2) to give the title compound 16 as a colourless oil in 
65 % yield (2.229 g, 9.76 mmol).  
Product characterization: 
Molecular formula: C10H9ClO4 
Molecular weight: 228.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.02 (d, J = 2.0 Hz, 1H, H4), 6.92 (dd, 1H, J = 8.0, 2.0 Hz, 
H8), 6.77 (d, J = 8.0 Hz, 1H, H7), 5.99 (d, part A of an AB system, J = 1.4 Hz, 1H, H9), 
5.98 (d, part B of an AB system, J = 1.4 Hz, 1H, H9), 5.28 (s, 1H, H2), 3.78 (s, 3H, H10)  
13C NMR (100 MHz, CDCl3, δ): 169.04 (COO, C1), 148.85 (ArC, C5/C6) 148.41 (ArC, 
C5/C6) 129.50 (ArC, C3) 122.89 (ArCH, C8) 109.39 (ArCH, C4) 108.39 (ArCH, C7) 
101.84 (OCH2O, C9), 53.67 (OCH3, C10), 46.96 (CH, C2) 
IR (neat) νmax: 2956, 2901, 1749, 1503, 1489, 1444, 1246, 1160, 1036 cm-1 
GCMS(EI) m/e: 228.0 (M+, 28 %), 230.0 (9), 193 (27), 171 (33), 169 (100) 
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(RS)-Methyl 2-bromo-2-(3,4-methylenedioxyphenyl) acetate (17)42 
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To a stirred solution of methyl 3,4-methylenedioxymandelate (13) (6.596 g, 31.41 mmol) 
(13) in CH2Cl2 (60 mL) at 0 oC was added thionyl bromide (2.44 mL, 31.41 mmol) 
dropwise, followed by TEA (4.36 mL, 31.41 mmol) also added dropwise and the reaction 
mixture was allowed to warm to room temperature. After stirring for 35 min the reaction 
mixture was washed with distilled water (3 × 15 mL). The organic phase was dried over 
anhydrous MgSO4, filtrated and concentrated under reduced pressure. The resulting oil was 
purified by column chromatography (SiO2, hexane:CH2Cl2, 50:50) to give the title 
compound 17 as a colourless oil in 68 % yield (5.843 g, 21.40 mmol).  
Product characterization: 
Molecular formula: C10H9BrO4 
Molecular weight: 273.08 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.12 (d, J = 2.0 Hz, 1H, H4), 6.94 (dd, J = 8.0, 2.0 Hz, 1H, 
H8), 6.74 (d, J = 8.0 Hz, 1H, H7), 5.97 (d, part A of an AB system, J = 1.4 Hz, 1H, H9), 
5.97 (d, part B of an AB system, J = 1.4 Hz, 1H, H9), 5.31 (s, 1H, H2), 3.78 (s, 3H, H10) 
13C NMR (100 MHz, CDCl3, δ): 168.99 (COO, C1), 148.86 (ArC, C5/C6), 148.42 (ArC, 
C5/C6), 129.51 (ArC, C3), 122.89 (ArCH, C8), 109.39 (ArCH, C4), 108.39 (ArCH, C7), 
101.84 (OCH2O, C9), 53.66 (OCH3, C10), 46.96 (CH, C2) 
IR (neat) νmax: 3002, 2954, 2899, 1740, 1627, 1609, 1502, 1488, 1445, 1436, 1369, 1270, 
1243, 1202, 1175, 1141, 1101, 1035 cm-1 
GCMS(EI) m/e: 271.9 (M+, 8.5 %), 273.9 (7.9), 135 (58), 165 (48), 193 (100)   
1H NMR in accordance with literature data42  
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(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, chloride salt 
(1a) 
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To a stirred solution of methyl 2-chloro-2-(3,4-dimethoxyphenyl)acetate (14) (0.398 g, 1.63 
mmol) in diethyl ether (10 mL) at -15 oC under a N2 atmosphere was added 1-
methylimidazole (0.11 mL, 1.38 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring for 24 h a white solid, which precipitated, was 
collected by filtration. The remaining organic layer was concentrated under reduced 
pressure to yield a white solid. The combined solids were dissolved in CH2Cl2 (12 mL) and 
the organic phase was extracted with water (4 × 2 mL). Water was evaporated under 
reduced pressure and product was coevaporated with chloroform at RT to give the title 
compound 1a as a white crystalline powder in 89 % yield (0.401 g, 1.23 mmol).  
Product characterization: 
Molecular formula: C15H19ClN2O4 
Molecular weight: 326.8 g/mol 
1H NMR (400 MHz, CDCl3, δ): 11.09 (s, 1H, H12), 7.42 (t, J = 1.6 Hz, 1H, H14), 7.41(s, 
1H, H2), 7.37 (d, J = 2.2 Hz, 1H, H4), 7.11 (t, J = 1.6 Hz, 1H, H13), 7.02 (dd, J = 8.4, 2.2 
Hz, 1H, H8), 6.87 (d, J = 8.4 Hz, 1H, H7), 4.01 (s, 3H, H15), 3.93 (s, 3H, H9), 3.88 (s, 3H, 
H10), 3.83 (s, 3H, H11) 
13C NMR (100 MHz, CDCl3, δ): 168.66 (COO, C1), 150.71 (ArC, C6), 150.03 (ArC, C5), 
138.10 (ArC, C12), 124.68 (ArC, C3), 123.13 (ArC, C13), 121.80 (ArC, C14), 121.03 
(ArCH, C8), 112.65 (ArCH, C4), 111.80 (ArCH, C7), 64.10 (NCH, C2), 56.62 (OCH3, C9), 
56.21 (OCH3, C10), 53.83 (OCH3, C11), 36.98 (NCH3, C15) 
IR (neat) νmax: 3376, 3013, 2954, 2840, 1745, 1593, 1517, 1442, 1425, 1264, 1215, 1146, 
1020 cm-1 
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ESI-MS (70 eV) m/z: [M-Cl]+: 291.10 
ESI-HRMS calc. for C15H19N2O4 [M-Cl]+: 291.1345, found: 291.1331 
m.p.: 93-95 oC 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, chloride salt 
(3a)  
7
6
5
4
3
8
O
O
2
N
1
O
O
15
N
16
17
18
11
12
13
14
10
9
Cl
 
To a stirred solution of butyl 2-chloro-2-(3,4-dimethoxyphenyl) acetate (15) (2.027 g, 7.07 
mmol) in diethyl ether (10 mL) at -15 oC under a N2 atmosphere was added 1-
methylimidazole (0.53 mL, 6.72 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring for 24 h a white solid precipitated, which was 
collected by filtration. The remaining organic layer was refluxed for 4h to yield a white 
solid. The combined solids were washed with diethyl ether. Product was dried under 
reduced pressure to give the title compound 3a as a white crystalline powder in 82 % yield 
(2.021 g, 5.48 mmol).  
Product characterization: 
Molecular formula: C18H25ClN2O4 
Molecular weight: 368.9 g/mol 
1H NMR (600 MHz, CDCl3, δ): 11.02 (s, 1H, H15), 7.40 (s, 1H, H17), 7.35 (d, 1H, J = 1.7 
Hz, H4), 7.23 (s, 1H, H2), 7.11 (s, 1H, H16), 7.02 (dd, J = 8.3, 1.7 Hz, 1H, H8), 6.87 (d, J 
= 8.3 Hz, 1H, H7), 4.27 (dt, J = 10.7, 6.8 Hz, 1H, H11), 4.20 (dt, 1H, J = 10.7, 6.8 Hz, 1H, 
H11), 4.02 (s, 3H, H18), 3.92 (s, 3H, H9), 3.88 (s, 3H, H10), 1.66-1.56 (m, 2H, H12), 1.28 
(tq, J = 7.5, 7.3 Hz, 2H, H13), 0.87 (t, J = 7.4 Hz, 3H, H14)   
13C NMR (150 MHz, CDCl3, δ): 168.39 (COO, C1), 150.85 (ArC, C6), 150.23 (ArC, C5), 
139.29 (ArC, C15), 125.05 (ArC, C3), 122.22 (ArC, C14), 121.90 (ArC, C17), 120.67 
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(ArCH, C8), 112.92 (ArCH, C4), 111.71 (ArCH, C7), 67.29 (OCH2, C11), 64.28 (NCH, 
C2), 56.80 (OCH3, C9), 56.32 (OCH3, C10), 37.05 (NCH3, C18), 30.56 (CH2, C12), 19.21 
(CH2, C13), 13.86 (CH3, C14) 
IR (neat) νmax: 3412, 3079, 3117, 2969, 2874, 1742, 1259, 1234, 1061, 1036, 1146, 1259, 
1234, 1464, 1452, 1514, 771, 755 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 333.10  
ESI-HRMS calc. for C18H25N2O4 [M-Cl]+: 333.1814, found: 333.1803 
m.p.: 96-98 oC 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(3-methylimidazolium)acetate, chloride 
salt (5a) 
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To a stirred solution of methyl 2-chloro-2-(3,4-methylenedioxyphenyl) acetate (16) (1.839 
g, 8.05 mmol) in diethyl ether (5 mL) at −15 oC under a N2 atmosphere was added 1-
methylimidazole (0.62 mL, 7.64 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. The reaction mixture was stirred for 48 h and then refluxed for 
24 h. A solid which had precipitated, was collected by filtration, washed with diethyl ether 
(5 × 10) and dried under reduced pressure to give the title compound 5a as a white powder 
in 96 % yield (2.283 g, 7.35 mmol).  
Product characterization: 
Molecular formula: C14H15ClN2O4 
Molecular weight: 310.7 g/mol 
1H NMR (400 MHz, CDCl3, δ): 10.54 (s, 1H, H11), 7.65 (s, 1H, H12), 7.52 (s, 1H, H13), 
7.34 (s, 1H, H2), 7.34-7.00 (m, 2H, H4, H8), 6.72 (d, J = 8.0 Hz, 1H, H7), 5.89 (d, J = 1.2 
Hz, 2H, H9), 3.98 (s, 3H, H14), 3.70 (s, 3H, H10) 
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13C NMR (100 MHz, CDCl3, δ): 168.45 (COO, C1), 149.40 (ArC, C6), 148.78 (ArC, C5), 
137.99 (ArC, C11), 125.97 (ArC, C3), 123.35 (ArCH, C8), 123.22 (ArC, C12), 121.85 
(ArCH, C13), 109.35 (ArCH, C7), 108.97 (ArCH, C4), 102.05 (OCH2O, C9), 63.73 (NCH, 
C2), 53.89 (OCH3, C10), 36.96 (NCH3, C14)  
IR (neat) νmax: 3407, 3013, 2951, 1755, 1742, 1590, 1552, 1492, 1449, 1321, 1284, 1238, 
1257, 1167, 1035 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 275.00  
ESI-HRMS calc. for C14H15N2O4 [M-Cl]+: 275.1032, found: 275.1019 
m.p.: 122-124 oC 
 
(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt (2a) 
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Pyridine (0.14 mL, 1.70 mmol) was added to methyl 2-chloro-2-(3,4-dimethoxyphenyl) 
acetate (14) (0.454 g, 1.86 mmol) and the reaction mixture was stirred in the darkness with 
drying tube at 35 oC for 20 hours. After that yellow solid was washed with diethyl ether (3 
× 10 mL) and appearing yellow powder was filtered. Then product was washed with hot 
acetone (6 × 10 mL) and the white powder was collected by filtration. Product was dried 
under reduced pressure to give the title compound 2a in 61 % yield (0.335 g, 1.04 mmol). 
Product characterization: 
Molecular formula: C16H18ClNO4 
Molecular weight: 323.8 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.56-9.55 (m, 2H, H12, H16), 8.53-8.49 (m, 1H, H14),  
8.29 (s, 1H, H2), 8.04-8.01 (m, 2H, H13, H15), 7.49 (d, J = 2.0 Hz, 1H, H4), 7.04 (dd, J = 
8.2, 2.0 Hz, 1H, H8), 6.81 (d, J = 8.2 Hz, 1H, H7), 3.77 (s, 3H, H9/H10), 3.76 (s, 3H, 
H9/H10), 3.72 (s, 3H, H11)  
 137
13C NMR (150 MHz, CDCl3, δ): 167.87 (COO, C1), 150.94 (ArC, C6), 149.94 (ArC, C5), 
146.55 (ArC, C14), 144.99 (ArC, C12, C16), 127.98 (ArC, C13, C15), 123.40 (ArC, C3), 
121.78 (ArCH, C8), 113.38 (ArCH, C4), 111.58 (ArCH, C7), 73.32 (NCH, C2), 56.42 
(OCH3, C9/C10), 56.96 (OCH3, C9/C10), 53.95 (OCH3, C11)  
IR (neat) νmax: 3357, 3050, 3011, 2940, 2847, 1735, 1634, 1591, 1517, 1481, 1438, 1306, 
1265, 1230, 1026, 1004 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 288.10 
ESI-HRMS calc. for C16H18NO4 [M-Cl]+: 288.1236, found: 288.1223 
m.p.: 118-119 oC 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt (4a) 
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Pyridine (0.24 mL, 2.95 mmol) was added to butyl 2-chloro-2-(3,4-dimethoxyphenyl) 
acetate (15) (0.941 g, 3.28 mmol) and the reaction mixture was stirred in the darkness with 
the drying tube at 35 oC for 18 hours. After that yellow solid was washed with diethyl ether 
(6 × 20 mL) and the white powder was collected by filtration. Product was dried under 
reduced pressure to give the title compound 4a in 66 % yield (0.710 g, 1.94 mmol). 
Product characterization: 
Molecular formula: C19H24ClNO4 
Molecular weight: 365.9 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.39-9.38 (m, 2H, H15, H19), 8.44-8.40 (m, 1H, H17), 
8.01 (s, 1H, H2), 7.95-7.91 (m, 2H, H16, H18), 7.35 (d, J = 1.6 Hz, 1H, H4), 6.92 (dd, J = 
8.4, 1.6 Hz, 1H, H8), 6.68 (d, J = 8.4 Hz, 1H, H7), 4.08 (dt, J = 10.8, 6.8 Hz, 1H, H11), 
3.91 (dt, J = 10.8, 6.8 Hz, 1H, H11), 3.62 (s, 3H, H9, H10), 1.40-1.29 (m, 2H, H12), 1.05-
0.96 (tq, J = 7.4 Hz, 2H, H13), (t, J = 7.4 Hz, 3H, H14) 
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13C NMR (100 MHz, CDCl3, δ): 167.25 (COO, C1), 150.62 (ArC, C5/C6), 149.64 (ArC, 
C5/C6), 146.40 (ArC, C17), 144.68 (ArC, C15, C19), 127.79 (ArC, C16, C18), 123.19 
(ArC, C3), 121.57 (ArCH, C8), 113.11 (ArCH, C4), 111.21 (ArCH, C7), 73.40 (NCH, C2), 
67.11 (OCH2, C11), 56.16 (OCH3, C9/C10), 55.73 (OCH3, C9/C10), 29.87 (CH2, C12), 
18.54 (CH2, C13), 13.24 (CH3, C14)  
IR (neat) νmax: 3380, 2959, 2937, 1739, 1631, 1517, 1479, 1464, 1348, 1263, 1239, 1207, 
1146, 1019 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 330.15 
ESI-HRMS calc. for C19H24NO4 [M-Cl]+: 330.1705, found: 330.1699 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, chloride salt (6a) 
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Pyridine (0.08 mL, 1.0 mmol) was added to methyl 2-chloro-2-(3,4-methylendioxyphenyl) 
acetate (16) (0.253 g, 1.11 mmol) and the reaction mixture was stirred in the darkness with 
the drying tube at 35 oC for 18 hours. The resulting white solid was washed with diethyl 
ether (6 × 5 mL) and collected by filtration. Product was dried under reduced pressure to 
give the title compound 6a in 80 % yield (0.272 g, 0.88 mmol). 
Product characterization: 
Molecular formula: C15H14ClNO4 
Molecular weight: 307.7 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.61-9.60 (m, 2H, H11, H15), 8.59-7.16 (m, 1H, H13), 
8.45 (s, 1H, H2), 8.10-8.06 (m, 2H, H12, H14), 7.18-7.16 (m, 2H, H4, H8), 6.79 (d, 1H, J = 
8.4 Hz, H7), 5.95 (d, part A of an AB system, J = 1.2 Hz, 1H, H9), 5.93 (d, part B of an AB 
system, J = 1.2 Hz, 1H, H9), 3.79 (s, 3H, H10) 
13C NMR (100 MHz, CDCl3, δ): 167.99 (COO, C1), 149.83 (ArC C6), 148.88 (ArC C5), 
146.53 (ArC, C13), 145.14 (ArC, C11, C15), 127.96 (ArC, C12, C14), 124.66 (ArC, C3), 
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124.24 (ArCH, C8),, 109.76 (ArCH, C4), 109.35 (ArCH, C7), 102.03 (OCH2O, C9), 72.92 
(CHN, C2), 54.13 (OCH3, C10) 
IR (neat) νmax: 3041, 3012, 2955, 2903, 2834, 2778, 2739, 1741, 1628, 1502, 1487, 1442, 
1396, 1240, 1216, 1167, 1024, 1005, 760 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 272.10 
ESI-HRMS calc. for C15H14NO4 [M-Cl]+: 272.0923, found: 272.0917 
m.p.: 152-154 oC 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, bromide salt (6d) 
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To a stirred solution of methyl 2-bromo-2-(3,4-methylenedioxyphenyl) acetate (17) (1.946 
g, 7.13 mmol) in diethyl ether (20 mL) at -15 oC under a N2 atmosphere was added pyridine 
(0.69  mL, 8.55 mmol) dropwise and the reaction mixture was allowed to warm to room 
temperature. The reaction mixture was stirred overnight, then refluxed for 8 h and stirred at 
room temperature for another 12 h. The solid which had precipitated, was collected by 
filtration, washed with diethyl ether and dried under reduced pressure to give the title 
compound 6d as a white powder in 79 % yield (1.969 g, 5.59 mmol).  
Product characterization: 
Molecular formula: C15H14BrNO4 
Molecular weight : 352.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.50-9.49 (m, 2H, H11, H15), 8.65-8.61 (m, 1H, H13), 
8.27 (s, 1H, H2), 8.13-8.09 (m, 2H, H12, H14), 7.19-7.17 (m, 2H, H4, H8), 6.81 (d, J = 8.4 
Hz, 1H, H7), 5.97 (d, part A of an AB system, J = 1.0 Hz, 1H, H9), 5.95 (d, part B of an 
AB system, J = 1.0 Hz, 1H, H9), 3.81 (s, 3H, H10) 
13C NMR (100 MHz, CDCl3, δ): 167.73 (COO, C1), 149.96 (ArC C5/C6), 148.96 (ArC 
C5/C6), 147.12 (ArC, C13), 144.84 (2ArC, C11, C15), 127.95 (2ArC, C12, C14), 124.39 
 140
(ArC, C3), 124.25 (ArCH, C4/C8), 109.87 (ArCH, C4/C8), 109.46 (ArCH, C7), 102.18 
(OCH2O, C9), 73.05 (CHN, C2), 54.34 (OCH3, C10) 
IR (neat) νmax: 3038, 3016, 2953, 2899, 2854, 2830, 2774, 1741, 1627, 1486, 1441, 1396, 
1239, 1215, 1171, 1025, 1003, 915, 760 cm-1  
ESI-MS (70 eV) m/z: [M-Br]+: 272.00  
ESI-HRMS calc. for C15H14NO4 [M-Br]+: 272.0923, found: 272.0919 
m.p.: 146-147 oC 
 
(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, octylsulfate 
salt (1b) 
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To a stirred solution of methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, 
chloride salt (1a) (0.675 g, 2.07 mmol) in distilled water (10 mL) was added sodium 
octylsulfate (0.817 g, 3.52 mmol) at room temperature. After stirring overnight the water 
was evaporated in vacuo and the resulting solid was dissolved in CH2Cl2 (12 mL). The 
organic phase was washed with water (5 × 2 mL) and concentrated under reduced pressure 
to give the title compound 1b as colourless oil in 46 % yield (0.480 g, 0.96 mmol). 
Product characterization: 
Molecular formula: C23H36N2O8 
Molecular weight: 500.61 g/mol 
1H NMR (600 MHz, CDCl3, δ): 9.30 (s, 1H, H12), 7.42 (t, J = 1.6 Hz, 1H, H13), 7.33 (t, J 
= 1.6 Hz, 1H, H14), 7.03 (d, J = 2.0 Hz, 1H, H4), 6.90 (dd, J = 8.4, 2.0 Hz, 1H, H8), 6.77 
(d, J = 8.4 Hz, 1H, H7), 6.57 (s, 1H, H2), 3.85 (t, J = 6.9 Hz, 2H, H16), 3.83 (s, 3H, H11), 
3.74 (s, 3H, H9), 3.72 (s, 3H, H10), 3.65 (s, 3H, H15), 1.47 (tt, J = 7.5, 6.9 Hz, 2H, H17), 
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1.19-1.15 (m, 2H, H18), 1.13-1.08 (m, 8H, H19, H20, H21, H22), 0.69 (t, J = 7.1 Hz, 3H, 
H23)  
 
13C NMR (150 MHz, CDCl3, δ): 168.16 (COO, C1), 150.40 (ArC, C6), 149.73 (ArC, C5), 
137.34 (NCH, C12), 124.27 (ArC, C3), 123.39 (NCH, C13), 121.80 (NCH, C14), 120.85 
(ArCH, C8), 112.23 (ArCH, C4), 111.58 (ArCH, C7), 67.64 (OCH2, C16), 64.12 (NCH, 
C2), 56.18 (OCH2, C9), 55.87 (OCH3, C10), 53.48 (OCH3, C11), 36.40 (NCH3, C15), 31.66 
(CH2, C21/C22), 29.39 (CH2, C17), 29.20 (CH2, C19), 29.09 (CH2, C20), 25.75 (CH2, C18), 
22.49 (CH2, C21/C22), 13.97 (CH3, C23) 
IR (neat) νmax: 3484, 3105, 2927, 2856, 1750, 1594, 1518, 1465, 1210, 1146, 1058 
790, 748 cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 291.10  
ESI-HRMS calc. for C15H19N2O4 [M-OctOSO3]+: 291.1345, found: 291.1333 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, octylsulfate salt 
(3b) 
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To a stirred solution of butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, 
chloride salt (3a) (0.672 g, 1.82 mmol) in distilled water (10 mL) was added sodium 
octylsulfate (0.440 g, 1.90 mmol) at room temperature. After stirring overnight the water 
was evaporated in vacuo and the resulting solid was dissolved in CH2Cl2 (12 mL). The 
organic phase was washed with water (2 × 2 mL) and concentrated under reduced pressure 
to give the title compound 3b as colorless oil in 88 % yield (0.866 g, 1.60 mmol). 
Product characterization: 
Molecular formula: C26H42N2O8S 
Molecular weight: 542.7 g/mol 
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1H NMR (400 MHz, CDCl3, δ): 9.55 (s, 1H, H15), 7.39 (t, J = 1.4 Hz, 1H, H16/H17), 7.32 
(t, J = 1.8, 1.8 Hz, 1H, H16/H17) 7.12 (d, J = 2.0 Hz, 1H, H4), 6.95 (dd, J = 8.4, 2.0 Hz, 
1H, H8), 6.83 (d, J = 8.4 Hz, 1H, H7), 6.62 (s, 1H, H2), 4.21 (dt, J = 10.8, 6.6 Hz, 1H, 
H11), 4.12 (dt, J = 10.8, 6.6 Hz, 1H, H11), 3.97 (t, J = 7.0 Hz, 2H, H19) 3.92 (s, 3H, H18), 
3.84 (s, 3H, H9/H10), 3.82 (s, 3H, H9/H10), 1.62-1.48 (m, 4H, H12, H20), 1.29-1.25 (m, 
2H, H21), 1.23-1.13 (m, 10H, H13, H22, H23, H24, H25), 0.804 (t, J = 7.6 Hz, 3H, H14), 
0.795 (t, J = 7.2 Hz, 3H, H26)   
13C NMR (100 MHz, CDCl3, δ): 168.05 (COO, C1), 150.62 (ArC, C5/C6), 150.00 (ArC, 
C5/C6), 137.99 (ArC, C15), 124.59 (ArC, C3), 123.31 (ArC, C16/C17), 121.83 (ArC, 
C16/C17), 120.80 (ArCH, C8), 112.47 (ArCH, C4), 111.60 (ArCH, C7), 67.98 (OCH2, 
C19), 67.03 (OCH2, C11), 64.42 (NCH, C2), 56.49 (OCH3, C9/C10), 56.15 (OCH3, 
C9/C10), 36.72 (NCH3, C18), 31.99 (CH2, C24/C25), 30.42 (CH2, C12), 29.71 (CH2, C20), 
29.53 (CH2, C22), 29.43 (CH2, C23), 26.07 (CH2, C21), 22.82 (CH2, C24/C25), 19.03 (CH2, 
C13), 14.29 (CH3, C14), 13.73 (CH3, C26 ) 
IR (neat) νmax: 3478, 3103, 2928, 2856, 1745, 1594, 1518, 1465, 1207, 1146, 1021, 791, 
752 cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 333.10 
ESI-HRMS calc. for C18H25N2O4 [M-OctOSO3]+: 333.1814, found: 333.1799 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(3-methylimidazolium)acetate, 
octylsulfate salt (5b) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-(3-
methylimidazolium)acetate, chloride salt (5a) (0.628 g, 2.20 mmol) in distilled water (10 
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mL) was added sodium octylsulfate (0.535 g, 2.31 mmol) at rom temperature. After stirring 
overnight the water was evaporated in vacuo and the resulting solid was dissolved in 
CH2Cl2 (12 mL). The organic phase was washed with water (3 × 3 mL) and concentrated 
under reduced pressure to give the title compound 5b as a pale yellow oil in 66 % yield 
(0.696 g, 1.44 mmol). 
Product characterization: 
Molecular formula: C22H32N2O8S 
Molecular weight : 484.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.50 (s, 1H, H11), 7.54 (t, J = 1.6 Hz, 1H, H12/H13), 7.38 
(t, J = 1.6 Hz, 1H, H12/H13), 6.93 (dd, 1H, J = 8.0, 1.7 Hz, H8), 6.92 (d, J = 1.7 Hz, 1H, 
H4), 6.73 (d, J = 8.0 Hz, 1H, H7), 6.63 (s, 1H, H2), 5.91 (d, part A of an AB system, J = 
1.0 Hz, 1H, H9), 5.90 (d, part B of an AB system, J = 1.0 Hz, 1H, H9), 3.95 (t, J = 6.9 Hz, 
2H, H15), 3.91 (s, 3H, H14), 3.71 (s, 3H, H10), 1.56 (tt, J = 7.7, 7.1 Hz, 2H, H16), 1.29-
1.24 (m, 2H, H17), 1.21-1.16 (m, 8H, H18, H19, H20, H21), 0.78 (t, J = 7.0 Hz, 3H, H22) 
13C NMR (100 MHz, CDCl3, δ): 168.20 (COO, C1), 149.42 (ArC, C5/C6), 148.82 (ArC, 
C5/C6), 137.87 (ArC, C11), 125.68 (ArC, C3), 123.76 (ArC, C12/C13), 123.12 (ArCH, 
C8), 121.91 (ArC, C12/C13 ), 109.27 (ArCH, C7), 109.06 (ArCH, C4), 102.01 (OCH2O, 
C9), 67.86 (OCH2, C15), 64.21 (CHN, C2), 53.75 (OCH3, C10), 36.68 (NCH3, C14), 31.91 
(CH2, C18/C19/C20/C21), 29.67 (CH2, C16), 29.45 (CH2, C18/C19/C20/C21), 29.34 (CH2, 
C18/C19/C20/C21), 26.01 (CH2, C17), 22.74 (CH2, C18/C19/C20/C21), 14.19 (CH3, C22) 
IR (neat) νmax: 3103, 2926, 2856, 1750, 1505, 1492, 1450, 1211, 1164, 1034, 790, 764  
cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 275.00  
ESI-HRMS calc. for C14H15N2O4 [M-OctOSO3]+: 275.1032, found: 275.1020 
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(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, octylsulfate salt (2b) 
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To a stirred solution of methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt 
(2a) (0.278 g, 0.86 mmol) in distilled water (8 mL) was added sodium octylsulfate (0.207 
g, 0.89 mmol) at room temperature. After stirring overnight the water was evaporated in 
vacuo and the resulting solid was dissolved in CH2Cl2 (15 mL). The organic phase was 
washed with water (3 × 5 mL) and concentrated under reduced pressure to give the title 
compound 2b as colourless oil in 42 % yield (0.178 g, 0.36 mmol). 
Product characterization: 
Molecular formula: C24H35NO8S 
Molecular weight: 497.6 g/mol 
1H NMR (600 MHz, CDCl3, δ): 9.08-9.07 (m, 2H, H12, H16), 8.48-8.45 (m, 1H, H14), 
8.02-8.00 (m, 2H, H13, H15), 7.26 (s, 1H, H2), 7.24 (d, J = 2.0 Hz, 1H, H4), 7.02 (dd, J = 
8.4, 2.0 Hz, 1H, H8), 6.85 (d, J = 8.4 Hz, 1H, H7), 3.92 (t, J = 6.9 Hz, 2H, H17), 3.779 (s, 
3H, H9/H10), 3.775 (s, 3H, H9/H10), 3.74 (s, 3H, H11), 1.51 (tt, J = 7.4, 6.9 Hz, 2H, H18), 
1.23-1.18 (m, 2H, H19), 1.16-1.11 (m, 8H, H20, H21, H22, H23), 0.75 (t, J = 7.1 Hz, 3H, 
H24) 
13C NMR (150 MHz, CDCl3, δ): 167.82 (COO, C1), 151.20 (ArC, C6), 150.28 (ArC, C5), 
146.96 (ArC, C14), 145.02 (ArC, C12, C16), 128.36 (ArC, C13, C15), 123.18 (ArC, C3), 
122.09 (ArCH, C8 ), 113.52 (ArCH, C4), 111.87 (ArCH, C7), 74.51(NCH, C2), 67.76 
(CH2, C17), 56.52 (OCH3, C9/C10), 56.10 (OCH3, C9/C10), 54.08 (OCH3, C11), 31.82 
(CH2, C22/C23), 29.61 (CH2, C18), 29.36 (CH2, C20), 29.25 (CH2, C21), 25.95 (CH2, C19), 
22.65 (CH2, C22/C23), 14.11 (CH3, C24) 
IR (neat) νmax: 3474, 2927, 2855, 1748, 1632, 1593, 1518, 1466, 1210, 1146, 1020 cm-1 
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ESI-MS (70 eV) m/z: [M-OctOSO3]+: 288.10 
ESI-HRMS calc. for C16H18NO4 [M-OctOSO3]+: 288.1236, found: 288.1223 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, octylsulfate salt (4b) 
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To a stirred solution of butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt 
(4a) (0.172 g, 0.47 mmol) in distilled water (5 mL) was added sodium octylsulfate (0.118 
g, 0.49 mmol) at room temperature. After stirring overnight the water was evaporated in 
vacuo and the resulting solid was dissolved in CH2Cl2 (12 mL). The organic phase was 
washed with water (5 × 2 mL) and concentrated under reduced pressure to give the title 
compound 4b as colourless oil in 90 % yield (0.228 g, 0.42 mmol). 
Product characterization: 
Molecular formula: C27H41NO8S 
Molecular weight: 539.7 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.12-9.11 (m, 2H, H15, H19), 8.53 (m, 1H, H17), 8.04-
8.01 (m, 2H, H16, H18), 7.36 (2H, H2, H4), 7.03 (dd, J = 8.2, 1.8 Hz, 1H, H8), 6.90 (d, J = 
8.2 Hz, 1H, H7), 4.30 (dt, J = 10.4, 6.8 Hz, 1H, H11), 4.19 (dt, J = 10.4, 6.8 Hz, 1H, H11), 
4.01 (t, J = 6.8 Hz, 2H, H20), 3.870 (s, 3H, H9/H10), 3.867 (s, 3H, H9/H10), 1.67-1.52 (m, 
4H, H12, H21), 1.31-1.23 (m, 4H, H13, H22), 1.22-1.18 (m, 8H, H23, H24, H25, H26), 
0.85 (t, J = 7.4 Hz, 3H, H14), 0.81 (t, J = 7.2 Hz, 3H, H27)   
13C NMR (100 MHz, CDCl3, δ): 167.60 (COO, C1), 151.07 (ArC, C6), 150.24 (ArC, C5), 
146.53 (ArC, C17), 145.03 (ArC, C15,C19), 127.99 (ArC, C16,C18), 122.98 (ArC, C3), 
121.58 (ArCH, C8), 113.53 (ArCH, C4), 111.36 (ArCH, C7), 74.53 (NCH, C2), 67.71 
(OCH2, C20), 67.54 (OCH2, C11), 56.49 (OCH3, C9/C10), 56.04 (OCH3, C9/C10), 31.83 
(CH2, C25/C26), 30.23 (CH2, C12), 29.58 (CH2, C21/C22), 29.38 (CH2, C23/C24), 29.27 
 146
(CH2, C23/C24), 25.94 (CH2, C21/C22), 22.66 (CH2, C25/C26), 18.89 (CH2, C13), 14.14 
(CH3, C27), 13.59 (CH3, C14) 
IR (neat) νmax: 3133, 3057, 2955, 2928, 1744, 1633, 1594, 1522, 1471, 1450, 1354, 1232, 
1205, 1169, 1146, 1016, 982, 956 cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 330.10 
ESI-HRMS calc. for C19H24NO4 [M-OctOSO3]+: 330.1705, found: 330.1700 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, octylsulfate salt (6b) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, 
chloride salt (6a) (0.189 g, 0.61 mmol) in distilled water (10 mL) was added sodium 
octylsulfate (0.148 g, 0.64 mmol) at room temperature. After stirring overnight the water 
was evaporated in vacuo and the resulting solid was dissolved in CH2Cl2 (10 mL). The 
organic phase was washed with water (3 × 3 mL) and concentrated under reduced pressure 
to give the title compound 6b as colourless oil in 59 % yield (0.174 g, 0.36 mmol). 
Product characterization: 
Molecular formula: C23H31NO8S 
Molecular weight : 481.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.14-9.12 (m, 2H, H11, H15), 8.56-8.54 (m, 1H, H13), 
8.09-8.05 (m, 2H, H12, H14), 7.31 (s, 1H, H2), 7.04 (dd, 1H, J = 8.0, 2.0 Hz, H8), 7.03 (s, 
1H, H4), 6.80 (d, 1H, J = 8.0 Hz, H7), 5.94 (d, part A of an AB system, J = 1.2 Hz, 1H, 
H9), 5.93 (d, part B of an AB system, J = 1.2 Hz, 1H, H9), 3.98 (t, J = 6.5 Hz, 2H, H16), 
3.80 (s, 3H, H10), 1.61-1.53 (m, 2H, H17), 1.30-1.20 (m, 2H, H18), 1.23-1.16 (m, 8H, 
H19, H20, H21, H22), 0.79 (t, J = 6.8 Hz, 3H, H23)    
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13C NMR (100 MHz, CDCl3, δ): 167.61 (COO, C1), 149.83 (ArC, C6), 148.92 (ArC, C5), 
146.98 (ArC, C13), 144.90 (ArC, C11, C15), 128.29 (ArC, C12, C14), 124.24 (ArCH, C8), 
124.04 (ArC, C3), 109.84 (ArCH, C4), 109.33 (ArCH, C7), 102.02 (OCH2O, C9), 74.09 
(NCH, C2), 67.67 (OCH2, C16), 54.12 (OCH3, C10), 31.74 (CH2, C21/C22), 29.47 (CH2, 
C17/C19/C20), 29.28 (CH2, C17/C19/C20), 29.18 (CH2, C17/C19/C20), 25.83 ( CH2, C18), 
22.59 (CH2, C21/C22), 14.07 (CH3, C23) 
IR (neat) νmax: 3478, 3131, 3058, 2955, 2926, 1748, 1631, 1490, 1450, 1371, 1212, 1032, 
1001 cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 272.10 
ESI-HRMS calc. for C15H14NO4 [M-OctOSO3]+: 272.0923, found: 272.0935 
 
(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, NTf2 salt (1c) 
7
6
5
4
3
8
O
O
2
N
1
O
O
12
N
13
14
15
10
9
11
16
S
N
O
O
S
17
O
O
F
F
F
F
F
F
 
To a stirred solution of methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, 
chloride salt (1a) (1.048 g, 3.21 mmol) in distilled water (10 mL) was added LiNTf2 (1.074 
g, 3.53 mmol) at room temperature. The reaction mixture was stirred vigorously overnight. 
A fine solid precipitated, which was collected by filtration, washed with distilled water (3 × 
3 mL) and dried under reduced pressure to give the title compound 1c as a white crystalline 
powder in 67 % yield (1.234g, 2.16 mmol).  
Product characterization: 
Molecular formula: C17H19F6N3O8S2 
Molecular weight: 571.5 g/mol 
1H NMR (400 MHz, CDCl3, δ):  8.94 (s, 1H, H12), 7.24 (t, J = 1.8 Hz, 1H, H13/H14), 7.18 
(t, J = 1.8 Hz, 1H, H13/H14), 6.99 (d, 1H, J = 2.0 Hz, H4), 6.96 (dd, J = 8.2, 2.0 Hz, 1H, 
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H8), 6.92 (d, J = 8.2 Hz, 1H, H7), 6.37 (s, 1H, H2), 3.97 (s, 3H, H15), 3.91 (s, 3H, 
H9/H10), 3.88 (s, 3H, H9/H10), 3.86 (s, 3H, H11) 
13C NMR (100 MHz, CDCl3, δ): 168.09 (COO, C1), 151.13 (ArC, C5/C6), 150.39 (ArC, 
C5/C6), 136.57 (ArC, C12), 123.50 (ArC, C13), 123.26 (ArC, C3), 122.46 (ArC, C14), 
121.28 (ArCH, C8), 120.02 (q, J = 319.2 Hz, 2CF3, C16, C17), 112.10 (ArCH, C4/C7), 
112.04 (ArCH, C4/C7), 64.97 (CHN, C2), 56.32 (ArC, C9/C10), 56.26 (ArC, C9/C10), 
54.04 (OCH3, C11), 36.81 (NCH3, C15)  
IR (neat) νmax: 3149, 3096, 2950, 2849, 1748, 1578, 1564, 1519, 1344, 1330, 1243, 1225, 
1177, 1129, 1058, 1020, 750, 741 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 291.10 
ESI-HRMS calc. for C15H19N2O4 [M-NTf2]+: 291.1345, found: 291.1334 
m.p.: 94-96 oC 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, NTf2 salt (3c) 
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To a stirred solution of butyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)acetate, 
chloride salt (3a) (0.235 g, 0.64 mmol) in distilled water (8 mL) was added LiNTf2 (0.201 
g, 0.70 mmol) at room temperature. After stirring overnight product was separated from 
aqueous phase by decantation. Product was washed with distilled water (2 × 3 mL) and 
dried under reduced pressure to give the title compound 3c as colourless oil in 69 % yield 
(0.272 g, 0.44 mmol).  
Product characterization: 
Molecular formula: C20H25F6N3O8S2 
Molecular weight: 613.6 g/mol 
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1H NMR (400 MHz, CDCl3, δ): 8.93 (s, 1H, H15), 7.24 (s, 1H, H16), 7.17 (s, 1H, H17), 
6.99 (d, 1H, J = 2.0 Hz, H4), 6.96 (dd, J = 8.3, 2.0 Hz, 1H, H8), 6.92 (d, J = 8.3 Hz, 1H, 
H7), 6.35 (s, 1H, H2), 4.26 (t, J = 6.4 Hz, 2H, H11), 3.99 (s, 3H, H18), 3.91 (s, 3H, 
H9/H10), 3.88 (s, 3H, H9/H10), 1.66-1.58 (m, 2H, H12), 1.29 (tq, J = 7.6, 7.4 Hz, 2H, 
H13), 0.88 (t, J = 7.4 Hz, 3H, H14) 
13C NMR (150 MHz, CDCl3, δ): 167.71 (COO, C1), 151.22 (ArC, C5/C6), 150.40 (ArC, 
C5/C6), 136.73 (ArC, C15), 123.57 (ArC, C3), 123.46 (ArC, C16), 120.12 (q, J = 319.2 
Hz, 2CF3, C19,  C20), 122.50 (ArC, C17), 121.30 (ArCH, C8), 112.19 (2ArCH, C4, C7), 
67.42 (OCH2, C11), 65.11 (NCH, C2), 56.40 (OCH3, C9/C10), 56.31 (OCH3, C9/C10), 
36.87 (NCH3, C18), 30.48 (CH2, C12), 19.08 (CH2, C13), 13.71 (CH3, C14) 
IR (neat) νmax: 3156, 2965, 1746, 1519, 1348, 1179, 1133, 1053, 1021, 789, 740 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 333.10 
ESI-HRMS calc. for C18H25N2O4 [M-NTf2]+: 333.1814, found: 333.1805 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(3-methylimidazolium)acetate, NTf2 salt 
(5c) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-(3-
methylimidazolium)acetate, chloride salt (5a) (0.713 g, 2.30 mmol) in distilled water (10 
mL) was added LiNTf2 (0.729 g, 2.54 mmol) at room temperature. After stirring overnight 
a white solid, which had precipitated, was separated from the solvent by decantation. The 
solid was washed with distilled water (3 × 3 mL) and dried under reduced pressure to give 
the title compound (5c) as yellow oil, which has crystallized out, in 79 % yield (1.010 g, 
1.82 mmol). 
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Product characterization: 
Molecular formula: C16H15F6N3O8S2 
Molecular weight: 555.4 g/mol 
1H NMR (600 MHz, CDCl3, δ): 8.80 (s, 1H, H11), 7.29 (m, 2H, H12, H13), 6.91 (dd, J = 
8.0, 1.7 Hz, 1H, H8), 6.86 (d, J = 8.0 Hz, 1H, H7), 6.83 (d, J = 1.7 Hz, 1H, H4), 6.25 (s, 
1H, H2), 6.02 (d, part A of an AB system, J = 1.3 Hz, 1H, H9), 6.01 (d, part B of an AB 
system, J = 1.3 Hz, 1H, H9) 3.93 (s, 3H, H14), 3.83 (s, 3H, H10) 
13C NMR (150 MHz, CDCl3, δ): 167.93 (COO, C1), 150.01 (ArC, C5/C6), 149.30 (ArC, 
C5/C6), 136.64 (ArC, C11), 124.52 (ArC, C3), 123.67 (ArC, C12/C13), 123.38 (ArCH, 
C8), 122.47 (ArC, C12/C13), 120.07 (q, J = 318 Hz, 2CF3, C15, C16), 109.65 (ArCH, C7), 
108.78 (ArCH, C4), 102.31 (OCH2O, C9), 64.95 (CHOH, C2), 54.05 (OCH3, C10), 36.82 
(NCH3, C14) 
IR (neat) νmax: 3156, 2964, 1751, 1506, 1493, 1451, 1347, 1177, 1132, 1052, 1036, 930, 
789, 740, 764 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 275.00  
ESI-HRMS calc. for C14H15N2O4 [M-NTf2]+: 275.1032, found: 275.1022 
m.p.: 55-56 oC 
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(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, NTf2 salt (2c) 
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To a stirred solution of methyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt 
(2a) (0.573 g, 1.75 mmol) in distilled water (8 mL) was added added LiNTf2 (0.749 g, 2.58 
mmol) at room temperature. After stirring overnight a white solid, which had precipitated, 
was collected by filtration. The solid was washed with distilled water (3 × 3 mL) and dried 
under reduced pressure to give the title compound 2c as white powder in 86 % yield (1.010 
g, 1.82 mmol), 
Product characterization: 
Molecular formula: C18H18F6N2O8S2 
Molecular weight: 568.4 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.87-8.85 (m, 2H, H12, H16), 8.54-8.50 (m, 1H, H14),  
8.07-8.03 (m, 2H, H13, H15), 7.06 (d, J = 2.1 Hz, 1H, H4), 7.02 (dd, J = 8.4, 2.1 Hz, 1H, 
H8), 6.98 (d, J = 8.4 Hz, 1H, H7), 6.88 (s, 1H, H2), 3.92 (s, 3H, H9/H10), 3.90 (s, 3H, 
H11), 3.86 (s, 3H, H9/H10) 
13C NMR (100 MHz, CDCl3, δ): 167.59 (COO, C1), 151.75 (ArC, C5/C6), 150.66 (ArC, 
C5/C6), 147.15 (ArC, C14), 144.58 (ArC, C12, C16), 128.54 (ArC, C13, C15), 122.25 
(ArC, C3), 121.84 (ArCH, C8), 120.04 (q, J = 319.0 Hz, 2CF3, C17, C18) 112.85 (ArCH, 
C4), 112.13 (ArCH, C7), 75.29 (NCH, C2), 56.42 (OCH3, C9/C10), 56.34 (OCH3, C9/C10), 
54.54 (OCH3, C11) 
IR (neat) νmax: 3139, 3094, 2971, 1748, 1637, 1519, 1476, 1466, 1348, 1329, 1267, 1178, 
1133, 1057, 1025 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 288.10 
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ESI-HRMS calc. for C16H18NO4 [M-NTf2]+: 288.1236, found: 288.1237  
m.p.: 104-105 oC 
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, NTf2 salt (4c) 
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To a stirred solution of butyl 2-(3,4-dimethoxyphenyl)-2-pyridinium acetate, chloride salt 
(4a) (0.23 g, 0.63 mmol) in distilled water (10 mL) was added LiNTf2 (0.198 g, 0.69 mmol) 
at room temperature. The reaction mixture was stirred vigorously overnight. A fine solid 
precipitated, which was collected by filtration, washed with distilled water (4 × 3 mL) and 
dried under reduced pressure to give the title compound 4c as a white crystalline powder in 
88 % yield (0.338 g, 0.55 mmol).  
Product characterization: 
Molecular formula: C21H24F6N2O8S2 
Molecular weight: 610.5 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.85-8.84 (m, 2H, H15, H19), 8.54-8.50 (m, 1H, H17), 
8.07-8.03 (m, 2H, H16, H18), 7.04 (s, 1H, H4), 7.03 (dd, J = 8.0, 2.0 Hz, 1H, H8), 6.98 (d, 
J = 8.0 Hz, 1H, H7), 6.81 (s, 1H, H2), 4.32 (dt, J = 10.8, 6.8 Hz, 1H, H11), 4.26 (dt, J = 
10.8, 6.8 Hz, 1H, H11), 3.91 (s, 3H, H9/H10), 3.84 (s, 3H, H9/H10), 1.67-1.57 (m, 2H, 
H12), 1.29 (tq, J = 7.4 Hz, 2H, H13), 0.8 (t, J = 7.4 Hz, 3H, H14) 
13C NMR (100 MHz, CDCl3, δ): 167.01 (COO, C1), 151.50 (ArC, C5/C6), 150.44 (ArC, 
C5/C6), 146.86 (ArC, C17), 144.41 (ArC, C15/C19), 128.28 (ArC, C16/C18), 121.98, 
(ArCH, C8), 121.82 (ArC, C3), 119.87 (q, J = 319.0 Hz, 2CF3, C20, C21),  112.66 (ArCH, 
C4), 111.84 (ArCH, C7), 75.18 (NCH, C2), 67.89 (OCH2, C11),  56.21 (OCH3, C9/C10), 
56.14 (OCH3, C9/C10), 30.19 (CH2, C12), 18.87 (CH2, C13), 13.55 (CH3, C14) 
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IR (neat) νmax: 3141, 3093, 2968, 1742, 1635, 1606, 1592, 1520, 1488, 1349, 1332, 1270, 
1186, 1141, 1052, 1016, 1034 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 330.10 
ESI-HRMS calc. for C19H24NO4 [M-NTf2]+: 330.1705, found: 330.1700 
m.p.: 67-68 oC 
 
 (RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, NTf2 salt (6c) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-pyridinium acetate, 
bromide salt (6d) (0.920 g, 2.61 mmol) in distilled water (15 mL) was added LiNTf2 (0.827 
g, 2.87 mmol) at room temperature. The reaction mixture was stirred vigorously overnight. 
A fine solid precipitated, which was collected by filtration, washed with distilled water (3 × 
5 mL) and dried under reduced pressure to give the title compound 6c as a white crystalline 
powder in 92 % yield (1.326 g, 2.40 mmol).  
Product characterization: 
Molecular formula: C17H14F6N2O8 S 2 
Molecular weight : 552.4 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.83-8.81 (m, 2H, H11, H15), 8.55-8.51 (m, 1H, H13), 
8.06-8.03 (m, 2H, H12, H14), 6.96 (dd, 1H, J = 8.0, 1.6 Hz, H8), 6.89 (d, 1H, J = 8.0 Hz, 
H7), 6.88 (d, 1H, J = 1.6 Hz, H4), 6.75 (s, 1H, H2), 6.02 (d, part A of an AB system, J = 
1.2 Hz, 1H, H9), 6.00 (d, part B of an AB system, J = 1.2 Hz, 1H, H9), 3.86 (s, 3H, H10)  
13C NMR (100 MHz, CDCl3, δ): 167.17 (COO, C1), 150.40 (ArC C6), 149.40 (ArC C5), 
147.14 (ArC, C13), 144.32 (ArC, C11, C15), 128.43 (ArC, C12, C14), 124.31 (ArCH, C8), 
122.85 (ArC, C3), 119.82 (q, J = 319 Hz, 2CF3, C16, C17), 109.71 (ArCH, C4/C7), 109.40 
(ArCH, C4/C7), 102.34 (OCH2O, C9), 74.90 (CHN, C2), 54.38 (OCH3, C10) 
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IR (neat) νmax: 3137, 3094, 2964, 2915, 1750, 1633, 1506, 1491, 1451, 1347, 1329, 1177, 
1131, 1052, 1036 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 272.10 
ESI-HRMS calc. for C15H14NO4 [M-NTf2]+: 272.0923, found: 272.0934 
m.p.: 78-80 oC 
 
Synthesis of ILs without a linker from (RS)-3,4-dihydroxymandelic acid 
(RS)-3,4-Dihydroxymandelic acid (18)15,16,43 
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Catechol (5.104 g, 46.40 mmol) was dissolved in aqueous NaOH (3.298 g, 83.65 mmol in 
55 mL of water) and Al2O3 (2.019 g, 19.79 mmol) was added. After 5 min stirring under N2 
atmosphere, glyoxylic acid (50 % aq. solution, 7.081 g, 47.80 mmol) was added and the 
reaction was heated to 60 oC under vigorous stirring. After 24 h the reaction mixture was 
allowed to cool for 10 min, filtered and the filter cake washed with a NaOH (1.0 M, 20 
mL). The basic washings were combined with the filtrate, acidified to pH 3-4 with 37 % 
HCl and extracted with ethyl acetate (5 × 50 mL) to remove unreacted catechol. The 
aqueous solution was then further acidified to pH 1 and extracted with ethyl acetate (10 × 
50 mL). Product was stirred in ethyl acetate (9 mL) for 2.5 h and then filtered to give the 
title compound 18 as a beige solid in 36 % yield (3.060 g, 1.66 mmol).   
Product characterization: 
Molecular formula: C8H8O5 
Molecular weight: 184.15 g/mol 
1H NMR (400 MHz, DMSO-d6, δ): 6.77 (s, 1H, H4), 6.60 (dd, J = 8.2, 1.4 Hz, 1H, H8), 
6.57 (d, J = 8.2 Hz, 1H, H7), 4.32 (s, 1H, H2) 
13C NMR (100 MHz, DMSO-d6, δ): 171.71 (COO, C1), 146.15 (ArC, C5/C6) 146.14 (ArC, 
C5/C6), 132.35 (ArC, C3), 119.17 (ArCH, C4), 116.34 (ArCH, C7/C8), 115.37 (ArCH, 
C7/C8) 73.38 (CHOH, C2) 
IR (neat) νmax: 3396-2573, 1691, 1605, 1536, 1430, 1348, 1208, 1191, 1085 cm-1 
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Compound prepared according to the reported procedures15,16 
1H, 13C NMR in agreement with literature data43 
 
(RS)-Methyl 2-(3,4-dihydroxyphenyl)-2-hydroxyacetate (19)40 
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To a stirred solution of 3,4-dihydroxymandelic acid (18) (1.495 g, 8.12 mmol) in methanol 
(25 mL) was added p-toluenesulfonic acid monohydrate (0.159 g, 0.84 mmol) at room 
temperature. After stirring for 3h Na2CO3 (0.160 g, 1.04 mmol) was added and solution 
was concentrated under reduced pressure. Distilled water (35 mL) was added and solution 
was acidified with conc. HCl (0.24 mL). Product was extracted with ethyl acetate and 
purified by column chromatography (SiO2, CH2Cl2:MeOH 90:10). Next, product was 
stirred with t-butyl methyl ether and filtered to give the title compound 19 as a white 
powder in 46 % yield (0.736, 3.72 mmol).    
Product characterization: 
Molecular formula: C9H10O5 
Molecular weight : 198.2 g/mol  
1H NMR (400 MHz, D2O, δ): 6.88 (d, J = 1.8 Hz, 1H, H4), 6.87 (d, J = 8.2 Hz, 1H, H7), 
6.81 (dd, J = 8.2, 1.8 Hz, 1H, H8), 5.16 (s, 1H, H2), 3.67 (s, 3H, H9) 
1H NMR (400 MHz, DMSO-d6, δ): 9.04 (bs, 2H, 2OH), 6.78 (d, J = 1.8 Hz, 1H, H4), 6.68 
(d, J = 8.0, Hz, 1H, H7), 6.63 (dd, J = 8.0, 1.8 Hz, 1H, H8), 4.92 (s, 1H, H2), 3.56 (s, 3H, 
H9) 
13C NMR (100 MHz, D2O, δ): 173.78 (COO, C1), 145.42 (ArC, C5/C6), 145.29 (ArC, 
C5/C6), 130.79 (ArC, C3), 118.26 (ArCH, C4) 115.53 (ArCH, C7), 114.40 (ArCH, C8),  
72.48 (CHOH, C2), 51.97 (OCH3, C9) 
IR (neat) νmax: 3415, 3230, 1747, 1612, 1520, 1440, 1399, 1354, 1277, 1234, 1188, 1112, 
1064 cm-1 
Compound prepared according to the reported procedure40 
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(RS)-Methyl 2-(3,4-dihyroxyphenyl)-2-(3-methylimidazolium)acetate, chloride salt 
(7a) 
7
6
5
4
3
8
HO
OH
2
1
N
O
O
9
12
11
N
10
13
Cl
 
To a stirred solution of methyl (3,4-dihydroxy)mandelate (19) (0.671 g, 3.39 mmol) in 
CH2Cl2 (10 mL) at 0 oC was added 1-methylimidazole (0.27 mL, 3.39 mmol) followed by 
thionyl chloride (0.25 mL, 3.39 mmol) added dropwise and the reaction mixture was 
allowed to warm to room temperature. After stirring for 5 h second portion of 1-
methylimidazole (0.27 mL, 3.39 mmol) was added and the reaction mixture was stirred 
overnight. The solvent was removed under reduced pressure and the resulting oil was 
purified twice by column chromatography (SiO2, CH2Cl2:MeOH 90:10) to give the title 
compound 7a as brown oil in 65 % yield (0.662 g, 2.22 mmol).  
Product characterization: 
Molecular formula: C13H15ClN2O4 
Molecular weight: 298.7 g/mol 
1H NMR (400 MHz, D2O, δ): 8.64 (s, 1H, H10), 7.42 (t, J = 1.6 Hz, 1H, H12), 7.40 (t, J = 
1.6 Hz, 1H, H11), 6.93 (d, J = 8.2 Hz, 1H, H7), 6.92 (s, 1H, H4), 6.83 (dd, J = 8.2, 2.2 Hz, 
1H, H8), 6.32 (s, 1H, H2), 3.82 (s, 3H, H13), 3.79 (s, 3H, H9) 
13C NMR (100 MHz, D2O, δ): 169.42 (COO, C1), 146.12 (ArC, C5/C6), 144.93 (ArC, 
C5/C6), 136.32 (ArCH, C10), 123.42 (ArCH, C11), 123.03 (ArC, C3), 122.11 (ArCH, 
C12), 121.45 (ArCH, C8), 116.72 (ArCH, C4/C7), 116.27 (ArCH, C4/C7), 64.27(CHOH, 
C2), 53.93 (OCH3, C9), 35.91 (NCH3, C13) 
IR (neat) νmax: 3157, 3120, 1733, 1595, 1520, 1470, 1448, 1334, 1247, 1175, 1132, 1052, 
1017 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 263.10 
ESI-HRMS calc. for C13H15N2O4 [M-Cl]+: 263.1032, found: 263.1035  
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(RS)-Methyl 2-(3,4-dihydroxyphenyl)-2-pyridinium acetate, chloride salt (8a) 
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To a stirred solution of methyl 3,4-dihydroxymandelate (19) (0.597 g, 3.01 mmol) in 
CH2Cl2 (12 mL) at −15 oC was added thionyl chloride (0.25 mL, 3.46 mmol) followed by 
pyridine (0.28 mL, 3.46 mmol) added dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring overnight a second portion of pyridine (0.28 mL, 
3.46 mmol) and white precipitate was collected by filtration. Product was dissolved in 10 
mL of water and washed with CH2Cl2 (stabilized with amylene) (5 × 100 mL). Water was 
removed under reduced pressure and product was precipitated upon acetonitrile addition. 
The title compound 8a was obtained in 41 % yield (0.369 g, 1.25 mmol).  
Product characterization: 
Molecular formula: C14H14ClNO4 
Molecular weight: 295.1 g/mol 
1H NMR (400 MHz, D2O, δ): 8.64-8.63 (m, 2H, H10, H14), 8.39-8.36 (m, 1H, H12), 7.87-
7.83 (m, 2H, H11, H13), 6.80 (d, J = 2.4 Hz, 1H, H4), 6.78 (d, J = 8.5 Hz, 1H, H7), 6.71 
(dd, J = 8.5, 2.4 Hz, H8), 6.68 (s, 1H, H2), 3.68 (s, 3H, H9) 
13C NMR (100 MHz, D2O, δ): 168.47 (COO, C1), 147.16 (ArCH, C12), 146.73 (ArC, C6), 
145.11 (ArC, C5), 144.14 (ArCH, C10,C14), 127.99 (ArCH, C11,C13), 122.45 (ArCH, 
C8), 121.76 (ArC, C3), 117.09 (ArCH, C4), 116.79 (ArCH, C7), 74.37 (NCH, C2), 54.26 
(OCH3, C9) 
IR (neat) νmax: 3082, 3046, 3035, 2951, 2934, 1747, 1628, 1616, 1595, 1525, 1480, 1449, 
1358, 1295, 1209, 1184, 1148, 1118 cm-1 
ESI-MS (70 eV) m/z: [M-Cl]+: 260.10 
ESI-HRMS calc. for C14H14NO4 [M-Cl]+: 260.0917, found: 260.0926 
m.p.: 158-159 oC 
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(RS)-Methyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (25)  
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To a flask charged with methyl 3,4-dimethoxymandelate (11) (3.012 g, 13.33 mmol) was 
added neutral Al2O3 (1.337 g, 13.11 mmol) followed by bromoacetyl bromide (3.0 mL, 
34.66 mmol) added dropwise. The reaction was allowed to continue without stirring for 2.5 
h at room temperature and then the reaction mixture was poured into a funnel charged with 
sodium bicarbonate (27.340 g, 323.50 mmol). After 12 h NaHCO3 was washed with 
toluene (4 × 100 mL). The combined extracts were concentrated under reduced pressure 
and the resulting oil was purified by column chromatography (SiO2, CH2Cl2:hexane 60:40) 
to give the title compound 25 as a colourless oil in 27 % yield (1.235 g, 3.56 mmol). 
Product characterization: 
Molecular formula: C13H15BrO6 
Molecular weight: 347.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.02 (dd, J = 8.2, 2.0 Hz, 1H, H8), 6.96 (d, J = 2.0 Hz, 1H, 
H4), 6.88 (d, J = 8.2 Hz, 1H, H7),  5.93 (s, 1H, H2), 4.02 (d, part A of AB system, J = 12.8 
Hz, 1H, H13), 3.98 (d, part B of AB system, J = 12.8 Hz, 1H, H13), 3.91 (s, 3H, H9/H10), 
3.90 (s, 3H, H9/H10), 3.75 (s, 3H, H11) 
13C NMR (100 MHz, CDCl3, δ): 169.10 (COO, C1/C12) , 166.92 (COO, C1/C12), 150.34 
(ArC, C5/C6), 149.51 (ArC, C5/C6), 125.50 (ArC, C3), 121.04 (ArCH, C8), 111.35 
(ArCH, C7), 110.65 (ArCH, C4), 72.96 (CH, C2), 56.28 (OCH3, C9/C10), 56.22 (OCH3, 
C9/C10), 53.13 (OCH3, C11), 25.67 (CH2, C13) 
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(RS)-Butyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (26) 
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Method A: 
To a flask charged with butyl 3,4-dimethoxymandelate (12) (1.532 g, 5.72 mmol) was 
added neutral Al2O3 (0.601 g, 5.89 mmol) followed by bromoacetyl bromide (1.37 mL, 
15.77 mmol) added dropwise. Reaction was allowed to continue without stirring for 2 h at 
room temperature and then the reaction mixture was poured into funnel charged with 
sodium bicarbonate (12.438 g, 148.07 mmol). After 12 h NaHCO3 was washed with 
toluene (4 × 50 mL). The combined extracts were concentrated under reduced pressure and 
the resulting crude oil was purified by column chromatography (SiO2, toluene:EtOAc 97:3) 
to give the title compound 26 as a colourless oil in 25 % yield (0.548 g, 1.41 mmol). 
 
Method B: 
To a stirred solution of of butyl-3,4-dimethoxymandelate (12) (2.270 g, 8.47 mmol) in 
CH2Cl2 (50 mL) at -78 oC under N2 atmosphere was added triethylamnie (2.35 mL, 16.92 
mmol) followed by bromoacetyl bromide (1.22 mL, 14.05 mmol) added dropwise. After 5 
h the reaction mixture was allowed to warm to – 20 oC and was quenched with water (20 
mL). The organic phase was washed with distilled water (3 × 10 mL), saturated ammonium 
chloride (3 × 10 mL), saturated sodium bicarbonate (3 × 10 mL) and brine (3 × 10 mL). 
The organic phase was then dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure. The resulting crude product was purified by column chromatography 
(SiO2, toluene:EtOAc 93:7) to give the title compound 26 as a colourless oil in 23 % yield 
(0.776 g, 1.99 mmol).  
Product characterization: 
Molecular formula: C16H21BrO6 
Molecular weight: 389.2 g/mol 
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1H NMR (400 MHz, CDCl3, δ): 6.95 (dd, J = 8.4, 2.0 Hz, 1H, H8), 6.89 (d, J = 2.0 Hz, 1H, 
H4), 6.80 (d, J = 8.4 Hz, 1H, H7), 5.88 (s, 1H, H2), 4.13-4.02 (m, 2H, H11), 3.93 (d, part A 
of an AB system, J = 12.8 Hz, 1H, H16), 3.89 (d, part B of an AB system, J = 12.8 Hz, 1H, 
H16), 3.83 (s, 3H, H9/H10), 3.81 (s, 3H, H9/H10), 1.60-1.53 (m, 2H, H12), 1.21 (tq, J = 
7.4 Hz, 2H, H13), 0.86 (t, J = 7.4 Hz, 3H, H14) 
13C NMR (100 MHz, CDCl3, δ): 168.61 (COO, C1/C15), 166.87 (COO, C1/C15), 150.17 
(ArC, C5/C6), 149.36 (ArC, C5/C6), 125.63 (ArC, C3), 120.93 (ArCH, C8), 111.20 
(ArCH, C7), 110.47 (ArCH, C4), 75.97 (CH, C2), 65.96 (OCH2, C11), 56.19 (OCH3, 
C9/C10), 56.16 (OCH3, C9/C10), 30.62 (CH2, C12), 25.71 (CH2, C16), 19.12 (CH2, C13), 
13.84 (CH3, C14) 
 
(RS)-Methyl 2-(2-bromoacetoxy)-2-(3,4-methylenedioxyphenyl)acetate (27) 
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To a stirred solution of methyl 3,4-methylenedioxymandelate (13) (3.350 g, 15.94 mmol) in 
CH2Cl2 (40 mL) at 0 oC was added potassium carbonate (3.488g, 25.24 mmol) followed by 
bromoacetyl bromide (2.08 mL, 23.93 mmol) added dropwise and the reaction mixture was 
allowed to warm to room temperature. After stiring overnight the reaction mixture was 
filtered and further potassium carbonate (3.481 g, 25.19 mmol) and bromoacetyl bromide 
(2.08 mL, 23.93 mmol) were added at 0 oC. After stirring overnight at room temperature 
the reaction mixture was filtered, dried over anhydrous MgSO4 and concentrated under 
reduced pressure. The resulting product was purified by column chromatography (SiO2, 
hexane:EtOAc 90:10) to give the title compound 27 as a colourless liquid in 69 % yield 
(3.648 g, 11.02 mmol). 
Product characterization: 
Molecular formula: C12H11BrO6 
Molecular weight: 331.1 g/mol  
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1H NMR (400 MHz, CDCl3, δ): 6.920 (dd, J = 8.4, 1.6 Hz, 1H, H8), 6.917 (d, J = 1.6 Hz, 
1H, H4), 6.80 (d, J = 8.4 Hz, 1H, H7), 5.973 (d, part A of an AB system, J = 1.4 Hz, 1H, 
H9), 5.969 (d, part B of an AB system, J = 1.4 Hz, 1H, H9), 5.86 (s, 1H, H2), 3.97 (d, part 
A of an AB system, J = 12.8 Hz, 1H, H12), 3.93 (d, part B of an AB system, J = 12.8 Hz, 
1H, H12 ) 3.72 (s, 3H, H10)  
13C NMR (100 MHz, CDCl3, δ): 168.68 (COO, C1), 166.62 (COO, C11), 148.77 (ArC, 
C6), 148.15 (ArC, C5), 126.56 (ArC, C3), 122.08 (ArCH, C8), 108.57 (ArCH, C7), 108.25 
(ArCH, C4), 101.58 (OCH2O, C9), 75.54 (CH, C2), 52.91 (OCH3, C10), 25.38 (CH2, C12) 
IR (neat) νmax: 2957, 2904, 1742, 1504, 1490, 1446, 1241, 1210, 1143, 1101, 1032 cm-1 
GCMS(EI) m/e: 329.9 (M+, 6.8 %), 331.9 (7.0), 219 (37), 151 (100) 
  
(RS)-Methyl 2-(3,4-dimethoxyphenyl)-2-[2-(3-methylimidazolium)acetoxy]acetate, 
bromide salt (21a) 
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To a stirred solution of methyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (25) 
(0.426 g, 1.23 mmol) in diethyl ether (10 mL) at -15 oC under a N2 atmosphere was added 
1-methylimidazole (90 µL, 1.13 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring overnight a white solid, which had precipitated, 
was separated from the solvent by decantation. The solid was washed with diethyl ether and 
dried under reduced pressure to give the title compound 21a as a white solid in 61 % yield 
(0.321 g, 0.75 mmol). 
Product characterization: 
Molecular formula: C17H21BrN2O6 
Molecular weight : 429.3 g/mol 
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1H NMR (400 MHz, CDCl3, δ): 10.46 (s, 1H, H14), 7.52 (t, J = 1.6 Hz, 1H, H15/H16), 
7.33 (t, J = 1.6 Hz, 1H, H15/H16), 6.98 (dd, J = 8.4, 2.0 Hz, 1H, H8), 6.94 (d, J = 2.0 Hz, 
1H, H4), 6.87 (d, J = 8.4 Hz, 1H, H7), 5.94 (s, 1H, H2), 5.81 (d part A of an AB system, J 
= 17.9 Hz, 1H, H13), 5.49 (d part B of an AB system, J = 17.9 Hz, 1H, H13), 4.07 (s, 3H, 
H17), 3.92 (s, 3H, H9/H10), 3.90 (s, 3H, H9/H10), 3.75 (s, 3H, H11)  
 
(RS)-Butyl 2-(3,4-dimethoxyphenyl)-2-[2-(3-methylimidazolium)acetoxy]acetate, 
bromide salt (22a) 
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To a stirred solution of butyl 2-(2-bromoacetoxy)-2-(3,4-dimethoxyphenyl)acetate (26) 
(0.662 g, 1.70 mmol) in diethyl ether (15 mL) at -15 oC under a N2 atmosphere was added 
1-methylimidazole (0.11 mL, 1.38 mmol) dropwise and the reaction mixture was allowed 
to warm to room temperature. After stirring overnight a white solid, which had precipitated, 
was separated from the solvent by decantation. The solid was washed with diethyl ether and 
dried under reduced pressure to give the crude title compound 22a as a white solid (0.621 g, 
1.32 mmol).  
Product characterization: 
Molecular formula: C20H27BrN2O6 
Molecular weight: 471.3 g/mol 
1H NMR (400 MHz, CDCl3, δ): 10.29 (s, 1H, H17), 7.53 (s, 1H, H18/H19), 7.36 (s, 1H, 
H18/H19), 6.98 (dd, J = 8.2, 2.0 Hz, 1H, H8), 6.95 (d, J = 2.0 Hz, 1H, H4), 6.87 (d, J = 8.2 
Hz, 1H, H7), 5.92 (s, 1H, H2), 5.78 (d, part A of an AB system, J = 17.9 Hz, 1H, H16), 
5.45 (d, part B of an AB system, J = 17.9 Hz, 1H, H16), 4.19-4.08 (m, 2H, H11), 4.06 (s, 
3H, H20), 3.91 (s, 3H, H9/H10), 3.89 (s, 3H, H9/H10), 1.59-1.52 (m, 2H, H12), 1.30-1.21 
(m, 2H, H13), 0.86 (t, J = 7.4 Hz, 3H, H14) 
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ESI-MS (70 eV) m/z: [M-Br]+: 391.0, 251.0, 291.0 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) 
acetoxy]acetate, bromide salt (23a) 
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To a stirred solution of methyl 2-(2-bromoacetoxy)-2-(3,4-methylenedioxyphenyl)acetate 
(27) (1.494 g, 4.51 mmol) in diethyl ether (10 mL) at −15 oC under a N2 atmosphere was 
added 1-methylimidazole (0.32 mL, 4.06 mmol) dropwise and the reaction mixture was 
allowed to warm to room temperature. After stirring for 48 h a solid, which precipitated, 
was collected by filtration, washed with diethyl ether and dried at room temperature under 
reduced pressure to give the title compound 23a as a white powder in 63 % yield (0.751 g, 
1.82 mmol). 
Product characterization: 
Molecular formula: C16H17BrN2O6 
Molecular weight: 413.2 g/mol  
1H NMR (400 MHz, CH3CN, δ): 9.23 (s, 1H, H13), 7.58 (t, J = 1.8 Hz, 1H, H15), 7.47 (t, J 
= 1.8 Hz, 1H, H14), 6.96 (d, J = 2.0 Hz, 1H, H4), 6.95 (dd, J = 8.4, 2.0 Hz, 1H, H8), 6.87 
(d, J = 8.4 Hz, 1H, H7), 6.002 (d, part A of an AB system, J = 1.2 Hz, 1H, H9), 5.997 (d, 
part B of an AB system J = 1.2 Hz, 1H, H9), 5.96 (s, 1H, H2), 5.40 (s, 2H, H12), 3.90 (s, 
3H, H16), 3.69 (s, 3H, H10)  
13C NMR (100 MHz, CH3CN, δ): 169.32 (COO, C1), 166.97 (COO, C11), 149.61 (ArC, 
C5/C6), 148.94 (ArC, C5/C6), 138.52 (ArCH, C13), 127.43 (ArCH, C3), 124.44 (ArC, 
C14/15), 124.32 (ArC, C14/C15), 122.97 (ArCH, C8), 109.15 (ArCH, C7), 108.63 (ArCH, 
C4), 102.79, (OCH2O, C9), 76.28 (CH, C2), 53.41 (OCH3, C10), 50.53 (CH2N, C12), 37.06 
(NCH3, C16)  
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IR (neat) νmax: 3071, 2954, 2907, 1743, 1502, 1489, 1442, 1370, 1241, 1195, 1168, 1029 
cm-1 
ESI-MS (70 eV) m/z: [M-Br]+: 330.10 
m.p.: 66-67 oC 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(2-pyridiniumacetoxy)acetate, bromide 
salt (24a) 
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To a stirred solution of methyl 2-(2-bromoacetoxy)-2-(3,4-methylenedioxyphenyl)acetate 
(27) (1.502 g, 4.54 mmol) in diethyl ether (10mL) at −15 oC under a N2 atmosphere was 
added pyridine (0.37 mL, 4.54 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring for 48 h the reaction mixture was refluxed for 4 h 
and then stirred at room temperature for further 16 h. Solid which had precipitated was 
washed with diethyl ether and dried under reduced pressure. Product was recrystallized 
from chloroform to give the title compound 24a as white crystals in 90 % yield (1.682 g, 
4.10 mmol). 
Product characterization: 
Molecular formula: C17H16BrNO6 
Molecular weight: 410.2 g/mol  
1H NMR (400 MHz, CDCl3, δ): 9.41-9.40 (m, 2H, H13, H17), 8.53-8.49 (m, 1H, H15), 
8.10-8.06 (m, 2H, H14, H16), 6.91 (dd, J = 8.0, 1.8 Hz, 1H, H8), 6.86 (d, J = 1.8 Hz, 1H, 
H4), 6.82 (d, J = 8.0 Hz, H7), 6.68 (d, part A of an AX system, J = 17.4 Hz, 1H, H12), 6.09 
(d, part X of an AX system, J = 17.4 Hz, 1H, H12), 6.01 (d, part A of an AB system, J = 
1.4 Hz, 1H, H9), 6.00 (d, part B of an AB system J = 1.4 Hz, 1H, H9), 5.92 (s, 1H, H2), 
3.89 (s, 3H, H10)   
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1H NMR (400 MHz, D2O, δ): 8.91-8.89 (m, 2H, H13, H17), 8.68-8.65 (m, 1H, H15), 8.17-
8.13 (m, 2H, H14, H16), 6.88 (dd, J = 8.0, 1.5 Hz, 1H, H8), 6.84 (d, J = 1.5 Hz, 1H, H4), 
6.73 (d, J = 8.0 Hz, 1H, H7), 6.09 (s, 1H, H2), 5.87 (s, 1H, H9), 5.85 (s, 1H, H9), 5.83 (d, 
part A of an AB system, J = 17.5 Hz, 1H, H12), 5.75 (d, part B of an AB system, J = 17.5 
Hz, 1H, H12), 3.67 (s, 3H, H10)  
1H NMR (400 MHz, CD3CN, δ): 8.92-8.90 (m, 2H, H13, H17), 8.64-8.60 (m, 1H, H15), 
8.13-8.09 (m, 2H, H14, H16), 6.952 (dd, J = 8.3, 1.9 Hz, 1H, H8), 6.947 (d, J = 1.9 Hz, 
1H, H4), 6.88 (d, J = 8.3 Hz, 1H, H7), 6.011 (d, part A of an AB system, J = 1.2 Hz, 1H, 
H9),  6.006 (d, part B of an AB system, J = 1.2 Hz, 1H, H9), 6.00 (s, 1H, H2), 5.77 (d part 
A of an AB system, J = 17.8 Hz, 1H, H12), 5.73 (d part B of an AB system, J = 17.8 Hz, 
1H, H12), 3.70 (s, 3H, H10)  
13C NMR (150 MHz, CD3CN, δ): 169.15 (COO, C1), 166.32 (COO, C11), 149.80 (ArC, 
C6), 149.08 (ArC, C5), 148.22 (ArCH, C15), 147.07 (ArCH, C13, C17), 129.11 (ArCH, 
C14, C16), 127.36 (ArC, C3), 123.12 (ArCH, C8), 109.25 (ArCH, C7), 108.72 (ArCH, C4), 
102.91 (OCH2O, C9), 76.79 (CH, C2), 61.37 (CH2N, C12), 53.53 (OCH3, C10) 
13C NMR (100 MHz, D2O, δ): 170.00 (COO, C1), 166.12 (COO, C11), 148.43 (ArC, C6), 
147.34 (ArC, C5), 147.37 (ArCH, C15), 145.80 (ArCH, C13, C17), 128.32 (ArCH, C14, 
C16), 125.64 (ArC, C3), 122.28 (ArCH, C8), 108.66 (ArCH, C7), 107.78 (ArCH, C4) 
101.71 (OCH2O, C9), 76.06 (CH, C2), 60.62 (CH2N, C12), 53.50 (OCH3, C10) 
IR (neat) νmax: 3387, 3021, 2967, 1743, 1637, 1496, 1451, 1434, 1372, 1361, 1242, 1195, 
1171, 1107, 1026 cm-1 
ESI-MS (70 eV) m/z: [M-Br]+: 330.10 
ESI-HRMS calc. for C17H16NO6 [M-Br]+: 330.0978 , found: 330.0977 
m.p.: 148 oC-149 oC 
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(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) 
acetoxy]acetate, octylsulfate salt (23b) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) 
acetoxy]acetate, bromide salt (23a) (0.169 g, 0.41 mmol) in distilled water (10 mL) was 
added sodium octylsulfate (0.099 g, 0.43 mmol) at room temperature. After stirring 
overnight the water was evaporated in vacuo and the resulting solid was dissolved in 
CH2Cl2 (10 mL). The organic phase was washed with water (3 × 2 mL) and concentrated 
under reduced pressure. The product was washed with diethyl ether (5 × 3 mL) to give the 
title compound 23b as colourless oil in 55 % yield (0.121 g, 0.22 mmol). 
Product characterization: 
Molecular formula: C24H34N2O10S 
Molecular weight : 542.6 g/mol 
1H NMR (400 MHz, CD3CN, δ): 8.83 (s, 1H, H13), 7.48 (t, J = 1.8 Hz, 1H, H15), 7.42 (t, J 
= 1.8 Hz, 1H, H14), 6.95 (dd, J = 8.4, 2.0 Hz, 1H, H8), 6.94 (d, J = 2.0 Hz, 1H, H4), 6.87 
(d, J = 8.4 Hz, 1H, H7), 6.002 (d, part A of an AB system, J = 1.0 Hz, 1H, H9), 5.998 (d, 
part B of an AB system J = 1.0 Hz, 1H, H9), 5.95 (s, 1H, H2), 5.24 (d, part A of an AM 
system, J = 17.8 Hz, 1H, H12), 5.19 (d, part M of an AM system, J = 17.8 Hz, 1H, H12), 
3.87 (s, 3H, H16), 3.79 (t, J = 6.8 Hz, 2H, H17) 3.69 (s, 3H, H10), 1.57-1.50 (m, 2H, H18), 
1.31-1.27 (m, 10H, H19-23), 0.87 (t, J = 6.8, 3H, H24) 
13C NMR (100 MHz, CD3CN, δ): 169.45 (COO, C1), 167.06 (COO, C11), 149.79 (ArC, 
C6), 149.11 (ArC, C5), 138.80 (ArCH, C13), 127.59 (ArCH, C3), 124.62 (ArCH, 
C14/C15) 124.56 (ArC, C14/C15), 123.11 (ArCH, C8), 109.304 (ArCH, C7), 108.77 
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(ArCH, C4) 102.94 (OCH2O, C9), 76.46 (CH, C2), 67.32 (OCH2, C17), 53.52 (OCH3, 
C10), 50.53 (CH2, C12), 37.14 (CH3, C16), 32.56 (CH2, C22/C23), 30.35 (CH2, C20/C21), 
30.06 (CH2, C18), 29.98 (CH2, C20/C21), 26.76 (CH2, C19), 23.36 (CH2, C22/C23), 14.37 
(CH3, C24) 
IR (neat) νmax: 3432, 2999, 2952, 2912, 1732, 1486, 1436, 1384, 1360, 1232, 1202, 1172, 
1122, 1103, 1083 cm-1 
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 333.10 
ESI-HRMS calc. for C16H17N2O6 [M-OctOSO3]+: 333.1081, found: 333.1087 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(2-pyridiniumacetoxy)acetate, 
octylsulfate salt (24b) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-(2-pyridiniumacetoxy) 
acetate, bromide salt (24a) (0.232 g, 0.57 mmol) in distilled water (10 mL) was added 
sodium octylsulfate (0.140 g, 0.59 mmol) at room temperature. After stirring overnight the 
water was evaporated in vacuo and the resulting solid was dissolved in CH2Cl2 (12 mL). 
The organic phase was washed with water (3 × 3 mL) and concentrated under reduced 
pressure. The product was washed with diethyl ether (5 × 3 mL) to give the title compound 
24b as colourless oil in 45 % yield (0.136 g, 0.25 mmol). 
Product characterization: 
Molecular formula: C25H33NO10S 
Molecular weight : 539.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 9.05-9.03 (m, 2H, H13, H17), 8.49-8.45 (m, 1H, H15), 
8.02-7.98 (m, 2H, H14, H16), 6.89 (dd, J = 8.0, 1.2 Hz, 1H, H8), 6.87 (d, J = 1.2 Hz, 1H, 
H4), 6.75 (d, J = 8.0 Hz, H7),  5.96 (d, part A of an AX system, J = 17.4 Hz, 1H, H12), 
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5.95 (d, part A of an AB system, J = 1.0 Hz, 1H, H9), 5.901 (d, part B of an AB system, J = 
1.0 Hz, 1H, H9), 5.903 (s, 1H, H2), 5.81 (d, part X of an AX system, J = 17.4 Hz, 1H, 
H12), 3.92 (t, J = 7.0 Hz, 2H, H18), 3.68 (s, 3H, H10), 1.57 (m, 2H, H19), 1.30-1.22 (m, 
10H, H20-H24 ), 0.84 (t, J = 6.8 Hz, 3H, H25)  
 
13C NMR (100 MHz, CDCl3, δ): 168.48 (COO, C1), 165.81 (COO, C11), 148.86(ArC, 
C6), 148.10 (ArC, C5), 146.86 (ArCH, C13,C17), 146.41 (ArCH, C15), 128.02 (ArCH, 
C14,C16), 126.05 (ArC, C3), 122.39 (ArCH, C8), 108.64 (ArCH, C7), 108.22 (ArCH, C4), 
101.61 (OCH2O, C9), 76.40 (NCH, C2), 67.81 (CH2, C18), 60.79 (NCH2, C12), 53.01 
(OCH3, C10), 31.89 (CH2, C23/C24), 29.56 (CH2, C19), 29.44 (CH2, C18/C21), 29.34 (CH2, 
C18/C21), 25.94 (CH2, C20), 22.73 (CH2, C23/C24), 14.20 (CH3, C25) 
IR (neat) νmax: 3063, 2951, 2928, 1748, 1638, 1493, 1436, 1447, 1367, 1239, 1199, 1173, 
1031 cm-1  
ESI-MS (70 eV) m/z: [M-OctOSO3]+: 330.10 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) 
acetoxy]acetate, NTf2 salt (23c) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-[2-(3-methylimidazolium) 
acetoxy]acetate, bromide salt (23a) (0.534 g, 1.29 mmol) in distilled water (10 mL) was 
added LiNTf2 (0.408 g, 1.42 mmol) at room temperature. The reaction mixture was stirred 
vigorously overnight. A fine solid precipitated, which was collected by filtration, washed 
with distilled water (3 × 3 mL) and dried under reduced pressure to give the title compound 
23c as a white crystalline powder in 76 % yield (0.603 g, 0.98 mmol). 
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Product characterization: 
Molecular formula: C18H17F6N3O10S2  
Molecular weight: 613.5 g/mol  
1H NMR (400 MHz, CDCl3, δ): 8.87 (s, 1H, H13), 7.39 (br s, 1H, H15), 7.31 (br s, 1H, 
H14), 6.89 (dd, J = 8.0, 1.6 Hz, 1H, H8), 6.85 (d, J = 1.6 Hz, 1H, H4), 6.80 (d, J = 8.0 Hz, 
1H, H7), 5.98 (bs, 2H, H9), 5.89 (s, 1H, H2), 5.16 (s, 2H, H12), 3.49 (s, 3H, H16), 3.71 (s, 
3H, H10)  
13C NMR (100 MHz, CDCl3, δ): 168.49 (COO, C1), 165.35 (COO, C11), 148.98 (ArC, 
C6), 148.17 (ArC, C5), 137.78 (ArCH, C13), 125.72 (ArCH, C3), 123.78 (ArC, C15), 
123.36 (ArC, C14), 122.36 (ArCH, C8), 119.68 (q, J = 319.5 Hz, 2CF3, C17, C18), 108.64 
(ArCH, C7), 107.97 (ArCH, C4), 101.62, (OCH2O, C9), 76.20 (CH, C2), 53.04 (OCH3, 
C10), 49.90 (CH2N, C12), 36.68 (NCH3, C16)  
IR (neat) νmax: 3161, 3130, 3106, 2973, 1769, 1729, 1577, 1508, 1496, 1343, 1329, 1288, 
1195, 1183, 1139, 1054, 1036, 1005 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 333.10 
ESI-HRMS calc. for C16H17N2O6 [M-NTf2]+: 333.1081, found: 333.1086 
m.p.: 82-83 oC 
 
(RS)-Methyl 2-(3,4-methylenedioxyphenyl)-2-(2-pyridiniumacetoxy)acetate, NTf2 salt 
(24c) 
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To a stirred solution of methyl 2-(3,4-methylenedioxyphenyl)-2-(2-
pyridiniumacetoxy)acetate, bromide salt (24a) (0.621 g, 1.51 mmol) in distilled water (15 
mL) was added LiNTf2 (0.478 g, 1.67 mmol) at room temperature. The reaction mixture 
was stirred vigorously overnight. A fine solid precipitated, which was collected by 
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filtration, washed with distilled water (5 × 5 mL) and dried under reduced pressure to give 
the title compound 24c as a white crystalline powder in 78 % yield (0.722 g, 1.18 mmol).  
Product characterization: 
Molecular formula: C19H16F6N2O10S2 
Molecular weight: 610.5 g/mol  
1H NMR (400 MHz, CD3CN, δ): 8.70-8.68 (m, 2H, H13, H17), 8.65-8.60 (m, 1H, H15), 
8.13-8.09 (m, 2H, H14, H16), 6.95 (dd, J = 8.0, 1.6 Hz, 1H, H8), 6.93 (d, J = 1.6 Hz, 1H, 
H4), 6.88 (d, J = 8.0 Hz, H7), 6.007 (d, part A of an AB system, J = 1.2 Hz, 1H, H9), 6.005 
(d, part B of an AB system J = 1.2 Hz, 1H, H9), 6.003 (s, 1H, H2), 5.60 (d, part A of an AX 
system, J = 17.4 Hz, 1H, H12), 5.49 (d, part X of an AX system, J = 17.4 Hz, 1H, H12), 
3.70 (s, 3H, H10) 
13C NMR (100 MHz, CD3CN, δ): 169.16 (COO, C1), 166.17 (COO, C11), 149.90 (ArC, 
C6), 149.16 (ArC, C5), 148.44 (ArCH, C15), 146.92 (ArCH, C13, C17), 129.35 (ArCH, 
C14, C16), 127.35 (ArC, C3), 123.21 (ArCH, C8), 120.90 (q, J = 318.7 Hz, 2CF3, C18, 
C19), 109.34 (ArCH, C7), 108.69 (ArCH, C4), 102.98, (OCH2O, C9), 76.86 (NCH, C2), 
61.49 (CH2N, C12), 53.62 (OCH3, C10) 
IR (neat) νmax: 3142, 3091, 3071, 2972, 1766, 1721, 1640, 1494, 1454, 1437, 1347, 1333, 
1194, 1139, 1053, 1036, 1008 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 330.10 
ESI-HRMS calc. for C17H16NO6 [M-NTf2]+: 330.0978 , found: 330.0984 
m.p.: 91-93 oC 
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Chiral resolution 
Synthesis of diastereomers 
(RS)-2-(3,4-Dimethoxyphenyl)-2-(3-methylimidazolium) acetic acid, NTf2 salt (30c) 
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To a stirred solution of methyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetate, 
NTf2 salt (1c) (0.429 g, 0.75 mmol) in methanol (3.0 mL) at 35 oC was added KOH (0.086 
g, 1.54 mmol) and the reaction was stirred for 2 h. Then distilled water (5 mL) was added 
and the solution was acidified to pH 2 with 6M HCl. The reaction mixture was extracted 
with CH2Cl2 (3 × 10 mL) and concentrated under reduced presure to give the title 
compound 30c as white crystals in 93 % yield (0.390 g, 0.70 mmol). 
Product characterization: 
Molecular formula: C17H17F6N3O8S2 
Molecular weight: 557.4 g/mol 
1H NMR (400 MHz, DMSO-d6, δ): 9.10 (s, 1H, H11), 7.81 (t, J = 1.8 Hz, 1H, H13), 7.70 
(t, J = 1.8 Hz, 1H, H12), 7.08-7.06 (m, 3H, H4, H7, H8), 6.48 (s, 1H, H2), 3.85 (s, 3H, 
H14), 3.79 (s, 3H, H9/H10), 3.78 (s, 3H, H9/H10) 
13C NMR (150 MHz, DMSO-d6, δ): 169.26 (COO, C1), 150.33 (ArC, C5/C6), 149.57 
(ArC, C5/C6), 136.96 (NCHN, C11), 125.42 (ArC, C3), 123.74 (ArC, C12) 122.88 (ArC, 
C13), 121.79 (ArCH, C4/C7/C8), 119.92 (q, J = 319.8 Hz, 2CF3, C15, C16), 112.48 
(ArCH, C4/C7/C8), 112.50 (ArCH, C4/C7/C8), 64.68 (NCH, C2) 56.02 (OCH3, C9/C10) 
56.00 (OCH3, C9/C10), 36.39 (NCH3, C14)  
IR (neat) νmax: 3157, 3120, 2946, 2847, 1733, 1595, 1519, 1470, 1425, 1336, 1287, 1246, 
1176, 1155, 1131, 1051, 1017 cm-1  
ESI-MS (70 eV) m/z: [M-NTf2]+: 277.10 
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ESI-HRMS calc. for C14 H17N2O4 [M-NTf2]+: 277.1183, found: 277.1182 
m.p.: 135-137 oC 
(RS)-2-(3,4-Methylenedioxyphenyl)-2-(3-methylimidazolium) acetic acid, NTf2 salt 
(31c) 
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To a stirred solution of methyl 2-(3,4-methylendioxyphenyl)-2-(3-methylimidazolium) 
acetate, NTf2 salt (5c) (0.385 g, 0.69 mmol) in methanol (3.0 mL) at 35 oC was added KOH 
(0.08 g, 1.42 mmol) and the reaction was stirred for 2 h. Then distilled water (5 mL) was 
added and the solution was acidified to pH 2 with 6M HCl. The reaction mixture was 
extracted with CH2Cl2 (3 × 10 mL) and concentrated under reduced presure to give the title 
compound 31c as yellow oil in 98 % yield (0.370 g, 0.68 mmol). 
Product characterization: 
Molecular formula: C15H13F6N3O8S2 
Molecular weight: 541.4 g/mol 
1H NMR (400 MHz, CD3CN, δ): 8.60 (br s, 1H, OH), 8.51 (s, 1H, H10), 7.45 (t, J = 1.8 
Hz, 1H, H12), 7.39 (t, J = 1.8 Hz, 1H, H11), 7.02 (dd, J = 8.0, 1.6 Hz, 1H, H8), 6.97 (d, J 
= 1.6 Hz, 1H, H4), 6.95 (d, J = 8.0 Hz, 1H, H7), 6.22 (s, 1H, H2), 6.052 (d, part A of an 
AB system, J = 0.8 Hz, 1H, H9), 6.046 (d, part B of an AB system J = 0.8 Hz, 1H, H9), 
3.84 (s, 3H, H13) 
13C NMR (100 MHz, CD3CN, δ): 167.65 (COO, C1), 149.05 (ArC, C6), 148.43 (ArC, C5), 
135.96 (NCHN, C10), 124.82 (ArC, C3), 123.13 (NCH, C11), 122.93 (ArCH, C8), 122.01 
(NCH, C12), 119.54 (q, J = 318.7 Hz, 2CF3, C14, C15), 108.59 (ArCH, C7), 108.28 
(ArCH, C4), 101. 96 (OCH2O, C9), 64.09 (NCH, C2), 35.79 (NCH3, C13) 
IR (neat) νmax: 3157, 2913, 1750, 1610, 1555, 1506, 1493, 1450, 1347, 1328, 1253, 1228, 
1181, 1131, 1053, 1035 cm-1 
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ESI-MS (70 eV) m/z: [M-NTf2]+: 261.10 
ESI-HRMS calc. for C13 H13N2O4 [M-NTf2]+: 261.0870, found: 261.0881 
 
(RS)-2-(3,4-Methylenedioxyphenyl) -2-pyridinium acetic acid, NTf2 salt (32c) 
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To a stirred solution of methyl 2-(3,4-methylendioxyphenyl)-2-(pyridinium) acetate, NTf2 
salt 6c (0.313 g, 0.57 mmol) in methanol (1.5 mL) at 35 oC was added KOH (0.067 g, 1.16 
mmol) and the reaction was stirred for 17 h. Then distilled water (2 mL) was added and the 
solution was acidified to pH 2 with 6M HCl. The reaction mixture was extracted with 
CH2Cl2 (3 × 5 mL) and concentrated under reduced pressure to give the title compound 32c 
as brown oil in 80 % yield (0.246 g, 0.46 mmol). 
Product characterization: 
Molecular formula: C16H12F6N2O8S2 
Molecular weight: 538.4 g/mol 
1H NMR (400 MHz, CD3CN, δ): 8.90 (br s, 1H, OH), 8.751-8.748 (m, 2H, H10, H14), 
8.61-8.56 (m, 1H, H12), 8.08-8.04 (m, 2H, H11, H13), 7.09 (dd, J = 8.0, 1.9 Hz, H8), 7.03 
(d, J = 1.9 Hz, H4), 6.99 (d, J = 8.0 Hz, H7), 6.08 (d, part A of an AB system, J = 0.8 Hz, 
1H, H9), 6.07 (d, part B of an AB system J = 0.8 Hz, 1H, H9) 
13C NMR (100 MHz, CD3CN, δ): 166.85 (COO, C1), 149.61 (ArC, C5/C6), 148.64 (ArC, 
C5/C6), 147.00 (ArC, C12), 144.05 (2ArC, C10, C14), 127.80 (2ArC, C11, C13), 124.16 
(ArCH, C8), 123.27 (ArC, C3), 119.53 (q, J = 318.7 Hz, 2CF3, C15, C16), 109.28 (ArCH, 
C4/C7), 108.72 (ArCH, C4/C7), 102.15 (OCH2O, C9), 74.19 (NCH, C2) 
IR (neat) νmax: 3136, 3092, 1745, 1633, 1505, 1490, 1449, 1346, 1327, 1180, 1130, 1052, 
1035 cm-1 
ESI-MS (70 eV) m/z: [M-NTf2]+: 258.10 
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ESI-HRMS calc. for C14H12NO4 [M-NTf2]+:  258.0761, found: 258.0776 
 
(RS)-1-Phenylbutyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetate, NTf2 
salt (33c) 
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To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetic acid, 
NTf2 salt (30c) (0.269 g, 0.48 mmol) in CH2Cl2 (12 mL) was added DCC (0.111 g, 0.53 
mmol), DMAP (0.006 g, 0.05 mmol) and (S)-1-phenylbutanol (0.0793 g, 0.53 mmol) at 
room temperature. After stirring overnight the reaction mixture was filtered and 
concentrated under reduced pressure. The resulting crude product was purified twice by 
column chromatography (SiO2, toluene:methanol 90:10); (SiO2, CH2Cl2:acetonitrile 93:7) 
to give the title compound 33c as a white solid in 5 % yield (0.016 g, 0.02 mmol). 
Product characterization: 
Molecular formula: C26H29F6N3O8S2  
Molecular weight: 689.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.89 (s, 1H, H21) , 8.80 (s, 1H, H21”),  7.39-7.24 (m, 14H, 
H16-H23, H16”-H23”), 7.04 (d, J = 1.8 Hz, 1H, H4”),  7.02 (dd, J = 8.1, 1.8  Hz, 1H, 
H8”), 6.95 (d, J = 8.1 Hz, 1H, H7”), 6.79 (d, J = 8.4 Hz, 1H, H7) 6.70 (dd, J = 8.4, 2.1 
Hz, 1H, H8), 6.67 (d, J = 2.1 Hz, 1H, H4), 6.41 (s, 1H, H2), 6.37 (s, 1H, H2”),  5.81-5.78 
(m, 2H, H11,H11”), 3.94 (s, 3H, H9/H10/H9”/H10”/H24/H24”) 3.90 (s, 6H, 
H9/H10/H9”/H10”/H24/H24”) 3.89 (s, 3H, H9/H10/H9”/H10”/H24/H24”), 3.64 (s, 3H, 
H9/H10/H9”/H10”/H24/H24”), 2.01-1.93 (m, 1H, H12) 1.92-1.85 (m, 1H, H12”), 1.78-
1.73 (m, 1H, H12), 1.72-1.67 (m, 1H, H12”), 1.44-1.36 (m, 1H, H13/H13”), 1.31-1.22 (m, 
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1H, H13/H13”), 1.21-1.15 (m, 1H, H13/H13”), 1.13-1.06 (m, 1H, H13/H13”), 0.92 (t, J = 
6.0 Hz, H14/H14”), 0.83 (t, J = 6.0 Hz, H14/H14”)  
13C NMR (100 MHz, CDCl3, δ): 167.02 (COO, C1/C1”), 166.90 (COO, C1/C1”), 151.00 
(ArC, C5/C5”/C6/C6”), 150.81 (ArC, C5/C5”/C6/C6”), 150.19 (ArC, C5/C5”/C6/C6”), 
149.94 (ArC, C5/C5”/C6/C6”), 139.11 (ArC, C15/C15”), 139.06 (ArC, C15/C15”), 
136.85 (ArCH, C21/C21”), 136.65 (ArCH, C21/C21”), 128.74 (2ArCH), 128.54 (ArCH), 
128.38 (2ArCH), 126.74 (3ArCH), 126.39 (2ArCH), 123.20 (ArC, C3/C3”), 122.76 
(ArCH), 122.56 (ArCH), 122.52 (ArC, C3/C3”), 122.04 (ArCH), 121.67 (2ArCH), 120.88 
(ArCH), 119.80 (q, J = 319.5 Hz, 4CF3, C25,C25”,C26,C26”), 112.01 (ArCH, 
C4/C4”/C7/C7”), 111.74 (ArCH, C4/C42/C7/C7”), 111.60 (ArCH, C4/C42/C7/C7”), 
111.43 (ArCH, C4/C42/C7/C7”), 79.97 (OCH, C11/C11”), 79.88 (OCH, C11/C11”), 64.78 
(NCH, C2/C2”), 64.65 (NCH, C2/C2”), 56.15 (OCH3, C9/C9”/C10/C10”), 56.06 (OCH3, 
C9/C9”/C10/C10”), 56.03 (OCH3, C9/C9”/C10/C10”), 55.88 (OCH3, C9/C9”/C10/C10”), 
37.98 (CH2, C12/C12”), 37.78 (CH2, C12/C12”), 36.62 (NCH3, C24/C24”), 36.60 (NCH3, 
C24/C24”), 18.59 (CH2, C13/C13”), 18.56 (CH2, C13/C13”), 13.54 (CH3, C14/C14”), 
13.48 (CH3, C14/C14”) 
 
Enzymatic resolution 
(RS)-1-Trifluoromethylheptyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) 
acetate, NTf2 salt (34c) 
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To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetic acid, 
NTf2 salt (30c) (0.451 g, 0.81 mmol) in CH2Cl2 (20 mL), (S)-(−)-1,1,1-trifluoro-2-octanol 
(0.16 mL, 0.89 mmol) and DMAP (0.01 g, 0.08 mmol) were added and the solution was 
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stirred for 10 min. at room temperature under a N2 atmosphere. After the addition of 
triethylamine (0.11 mL, 0.89 mmol), the mixture was cooled to 0 oC, whereupon a 50% 
solution of n-propylphosphonic anhydride in ethyl acetate (0.48 mL, 0.81 mmol) was 
slowly added. The resulting mixture was stirred for 30 min at 0 °C and then for 12 h at 
room temperature. Organic phase was extracted with water (6 × 6 mL) and solvent was 
removed under reduced pressure to give the title compound 34c as yellow oil in 59 % 
(0.348 g, 0.48 mmol). 
Product characterization: 
Molecular formula: C24H30F9N3O8S2 
Molecular weight: 723.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.85 (s, 1H, H19/H19”), 8.82 (s, 1H, H19/H19”), 7.38 (s, 
1H, H20/H21/H20”/H21”), 7.34 (s, 1H, H20/H21/H20”/H21”), 7.32 (s, 1H, 
H20/H21/H20”/H21”), 7.27 (s, 1H, H20/H21/H20”/H21”), 7.02-6.92 (m, 6H, H4, H7, H8, 
H4”, H7”, H8”), 6.49 (s, 1H, H2/H2”), 6.38 (s, 1H, H2/H2”), 5.39-5.32 (m, 2H, H11, 
H11”), 3.95 (s, 3H, H22/H22”), 3.94 (s, 3H, H22/H22”), 3.89 (s, 6H, H9/H10/H9”/H10”), 
3.88 (s, 3H, H9/H10/H9”/H10”), 3.85 (s, 3H, H9/H10/H9”/H10”), 1.81-1.76 (m, 2H, 
H12/H13/H12”/H13”), 1.72-1.65 (m, 2H, H12/H13/H12”/H13”), 1.35-1.20 (m, 12H, H14-
H16, H14”-H16”), 1.17-1.13 (m, 2H, H12/H13/H12”/H13”), 1.12-1.10 (m, 2H, 
H12/H13/H12”/H13”), 0.83 (t, J = 6.4 Hz, 3H, H17/H17”), 0.81 (t, J = 6.8 Hz, 3H, 
H17/H17”)  
13C NMR (100 MHz, CDCl3, δ):  166.79 (C1/C1”), 166.59 (C1/C1”), 151.13 
(C5/C6/C5”/C6”), 150.96 (C5/C6/C5”/C6”), 150.16 (C5/C6/C5”/C6”), 150.00 
(C5/C6/C5”/C6”), 136.51 (C19/ C19”), 136.38 (C19/ C19”), 123.48 
(C20/C21/C20”/C21”), 123.28 (C20/C21/C20”/C21”), 123.28 (q, J = 279.6 Hz, 2CF3 , 
C18, C18”), 122.35 (C3,C3’) 122.10 (C20/C21/C20”/C21”), 122.06 
(C20/C21/C20”/C21”), 121.39 (C8/C8”), 120.82 (C8/C8”), 119.75 (q, J = 319.1 Hz, 4CF3, 
C23, C24, C23”, C24”), 111.81 (C4/C7/C4”/C7”), 111.72 (C4/C7/C4”/C7”), 111.68 
(C4/C7/C4”/C7”), 111.50 (C4/C7/C4”/C7”), 72.45 (q, J = 32.2 Hz, C11/C11”), 72.25 (q, 
J = 32.3 Hz, C11/C11”), 64.49 (C2/C2”), 64.30 (C2/C2”), 56.03 (C9/C10/C9”/C10”), 
55.98 (C9/C10/C9”/C10”), 55.97 (C9/C10/C9”/C10”), 55.94 (C9/C10/C9”/C10”), 36.63 
(C22/C22”), 36.61 (C22/C22”), 31.29 (C12-C16/C12”-C16”), 31.19 (C12-C16/C12”-
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C16”), 28.60 (C12-C16/C12”-C16”), 28.43 (C12-C16/C12”-C16”), 27.47 
(C12/C13/C12”/C13”), 27.31 (C12/C13/C12”/C13”), 24.27 (C12-C16/C12”-C16”), 24.07 
(C12-C16/C12”-C16”), 22.47 (C12-C16/C12”-C16”), 22.31 (C12-C16/C12”-C16”), 
13.93 (C17/C17”), 13.91 (C17/C17”)  
19F NMR (376 MHz, CDCl3, δ):  76.42 (d, J = 7.5 Hz, CF3), 77.00 (d, J = 7.5 Hz, CF3), 
78.99 (s, 2CF3) 
 
(RS)-2-Trifluoroethyl 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetate, NTf2 
salt (35c) 
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To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium) acetic acid, 
NTf2 salt (30c) (0.155 g, 0.28 mmol) in CH2Cl2 (7.0 mL), 2,2,2-trifluoroethanol (0.02 mL, 
0.31 mmol) and DMAP (0.004 g, 0.03 mmol) were added and the solution was stirred for 
10 min. at room temperature under a N2 atmosphere. After the addition of triethylamine 
(0.04 mL, 0.31 mmol), the mixture was cooled to 0 oC, whereupon a 50% solution of n-
propylphosphonic anhydride in ethyl acetate (0.17 mL, 0.28 mmol) was slowly added. The 
resulting mixture was stirred for 30 min at 0 °C and then for 12 h at room temperature. 
After that second portion of of n-propylphosphonic anhydride in ethyl acetate (0.17 mL, 
0.28 mmol) and 2,2,2-trifluoroethanol (0.02 mL, 0.31 mmol) were added and the solution 
was stirred for 6 h. Organic phase was extracted with water (10 × 5 mL) and solvent was 
removed under reduced pressure to give the title compound 35c as yellow oil in 55 % 
(0.098 g, 0.15 mmol). 
Product characterization: 
Molecular formula: C18H18F9 N3O8S2 
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Molecular weight: 639.47 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.88 (s, 1H, H13), 7.30 (t, J = 1.6 Hz, 1H, H14/H15), 7.26 
(br s, 1H, H14/H15), 6.96 (dd, J = 8.2, 1.8 Hz, 1H, H8), 6.92 (d, J = 8.2 Hz, 1H, H7), 6.91 
(d, J = 1.8 Hz, 1H, H4), 6.42 (s, 1H, H2), 4.81 (dq, J = 12.6, 8.2 Hz, 1H, H11), 4.46 (dq, J 
= 12.6, 8.2 Hz, 1H, H11), 3.92 (s, 3H, H16), 3.87 (s, 3H, H9/H10), 3.83 (s, 3H, H9/H10) 
13C NMR (100 MHz, CDCl3, δ): 166.44 (COO, C1), 151.12 (ArC, C5/C6), 150.15 (ArC, 
C5/C6), 136.59 (ArC, C13), 124.57, 123.39 (ArC, C14/C15), 122.36 (q, J = 277.2 Hz, CF3, 
C12), 122.15 (ArC, C14/C15), 121.93 (ArC, C3), 121.37 (ArCH, C8), 119.78 (q, J = 319.1 
Hz, 2CF3, C17, C18), 111.89 (ArCH, C4/C7), 111.54 (ArCH, C4/C7), 64.52 (NCH, C2), 
61.75 (q, CH2, J = 37.0 Hz, C11), 56.04 (2OCH3, C9, C10), 36.67 (NCH3, C16) 
19F NMR (376 MHz, CDCl3, δ): 73.43 (t, J = 7.5 Hz, CF3), 78.92 (s, 2CF3) 
IR (neat) νmax: 3154, 2968, 2846, 1771, 1596, 1580, 1555, 1519, 1468, 1445, 1426, 1348, 
1330, 1267, 1227, 1177, 1133, 1052, 1020 cm-1  
ESI-MS (70 eV) m/z: [M-NTf2]+: 359.10 
 
Enzymatic resolution of 13 in hexane 
To a stirred solution of methyl 3,4-methylenedioxymandelate (13) (0.320 g, 1.52 mmol) in 
hexane (30 mL), was added vinyl acetate (1.38 mL, 15.0 mmol), followed by addition of 
Novozyme 435 (component B of the lipase from Candida Antarctica immobilized on 
macroporous polyacrylate resin) (0.111 g). The reaction mixture was stirred at 25 oC for 7 
days. After that time enzyme beds were filtered and washed with dichloromethane. Organic 
phases were combined and removed via rotary evaporation. Unreacted starting material 13 
was obtained in quantitative yield. 
 
Enzymatic resolution of 34c in water-saturated isooctane 
To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) heptyl acetate, NTf2 salt (34c) (22.0 mg) in water-saturated isooctane (10 
mL) was added Novozym 435 (10.5 mg). The reaction mixture was stirred at 45 oC, for two 
weeks. After that time enzyme beds were filtered and washed with dichloromethane. 
Organic phases were combined and solvent was removed by rotary evaporation. Unreacted 
starting material 34c was obtained in quantitative yield. 
 179
Enzymatic resolution of 35c in water-saturated isooctane 
To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) ethyl acetate, NTf2 salt (35c) (26.8 mg) in water-saturated isooctane (5 
mL) was added Novozym 435 (10.0 mg). The reaction mixture was stirred at 45 oC, for 5 
days. After that time enzyme beds were filtered and washed with dichloromethane. Organic 
phases were combined and solvent was removed by rotary evaporation. Unreacted starting 
material 35c was obtained in quantitative yield. 
 
Enzymatic resolution of 34c in biphasic solution 
To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) heptyl acetate, NTf2 salt (34c) (56.0 mg) in hexane (0.5 mL) and methanol 
(0.05 mL) was added a solution of Novozym 435 (12.5 mg) in phosphate buffer (4.5 mL, 
100 mM, pH 7.4). The reaction mixture was stirred at 37 oC, under N2 atmosphere for 32 h. 
After that time aqueous and organic phases were separated and enzyme beds were washed 
with dichloromethane. Organic phases were combined and solvent was removed by rotary 
evaporation. Unreacted starting material 34c was obtained in 64 % (36 mg). Aqueous phase 
was extracted with ethyl acetate and both phases were evaporated. NMR spectra were 
recorded. 
 
Control reaction of 34c without enzyme in biphasic solution 
 To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) heptyl acetate, NTf2 salt (34c) (34.0 mg) in hexane (0.5 mL) and methanol 
(0.05 mL) was added a phosphate buffer (4.5 mL, 100 mM, pH 7.4). The reaction mixture 
was stirred at 37 oC, under N2 atmosphere for 24 h. After that time aqueous and organic 
phases were separated. Organic solvent was removed by rotary evaporation. Unreacted 
starting material 34c was obtained in 71 % (24.0 mg). Aqueous phase was extracted with 
ethyl acetate and both phases were evaporated. NMR spectra were recorded. 
 
Enzymatic resolution of 35c in biphasic solution 
To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) ethyl acetate, NTf2 salt (35c) (51.0 mg) in hexane (0.5 mL) and methanol 
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(0.05 mL) was added a solution of Novozym 435 (12.0 mg) in phosphate buffer (4.5 mL, 
100 mM, pH 7.4). The reaction mixture was stirred at 37 oC, under N2 atmosphere for 24 h. 
After that time aqueous and organic phases were separated and enzyme beds were washed 
with dichloromethane. Organic phases were combined and solvent was removed by rotary 
evaporation. Unreacted starting material 35c was obtained in 18 % (9.0 mg). Aqueous 
phase was extracted with ethyl acetate and both phases were evaporated. NMR spectra were 
recorded. 
 
Control reaction of 35c without enzyme in biphasic solution  
To a stirred solution of 2-(3,4-dimethoxyphenyl)-2-(3-methylimidazolium)-(1-
trifluoromethyl) ethyl acetate, NTf2 salt (35c) (49.0 mg) in hexane (0.5 mL) and methanol 
(0.05 mL) was added a phosphate buffer (4.5 mL, 100 mM, pH 7.4). The reaction mixture 
was stirred at 37 oC, under N2 atmosphere for 24 h. After that time aqueous and organic 
phases were separated. Organic solvent was removed by rotary evaporation. Unreacted 
starting material 35c was obtained in 2 % (1.0 mg). Aqueous phase was extracted with 
ethyl acetate and both phases were evaporated off. NMR spectra were recorded. 
 
Chiral auxiliary method 
(RS)-2-Bromo-2-(3,4-methylenedioxyphenyl) acetic acid (36)43,44 
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To a stirred solution of 3,4-methylenedioxy mandelic acid (9) (1.934 g, 9.87 mmol) in 
CH2Cl2 (20 mL) at 0 oC was added hydrobromic acid (62 % aq. solution, 20 mL). The 
reaction mixture was allowed to warm to room temperature and after stirring for 20 h, the 
two layers were separated. The aqueous phase was extracted with CH2Cl2 (4 × 15 mL). The 
CH2Cl2 extracts were combined with the organic phase, dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure to give the title compound (36) as a brown 
oil in 98 % yield (2.515 g, 9.71 mmol). 
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Product characterization: 
Molecular formula: C9H7BrO4 
Molecular weight: 259.1 g/mol 
1H NMR (400 MHz, CDCl3, δ): 11.86 (br s, COOH), 7.14 (d, J = 2. 0 Hz, 1H, H4), 6.97 
(dd, J = 8.0, 2.0 Hz, 1H, H8), 6.75 (d, J = 8.0 Hz, 1H, H7), 5.98 (br s, 1H, H9), 5.97 (br s, 
1H, H9), 5.31 (s, 1H, H2) 
13C NMR (100 MHz, CDCl3, δ): 174.45 (COOH, C1), 148.79 (ArC, C5/C6), 148.21 (ArC, 
C5/C6), 128.32 (ArC, C3), 122.86 (ArCH, C8), 109.20 (ArCH, C4), 108.21 (ArCH, C7), 
101.69 (CH2, C9), 46.27 (CH, C2)   
IR (neat) νmax: 2992, 2897, 2677, 1711, 1628, 1609, 1501, 1487, 1445, 1415, 1386, 1244, 
1182, 1161, 1101, 1034 cm-1 
Compound prepared according to the reported procedure43 
1H NMR in agreement with lit. data 44 
 
(1'S,2RS)-(1'-Methoxycarbonyl-1'-phenylmethyl) 2-bromo-2-(3,4-
methylenedioxyphenyl) acetate (37) 
7
6
5
4
3
8
O
9
O
2
1
Br
O
O
10
11
13
18
17
16
15
14
O
O
12
 
 
To a stirred solution of 2-bromo-2-(3,4-methylenedioxyphenyl) acetic acid (36) (1.424 g, 
5.50 mmol) in CH2Cl2 (20 mL), (S)-(+) methyl mandelate (1.17 g, 7.04 mmol) and DMAP 
(0.172 g, 1.41 mmol) were added and the solution was stirred for 10 min. at room 
temperature under a N2 atmosphere. After the addition of TEA (0.89 mL, 7.04 mmol), the 
mixture was cooled to 0 oC, whereupon a 50% solution of n-propylphosphonic anhydride in 
ethyl acetate (4.19 mL, 7.04 mmol) was slowly added. The resulting mixture was stirred for 
30 min at 0 °C and then for 24 h at room temperature. Organic phase was extracted with 
distilled water (3 × 10 mL) and solvent was removed under reduced pressure. The resulting 
oil was purified twice by column chromatography (SiO2, hexane:EtOAc, 90:10) and (SiO2, 
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CH2Cl2) to give the title compound 37 as a colourless oil in 42 % yield (1.202 g, 2.95 
mmol). 
Product characterization: 
Molecular formula: C18H15BrO6 
Molecular weight: 407.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.46-7.38 (m, 10H, H14-18, H14”-18”), 7.17 (d, J = 1.8 
Hz, 1H, H4/H4”), 7.15 (d, J = 1.8 Hz, 1H, H4/H4”), 7.01 (dd, J = 8.0, 1.8 Hz, 1H, 
H8/H8”), 6.98 (dd, J = 8.0, 1.8 Hz, 1H, H8/H8”), 6.77 (d, J = 8.0 Hz, 1H, H7/H7”), 6.74 
(d, J = 8.0 Hz, 1H, H7/H7”), 5.99-5.97 (m, 6H, H9, H9”, H10, H10”), 5.46 (s, 1H, 
H2/H2”), 5.44 (s, 1H, H2/H2”), 3.75 (s, 3H, H12/H12”), 3.69 (s, 3H, H12/H12”)        
13C NMR (100 MHz, CDCl3, δ): 168.40 (COO, C11/C11”), 168.37 (COO, C11/C11”), 
167.51 (COO, C1/C1”), 167.44 (COO, C1/C1”), 148.59 (ArC, C6,C6”), 148.09 (ArC, 
C5/C5”), 148.04 (ArC, C5/C5”), 132.92 (ArC, C13/C13”), 132.90 (ArC, C13/ C13”), 
129.50 (ArCH), 129.46 (ArCH), 128.86 (2ArCH), 128.83 (2ArCH), 128.74 (ArC, C3/C3”), 
128.64 (ArC, C3/C3”), 127.58 (2ArCH), 127.52 (2ArCH), 122.87 (ArCH, C8/C8”), 122.79 
(ArCH, C8/C8”), 109.26 (ArCH, C4/C4”), 109.18 (ArCH, C4/C4”), 108.10 (ArCH, 
C7,C7”), 101.53 (OCH2O, C9,C9”), 75.79 (CH, C10/C10”), 75.69 (CH, C10/C10”), 52.78 
(OCH3, C12/C12”), 52.71 (OCH3, C12/C12”), 46.15 (CH, C2/C2”), 46.04 (NCH, C2/C2”) 
IR (neat) νmax: 3066, 2954, 2899, 1744, 1608, 1502, 1489, 1445, 1370, 1326, 1246, 1217, 
1171, 1130, 1102, 1033 cm-1 
ESI-MS (70 eV) m/z: [M-Br]+ 327.10, 367.05  
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(1'S,2RS)-(1'-Methoxycarbonyl-1'-phenylmethyl) 2-(3-methylimidazolium)-2-(3,4- 
methylenedioxyphenyl)acetate, bromide salt (38a) 
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To a stirred solution of (2-methoxy-2-oxo-(S)-1-phenylethyl) 2-bromo-2-(3,4-
methylenedioxyphenyl)acetate (37) (0.896 g, 2.20 mmol) in dichloromethane (10 mL) at -
15 oC under a N2 atmosphere was added 1-methylimidazole (90 µL, 1.1 mmol) dropwise 
and the reaction mixture was allowed to warm to room temperature. After stirring for 17 h 
reaction mixture was extracted with distilled water (4 × 3 mL). Solvent was removed under 
reduced pressure to give the title compound 38a as colourless oil in 19 % yield (0.10 g, 
0.20 mmol). 
 
Product characterization: 
Molecular formula: C22H21BrN2O6  
Molecular weight: 489.3 g/mol 
1H NMR (400 MHz, CDCl3, δ): 10.22 (s, 1H, H19/H19”), 10.19 (s, 1H, H19/H19”), 7.81 
(br s, 1H, H20/H20”/H21/H21”), 7.53 (br s, 1H, H20/H20”/H21/H21”), 7.57 (br s, 1H, 
H20/H20”/H21/H21”), 7.45 (br s, 1H, H20/H20”/H21/H21”), 7.41 (s, 1H, H2/H2”), 7.37 
(s, 1H, H2/H2”), 7.35-7.30 (m, 11H, H4/H4”, H14-H18, H14”-H18”), 7.27 (dd, J = 8.2, 
1.6 Hz, 1H, H8/H8”), 7.12 (s, 1H, H4/H4”), 7.11 (dd, J = 8.2, 1.6 Hz, 1H, H8/H8”), 6.85 
(d, J = 8.2 Hz, H7/H7”), 6.72 (d, J = 8.2 Hz, H7/H7”), 6.02 (s, 1H, H10/H10”), 5.99 (s, 
2H, H9/H9”), 5.95 (s, 1H, H10/H10”), 5.95 (d, part A of an AB system, J = 0.8 Hz, 1H, 
H9/H9”), 5.93 (d, part B of an AB system, J = 0.8 Hz, 1H, H9/H9”), 3.99 (s, 6H, 
H22/H22”), 3.70 (s, 3H, H12/H12”), 3.69 (s, 3H, H12/H12”)   
13C NMR (100 MHz, CDCl3, δ): 168.17 (COO, C11/C11”), 168.04 (COO, C11/C11”), 
167.06 (COO, C1/C1”), 166.42 (COO, C1/C1”), 149.07 (2ArC, C5,C5”/C6,C6”), 148.30 
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(ArC, C5/C5”/C6/C6”), 148.24 (ArC, C5/C5”/C6/C6”), 136.86 (ArCH, C19/C19”), 
136.82 (ArCH, C19/C19”), 131.91 (ArC, C13/C13”), 131.76 (ArC, C13/C13”), 129.57 
(ArCH), 129.53 (ArCH), 128.74 (2ArCH), 128.68 (2ArCH), 127.54 (2ArCH), 127.37 
(2ArCH), 124.90 (ArC, C3/C3”), 124.62 (ArC, C3/C3”), 123.59 (ArCH, 
C20/C20”/C21/C21”), 123.54 (ArCH, C20/C20”/C21/C21”), 123.37 (ArCH, 
C20/C20”/C21/C21”), 123.13 (ArCH, C20/C20”/C21/C21”), 121.42 (2ArCH, C8,C8”), 
109.21 (ArCH, C4/C4”/C7/C7”),108.88 (ArCH, C4/C4”/C7/C7”), 108.83 (ArCH, 
C4/C4”/C7/C7”), 108.79 (ArCH, C4/C4”/C7/C7”), 101.65 (2OCH2O, C9,C9”), 76.41 
(CH, C10/C10”), 76.16 (CH, C10/C10”), 63.46 (NCH, C2/C2”), 63.25 (NCH, C2/C2”), 
52.94 (OCH3, C12/C12”), 52.74 (OCH3, C12/C12”), 36.68 (NCH3, C22/C22”)  
IR (neat) νmax: 3395, 3023, 2955, 2903, 1742, 1609, 1578, 1551, 1502, 1490, 1446, 1370, 
1327, 1248, 1220, 1161, 1104, 1031 cm-1 
ESI-MS (70 eV) m/z: [M-Br]+:
 
409.10 
ESI-HRMS calc. for C22H21N2O6 [M-Br]+:  409.1394, found: 409.1414 
 
(1'S,2RS)-(1'-Methoxycarbonyl-1'-phenylmethyl) 2-(3-methylimidazolium)-2-(3,4- 
methylenedioxyphenyl)acetate, NTf2 salt (38c) 
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To a stirred solution of 37 (0.896 g, 2.20 mmol) in CH2Cl2 (10 mL) at room temperature 
under a N2 atmosphere was added 1-methylimidazole (0.09 mL, 1.10 mmol) dropwise and 
the reaction mixture was allowed to warm to room temperature. After stirring for 17 h 
reaction mixture was washed with distilled water (4 × 3 mL). Organic solvent was removed 
under reduced pressure and product was dissolved in distilled water (20 mL) and LiNTf2 
(0.695 g, 2.42 mmol) was added at room temperature. After stirring for 12 h product was 
extracted with CH2Cl2 and purified by column chromatography (SiO2, CH2Cl2:EtOAc, 
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90:10, then EtOH). The title compound 38c was obtained as colorless oil in 26 % yield 
(0.196 g, 0.28 mmol). 
Product characterization: 
Molecular formula: C24H21F6N3O10S2  
Molecular weight: 689.6 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.76 (s, 1H, H19), 8.67 (s, 1H, H19”), 7.35-7.25 (m, 10 H, 
H14-18, H14”-18”), 7.24 (t, J = 1.4 Hz, 1H, H20”/H21”), 7.23 (t, J = 1.4 Hz, 1H, 
H20”/H21”), 7.20 (t, J = 1.4 Hz, 1H, H20/H21), 7.16 (t, J = 1.4 Hz, 1H, H20”/H21”), 
7.03 (dd, J = 8.0 Hz, 1.8 Hz, , 1H, H8), 6.96 (d, J = 1.8 Hz, 1H, H4), 6.84 (d, J = 8.0, 1H, 
H7), 6.84 (dd, J = 8.0, 1.8 Hz, 1H, H8”), 6.79 (d, J = 1.8 Hz, 1H, H4”), 6.74 (d, J = 8.0, 
1H, H7”), 6.32 (s, 1H, H2”), 6.31 (s, 1H, H2”), 5.97 (d, part A of an AB system, J = 1.2 
Hz, 1H, H9), 5.96 (d, part B of an AB system J = 1.2 Hz, 1H, H9), 5.96 (s, 1H, H10), 5.92 
(d, part A of an AB system, J = 1.2 Hz, 1H, H9”), 5.91  (d, part B of an AB system J = 1.2 
Hz, 1H, H9”), 5.90 (s, 1H, H10”), 3.84 (s, 3H, H22), 3.83 (s, 3H, H22”), 3.66 (s, 3H, 
H12”), 3.65 (s, 3H, H12) 
13C NMR (100 MHz, CDCl3, δ): 168.44 (COO, C11), 168.33 (COO, C11”), 166.86 (COO, 
C1), 166.52 (COO, C1”), 149.87 (ArC, C6”), 149.78 (ArC, C6), 149.00 (ArC, C5”), 
148.89 (ArC, C5), 136.44 (ArCH, C19), 136.26 (ArCH, C19”), 132.19 (ArC, C13”), 
132.00 (ArC, C13), 129.89 (ArCH), 129.83 (ArCH), 129.00 (2ArCH), 128.95 (2ArCH), 
127.80 (2ArCH), 127.65 (2ArCH), 123.84 (ArCH, C20/C21), 123.72 (ArCH, C20”/C21”), 
123.51 (ArCH, C20/C21), 123.47 (2ArC, C3, C3”), 123.36 (ArCH, C20”/C21”), 122.15 
(ArCH, C8”), 122.09 (ArCH, C8), 119.73 (q, J = 319.3 Hz, 4CF3, C23,C23”,C24,C24”), 
109.37 (ArCH, C4/C4”/C7/C7”), 109.33 (ArCH, C4/C4”/C7/C7”), 109.19 (ArCH, 
C4/C4”/C7/C7”), 108.74 (ArCH, C4/C4”/C7/C7”), 102.08 (2OCH2O, C9, C9”), 76.84 
(CH, C10/C10”), 76.62 (CH, C10/C10”), 64.66 (NCH, C2), 64.53 (NCH, C2”), 53.16 
(OCH3, C12”), 52.96 (OCH3, C12), 36.62 (NCH3, C22/C22”), 36.58 (NCH3, C22/C22”)  
IR (neat) νmax: 3155, 2960, 2910, 1749, 1610, 1579, 1554, 1506, 1493, 1450, 1347, 1329, 
1180, 1132, 1036, 1054 cm-1 
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Preparation of ILs on large scale as solvents for hydrogenation reaction 
Determination of optical purity of ILs prepared by two methods 
(S)-(+)-Methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) 
Method A  
To a stirred solution of (S)-(+)-methyl mandelate (45) (0.615 g, 3.71 mmol)  in CH2Cl2 (10 
mL) at 0 oC was added potassium carbonate (0.768 g, 5.59 mmol) followed by  
bromoacetyl bromide (0.48 mL, 5.56 mmol) added dropwise and the reaction mixture was 
allowed to warm to room temperature. After stiring for 48 h the reaction mixture was 
filtered and second portion of potassium carbonate (0.768 g, 5.59 mmol) and bromoacetyl 
bromide (0.48 mL, 5.56 mmol) were added at 0 oC. After stirring overnight at room 
temperature the reaction mixture was filtered, dried over anhydrous MgSO4 and 
concentrated under reduced pressure to give the title compound 46 as a colourless liquid in 
61 % yield (0.653 g, 2.27 mmol). 
 
Method B  
(S)-(+)-methyl mandelate (45) (0.820 g, 4.93 mmol) was mixed thoroughly with neutral 
Al2O3 (0.756 g, 7.41 mmol) and bromoacetyl bromide (0.86 mL, 9.90 mmol) was added 
dropwise. Reaction was allowed to stand without stirring for 24 h at room temperature and 
then the reaction mixture was poured over funnel charged with sodium bicarbonate (15.560 
g, 185.24 mmol). After 24 h NaHCO3 was washed with toluene (4 × 10 ml). The combined 
extracts were concentrated under reduced pressure to give the title compound 46 as a 
colourless oil in 48 % yield (1.010 g, 3.52 mmol). 
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Product characterization: 
Molecular formula: C11H11BrO4 
Molecular weight: 287.1 g/mol 
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1H NMR (400 MHz, CDCl3, δ): 7.48-7.40 (m, 5H, H4, H5, H6, H7, H8), 5.98 (s, 1H, H2), 
4.00 (d, part A of an AB system, J = 12.8 Hz, 1H, H11), 3.96 (d, part B of an AB system, J 
= 12.8 Hz, 1H, H11), 3.74 (s, 3H, H9) 
[α]20 +113.2 (0.60 c, CHCl3) 
1H NMR in agreement with literature6 
 
Hydrolysis of S-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) obtained by 
method A  
To a stirred solution of (S)-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) 
 (0.653 g, 2.27 mmol) in methanol (20 mL) was added thionyl chloride (1.50 mL, 20.56 
mmol) dropwise and the reaction mixture was refluxed for 75 min. The reaction mixture 
was extracted with CH2Cl2 (3 × 20 mL) and the combined organic extracts were dried over 
anhydrous MgSO4, filtered and concentrated under reduced pressure. The resulting crude 
product was purified by column chromatography (SiO2, hexane:EtOAc 80:20) to give (S)-
(+)-methyl mandelate (45) in 45 % yield (0.168 g, 1.01 mmol).  
1H NMR (400 MHz, CDCl3, δ): 7.47-7.32 (m, 5H, H4, H5, H6, H7, H8), 5.19 (s, 1H, H2), 
3.77 (s, 3H, H9) 
1H NMR in agreement with literature6 
 
Hydrolysis of (S)-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) obtained by 
method B  
To a stirred solution of (S)-(+)-methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) (1.010 g, 
3.52 mmol) in methanol (20 mL) was added thionyl chloride (2.0 mL, 27.41 mmol) 
dropwise and the reaction mixture was refluxed for 3 h. The reaction mixture was extracted 
with CH2Cl2 (4 × 25 mL) and the combined organic extracts were dried over  anhydrous 
MgSO4, filtered and concentrated under reduced pressure. The resulting crude product was 
purified by column chromatography (SiO2, hexane: EtOAc 80:20) to give (S)-(+)-methyl 
mandelate (45) in 64 % yield (0.375 g, 2.26 mmol).    
 
 
 
 188
Product characterization: 
1H NMR (400 MHz, CDCl3, δ): 7.43-7.31 (m, 5H, H4, H5, H6, H7, H8), 5.19 (s, 1H, H2), 
3.76 (s, 3H, H9) 
1H NMR in agreement with literature6 
 
Metyl (2S,1’S) -2-phenyl-2-(3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane) 
carbonyloxy)acetate (47) 
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To a stirred solution of (S)-(+)-methyl mandelate (method A derivative) 45 (53 mg, 0.32 
mmol) in CH2Cl2 (0.50 mL) (S)-(−)- camphanoyl chloride (69 mg, 0.32 mmol) and DMAP 
(7 mg, 0.05 mmol) was added. TEA (40 µL, 0.32 mmol) was added at 0 oC and then the 
reaction mixture was allowed to warm to room temperature. The organic phase was washed 
with water and concentrated under reduced pressure to give the title compound 47. 
Product characterization: 
Molecular formula: C19H22O6 
Molecular weight: 346.4 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.47-7.39 (m, 5H, H5, H6, H7, H8), 6.03 (s, 1H, H2), 3.74 
(s, 3H, H9), 2.46 (ddd, J = 13.6, 10.8, 4.4 Hz, 1H, H12/H13), 2.08 (ddd, J = 13.2, 9.2, 4.4 
Hz, 1H, H12/H13), 1.95 (ddd, J = 13.3, 10.7, 4.5 Hz, 1H, H12/H13), 1.71 (ddd, J = 13.2, 
9.2, 4.0 Hz, 1H, H12/H13), 1.23 (s, 3H, H17/H18/H19), 1.14 (s, 3H, H17/H18/H19), 1.05 
(s, 3H, H17/H18/H19)  
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Metyl (2S,1’S) -2-phenyl-2-(3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane) 
carbonyloxy)acetate (47) 
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To a stirred solution of (S)-(+)-methyl mandelate (method B derivative) 45 (31 mg, 0.18 
mmol) in CH2Cl2 (0.50 mL) (S)-(−)-camphanoyl chloride (42 mg, 0.18 mmol) and DMAP 
(5 mg, 0.03 mmol) was added. TEA (30 µL, 0.18 mmol) was added at 0 oC and then the 
reaction mixture was allowed to warm up to room temperature. The organic phase was 
washed with water and concentrated under reduced pressure to give the title compound 47. 
Product characterization: 
Molecular formula: C19H22O6 
Molecular weight: 346.4 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.47-7.40 (m, 5H, H5, H6, H7, H8), 6.03 (s, 1H, H2), 3.73 
(s, 3H, H9), 2.46 (ddd, J = 13.6, 10.8, 4.2 Hz, 1H, H12/H13), 2.08 (ddd, J = 13.2, 9.3, 4.8 
Hz, 1H, H12/H13), 1.95 (ddd, J = 13.2, 10.6, 4.8 Hz, 1H, H12/H13), 1.71 (ddd, J = 13.2, 
9.2, 4.1 Hz, 1H, H12/H13), 1.23 (s, 3H, H17/H18/H19), 1.14 (s, 3H, H17/H18/H19), 1.05 
(s, 3H, H17/H18/H19)  
 
Metyl (2RS,1’S) -2-phenyl-2-(3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane) 
carbonyloxy)acetate (48) 
13
14
15
O
12
11
16
O
19
10
O
O
17 18
2
1
3
O O
9
8
7
6
5
4
13
14
15
O
12
11
16
O
19
10
O
O
17 18
2
1
3
O O
9
8
7
6
5
4
 
To a stirred solution of (R, S)-methyl mandelate (29 mg, 0.18 mmol) in CH2Cl2 (0.50 mL) 
(S)-(−)- camphanoyl chloride (38 mg, 0.18 mmol) and DMAP (4 mg, 0.03 mmol) was 
added. TEA (25 µL, 0.18 mmol) was added at 0 oC and then the reaction mixture was 
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allowed to warm to room temperature. The organic phase was washed with water and 
concentrated under reduced pressure to give the title compound 48. 
Product characterization: 
Molecular formula: C19H22O6 
Molecular weight: 346.4 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.47-7.38 (m, 10H, H5-H8, H5”-H8”), 6.03 (s, 1H, H2), 
6.00 (s, 1H, H2”), 3.73 (s, 6H, H9, H9”), 2.53 (ddd, J = 13.7, 10.7, 4.3 Hz, 1H, H12/H13/ 
H12”/H13”), 2.46 (ddd, J = 13.2, 10.8, 4.2 Hz, 1H, H12/H13/ H12”/H13”), 2.07 (ddd, J = 
13.6, 9.2, 4.5 Hz, 2H, H12/H13/ H12”/H13”), 1.94 (m, 2H, H12/H13/ H12”/H13”), 1.69 
(m, 2H, H12/H13/H12”/H13”), 1.134 (s, 3H, H17/H18/H19/ H17”/H18”/H19”), 1.128 (s, 
3H, H17/H18/H19/ H17”/H18”/H19”), 1.12 (s, 3H, H17/H18/H19/ H17”/H18”/H19”), 
1.06 (s, 3H, H17/H18/H19/ H17”/H18”/H19”), 1.05 (s, 3H, H17/H18/H19/ 
H17”/H18”/H19”). 
 
Synthesis of mandelic acid derived ILs 
(S)-(+)-Methyl mandelate (45) 
The title compound was prepared (80 % yield 27.0 g, 162.5 mmol) from (S)-(+)-mandelic 
acid according to the reported procedure.6 
1H in agreement with lit. data6,45  
 
(S)-(+)-Methyl 2-(2-bromoacetoxy)-2-phenylacetate (46) 
The title compound 46 was prepared according to method A from (S)-(+)-methyl mandelate 
(45) (26.09 g, 157.0 mmol) in 87 % yield (39.33 g, 137.0 mmol). 
 
(S)-(+)-Methyl 2-phenyl-2-[2-(3-methylimidazolium)acetoxy]acetate, bromide salt 
(40a) 
The title compound 40a was prepared (86 % yield, 41.903 g, 113.6 mmol, [α]20 +89.1 (0.60 
c, CHCl3)) from 46 according to the procedure previously reported by our group.6 
1H in agreement with lit. data6 
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(S)-(+)-Methyl 2-phenyl-2-[2-(3-methylimidazolium)acetoxy]acetate, NTf2 salt (40c) 
The title compound 40c was prepared (95 % yield, 45.51 g, 79.9 mmol) [α]20 +58.7 (0.60 c, 
CHCl3)) from 40a according to the procedure previously reported by our group.6 
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Product characterization: 
Molecular formula: C17H17F6N3O8S2 
Molecular weight: 569.5 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.80 (s, 1H, H12), 7.37 (t, J = 1.8 Hz, 1H, H13/H14), 7.27 
(s, 1H, H13/H14), 7.41 (s, 5H, H4- H8), 5.99 (s, 1H, H2), 5.14 (s, 1H, H11), 3.92 (s, 3H, 
H15), 3.71 (s, 3H, H9)  
 
(R)-(−)-Methyl mandelate (49) 
The title compound 49 was prepared in 90 % yield (50.20 g, 302.1 mmol) from (R)-(−)-
mandelic acid according to the reported procedure.6 
1H in agreement with lit. data6,45 
 
(R)-(−)-Methyl 2-(2-bromoacetoxy)-2-phenylacetate (50):  
The title compound 50 was prepared from (R)-(−)-methyl mandelate (49) (49.76 g, 299.4 
mmol) according to method A in 72 % yield (61.61 g, 214.7 mmol). 
Product characterization: 
Molecular formula: C11H11BrO4 
Molecular weight: 287.1 g/mol 
1H NMR (400 MHz, CDCl3, δ): 7.48-7.39 (m, 5H, H4-H8), 5.99 (s, 1H, H2), 4.00 (d, part 
A of an AB system, J = 12.8 Hz, 1H, H11), 3.97 (d, part B of an AB system, J = 12.8 Hz, 
1H, H11), 3.74 (s, 3H, H9) 
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1H in agreement with lit. data6 
 
(R)-(−)-Methyl 2-phenyl-2-[2-(3-methylimidazolium)acetoxy]acetate, bromide salt 
(41a) 
The title compound 41a was prepared (60 % yield, 42.18 g, 114.3 mmol, [α]20 -89.1 (0.607 
c, CHCl3) from 50 according to procedure previously reported by our group. 
1H in agreement with lit. data6 
 
(R)-(−)-Methyl 2-phenyl-2-[2-(3-methylimidazolium)acetoxy]acetate, NTf2 salt (41c) 
The title compound 41c was prepared (78 % yield, 21.21 g, 37.2 mmol, [α]20 -57.9 (0.60 c, 
CHCl3)) from 41a according to the procedure previously reported by our group.6 
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Product characterization: 
Molecular formula: C17H17F6N3O8S2 
Molecular weight: 569.5 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.91 (s, 1H, H12), 7.37 (t, J = 1.8 Hz, 1H, H13/H14), 7.27 
(t, J = 1.8 Hz, 1H, H13/H14), 7.42 (s, 5H, H4-H8), 6.01 (s, 1H, H2), 5.20 (d, part A of an 
AB system, J = 18.0 Hz, 1H, H11), 5.19 (d, part B of an AB system, J = 18.0 Hz, 1H, 
H11), 3.96 (s, 3H, H15), 3.73 (s, 3H, H9)  
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Synthesis of achiral ILs on Large Scale 
Pentyl 2-bromoacetate (51) 
5
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Method A 
To a stirred solution of pentanol (20.003 g, 227.27 mmol) in CH2Cl2 (200 mL) at −10 oC 
was added sodium carbonate (26.709 g, 250.0 mmol) followed bromoacetyl bromide (29.5 
mL, 340.96 mmol) added dropwise and the reaction mixture was allowed to warm to room 
temperature. After 48 h the reaction mixture was filtered, dried over anhydrous MgSO4 and 
concentrated under reduced pressure to give the title compound 51 as a colourless liquid in 
81 % yield (38.560 g, 184.43 mmol). 
Method B 
The title compound was prepared (64 % yield, 6.750 g, 32.0 mmol) from pentan-1-ol 
according to the procedure previously reported by our group. 
1H in agreement  with lit. data6,13 
Product characterization: 
Molecular formula: C7H13BrO2 
Molecular weight : 209.1 g/mol 
1H NMR (400 MHz, CDCl3, δ): 4.17 (t, J = 6.8 Hz, 1H, H2), 3.83 (s, 2H, H7), 1.70-1.67 
(tt, J = 7.2, 6.8 Hz, 2H, H3), 1.37-1.32 (m, 4H, H4, H5), 0.92 (t, J = 7.2 Hz, 3H, H6) 
1H in agreement  with lit. data (64 % yield)6,13 
 
Pentyl 2-(3-methylimidazolium)acetate, bromide salt (43a) 
The title compound was prepared (89 % yield, 47.220 g, 162.16 mmol) from (52) according 
to the procedure previously reported by our group. 
1H in agreement  with lit. data6,13 
 
Pentyl 2-(3-methylimidazolium)acetate, NTf2 (43c) 
The title compound 43c was prepared (91 % yield, 72.725 g, 148.12 mmol) from (43a) 
according to the procedure previously reported by our group. 
1H in agreement  with lit. data6,13 
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2-(2-Butoxyethoxy)ethyl 2-bromoacetate (52) 
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To a stirred solution of di(ethylene glycol) n-butyl ether (53.70 mL, 318.3 mmol) in CH2Cl2 
(500 mL) at −10 oC was added sodium carbonate (37.11 g, 350.1 mmol) followed by 
bromoacetyl bromide (40.19 mL, 462.4 mmol) added dropwise and the reaction mixture 
was allowed to warm to room temperature. After 96 h the reaction mixture was filtered and 
washed with saturated sodium bicarbonate (6 × 50 mL) and sodium chloride (3 × 50 mL). 
The organic phase was then dried over anhydrous MgSO4, filtered and concentrated under 
reduced pressure to give the title compound 52 as a colourless liquid in 90 % yield (81.33 
g, 287.4 mmol). 
Product characterization: 
Molecular formula: C10H19BrO4 
Molecular weight: 283.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 4.34-4.32 (m, 2H, H2), 3.87 (s, 2H, H10), 3.74-3.72 (m, 
2H, H3), 3.66-3.63 (m, 2H, H4), 3.60-3.56 (m, 2H, H5), 3.45 (t, J = 6.8 Hz, 2H, H6), 1.60-
1.53 (m, 2H, H7), 1.40-1.31 (m, 2H, H8), 0.91 (t, J = 7.4 Hz, H9)   
1H in agreement  with lit. data (72 % yield).6,13 
 
(Butoxyethoxy)ethyl 2-(3-methylimidazolium)acetate, bromide salt (44a) 
The title compound 44a was prepared (82 %, 86.36 g, 236.4 mmol) from 53 according to 
the procedure previously reported by our group. 
1H in agreement  with lit. data6,13 
 
(Butoxyethoxy)ethyl 2-(3-methylimidazolium)acetate, bromide salt NTf2 (44c) 
The title compound 44c was prepared (91 %, 121.39 g, 214.7 mmol) from (44a) according 
to the procedure previously reported by our group (86 % yield).  
1H and 13C in agreement  with lit. data6,13 
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Synthesis of amide ILs 
2.4.4 Amide IL synthesis. 
(2S)-2-Bromoacetic acid-(2-methylpiperidinamide) (53) 
5
6
N
2
3
4
CH3
7
1
8O
Br
 
To a stirred solution of (S)-(+)-2-methylpiperidine (1.096 g, 11.05 mmol) in CH2Cl2 (10 
mL) at −10 oC was added sodium carbonate (1.287 g, 12.16 mmol) followed by 
bromoacetyl bromide (1.44 mL, 16.58 mmol) added dropwise. The reaction mixture was 
stirred at room temperature for 48 h and then second portion of sodium carbonate (1.287 g, 
12.16 mmol) and bromoacetyl bromide (1.44 mL, 16.58 mmol) were added. After stirring 
overnight the reaction mixture was filtered, washed with sodium bicarbonate (7 × 5 mL) 
and ammonium chloride (4 × 5 mL) and dried over anhydrous MgSO4. Solvent was 
evaporated under reduced pressure to give the title compound 53 as colourless oil in 76 % 
yield (1.856 g, 8.44 mmol). 
Product characterization:  
Molecular formula: C8H14BrNO 
Molecular weight: 220.11 g/mol 
1H NMR (400 MHz, CDCl3, δ): 4.85 (s, 1H, H2, rot. 2), 4.45-4.42 (m, 1H, H6, rot. 1), 4.16-
4.13 (m, 1H, H2, rot. 1), 3.86 (s, 2H, H8, rot. 1/rot. 2), 3.84 (s, 2H, H8, rot. 1/rot. 2), 3.62-
3.59 (m, 1H, H6, rot. 2), 3.24-3.17 (m, 1H, H6, rot. 2), 2.76-2.70 (m, 1H, H6, rot. 1), 1.77-
1.39 (m, 12H, H3-H5, rot. 1, rot. 2), 1.32 (d, J = 6.8 Hz, 3H, H7, rot. 1), 1.15 (d, J = 7.2 
Hz, 3H, H7, rot. 2) 
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(2S)-2-(3-Methylimidazolium) acetic acid (2-methylpiperidinamide) bromide salt (42a)  
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To a stirred solution of 2-bromo-1-[(2S)-2-methylpiperidin-1-yl]ethanone (53) (1.675 g, 
7.62 mmol) in diethyl ether (20 mL) at -15oC under a N2 atmosphere was added 1-
methylimidazole (0.55 mL, 6.85 mmol) dropwise and the reaction mixture was allowed to 
warm to room temperature. After stirring for 24 h a white solid, which had precipitated, 
was collected by filtration, washed with diethyl ether (5 × 10 mL) and dried under reduced 
pressure to give the title compound (42a) as a white crystalline powder in 76 % yield 
(1.749 g, 5.79 mmol).  
Product characterization: 
Molecular formula: C12H20BrN3O 
Molecular weight: 302.2 g/mol 
1H NMR (400 MHz, CDCl3, δ): 10.22 (s, 1H, H9, rot. 1), 10.17 (s, 1H, H9, rot. 2),  7.46 (s, 
1H, H10/H11, rot. 1, rot. 2), 7.18 (s, 1H, H10/H11, rot. 1, rot. 2), 5.90 (d, part A of an AB 
system, J = 16.4 Hz, 1H, H8, rot. 1), 5.69 (d, part A of an AB system, J = 16.4 Hz, 1H, H8, 
rot. 2) 5.63 (d, part B of an AB system, J = 16.4 Hz, 1H, H8, rot. 2), 5.54 (d, part B of an 
AB system, J = 16.4 Hz, 1H, H8, rot. 1), 4.77-4.76 (m, 1H, H2, rot. 2), 4.37-4.33 (m, 1H, 
H6, rot. 1), 4.23-4.18 (m, 1H, H2, rot. 1), 4.00 (s, 6H, H12, rot. 1 , rot. 2), 3.71-3.68 (m, 
1H, H6, rot. 2), 3.34-3.27 (m, 1H, H6, rot. 2), 2.82-2.76 (m, 1H, H6, rot. 1), 1.90-1.56 (m, 
12H, H3-H5, rot. 1, rot. 2), 1.40 (d, J = 7.0 Hz, H7, rot. 1), 1.18 (d, J = 7.0 Hz, H7, rot. 2) 
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(2S)-2-(3-Methylimidazolium) acetic acid (2-methylpiperidinamide), NTf2 salt (42c) 
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To a solution of 3-methyl-1-(((2S)-2-methylpiperidinyl)carbonylmethyl)imidazolium 
bromide (42a) (1.268 g, 4.20 mmol) in distilled water (15 mL) was added LiNTf2 (1.205 g, 
4.20 mmol) at room temperature. The reaction mixture was stirred vigorously overnight. A 
solid, which had precipitated,  was collected by filtration, washed with distilled water (5 × 
3 mL) and dried under reduced pressure to give the title compound (42c) as white crystals 
in 64 % yield (1.339 g, 2.66 mmol).  
Product characterization: 
Molecular formula: C14H20F6N4O5S2 
Molecular weight: 502.5 g/mol 
1H NMR (400 MHz, CDCl3, δ): 8.65 (s, 2H, H9 rot. 1, rot. 2), 7.34 (s, 2H, H10/H11, rot. 1, 
rot. 2), 7.26 (s, 2H, H10/H11, rot. 1, rot. 2), 5.22 (d, part A of an AB system, J = 11.0 Hz, 
1H, H8, rot.1), 5.11 (d, part A of an AB system, J = 11.0 Hz, 1H, H8, rot. 2), 5.04 (d, part 
B of an AB system, J = 11.0 Hz, 1H, H8, rot. 2), 5.01 (d, part B of an AB system, J = 11.0 
Hz,1H, H8, rot. 1), 4.76-4.72 (m, 1H, H2, rot. 2), 4.34-4.31 (m, 1H, H6, rot. 1), 4.01-3.96 
(m, 1H, H2, rot. 1), 3.89 (s, 6H, H12, rot. 1, rot. 2), 3.46-3.44 (m, 1H, H6, rot. 2), 3.25-3.20 
(td, J = 9.0 Hz, 1.8 Hz, 1H, H6, rot. 2), 2.79-2.74 (m, 1H, H6, rot. 1), 1.78-1.36 (m, 12H, 
H3-H5, rot. 1, rot. 2), 1.31 (d, J = 4.4 Hz, 3H, H7, rot. 1), 1.15 (d, J = 4.4 Hz, 3H, H7, rot. 
2)   
13C NMR (100 MHz, CDCl3, δ): 162.15 (CO, C1, rot. 1, rot. 2), 137.74 (ArC, C9, rot. 1, 
rot. 2), 124.55 (ArC, C10/C11, rot.1, rot. 2), 122.53 (ArC, C10/C11, rot.1, rot. 2), 119.84 
(q, J = 319.0 Hz, 4CF3, C13,C14, rot. 1, rot. 2), 50.75 (CH2, C8, rot. 1/rot. 2) 50.51 (CH2, 
C8, rot. 1/rot. 2), 48.30 (CH, C2, rot. 1), 45.45 (CH, C2, rot. 2), 40.30 (CH2, C6, rot. 2), 
37.56 (CH2, C6, rot. 1), 36.38 (NCH3, C12, rot. 1, rot. 2), 30.28 (CH2, C3/C4/C5, rot. 1, rot. 
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2), 29.65 (CH2, C3/C4/C5, rot. 1, rot. 2), 25.65 (CH2, C3/C4/C5, rot. 1, rot. 2), 25.22 (CH2, 
C3/C4/C5, rot. 1, rot. 2), 18.49 (2CH2, C3/C4/C5, rot. 1, rot. 2), 16.52 (CH3, C7, rot. 1), 
15.41 (CH3, C7, rot. 2)  
ESI-MS (70 eV) m/z: [M-NTf2]+: 222.10 
ESI-HRMS calc. for C12H20N3O [M-NTf2]+: 222.1601, found: 222.1600 
m.p.: 63-65 oC 
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Chapter 3.0  
Ionic Liquids Stability, Toxicity and 
Biodegradation Studies 
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3.1 Aim of the study 
One of the aims of our study was to examine ILs’ toxicity and biodegradation – two 
significant factors determining potential impact of a compound on the environment. 
Environmental toxicity is a very complex issue, where influence of a chemical on life of 
plants, microorganisms, and animals as well as on human health needs to be determined. 
Antibacterial and antifungal tests are good starting points in such toxicological evaluation 
and they were carried out for our ILs in collaboration with Faculty of Pharmacy at Charles 
University and School of Biotechnology at DCU. IL biodegradation tests, allow 
determination of whether a compound may become a persistent pollutant, were done in 
collaboration with Department of Chemical Technology at Gdansk University of 
Technology. Prior to the biodegradation test, a stability study in water was performed in 
order to identify ILs suitable for such test. Stability study results were also important in 
interpretation of the toxicity data.       
 
3.2 ILs stability study 
During synthesis of ILs containing a halide counteranion the question regarding their 
stability emerged, since in some cases decomposition upon storage at room temperature (IL 
1a) or upon heating (IL 5a) was observed. Biodegradation studies of halide ILs were also 
planned and therefore information about stability in water was necessary.   
The stability of seven ILs (1a, 2a, 5a, 6d, 8a, 23a, 24a, Figure 3.1) was examined, in which 
they were dissolved in D2O, stored at room temperature and monitored over a period of 28 
days (23 days for 6d) with 1H NMR spectrum being recorded daily. Due to a suspected low 
stability of ILs with an acetoxy linker, IL 23a and 24a were monitored initially every hour 
over 1 day. The study was then continued until complete disappearance of the original 
compounds.  
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Figure 3.1 ILs included in stability study 
  
3.2.1 Stability of ILs without an acetoxy linker  
Results indicated that all ILs (0.5 M solutions) undergo decomposition, however in the case 
of IL 1a, 2a, 5a and 6d only a small degree (8-10 %) of hydrolysis was observed over the 
28 day period. 
Decomposition of ILs was evident from the 1H and 13C NMR spectra, where additional 
signals were observed over time (Figure 3.2-3.4). In the 1H NMR spectrum of IL 5a, new 
signals at 8.55 and 7.35 ppm were assigned to the methylimidazolium moiety and at 6.10 
ppm to the benzylic proton (Figure 3.2, 3.3). These peaks were significantly shifted 
compared with the parent ILs and were used to estimate the ratio of products present as 
well as percentage of decomposition. Integration values of the new IL and the gradual 
increase in the intensity of the appearing methanol signal, suggested that the methyl ester of 
IL 5a was undergoing hydrolysis. This was further confirmed by the 13C NMR spectra, 
where all carbon signals, except one corresponding to the methyl ester, had small 
accompanying peaks, slightly shifted as compared to the parent IL 5a (Figure 3.4). The 
biggest shift was noted for the carboxyl group, where a new signal appeared downfield 
(171.02 ppm) as compared with methyl ester group (169.18 ppm). Also signals 
corresponding to C3 (124.51) and C2 (64.09) were shifted, by approx. 1 ppm.  
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Figure 3.2 1H NMR spectrum of IL 5a at the start of the study 
 
Figure 3.3 1H NMR spectrum of 5a after 28 days. Hydrolysis products shown in red and 
blue 
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Figure 3.4 13C NMR spectrum of 5a at the end of stability testing. Hydrolysis products 
shown in red and blue 
 
The presence of methanol was confirmed by HMQC, in which a correlation was observed 
between proton at 3.30 ppm and carbon at 48.83 ppm. First quantitative changes were 
observed in the 1H NMR spectrum of 5a after 7 days and at the end of the study, after 28 
days, about 10 % of the original sample was hydrolysed.  
Stability study of IL 1a displayed similar changes in the NMR spectra as IL 5a. In the 1H 
and 13C NMR spectra of 1a additional peaks were observed for all signals, except those 
corresponding to the methyl group of the ester. As in the previous example, the carbon 
signal of the hydrolysed product was observed downfield at 171.50 ppm. The presence of 
methanol was confirmed once again via HMQC.  
Stability of three pyridinium based ILs 2a, 6d and 8a were also investigated over a 28 or 23 
day period. Decomposition of 8 % of IL 6d was observed after 23 days, 9 % of IL 2a after 
28 days and 20 % of IL 8a after 28 days. It was concluded, based on the 1H NMR and 13C 
NMR spectra, IL 2a was undergoing ester hydrolysis, as described for IL 5a and 1a. 
Distinct signals from pyridinium and benzylic protons were visible in the spectra along 
with an increase in integration of the aromatic and methoxy groups. In the 1H NMR spectra 
of IL 6d, additional peaks appeared over the time, however the signals from the benzylic 
proton was not visible and suggest other process, except hydrolysis could have been taking 
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place. The biggest changes among this class of ILs were observed for IL 8a, where after 28 
days approx. 20 % of the ILs had decomposed (Figure 3.5). In the 1H NMR spectra of IL 8a 
two additional multiplets, located upfield from the multiplet at 8.6-8.7 ppm (H10 and H14), 
appeared over the time, indicating the presence of two new pyridinium species (Figure 3.5, 
new signals highlighted in red colour). Each of the remaining pyridinium signals (H11-
H13) has one additional multiplet, but an increase in integration compared with the H10 
and H14 signals suggests other multiplets are overlapping with the main signals. One of the 
decomposition products possibly could be hydrolysed IL 8a, however those two products 
were not identified.    
 
Figure 3.5 1H NMR spectrum of IL 8a after 28 days. Substrate shown in grey 
 
3.2.2 Stability study of the acetoxy-linked ILs 
0.1 M solutions of two acetoxy-linked ILs, 23a and 24a, in D2O were prepared and 
monitored every hour over a 24 h period. Both IL 23a and 24a had undergone rapid 
hydrolysis with that process being faster for pyridinium IL 24a than for methylimidazolium 
IL 23a. However, unlike ILs 1a, 2a, 5a and 6d in which methyl esters were cleaved, the 
acetoxy-linked ILs (23a and 24a), hydrolysis of the C11 ester had taken place (Figure 3.6). 
After 24 h 41 % of IL 24a was hydrolysed and as a result a mixture of methyl 3,4-
methylenedioxymandelate (13), N-carboxymethylpyridinium bromide and the original IL 
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24a was observed in the 1H NMR spectra (Figure 3.6, 3.7). The reaction was further 
monitored until complete disappearance of the original IL 24a, which had occurred after 7 
days (Figure 3.8). At that point hydrolysis of methyl 3,4-methylenedioxymandelate (13) to 
the acid 1 was also occurring and the respected signals, accompanied by methanol, were 
observed (Figure 3.9). 13C NMR data of the fully hydrolysed sample confirmed the 
presence of N-carboxymethylpyridinium bromide, 3,4-methylenedioxymandelic acid (10) 
and methyl ester (13) (Figure 3.9). Three carbonyl groups were visible belonging to the 
methyl ester and two free carboxylic acids groups. The rate of hydrolysis of IL 24a 
decreased over time (Table 3.1). The presence of N-carboxymethylpyridinium cation was 
also confirmed via LCMS analysis, where its respective ions m/z: 138.10 (M+) and 160.00 
(M-H + Na+) were observed.  
 
Figure 3.6 1H NMR spectrum of IL 24a at the start of the test 
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Figure 3.7 1H NMR spectrum of IL 24a after 24 h. Hydrolysis products shown in blue and 
green 
 
Figure 3.8 1H NMR spectrum of IL 24a after 7 days. Hydrolysis products shown in blue, 
red, green and violet 
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Figure 3.9 13C NMR spectrum of IL 24a after 7 days. Hydrolysis products shown in blue, 
red, green and violet 
 
Table 3.1 Rate of hydrolysis for IL 24a. 
 Time % Hydrolysis 
1. 12 h 23 % 
2. 24 h 41 % 
3. 48 h 61 % 
4. 168 h (7 days) 100 % 
 
The same type of hydrolysis, as for IL 24a, was taking place in case of IL 23a, however the 
reaction rate was twice as slow (Table 3.2). Under the same conditions as for 24a, only 20 
% of IL 23a underwent decomposition after 24 h, and complete disappearance of the 
original IL 23a was observed after 14 days (Table 3.2) (Figure 3.10). As demonstrated by 
the 1H and 13C NMR data N-carboxymethylimidazolium bromide, 3,4-
methylenedioxymandelic acid (10), methyl 3,4-methylenedioxymandelate (13) and 
methanol were present in the final reaction mixture as a result of hydrolysis of 23a (Figure 
3.10). Presence of N-carboxymethylimidazolium cation was also confirmed by LCMS 
analysis, where respective ions m/z: 141.10 (M+) and 163.00 (M-H + Na+) were observed.  
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Figure 3.10 1HNMR spectrum of IL 23a after 24 h. Hydrolysis products shown in blue and 
green 
 
Table 3.2 Rate of hydrolysis for IL 23a. 
 Time % Hydrolysis 
1. 12 h 11 % 
2. 24 h 19 % 
3. 48 h 41 % 
4. 336 h (14 days) 100 % 
 
3.2.3 Possible mechanisms of ILs hydrolysis 
It has been reported that some ILs without an acidic functionality, in the presence of protic 
solvents can act as acid catalysts. Connon and Gathergood et al. published work on 
acetalization and thioacetalization reactions, carried out in methanol, catalysed by ILs with 
pyridinium ring activated by electron withdrawing groups.1,2  Later they also successfully 
applied imidazolium ILs for those reactions.3 This group suggested that methanol was 
attacking an activated pyridinium or methylimidazolium ring, forming catalytically active 
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species able to donate a proton. These acidic compounds have not been isolated or fully 
characterised, however existence of similar systems have been investigated by other 
groups. Grubert and Abraham have studied the equilibrium between acridinium and 
acridane compounds, incorporated in a calixarene structure (Figure 3.11).4,5 They found that 
reversible switching between both structures can be induced by photoreactions or acid/base 
addition.  
N N
R OMeR
PF6
+ HPF6
MeOH
R = calix[4]arene
 
Figure 3.11 Acridinium and acridane equilibrium studied by Grubert and Abraham4,5 
 
Formation of 2-hydro-2-hydroxypyridine in equilibrium with the respective pyridinium 
compound (possessing electron withdrawing substituents on the aromatic ring) under basic 
conditions was assumed to take place in ferricyanide oxidation of quaternary salts as 
described by Abramovitch, Vinutha6 and others.7 
It was postulated, that formation of acidic catalytic species may occur in an analogous way 
with water attacking the pyridinium ring (Figure 3.12).    
 
R COOMe
N
H2O
R COOMe
NO
H
H
R COOMe
NHHOCl
R COOMe
NHOCl Cl ClH
R = 3,4-methylenedioxy- or 3,4-dimethoxyphenyl 
Figure 3.12 Postulated mechanism of generating an acidic species from pyridinium ILs. 
(Attack at ortho position shown, para also possible) 
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The same mechanism may be occurring in methylimidazolium based ILs (Figure 3.13).3  
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N
OH
Cl ClH
 
R = 3,4-methylenedioxy- or 3,4-dimethoxyphenyl 
Figure 3.13 Postulated mechanism of generating an acidic species in methylimidazolium 
ILs. (Attack at C2 shown, also possible at C4 or C5) 
 
Following generation of the acidic compounds, ILs hydrolysis could take place (Figure 
3.14).8 Although the generated acid was probably weak, it could possibly be enough to 
cause hydrolysis at such low level, which was observed in ILs 1a, 2a, 5a and 6d (approx. 
10 % over 28 days).  
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H
Cl Cl Cl
Cl Cl Cl
 
R = 3,4-methylenedioxy- or 3,4-dimethoxyphenyl 
Figure 3.14 Proposed acid catalysed hydrolysis of ILs 
 
A similar mechanism for generating an acidic species may be taking place in ILs with an 
acetoxy linker 23a and 24a. However in these ILs, before the methyl ester group was 
cleaved, a much faster hydrolysis of the C11 ester occurred (11 % or 23 % after 12 h vs. 28 
days) (Tables 3.1, 3.2). One reason for this discrepancy may be due to methyl 3,4-
methylenedioxymandelate being a better leaving group than methanol. Difference in 
hydrolysis rate may also be due to the slightly different mechanism, including an 
intramolecular process, which is possible in acetoxy linked ILs (Figure 3.15). After 
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formation of an acidic species, the hydroxyl group on the dihydropyridinium ring may 
attack the carbonyl group, forming a five-membered lactone, from which alcohol was 
expelled with use of a lone pair of electrons on the nitrogen atom. The presented 
mechanism was also possible in the case of ILs 1a, 2a, 5a, 6d and 8a, however lactone 
formation may be more hindered, due to the 3,4-methylenedioxy- or 3,4-dimethoxyphenyl 
ring α to the ester group (Figure 3.14).  
NH OH
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N O
OH
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N O
OH
O
H N
OH
O
Br
+
Br
Br
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R
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N
Br
O
O COOMe
R
H2O
 
R = 3,4-methylenedioxy- or 3,4-dimethoxyphenyl 
Figure 3.15 Proposed acid catalysed intramolecular hydrolysis of acetoxy-linked ILs 
 
Such an intramolecular mechanism would also explain the difference in hydrolysis rate 
between methylimidazolium and pyridinium ILs 23a and 24a, not seen in ILs 1a, 2a, 5a, 6d 
and 8a without the acetoxy linker. Formation of such cyclic intermediate would be more 
difficult in methylimidazolium IL 23a (Figure 3.16) due to the rings constrains. In 
methylimidazolium IL 23a, bearing two five-membered fused rings would have to be 
created, as compared with less strained six and five-membered fused rings in pyridinium IL 
24a (Figure 3.15). 
N O
HO
O
Br
COOMe
R
N
H
 
Figure 3.16 Formation of intramolecular intermediate during hydrolysis of IL 23a 
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3.3 ILs Toxicity Studies 
3.3.1 ILs antibacterial and antifungal toxicity introduction 
ILs are designed to serve as “green solvents”, which may be used in large scale reactions, 
therefore knowledge regarding their toxicity and potential environmental impact is 
crucial.9-12 There is a very large number of possible ILs13 and their structures can vary 
greatly, therefore ILs toxicity may differ dramatically moving from one example to another. 
ILs with very low toxicities are known,9,14,15 as well as examples with very strong 
antimicrobial 14,16,17,18 and biocidal19 properties. Antimicrobial screening is a good starting 
point for ecotoxicties study, since various rapid assays are available, bacteria and are 
relatively easy to grow and have short generation times.9-11 Both of those microorganisms 
are ubiquitous in all environmental compartments and fungi are responsible for the biotic 
decay of pollutants.11 Antimicrobial screening has been carried out by various research 
groups using different assays, organisms, test conditions, time frames and ways of 
presenting the results and comparison of toxicity data may be troublesome, however over 
the time some correlations between structure and antimicrobial activity have been 
identified.10,11 
Docherty et al. investigated antibacterial activity of ILs with various side chain length on 
the heteroaromatic ring. In accordance with findings of others,12,14,17,18,20-22 they observed 
an increase of toxicity by increasing the alkyl chain length on both the methylimidazolium 
and pyridinium ring. IL with a butyl side chain [bmim][Br] exhibited similar toxicity 
towards Vibrio fischeri (EC50 of 10.3 mM) as common organic solvents (chloroform EC50 
of 10 mM, ethylene glycol EC50 of 10 mM, dichloromethane EC50 of 29.8 mM, ethyl 
acetate EC50 of 66 mM). ILs with an octyl [omim][Br] or hexyl [hmim][Br] side chain were 
much more toxic (EC50 of 4 µM and 26 µM respectively). No clear difference in toxicity of 
imidazolium and pyridinium was found. [Bmim][Br] was less toxic than [bmpy][Br], but 
[hmim][Br] was more toxic than [hmpy][Br], while [omim][Br] and [ompy][Br] had similar 
toxicities. Higher toxicity was found with a prolonged exposure time, however that effect 
was not significant. Besides Vibrio fischeri assay, further tests including Gram-positive 
rods: B. subtilis (aerobe), a Gram-positive coccus: S. aureus (anaerobe), Gram-negative 
rods: E. coli (anaerobe), P. fluorescens (aerobe) and yeast (S. cerevisiae) were carried out. 
All ILs were most inhibitory towards B. subtilis and E. coli. Growth of P. fluorescens was 
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also significantly affected by the ILs presence. Organisms most resistant against tested ILs 
were S. aureus and S. cerevisiae. Antimicrobial activity appeared not to be related to the 
type of cellular wall, since the most and least sensitive organisms belonged to the Gram-
positive species.9 Pernak et al. studied antimicrobial activity of a series of 3-alkoxymethyl-
1-methylimidazolium ILs (Cl−, BF4− and PF6− as counteranion) against Gram-positive 
cocci: M. luteus, S. epidermidis, S. aureus, S. aureus (MRSA), E. hirae, Gram-negative 
rods: E. coli, P. vulgaris, K. pneumoniae, P. aeruginosa and fungi: C. albicans and R. 
rubra.14 They also found that ILs activity was greatly affected by the alkyl chain length in 
the alkoxymethyl substituent and in negligible degree was depending on the type of anion 
(e.g. Cl−: MIC of 8.6 mM, BF4−: MIC of 7.0 mM, PF6−: MIC of 5.9 mM). In the case of 
bacteria, toxicity increased with side chain elongation, but reached the maximum at 10-14 
carbon atoms. This was not the case with fungi, where the highest activity was observed for 
ILs with the longest side chain (16 carbon atoms). Among the tested compounds, IL the 
most toxic against bacteria (12 carbon atoms in alkoxy chain) exhibited MIC values (25 – 
395 µM (depending on the strain)) similar to benzalkonium chloride (BAC), a known 
biocide (MIC of 3-54 µM (depending on the strain)). IL with 16 carbon atoms in the alkoxy 
side chain exhibited the highest antifungal activity (MIC of 42-84 µM; MIC for BAC of 7-
11 µM). ILs with the shortest side chain (3-4 carbon atoms) were the least toxic towards 
both bacteria and fungi (MIC > 8.6 mM). In the assay Gram-positive cocci, except S. 
aureus (MRSA) were most sensitive to ILs presence. Gram-negative rods were more 
resistant to ILs and their response was similar to fungi.           
 
3.3.2 ILs antifungal toxicity 
In vitro antifungal toxicity of ILs was assessed in collaboration with the Faculty of 
Pharmacy at Charles University in Czech Republic. Tests were based on microorganism 
growth inhibition and ILs toxicity was expressed as IC80 values in case of yeast (unicellular 
fungi) and as IC50 values in case of filamentous fungi. IC80 is defined as 80 % inhibition of 
the growth of control microorganisms and IC50 as 50 % inhibition of the growth.  
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Figure 3.17 ILs included in antimicrobial toxicity studies 
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The majority of ILs (1a-8a, 6d, 23a, 24a, 3b-5b, 24b, 1c-5c, 23c, 24c) were screened at 
concentrations up to 2.0 mM against 12 fungi strains. Four ILs, with OctOSO3− (1b, 2b, 
23b) and NTf2− (6c) anions, due to their low solubility in DMSO were tested up to 1.0 mM 
concentration. ILs toxicity was assessed at two time intervals 24 and 48 h (except T. 
mentagrophytes: 72 h and 120 h). Antifungal activities were evaluated on four ATCC 
strains (Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) and five clinical isolates of yeasts 
(Candida krusei E28, Candida tropicalis 156, Candida glabrata 20/I, Candida lusitaniae 
2446/I, Trichosporon asahii 1188) and three filamentous fungi (Aspergillus fumigatus 231, 
Absidia corymbifera 272, Trichophyton mentagrophytes 445). 
Most of the compounds tested were not toxic towards yeast fungi (IC80 > 2.0 mM) and 
towards filamentous fungi (IC50 > 2.0 mM) (Table 3.3). Three ILs 8a, 24a and 4b exhibited 
toxicity towards fungi at the concentrations tested. IL 24a was toxic at 2.0 mM towards T. 
asahii and T. mentagrophytes and only after 24 h towards C. albicans ATCC 44859 and A. 
corymbifera (Table 3.3, entries 1,17,18,21,23,24). IL 4b at a concentration of 1.0 mM, 
inhibited the growth of C. parapsilosis, both strains of C. krusei, C. tropicalis and only 
after 24 h growth of T. asahii (Table 3.3 entries 5-12). IL 8a showed the highest antifungal 
activity and was toxic towards all fungi, except three strains (C. tropicalis, A. fumigatus, A. 
corymbifera). IL 8a exhibited highest toxicity (0.5 mM) towards C. albicans ATCC 44859, 
T. mentagrophytes and only after 24 h towards T. asahii (Table 3.3, entries 1,2,17,23,24). 
In the presence of 1.0 mM of IL 8a growth inhibition was observed in both C. krusei strains 
and C. glabrata and after 48 h in C. albicans ATCC 90028 and T. asahii (Table 3.3, entries 
4,7-10,13,14,18). IL 8a at 2.0 mM suppressed the growth of C. parapsilosis and C. 
lusitaniae, and after 24 h of C. albicans ATCC90028 (Table 3.3, entries 3,5,15,16).  
As can be seen from the results, in many cases different toxicity levels were observed at 
both time intervals for the same fungi strain (e.g. Table 3.3, IL 4b, entries 17,18). 
Unexpectedly, in most of the cases ILs were more toxic after 24 h than after 48 h. Only IL 
8a, when tested against C. albicans ATCC 90028, exhibited higher toxicity upon longer 
exposure (IC80 of 2.0 mM after 24 h and 1.0 mM after 48 h).  
Lower toxicity of ILs, upon longer exposure to fungi may be due to the fact, that during the 
tests the ILs structure might have been altered (e.g. via hydrolysis) or they could have been 
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degraded or metabolised by the microorganisms. In such cases toxicity after 24 h would be 
due to the IL presence and toxicity after 48 h would be attributed to ILs metabolites or 
degradation products. For the cases where toxicity was higher after 24 h than after 48 h, it 
would mean that IL was more toxic towards fungi strain than its metabolite or degradation 
products. That scenario was plausible in case of IL 24a which, in stability studies, was 
shown to undergo partial decomposition (61 %) in water within 48 h. This was probably 
not the case for IL 8a and IL 4b, where the hydrolysis level should be very low after 48 h. 
IL 8a was shown to undergo approx. 2 % decomposition over 48 h (20 % decomposition 
over the 28 day period). For IL 4b the stability study was not carried out, however it was 
expected to be similar to directly linked ILs 1a, 2a, 5a and 6d, which underwent approx. 1 
% hydrolysis over 48 h (8-10 % hydrolysis over 28 days).  
Decomposition via hydrolysis was possible during the toxicity test, hence the experiment 
was carried out in aqueous media, with a small quantity of DMSO (approx. 1 % of DMSO 
in the final solution). Level of IL hydrolysis in the toxicity test might be even higher than in 
the stability study, due to higher temperature (35 oC) applied. Further IL decomposition 
may also occur due to the fungi presence, which may excrete degradative compounds and 
enzymes and also may metabolise organic compounds.50-52 Another explanation could be 
that microorganisms are able to adapt over time to the ILs presence and therefore toxicity is 
lower after 48 h as compared to 24 h. Changes in the fungi metabolism upon exposure to 
ILs have been first reported by Pereira et al.20 The authors found that fungal cultures 
respond to specific IL’s by changing their cell biochemistry, resulting in an altered pattern 
of secondary metabolites. Authors also postulate that, these metabolic alterations could not 
be, in the case of all ILs tested, a result of their co- or direct metabolism by the fungi.  
All of the fungi strain tested had similar susceptibility towards ILs, with no strain being 
particularly sensitive. Only one filamentous fungi, A. fumigatus exhibited higher tolerance 
for ILs presence.     
Among ILs tested, hydrophilic IL 8a (with chloride counteranion and two hydroxyl groups 
on the aromatic ring), hydrophobic IL 4b (with butyl ester side chain and OctOSO4− 
counteranion) and moderately hydrophilic IL 24a exhibited antifungal properties at the 
concentrations tested. The trend of increased toxicity of ILs with high hydrophobicity, as in 
the case of IL 4b has been widely reported before.9,12,17,20,24 High antifungal activity of IL 
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8a, as compared with other ILs with very similar structures, might be due to the presence of 
weakly acidic hydroxyl groups on the aromatic ring. According to Terada et al. 
hydrophobic ionogenic organic compounds with acidic or basic groups, may have, in 
addition to baseline toxicity (membrane disturbance), additional toxicity due to interfering 
with energy producing processes. Especially compounds with weak acid functionality, may 
interfere with proton transfer systems and thus with oxidative and photo-phosphorylation in 
energy transducting membranes.25,26 
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Table 3.3 ILs Antifungal activity. 
No Fungi  
strain 
Time  
Hour 
Ionic Liquid Number, IC80  mM 
1a-7a, 6d 
23a  
5b, 6b,  
24b, 3b 
1c-5c, 
23c, 24c 
24a 4b 8a 1b, 2b 
23b, 6c 
1. CA1 24h > 2.0 > 2.0 > 2.0 2.0 > 2.0 0.5 > 1.0 
2. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 0.5 > 1.0 
3. CA2 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
4. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 1.0 > 1.0 
5. CP 24h > 2.0 > 2.0 > 2.0 > 2.0 1.0 2.0 > 1.0 
6. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 1.0 2.0 > 1.0 
7. CK1 24h > 2.0 > 2.0 > 2.0 > 2.0 1.0 1.0 > 1.0 
8. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 1.0 1.0 > 1.0 
9. CK2 24h > 2.0 > 2.0 > 2.0 > 2.0 1.0 1.0 > 1.0 
10. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 1.0 1.0 > 1.0 
11. CT 24h > 2.0 > 2.0 > 2.0 > 2.0 1.0 > 2.0 > 1.0 
12. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 1.0 > 2.0 > 1.0 
13. CG 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 1.0 > 1.0 
14. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 1.0 > 1.0 
15. CL 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
16. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
17. TA 24h > 2.0 > 2.0 > 2.0 2.0    1.0 0.5 > 1.0 
18. 
 
48h > 2.0 > 2.0 > 2.0 2.0 > 2.0 1.0 > 1.0 
19. AFa 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
20. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
21. ACa 24h > 2.0 > 2.0 > 2.0 2.0 > 2.0 > 2.0 > 1.0 
22. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
23. TMa 72h > 2.0 > 2.0 > 2.0 2.0 > 2.0 0.5 > 1.0 
24. 
 
120h > 2.0 > 2.0 > 2.0 2.0 > 2.0 0.5 > 1.0 
CA1-C. albicans 44859, CA2-C. albicans 90028, CP-C. parapsilosis 22019, CK1-C. krusei 6258, 
CK2-C. krusei E28, CT-C. tropicalis, CG-C. glabrata, CL-C. lusitaniae, TA-T. asahii, AF-A. 
fumigatus, AC-A. corymbifera, TM-T. mentagrophytes 
>2.0 mean IC80/IC50 value was above the highest concentration tested (2.0 mM), >1.0 mean 
IC80/IC50 value was above the highest concentration tested (1.0 mM), number in bold is IC80/IC50 
value (mM). a IC50 values were determined for filamentous fungi: AF, AC and TM   
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3.3.3 ILs antibacterial toxicity 
ILs antibacterial toxicity was assessed in two assays, one carried out in collaboration with 
Faculty of Pharmacy at Charles University in Czech Republic and the second in 
collaboration with School of Biotechnology at DCU. At Charles University ILs were tested 
at a concentration up to 2.0 mM, against 8 bacteria strains. Four ILs (1b, 2b, 23b, 6c) due 
to low solubility were tested up to 1.0 mM concentration. Inhibition of bacteria growth was 
determined and IC95 (MIC) values after 24 and 48 h were calculated.  
At DCU halide ILs were further tested at a much higher concentration of 200 mM, against 
5 bacteria strains, and IC50 values after 24 h were determined. Screening at high ILs 
concentration was possible due to very good water solubility of halide ILs.  
Antibacterial activities of ILs at 2.0 mM were evaluated on three ATCC strains (Gram-
positive: Staphylococcus aureus ATCC 6538, Gram-negative: Escherichia coli ATCC 
8739, Pseudomonas aeruginosa ATCC 9027) and five clinical isolates (Gram-positive: 
Staphylococcus aureus MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, 
Enterococcus species HK14365/08, Gram-negative: Klebsiella pneumoniae HK11750/08, 
Klebsiella pneumoniae ESBL HK14368/08).  
The majority of compounds (Figure 3.17), (Table 3.4) screened in this assay were not toxic 
towards any of the bacteria strains (did not inhibit bacteria growth by 95 %) at 
concentrations tested (MIC/IC95 > 2.0 mM). ILs 7a and 5c were toxic only towards one 
bacterium, S. epidermidis (MIC/IC95 of 2.0 mM after 24 h) (Table 3.4, entry 5). IL 8a 
caused growth inhibition of three strains: S. epidermidis (0.5 mM after 24 and 48 h), S. 
aureus (2.0 mM after 24 and 48 h) and S. aureus MRSA (2.0 mM after 24 and 48 h) (Table 
3.4, entries 1-6). For IL 7a and 5c lower IC95 values were obtained after 24 h than after 48 h 
towards S. epidermidis. As discussed previously for the antifungal tests, the difference may 
be due to ILs structure being altered during the given test. This could occur due to IL 
hydrolysis and enzymatic and non-enzymatic processes caused by microorganisms.50-52 
Bacteria adaptation to the ILs presence might also be a reason for discrepancies in toxicity 
values observed at 24 h and 48 h. ILs 7a, 8a and 5c do not have acetoxy linkers, therefore 
their hydrolysis were not expected to be significant (approx. 1-2 % over 48 h) and any 
changes in their structure would be caused by the action of microorganisms. 
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IL 5c having NTf2− counteranion belongs to ILs of higher lipophilicity, therefore higher 
antibacterial activity may be expected. Halide ILs 8a and 7a both have weakly acidic 
hydroxyl groups on the aromatic ring, which may be responsible for their increased 
toxicity, as discussed in the case of antifungal screening. Gram-positive bacteria (S. aureus, 
S. aureus MRSA, S. epidermidis), except Enterococcus sp. were most sensitive towards ILs 
and significant growth inhibition was not observed in any of the Gram-negative species. 
This finding was consistent with data reported by Pernak et al. 14,16,17,20,27 Although Gram-
positive bacteria have a thicker cell wall with a high content of peptydoglican, Gram-
negative species have a more chemically diverse cell wall as well as outer 
lipopolysaccharide membrane and the latter is believed to be responsible for their higher 
resistance to biocides.11,28 Stolte and Ranke classified solvents with EC50 > 10 mM, towards 
Photobacterium phosphoreum (same as Vibrio fischeri), as having low toxicity towards 
bacteria and those with EC50 > 1.0 mM as of moderate toxicity.12 Considering, that in our 
antibacterial assay MIC/IC95 (with 95 % growth inhibition) and not IC50 or EC50 (50 % 
growth inhibition) was determined IL 8a showing MIC/IC95 0.5-2.0 mM can be classified 
as of moderate or high toxicity. This IL falls in the same toxicity range as toluene (EC50 of 
0.34 mM), o-xylene (EC50 of 0.1 mM), methyl isobutyl ketone (EC50 0.8 mM), and benzene 
(EC50 of 1.38 mM).9,12,29  
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Table 3.4 ILs antibacterial activity. 
No. Bacteria 
strain 
Time 
hour 
Ionic Liquid Number, MIC/IC95 mM 
1a-6a, 
6d, 23a 
3b-6b, 
24b 
1c-4c, 
23c, 24c 
  
5c, 7a 8a 2b, 1b, 
23b, 6c  
1. SA 24h > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
2. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
3. MRSA 24h > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
4. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 2.0 > 1.0 
5. SE 24h > 2.0 > 2.0 > 2.0 2.0 0.5  > 1.0 
6. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 0.5  > 1.0 
7. ESP 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
8. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
9. EC 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
10. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
11. KP 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
12. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
13. KP-E 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
14. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
15. PA 24h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
16. 
 
48h > 2.0 > 2.0 > 2.0 > 2.0 > 2.0 > 1.0 
SA-S. aureus 4516/08, MRSA-S. aureus 5996/08, SE-S. epidermidis, ESP-Enterococcus sp., EC-
E. coli, KP-K. pneumoniae  D 11750/08, KP-E-K. pneumoniae  J 14368/08, PA-P. aeruginosa   
>2.0 mean MIC/IC95 value was above the highest concentration tested (2.0 mM), >1.0 mean 
MIC/IC95 value was above the highest concentration tested (1.0 mM), number in bold is MIC/IC95 
value (mM)   
 
3.3.4 Antibacterial toxicity at high ILs concentration 
In collaboration with School of Biotechnology at DCU, ILs 1a-6a, 8a, 24a and 6d with Cl− 
or Br− counteranions were screened at concentrations up to 200 mM against five bacteria 
strains: Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli, 
Pseudomonas fluorescence, Pseudomonas putida CP1, Pseudomonas putida KT2440) 
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(Table 3.5, entries 1-9). IL toxicity determination was based upon bacteria growth 
inhibition in a 24 hour assay and was expressed as IC50 values.  
All ILs tested in this assay, except IL 8a, proved to be of low toxicity, according to Stolte 
and Ranke classification, with the lowest IC50 in the range of 25-50 mM.12 (Table 3.5, 
entries 1-9). ILs with the lowest toxicity were 1a and 2a, both derivatives of methyl 3,4-
dimethoxymandelate (Table 3.5, entries 1,2). These two ILs did not show toxic effects 
towards four bacteria strains at the highest concentration tested (IC50 > 200 mM) and 
exhibited low toxicity (IC50 100-200 mM) towards one strain (B. subtilis in case of 1a and 
P. putida (KT2440) in case of 2a) (Table 3.5, entries 1,2). Other two derivatives of 3,4-
dimethoxymandelic acid, but with butyl esters, ILa 3a and 4a, were the most toxic 
examples identified in the assay, with IC50 range of 50-100 mM and 25-50 mM, depending 
on the bacteria strain (Table 3.5, entries 3,4). That data correlates very well with findings of 
other researchers, where longer alkyl chain caused an increase in toxicity of ILs.12,14,17,18,20-
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 ILs based on methyl 3,4-methylenedioxymandelate 5a, 6a and 6d were slightly more 
toxic than 1a and 2a, with their IC50 values in the range of 100-200 mM towards all strains 
except B. subtilis (IC50 50-100 mM) and except B. subtilis and E. coli in the case of 5a 
(IC50 50-100 mM) (Table 3.5, entries 5-7).  
ILs with an acetoxy linker between benzylic carbon and heterocycle moiety 24a was more 
toxic than ILs 5a, 6a and 6d and for most of the strains its toxicity was in the IC50 50-100 
mM range (Table 3.5, entry 9). As presented in the stability study, rapid hydrolysis of IL 
24a occurs in the presence of water (approx. 41 % after 24 h). Therefore in the case of 24a, 
data obtained in the test correspond rather to the toxicity of hydrolysis products and 
metabolites than parent IL. That is probably not the case for ILs 1a, 2a, 5a, 8a and 6d 
without the linker, which were shown to be hydrolysed at a very low level within 48 h (1-2 
%). An unusual toxicity result was observed for IL 8a, where significant toxicity was 
observed for Gram-positive bacterium B. subtilis (IC50 3.13-6.25 mM) and no inhibition 
was observed for any of the other bacteria strains (Table 3.5, entry 8). However this data 
matches well with the results obtained in collaboration with Faculty of Pharmacy at Charles 
University, where IL 8a was shown to inhibit growth of three bacteria strains (S. 
epidermidis, S. aureus and S. aureus MRSA) at 0.5–2.0 mM, which are also a Gram-
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positive species. This finding suggests Gram-positive species were particularly sensitive 
towards IL 8a.    
No clear difference between toxicity of 1-methylimidazolium and pyridinium based ILs 
was observed in the assay. ILs 1a and 2a, with both heterocycles, based on methyl 3,4-
dimethoxymandelate, exhibited the same levels of toxicity (Table 3.5, entries 1,2). Among 
ILs with butyl ester, 3a and 4a, IL with pyridinium ring 4a was slightly more toxic than ILs 
with a methylimidazolium ring (Table 3.5, entries 3,4). In the case of ILs based on methyl 
3,4-methylenedioxymandelate, 5a was more toxic than pyridinium ILs 6d and 6a (Table 
3.5, entries 5-7). The same toxicity levels were observed for ILs 6d and 6a with chloride 
and bromide counterions respectively (Table 3.5, entries 6,7). IL 24a with an acetoxy 
linker, was more toxic than 6d without the linker (Table 3.5, entries 6,9). Gram-positive 
bacterium B. subtilis was the most sensitive towards all ILs, similarly as was found by 
Pernak et al.14,16,17,20,27   
Although toxicity data provided by Kaiser and Palabrica29 for organic solvents were 
recorded after 30 min exposure time and for different bacteria strains (Vibrio fischeri), than 
used in our assay, they still could be used as rough guidelines in our studies.12 Based on 
that data it could be estimated that the toxicity of IL 1a and 2a was higher than methanol 
(EC50 of 3000 mM), similar to acetone (EC50 of 300 mM) and it is in the range of low 
toxicity. The most toxic ILs 3a and 4a, have toxicity similar to ethyl acetate (EC50 of 60 
mM) and dichloromethane (EC50 of 30 mM) and also fall in range of low toxicity. Activity 
of IL 8a against B. subtilis is similar to chloroform (EC50 of 10 mM), pyridine (EC50 of 7.4 
mM) or [bmim][Cl] (EC50 of 5.14 mM) and it can be classified as moderate toxicity.9,12,29 
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Table 3.5 High concentration ILs toxicity. 
 IL structure Bateria strain IC50 mM 
1. 
MeO
OMe
N
O
OMe
N
Cl
 
1a 
E.coli 
 
>200 mM 
B.subtilis 
 
100−200 mM 
P.fluorescens 
 
>200 mM 
P.putida (CP1) 
 
>200 mM 
P.putida (KT2440) >200 mM 
2. 
MeO
OMe
N
O
OMe
Cl
 
2a 
E.coli 
 
>200 mM 
B.subtilis 
 
>200 mM 
P.fluorescens 
 
>200 mM 
P.putida (CP1) 
 
> 200 mM 
P.putida (KT2440) 100−200 mM 
3. 
MeO
OMe
N
O
OBu
N
Cl
 
3a 
E.coli 
 
25-50 mM 
B.subtilis 
 
25-50 mM 
P.fluorescens 
 
25-50 mM 
P.putida (CP1) 
 
50-100 mM 
P.putida (KT2440) 50-100 mM 
4. 
MeO
OMe
N
O
OBu
Cl
 
4a 
E.coli 
 
25-50 mM 
B.subtilis 
 
25-50 mM 
P.fluorescens 
 
50-100 mM 
P.putida (CP1) 
 
25-50 mM 
P.putida (KT2440) 25-50 mM 
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5. 
N
O
OMe
N
O
O
Cl
 
5a 
E.coli 
 
50-100 mM 
B.subtilis 
 
50-100 mM 
P.fluorescens 
 
100−200 mM 
P.putida (CP1) 
 
100−200 mM 
P.putida (KT2440) 100−200 mM 
6. 
N
O
OMe
O
O
Br
 
6d 
E.coli 
 
100−200 mM 
B.subtilis 
 
50-100 mM 
P.fluorescens 
 
100−200 mM 
P.putida (CP1) 
 
100−200 mM 
P.putida (KT2440) 100−200 mM 
7. 
 
N
O
OMe
O
O
Cl
 
6a 
E.coli 
 
100−200 mM 
B.subtilis 
 
50-100 mM 
P.fluorescens 
 
100−200 mM 
P.putida (CP1) 
 
100−200 mM 
P.putida (KT2440) 100−200 mM 
8. 
HO
OH
N
O
OMe
Cl
 
8a 
E.coli 
 
>200 mM 
B.subtilis 
 
3.13-6.25 mM 
P.fluorescens 
 
>200 mM 
P.putida (CP1) 
 
>200 mM 
P.putida (KT2440) >200 mM 
9. 
O
O
OMe
O
O
O
N
Br
24a 
 
E.coli 
 
50-100 mM 
B.subtilis 
 
50-100 mM 
P.fluorescens 
 
50-100 mM 
P.putida (CP1) 
 
50-100 mM 
P.putida (KT2440) 100−200 mM 
  
 
 
 229
3.4 ILs biodegradation studies  
3.4.1 ILs biodegradation introduction 
Since the first reports by Gathergood et al.30 on ILs biodegradation appeared, many studies 
involving ILs based on various cations (methylimidazolium, pyridinium, imidazolium, 
ammonium, phosphonium and nonaromatic heterocycles) and various anions (Br−, Cl−, 
OctOSO3−, BF4−, PF6−, NTf2−, lactate, saccharinate, acylsulfamate) have been carried out.31-
39
 However results for ILs containing readily biodegradable counteranions, such as 
OctOSO3− should be treated with caution since such anions may mask lack of cation 
degradation, by causing IL as overall to pass the test (70 % biodegradation required for 
DOC tests, 301 A, 301D and 60 %  for other OECD tests for compound to be classified as 
biodegradable). Over the years promising reports including degradation studies using only 
one bacteria strain,40-42 fungal isolate,34 electrochemical43 or photochemical methods44 have 
appeared. Such methodologies however would not be useful in the case of accidental ILs 
release to the environment. Considering the above points only a few examples have been 
found in the literature, where ILs could be biodegraded effectively in the presence of 
mixture of microorganisms found in the environment.36  
The first biodegradable halide IL, 1-octyl-3-methylpyridinium bromide, was reported by 
Docherty and Kulpa in 2006.36 OECD DOC Die-Away method was applied in the study 
and IL was biodegraded by activated sludge in 96 %. Moreover this IL proved to be readily 
biodegradable, since the degradation occurred within a 10 day window, within a 28 day 
incubation period. In the same test 1-hexyl-3-methylpyridinium bromide was fully (97 %) 
mineralized after 35-49 days of incubation. Methylimidazolium ILs 1-hexyl-3-
methylimidazolium bromide was degraded in 54 % after 37 days and 1-octyl-3-
methylimidazolium bromide in 41 % after 38 days.       
Similar results for 1-octyl-3-methylpyridinium IL, but with chloride counteranion were 
obtained by Stolte and Thoeming, in which 97 % biodegradation was achieved in OECD 
301 D test after 24 days, however in their test the IL was not readily biodegradable.43 These 
researcher discovered two more biodegradable pyridinium ILs: 1-octylpyridinium chloride 
(100 % after 24 days) and 1-octyl-4-(dimethylamino)pyridinium chloride (93 % after 24 
days). Three methylimidazolium ILs were also found to undergo 100 % primary 
biodegradation (complete removal of the parent compound): 1-octyl-3-methyl- imidazolium 
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chloride (100 % after 24 days), 1-(8-hydroxy-octyl)-3-methylimidazolium chloride and 1-
(8-carboxy-octyl)-3-methylimidazolium chloride (both 100 % after 17 days). Following 
these findings Harjani and Scammells successfully identified more of biodegradable 
pyrdinium ILs. In CO2 Headspace test (ISO 14593) three halide ILs underwent 
biodegradation during a 28 day period: 1-(2-ethoxycarbonyl)methylpyridinium bromide (87 
% during 28 days),37 3-(butoxycarbonyl)-1-methylpyridinium iodide (nicotinic acid 
derivative) (74 %)37 and 1-(2-hydroxyethyl)pyridinium (65 %).45 Notably the first two ILs 
degraded in more than 70 % in the first 7 days of the tests, thus can be classified as readily 
biodegradable.37 None of halide methylimidazolium ILs tested by Harjani and Scammells 
passed the degradation test.46 Recently Zhang et al. have prepared a series of ILs with 
choline as the cation and various carboxylate counteranions. In the biodegradation studies, 
using the Closed-Bottle method, (OECD 301 D) eight of the ILs, except ILs with 
counteranions with fused two and three aromatic rings, passed the biodegradation test.47   
 
3.4.2 ILs biodegradation studies 
Biodegradation studies of six halide ILs: with methylimidazolium (1a, 3a, 5a) and 
pyridinium heterocycle (2a, 4a, 6a, 8a, 6d) (Figure 3.18) had been carried out with the 
Manometric Respirometry method (301 F) according to OECD guidelines.48 
Biodegradation evaluated by that method was expressed as a percentage ratio of 
biochemical oxygen demand (BOD) and theoretical oxygen demand (ThOD). BOD is the 
amount of oxygen consumed by microorganisms when metabolizing a test compound and 
ThOD is the total amount of oxygen required to oxidize a chemical completely and it is 
calculated from the molecular formula. A consumption of oxygen was determined based on 
the change in pressure, measured in the closed biodegradation apparatus, where inoculated 
mineral medium and test substance were stirred at constant temperature. Evolved carbon 
dioxide was absorbed in a solution of potassium hydroxide or another suitable absorbent. 
60 % biodegradation within 28 days was required to pass the test. 
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Figure 3.18 ILs included in biodegradation study. 
 
Biodegradation of two pyridinium ILs 2a and 6d, based on methyl 3,4-dimethoxymandelate 
(2a) and methyl 3,4-methylenedioxymandelate (6d) was tested at a concentration of 25 mM 
and 2.5 mM. High concentration, unusual for similar studies (e.g. Scammells et al. 0.02-
0.06 mM, Docherty et al. 0.1-0.2 mM, Stolte et al. 0.20 mM ),36,43,45 was chosen due to the 
very low antibacterial toxicity of ILs 2a (IC50 > 200 mM, 100-200 mM) and 6d (IC50 50-
200 mM). It was expected that due to their low toxicity, ILs will not inhibit activity of 
activated sludge, even at high concentrations and biodegradation will be possible. However 
at 25 mM both ILs 2a and 6d, as well as a reference compound, sodium glutamate, 
underwent biodegradation at a very low level (3 % and 4 % for ILs 6d and 2a and 12 % for 
sodium glutamate) (Figure 3.19). Slightly better results were obtained at lower 
concentration, 2.5 mM, where 2a and 6d degraded in 10 %. Due to an observed increase in 
biodegradation values at the end of the test, the experiment was extended until the 37-th 
day, however no further improvement was found (Figure 3.19).     
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Figure 3.19 Biodegradation study at high ILs concentrations, 2.5 mM and 25 mM 
 
Following those results biodegradation test was repeated for ILs 2a and 6d at a lower 
concentration of 0.25 mM (Figure 3.20). After 28 days 34 % of IL 2a and 66 % of 6d 
underwent biodegradation and thus IL 6d can be classified as a biodegradable compound 
(Table 3.6, entries 2 and 6).  According to OECD guidelines IL 6d was not readily 
biodegradable, since the pass level was reached after 15 days and not within the 10 day 
window (10 day window counted from attainment of 10 % biodegradation). The value 
obtained in our test with the Manometric Respirometry method means that 66 % of the 
theoretical oxygen demand, needed for complete mineralization of the elements in the IL 
structure, was absorbed by the system. In our test an additive to suppress the nitrification 
process was used and only oxidation of carbon to carbon dioxide
 
and hydrogen to water 
was included into ThOD calculation.  
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Figure 3.20 Biodegradation study of IL 6d and IL 2a at 0.25 mM concentration 
 
Next, biodegradation of four more samples IL 1a, 3a, 5a and 6a was carried out, including 
IL 6a, with the same cation structure as IL 6d, but with a chloride counteranion, instead of 
a bromide. After 28 days IL 6a reached 52 % biodegradation, IL 1a 31 %, IL 3a 25 % and 
the lowest value of 13 % was obtained for IL 5a (Table 3.6, entries 1,3,6,7). Since none of 
the ILs tested reached 60 % degradation within the required time, the assay was extended 
for another 28 days. Upon that time biodegradation of IL 6a, improved up to 79 % and IL 
1a to 57 %, but no increase in mineralization was found in the case of IL 3a and IL 5a. As 
seen from the results, chloride IL 6a exhibited a lower level of biodegradation than its 
bromide equivalent and required 39 days to pass the test, as compared to the 15 days time 
period for IL 6d. This discrepancy may be due to the slightly varying properties of both 
ILs, emerging from counteranions or due to activated sludge, which as a community of 
living organisms was constantly changing and may not give reproducible results in tests 
carried out at different times. 
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Figure 3.21 Biodegradation of IL 1a, 3a, 5a and 6a at 0.25 mM concentration 
 
After completion of the biodegradation process of ILs 1a, 3a, 5a and 6a, media containing 
activated sludge and ILs were centrifuged and supernatant was analyzed by 1H NMR and 
LCMS. Clean spectra of 5a (Figure 3.22), 6a, 1a and 3a (Figure 3.23) with entirely 
hydrolyzed ester groups were obtained, however no other degradation products were found 
in the samples. That may be due to unsuitable sampling procedures applied and alternative 
methods should be used in the future work.    
 
Figure 3.22 1H NMR spectrum of IL 6a after biodegradation 
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Figure 3.23 1H NMR spectrum of IL 3a after biodegradation 
 
Next a biodegradation study of IL 4a and 8a was also carried out, but none of the ILs 
reached the pass level (Figure 3.24). IL 4a underwent 33 % degradation within 28 days and 
IL 8a degraded in 45 % during the same time. During the stability test IL 8a hydrolyzed in 
approx. 20 % over 28 days, therefore the final result has to be interpreted as a sum of 
biodegradation ability and chemical decomposition taking place at the same time.   
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Figure 3.24 Biodegradation of IL 4a and 8a at 0.25 mM concentration 
 
Considering structure and biodegradation ability correlation, the data collected in 28 days 
test suggest that pyridinium ILs (2a, 4a, 6d, 6a) were more easily metabolized by activated 
sludge than their methylimidazolium counterparts (1a, 3a, 5a). The difference was most 
significant in the case of 5a and 6a or 6d, where only 13 % biodegradation was reached for 
methylimidazolium IL 5a and 66 % and 52 % biodegradation occurred for pyridinium 
counterparts 6d and 6a respectively.  
No improvement in the results was found for ILs with longer alkyl chain. Lower 
biodegradation was reached for IL 3a bearing butyl ester group (25 %), than IL 1a bearing 
a methyl ester group (31 %). Nearly identical results were obtained for IL 4a (33 %) and IL 
2a (34 %) with butyl and methyl esters respectively. In general ILs with longer alkyl chain 
at the heterocycle moiety are known to undergo better biodegradation, however that relates 
to ILs with long hydrocarbon chains (more than 6 carbon atoms).33,40 In our case the 
difference between IL 3a and 1a degradation may be due to higher toxicity of IL 3a (IC50 
25-100 mM) as compared with IL 1a (IC50 >200 mM and 100-200 mM). Higher toxicity of 
IL 3a might have impaired productivity of activated sludge.  
No clear correlation between mandelic acid structure and biodegradation ability was found 
during the study. Methyl 3,4-methylenedioxymandelate based IL 6a, exhibited a better 
degradation ability than, methyl 3,4-dimethoxymandelate based IL 2a (Table 3.6, entries 
2,7). However the opposite trend was found for methylimidazolium ILs 5a and 1a, 
derivatives of these two 3,4-substituted mandelic acids esters (Table 3.6, entries 1,6). 
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Biodegradation result obtained for methyl 3,4-dihydroxymandelate derived IL 8a was 
higher than for methyl 3,4-dimethoxymandelate based IL 2a and lower than for methyl 3,4-
methylenedioxymandelate based IL 6a (Table 3.6, entries 2,7,8). However no conclusions 
can be drawn from this data, hence the result for IL 8a is unreliable due to a high degree of 
hydrolysis of that IL (approx. 20 % over 28 days).  
Previously the observed correlation between ILs concentration and biodegradation facility 
had been reported before by Markiewicz et al., who found that 0.20 mM was the upper 
concentration threshold for primary biodegradation of [omim][Cl]. This IL however had 
much higher antimicrobial toxicity (MIC approx. 0.5-2.0 mM)49 than our ILs 2a and 6d, 
therefore the same concentration limit was surprising. Authors had shown that at higher 
IL’s concentration an inhibition of alcohol dehydrogenase, which was believed to 
participate in biodegradation, occurs, resulting in decrease of sludge activity.49,43   
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Table 3.6 Biodegradation study results. 
No IL structure % Biodegradation  IL structure % Biodegradation 
1. 
MeO
OMe
N
O
OMe
N
Cl
 
1a 
31 % (28 days) 
57 % (56 days) 
5. 
N
O
OMe
N
O
O
Cl
 
5a 
 
 
 
13 % (28 days) 
13 % (56 days) 
2. 
MeO
OMe
N
O
OMe
Cl
 
2a 
34 % (28 days) 
6. 
N
O
OMe
O
O
Br
 
6d 
 
 
 
66 % (28 days) 
3. 
MeO
OMe
N
O
OBu
N
Cl
 
3a 
25 % (28 days) 
26 % (56 days) 
7. 
N
O
OMe
O
O
Cl
 
6a 
 
 
52 % (28 days) 
79 % (56 days) 
4. 
MeO
OMe
N
O
OBu
Cl
 
4a 
 
 
33 % (28 days) 
8. 
HO
OH
N
O
OMe
Cl
 
8a 
 
 
45 % (28 days) 
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3.5 Conclusions 
Antimicrobial toxicity and susceptibility to biodegradation of new class of ILs have been 
examined. Prior to these studies, the stability of selected examples in water was tested in 
order to identify ILs suitable for further examination. ILs without an acetoxy linker, except 
IL 8a, proved to be relatively stable, with hydrolysis of methyl esters occurring at approx. 
8-10 % over a 28 day period. In the case of IL 8a, with unprotected hydroxyl groups on the 
aromatic ring, decomposition of approx. 20 % was observed. ILs 23a and 24a, with the 
acetoxy linker, were very unstable in water and complete hydrolysis of the C11 ester 
occurred within 7 days (pyridinium IL 24a) and 14 days (methylimidazolium IL 23a). 
Hydrolysis of the C11 esters and methyl esters occurred probably due to the presence of an 
acidic species, which may be generated from ILs in protic solvents. Rapid hydrolysis of the 
former ester may be due to the presence of a good leaving group (methyl 3,4-
methylenedioxymandelate) or an intramolecular mechanism. Based on these findings, only 
stable ILs without an acetoxy linker were chosen for biodegradation studies.   
Antifungal and antibacterial activity of ILs has been tested and the most toxic examples 
were identified. Three ILs (8a, 24a, 4b) tested at 2.0 mM exhibited toxicity towards some 
of the fungi strains; IL 24a of 2.0 mM, IL 4b of 1.0-2.0 mM and IL 8a within 0.5-2.0 mM 
range. Considering that known antimicrobial compounds have antifungal activity within 
µM range (e.g. benzalkonium chloride, MIC of 3-54 µM) and taking Stolte and Ranke’s 
classification as guidelines, IL 8a can be classified as being of high toxicity towards fungi, 
ILs 24a and 4b can be classified as compounds of moderate toxicity.12 Remaining ILs, not 
showing fungi growth inhibition, can be classified as compounds of low or moderate 
toxicity, where further tests at higher concentrations should be carried out.      
Antibacterial activity was tested at a concentration of 2.0 mM and 1.0 mM, depending on 
ILs solubility, and further tests at 200 mM were carried out for halide ILs. One IL (8a) 
exhibited toxicity within 2.0-0.5 mM range and two other ILs (7a, 5c) inhibited growth of 
only one bacteria strain at 2.0 mM. Taking into account the similar criteria as for fungi, IL 
8a can be classified as beign of high toxicity, ILs 7a and 5c as moderately toxic and the 
remaining ILs as low or moderately active with further test required.     
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Regarding toxicity at high concentration, two ILs (1a, 2a) were non toxic towards bacteria 
at 200mM, except one strain. Three ILs (3a, 4a, 8a) were the most toxic examples, with 
IC50 values within 25-100 mM (3a, 4a) and within 3.13-200 mM range (8a).  
All halide ILs tested, except 8a, can be classified as having very low toxicity (EC50 > 10 
mM).12 In this assay, IL 8a would be regarded as a compound of moderate toxicity (EC50 > 
1 mM). Considering correlation between ILs structure and antimicrobial activity, two 
trends were observed. One, of increased toxicity with higher hydrophobicity of ILs as in 
case of ILs 3a, 4a, 4b and 5c. Second, a more surprising trend, that the most hydrophilic 
compounds in the series were among the most toxic ones, as in the case of IL 7a, 8a and 
24a. ILs with the acetoxy linker 23a and 24a, were shown to undergo rapid hydrolysis 
under aqueous conditions, therefore toxicity values obtained in the test were more likely to 
refer to their degradation products rather than to their parent ILs.      
Biodegradation of halide ILs was studied using Manometric Respirometry method. Initially 
ILs 2a and 6d were tested at three concentrations 25 mM, 2.5 mM and 0.25 mM and a 
reversed correlation between concentration of IL and biodegradation level was found. Out 
of six ILs screened to date, only IL 6d underwent 66 % degradation over a 28 day period 
and was classified as biodegradable compound. IL 6a, of the same cation structure, but 
bearing a chloride anion instead of bromide, within the same time frame reached 52 % 
biodegradation. The remaining ILs 1a-6a and 8a were also mineralised, but to a smaller 
degree. None of the ILs was completely recalcitrant to biodegradation. IL 6a, as well as IL 
1a, improved their biodegradation over doubled the time frame (up to 79 % and 57 % after 
56 days). In the case of two others ILs 5a (13 %) and 3a (25 %) with the lowest level of 
biodegradation, extension of test length did not improve the results. 
Pyridinium ILs (2a, 4a, 6a and 6d) exhibited slightly better biodegradation susceptibility 
than methylimidazolium ILs (1a, 3a, 5a). Introducing a longer alkyl chain (butyl ester) into 
the IL structure did not improve biodegradation results Analysis of metabolites was 
attempted, however no other degradation products, except hydrolyzed ILs, were identified 
in the final samples isolated from activated sludge.  
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3.6 Experimental section 
Materials and methods: 
Stability study 
The ionic liquids subjected to the test were IL: 1a, 2a, 5a, 8a, 23a, 24a, 6d and were 
prepared in DCU as described in Chapter 2.0 (Sections 2.2-2.4 and 2.8). 0.75 mL of 0.5 M 
solutions of ILs 1a, 2a, 5a, 8a and 6d were prepared in D2O and were placed in the NMR 
tubes. Samples were kept at room temperature (25 oC) and NMR spectra were recorded 
daily over 28 day (1a, 2a, 5a, 8a) or 23 day (6d) period on Bruker 400 MHz. Samples (0.1 
M) of 23a and 24a were kept at room temperature (25 oC) and NMR spectra were recorded 
every hour over 24 h and then daily over 7 (24a) and 14 days (23a) on Bruker 400 MHz 
and 600 MHz. 
 
Antifungal activity 
In vitro antifungal activities of the compounds were evaluated on a panel of four ATCC 
strains (Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) and five clinical isolates of yeasts 
(Candida krusei E28, Candida tropicalis 156, Candida glabrata 20/I, Candida lusitaniae 
2446/I, Trichosporon beigelii 1188) and three filamentous fungi (Aspergillus fumigatus 
231, Absidia corymbifera 272, Trichophyton mentagrophytes 445) from the collection of 
fungal strains deposited at the Department of Biological and Medical Sciences, Faculty of 
Pharmacy, Charles University, Hradec Králové, Czech Republic. Three of the above ATCC 
strains (Candida albicans ATCC 90028, Candida parapsilosis ATCC 22019, Candida 
krusei ATCC 6258) also served as the quality control strains. All the isolates were 
maintained on Sabouraud dextrose agar prior to being tested. 
Minimum inhibitory concentrations (MICs) were determined by the microdilution format 
of the NCCLS M27-A guidelines.53 Dimethyl sulfoxide (100 %) served as a diluent for all 
compounds; the final concentration did not exceed 2 %. RPMI 1640 (Sevapharma, Prague) 
medium supplemented with L-glutamine and buffered with 0.165 M morpholine-
propanesulfonic acid (Serva) to pH 7.0 by 10 N NaOH was used as the test medium. The 
wells of the microdilution tray contained 100 µl of the RPMI 1640 medium with 2-fold 
serial dilutions of the compounds (2000 or 1000 to 0.48 µmol/l) and 100 µl of inoculum 
suspension. Fungal inoculum in RPMI 1640 was prepared to give a final concentration of 5 
 242
× 103 ± 0.2 cfu.ml-1. The trays were incubated at 35°C and MICs were read visually for 
filamentous fungi and photometrically for yeasts as an absorbance at 540 nm after 24 h and 
48 h. The MIC values for the dermatophytic strain (T. mentagrophytes) were determined 
after 72 h and 120 h. The MICs were defined as 80 % inhibition of the growth of control in 
the case of yeast (unicellular fungi) and as 50 % inhibition of the growth of control in the 
case of filamentous fungi. MICs were determined twice and in duplicate. The deviations 
from the usually obtained values were no higher than the nearest concentration value up 
and down the dilution. 
 
Antibacterial activity 
In vitro antibacterial activities54 of the compounds were evaluated on a panel of three 
ATCC strains (Staphylococcus aureus ATCC 6538, Escherichia coli ATCC 8739, 
Pseudomonas aeruginosa ATCC 9027) and five clinical isolates (Staphylococcus aureus 
MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, Enterococcus sp. 
HK14365/08, Klebsiella pneumoniae HK11750/08, Klebsiella pneumoniae ESBL 
HK14368/08) from the collection of fungal strains deposited at the Department of 
Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec 
Králové, Czech Republic. The abovementioned ATCC strains also served as the quality 
control strains. All the isolates were maintained on Mueller-Hinton dextrose agar prior to 
being tested. Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final 
concentration did not exceed 2 %. Mueller-Hinton agar (MH, HiMedia, Cadersky-Envitek, 
Czech Republic) buffered to pH 7.4 (±0.2) was used as the test medium. The wells of the 
microdilution tray contained 200 µl of the Mueller-Hinton medium with 2-fold serial 
dilutions of the compounds (2000 or 1000 to 0.48 µmol/l) and 10 µl of inoculum 
suspension. Inoculum in MH medium was prepared to give a final concentration of 0.5 
McFarland scale (1.5 × 108 cfu/mL). The trays were incubated at 36°C and MICs were read 
visually after 24 h and 48 h. The MICs were defined as 80 % inhibition of the growth of 
control. MICs were determined twice and in duplicate. The deviations from the usually 
obtained values were no higher than the nearest concentration value up and down the 
dilution scale. 
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Antibacterial activity up to 200 mM  
Mueller-Hinton broth was purchased from Oxoid. Five bacteria strains were used in the 
study: Gram Positive (B. Subtilis) and Gram Negative (E.Coli, P.Fluorescence, P. Putida 
CP1, P.Putida KT2440) all strains were purchased from DSMZ (German Collection of 
Microorganisms and Cell Cultures).  
IC50 for the compounds were determined by serial two-fold dilutions in Mueller-Hinton 
broth using modified broth microdilution method described by Amsterdam.55 Bacteria cell 
viability was measured using absorbance (OD) assay for 96-well plates. Each plate 
contained blanks, controls and two substance dilution series with three replicates each. 
Stock of ionic liquids (2.0 M) was prepared in Mueller-Hinton broth. Dilution series 
(1.562–200 mM) of the tested substances in medium were made in 96-well plates. Mueller-
Hinton broth was transferred to the wells by use of a multipipettor: 180 µL of broth was 
pipetted into the first row of wells and 100 µL into all the other wells. 20 µL of the 
chemical solution was transferred into the first row of wells and mixed (to give a 
concentration of 200 mM from 2.0 M stock solution). 100 µL of the solution from this row 
was transferred to the next row and mixed. The procedure was repeated until 100 µL of 
solution had been discarded from all 8 rows of the plate. 
Strains were grown in Mueller-Hinton broth overnight. The next day the cultures were 
centrifuged and the pellets washed twice with 0.01 M sodium phosphate buffer (10 mL). 
Bacteria were diluted with sodium phosphate buffer to give an OD of approximately 0.07 at 
660 nm. Cells were added to the plates and cultivated for 24 h at 37 oC.  
Each well was inoculated with 5 µL of bacterial culture while the 11th column was left free 
from the bacterium as a blank. To avoid contamination only one bacterium was used when 
preparing each plate. Cell viability was measured at 405 nm in a microplate reader (Tecan, 
SunriseTM). 
 
Biodegradation test 
The ionic liquids subjected to the test were IL: 1a-6a, 6d and 8a prepared in DCU as 
described in Chapter 2.0 (Sections 2.2, 2.8). The sewage sludge was taken from the aeration 
chamber of the “Gdansk-Wschod”. Biodegradation test was conducted according to OECD 
301 F “Manometric respirometry” procedure. In this test biodegradation is measures as a 
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decrease of pressure in gas-tight test vessel caused by depletion of oxygen used for aerobic 
degradation of IL reduced by the blank sample value (sample showing only endogenous 
respiration of bacteria, without addition of test compound) with respect to theoretical 
amount of oxygen necessary to completely oxidize compound tested. Each test bottle 
contained mineral medium composed of: 8.5 mg/L KH2 PO4, 21.75 mg/L K2HPO4, 22.3 
mg/L Na2 HPO4·2H2O, 1.7 mg/L NH4Cl, 27.5 mg/L CaCl2, 22.5 mg/L MgSO4·7H2O and 
0.25 mg/L FeCl3 dissolved in water, test substance in concentration of 0.25mM (all samples 
except control) and inoculum (cell density between 107 or 108 cells/L). 
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Chapter 4.0  
Hydrogenation Reactions in Ionic Liquids 
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4.1 Introduction 
Homogeneous reduction with gaseous hydrogen and chiral catalyst is one of the most 
popular asymmetric reactions and compared with other reduction methods it is a very clean 
process.1,2 ILs have been successfully employed as solvents for both homogeneous and 
heterogeneous catalytic hydrogenations, facilitating catalyst separation and recycling. 
Chauvin et al. in 1996 were the first to report application of ILs as solvents for 
hydrogenation reactions catalyzed by homogeneous metal catalysts. Successful reduction of 
1-pentene, catalyzed by [Rh(nbd)(PPh3)2][PF6] was carried out with [bmim][PF6] and 
[bmim][SbF6] as solvents. Catalyst immobilisation and recycling was demonstrated with 
less than 0.02 % of Rh metal present in the organic phase.3 Monteiro, Dupont et al. have 
applied mixture of [bmim][BF4] and methanol or IPA as solvents in Ru-BINAP catalyzed 
hydrogenation of 2-phenylacrylic acid. Product with ee values of 86 % was obtained in the 
mixture of [bmim][BF4]/methanol, however only [bmim][BF4]/IPA, giving lower ee value, 
has formed a biphasic system and it was recycled three times without any loss of 
conversion or enantioselectivity.4 Frater et al. have studied hydrogenation of (Z)-α-
acetamido cinnamic acid catalyzed by [Rh(COD)(DiPAMP)][BF4] in [bmim][BF4]/IPA 
biphasic system. High conversions 97-100 % and enantioselectivity values over 90 % were 
achieved in this system. Catalyst was recycled four times, maintaining its original 
enantioselectivity and 10 % drop in conversion values was observed at the last cycle.5 
Shariati et al. studied hydrogenation of methyl (Z)-α-acetamidocinnamate catalyzed by Rh-
MeDuPHOS in [bmim][BF4]. Experiments included investigation of H2 pressure and effect 
of CO2 introduction to the system on enantioselectivity of the reaction. With the Rh-
MeDuPHOS system enantiomeric excesses and conversions above 90 % were achieved at 5 
atm H2. However, while increasing the pressure of H2 marginally improved conversion, 
enantioselectivity was found to decrease. Recycling of Rh-MeDuPHOS in the biphasic 
system [bmim][BF4]/MTBE was carried out and ee drop from 91.9 % to 88.4 % was 
observed upon third recycle.6 Boyle et al. has studied hydrogenation of methyl (Z)-α-
benzamidocinnamate catalyzed by Rh-Et-DuPHOS, Ru-BINAP and achiral Rh-DiPFc 
(1,1’-bis(diisopropylphosphino)ferrocene) in [emim][OTf] and [bmim][BF4] ionic liquids. 
In [bmim][BF4] reaction did not proceed with any of the catalyst, but when [emim][OTf] 
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used as solvent conversions over 95 % were achieved with Rh-Et-DuPHOS and achiral Rh-
DiPFc after 24 hours. Product with 89 % ee was obtained with the chiral catalyst.7 
To date many ILs were prepared in their optically pure form and studies on their ability to 
induce chirality as solvents and catalysts have been carried out. Wasserscheid et al. 
published an interesting example of an chirality transfer between anion and cation in 
hydrogenation.8 In this hydrogenation, a ketone substituent on an N-methylimidazolium IL 
was hydrogenated asymmetrically to give the corresponding alcohol in 99 % yield and 80 
% ee. The heterogeneous catalyst, Ru/C was used with ethanol as a solvent for the IL at 60 
bar H2 pressure and a temperature of 60 °C, with camphorsulfonate anion as the sole source 
of chirality. When N-(5’-oxohexyl)-N-methylimidazolium IL with (R)-methyl mandelate as 
counteranion was applied in the hydrogenation reaction, respective alcohol was obtained 
with 66 % ee (Figure 4.1). Formation of ion-pairs of different “tightness”, depending on the 
IL concentration and anion provides a possible explanation for the varying efficiency of 
chirality transfer.9 
NN
O
O
O
OH
NN
HO
O
O
OH
60 bar H2, 60 oC
Ru/C, EtOH
 
Figure 4.1 Anion-cation chirality transfer in hydrogenation reaction 
 
Combining the advantages of metal catalysis, organocatalysis and ILs Leitner has 
investigated the rhodium catalyzed hydrogenation of methyl-2-acetamidoacrylate in the (S)-
proline derived IL NTf2 in the presence of biphenyl tropos ligand in CH2Cl2 (Figure 4.2).10 
Excellent conversions (> 99 %) were observed with moderate enantioselectivity. The 
sulfonate-substituted tropos ligand gave better results than unsubstituted one. A remarkable 
increase in enantioselectivity occurred upon adding of 20 equivalents of TEA (from 49 % 
to 69 % ee). The catalytic system could be recycled after scCO2 extraction up to three 
times.  
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AcHN COOMe AcHN COOMe
[Rh(cod)2]BF4
H2, CH2Cl2
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COOMe PPh2
PPh2
KO3S
KO3S
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49 % ee
69 % ee (with TEA)
 
Figure 4.2 Asymmetric hydrogenation in the presence of chiral IL. 
 
Very efficient enatioselectivities were achieved in the reduction of functionalized olefins 
with chiral phosphine ligands “tagged” to ionic liquid moiety as demonstrated by Lee et al. 
That group have prepared highly charged CILs with incorporated bisphosphane ligand, 
used in the rhodium catalyzed hydrogenation of N-acetyl-1-phenylethenamine in the 
biphasic system with [bmim][SbF6]/iPrOH as solvent (Figure 4.3).11 Excellent conversions 
(100 %) and high ees (97 %) were obtained within 1 h, and recycling of the catalytic system 
was possible up to four cycles, however with some loss of activity (82 % and 95 % ee). Use 
of this charged phoshine ligand has reduced catalyst leaching to below ICP-OES detection 
limits, compare to 2 % catalyst loss when underivatised ligand was applied.11  
NHAc NHAcH2, 1 atm
[bmim][SbF6]/iPrOH
> 99 % yield, 97 % ee
N N
N N
NN
O
Ph2P PPh2
 Rh
[cod]
3BF4
 
Figure 4.3 Hydrogenation reaction with catalyst “tagged” to IL11 
 
4.2 Aim of study 
The aim of our study was to investigate the applicability of a novel class of achiral and 
chiral ILs in the hydrogenation reactions catalyzed by various chiral rhodium catalysts. 
Possibility of chirality transfer from solvent to the product was investigated. Use of ILs as 
co-solvents and application of ILs in the large scale hydrogenation reactions were also 
studied. Hydrogenation of more challenging substrates with ILs as solvents was tested and 
selectivity towards ring reduction under mild conditions was also investigated.     
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Ionic liquids were tested as reaction solvents for asymmetric hydrogenation of unsaturated 
α-amino acids. Rhodium complexes with chiral phosphine ligand such as DiPAMP and 
phoshine ligands with chiral center such as Rh-(Rp,R)-Taniaphos SL-T001 and Rh-(Rp,R)-
Taniaphos SL-T002 were used as catalysts. In a preliminary study reduction of methyl (Z)-
α-acetamidocinnamate  (54) (Figure 4.4) was carried out in the presence of one achiral IL 
43c and two chiral ILs 40c and 41c (opposite enantiomers) at 1 atm of hydrogen gas. This 
work has been continued in collaboration of DCU with Celtic Catalyst, where with use of 
high hydrogen pressure parallel reaction apparatus, screening of wide number of reactions 
at various pressure conditions in a reproducible manner was possible. Hydrogenation of 
five substrates with various ILs in the presence of Rh-DiPAMP catalyst was investigated in 
this part of work. Further hydrogenation reactions were carried out in DCU, at ambient 
hydrogen pressure, involving new class of ILs, derivatives of disubstituted mandelic acids, 
1c, 2c, 3c, 5c and 6c, two substrates and three catalysts. 
CO2Me
NHAc
 Rh Catalyst
 H2, IL ∗ CO
2Me
NHAc
 
                                   54                              55 
Figure 4.4 Hydrogenation of methyl-(Z)-α-acetamidocinnamate (54) 
 
4.3 Preliminary study 
In a preliminary study imidazolium ILs 43c, 40c and 41c containing the bistriflimide 
(NTf2−) counterion were applied as solvents. IL 43c with a pentyl ester side chain and two 
ILs derived from S methyl mandelate IL 40c and R methyl mandelate IL 41c have been 
previously prepared in the group and their optimised synthesis has been detailed in chapter 
2.0 (Section 2.6 and 2.8).12,13 Phosphine catalysts [(R,R)-DiPAMP-Rh(cod)BF4 and 
Rh(nbd)2BF4 with (Rp,R) Taniaphos SL-T001 ligand were selected for the study (Figure 
4.5). 
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FePh2P
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Ph2P
H
BF4
Rh
 
       [(R,R)-DiPAMP-Rh(cod)]BF4                    (Rp,R) Rh-Taniaphos SL-T001 and Rh(nbd)2BF4 
Figure 4.5 Rhodium chiral catalysts used in the preliminary study 
 
In all of the hydrogenation reactions tested a C=C double bond was reduced and 
conversions and ee values of the product were recorded. In reactions performed in IL 40c, 
based on S methyl mandelate, and IL 41c, based on R methyl mandelate, with Rh-(Rp,R)-
Taniaphos SL-T001 catalyst, trace of by-product 56 resulting from the reduction of the 
aromatic ring was detected in the reaction mixture (Figure 4.6).  
 
CO2Me
NHAc 5 mol% Rh Catalyst
 H2, IL
∗ CO2Me
NHAc
* CO2Me
NHAc
+
 
               54                                                                   55                                     56 
Figure 4.6 Hydrogenation of substrate  54 resulting in the mixture of product 55 and 
by-product 56 
 
Conversions of the substrate 54 to the product 55 were determined based on respective 
signals integration in the 1H NMR spectra of the crude mixture extracted from the ILs with 
diethyl ether (Figure 4.7). Enantiomeric excess values of product 55 were determined with 
use of GC-MS equipped with chiral column. Results are presented in Table 4.1.   
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Figure 4.7 Overlaid spectra of substrate 54 and the reduced product 55 
 
In all of our experiments with [(R,R)-DiPAMP-Rh(cod)]BF4 as catalyst, substrate  54 was 
hydrogenated to the product methyl acetamidophenylalanine (55) with S (+) enantiomer as 
the major isomer. Experiments with [(Rp,R)-Taniaphos-Rh(nbd)2]BF4 resulted in product 55 
with R (−) enantiomer as the major isomer. In all experiments the main stereoisomer was 
determined based on order of peak elution on the GC chiral column, Chirasil L-Val, as 
compared to literature data.14,15 S (+) Enantiomer of 55 is retained longer on the column 
and thus has higher retention time, than enantiomer R (−).14,15 Our findings also match with 
the literature data showing that enantiomer S (+) is the main isomer obtained with [(R,R)-
DiPAMP-Rh(cod)]BF4 complex.16 Methyl acetamidophenylalanine (55) as the opposite 
enantiomer R (−) can be prepared using [(S,S)-DiPAMP-Rh(cod)]BF4 as catalyst.17 [(Rp,R)-
Taniaphos-Rh(nbd)2]BF4 is known to give product 55 with R (−) enantiomer as the major 
isomer.14,15 
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Table 4.1 Preliminary results of substrate 54 reduction: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Firstly IL 43c with a pentyl ester side chain was used in our study as a solvent in the 
hydrogenation of substrate 54 catalyzed by Rh-(R,R)-DiPAMP. Product 55 with 93 % ee 
and complete conversion was obtained after 120 hours (Table 4.1). IL 43c was also applied 
in the hydrogenation reaction with Rh-(Rp,R)-Taniaphos SL-T001 as catalyst and resulted 
in substrate  54 being reduced to product 55 with 80 % ee and 22 % conversion after 120 h 
(Table 4.1, entry 4). Next chiral IL 40c and 41c derived from S and R methyl mandelate 
were used for Rh-(R,R)-DiPAMP catalyzed hydrogenation of substrate  54. Hydrogenation 
carried out in IL 40c resulted in product 55 with 91 % ee and in IL 41c, the same 
No IL Structure 
Catalyst 
Loading 
Temp. 
oC 
Time h 
Conver.
% 
Product 55 
ee % 
Catalyst: Rh-(R,R)-DiPAMP 
1. 
O
O
NN
NTf2
 
43c 
 
0.6 mol% 
 
86 oC 120 h 100 % 93 % (S) 
2. 
Ph
O
OMe
O
O
NN
NTf2
40c 
2.0 mol% 100 oC 24 h 91 % 91 % (S) 
3. 
Ph
O
OMe
O
O
NN
NTf2
41c 
2.0 mol% 100 oC 24 h 83 % 90 % (S) 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 
4. 
O
O
NN
NTf2
43c 
 
0.7 mol% 
 
86 oC 120 h 22 % 80% (R) 
5. Ph
O
OMe
O
O
NN
NTf2
  
40c 
1.7 mol% 68 oC 42 h 100 % 
76 % (R) 
trace of 56 
6. 
Ph
O
OMe
O
O
NN
NTf2
41c 
2.2 mol% 95 oC 20 h 100 % 
85 % (R) 
trace of 56 
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selectivity, within margin of error, was obtained. In both cases IL 40c and IL 41c 
incomplete conversions of 91 % and 83 % respectively were achieved after 24 hours.  
Following that IL 40c and 41c were tested with Rh-(Rp,R)-Taniaphos SL-T001 catalyst. 
Product 55 with 76 % ee was achieved in the hydrogenation reaction run at 68 oC. 
Enantiomeric excess of 85 % was found when reduction was run with IL 41c at the higher 
temperature of 95 oC. At 68 oC conversion of 100 % was observed after 42 hours, while at 
the temperature of 95 oC this was attained in only 20 hours. For Rh-(Rp,R)-Taniaphos SL-
T001 catalyzed reactions run in IL 40c and 41c, presence of a product 56 with reduced C=C 
double bond and reduced aromatic ring was detected in the reaction mixture. Product 56 
was not observed in the NMR spectra due to its low concentration, but it was detected with 
GC-MS instrument.   
For hydrogenation of substrate 54 in IL 43c, Rh-(R,R)-DiPAMP proved to be more 
efficient catalyst than Rh-(Rp,R)-Taniaphos SL-T001 in terms of enantioselectivity and 
reaction rates. Excellent selectivity of 93 % ee was achieved in the reduction with Rh-
(R,R)-DiPAMP catalyst, which is similar to one obtained in methanol, where 95 % ee was 
achieved at room temperature with 1 mol% catalyst loading.19 However, as compared with 
methanol, where reduction was completed after 18 min, in the presence of IL 43c as a 
solvent a long reaction time of 120 hours was required.19 Therefore IL 43c was not a 
suitable solvent for hydrogenation reactions at the conditions tested. IL 40c and 41c also 
resulted in product 55 with high ee values and incomplete conversions after 24 hours. 
Product 55 with the same ee values was obtained in the hydrogenation with IL 40c and 41c 
and conclusion about lack of asymmetric induction emerging from the chiral solvents was 
made. In order to confirm that result and to screen wider range of ILs and substrates at 
various conditions, collaboration with Celtic Catalyst was initiated. Further study and 
results are presented in the following sections. 
Hydrogenation reaction of 54 catalyzed by Rh-(Rp,R)-Taniaphos SL-T001 in the presence 
of IL 40c and 41c resulted in product 55 with moderate ee values and complete conversions 
after 42 hours and 20 hours (Table 4.1, entry 5, 6). Selectivity and reaction rate of Rh-
(Rp,R)-Taniaphos SL-T001 catalyzed processes in IL 43c - 41c were less effective than in 
methanol, where 97 % ee was reached after 22 hours at 25 oC.19 
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Reduction of 54 in IL 40c and 41c resulted in the presence of traces of product 56, with the 
reduced C=C double bond and reduced aromatic ring, in the reaction mixture. At this point 
of the project this significant result was considered worthy of further study with Celtic 
Catalyst. However due to the patent deadlines the decision was made, to complete the 
hydrogenation study of the C=C in substrates 54, 57, 58, 59 and 60, important for the 
synthesis of chiral aminoacid products, instead of investigating of product 56. Further study 
of formation of the by-product was carried out later on at DCU.   
  
4.4 Celtic Catalyst study 
Following the preliminary study, collaboration with Celtic Catalyst company, specializing 
in the manufacture and use of homogenous catalysts, was initialize and hydrogenation of 54 
in four different ILs 43c, 40c, 41c and 44c (Figure 4.8) was screened at various temperature 
and pressure conditions with Rh-(R,R)-DiPAMP, Rh-(S,S)-DiPAMP and Rh-DPPE (Rh-
DIPHOS) as the catalysts (Figure 4.9).  
Ph
O
OMe
O
O
NN
NTf2
      
Ph
O
OMe
O
O
NN
NTf2
 
40c        41c 
 
 
O
O
NN
NTf2
             
OBu
O
O
O
NN
NTf2             
43c      44c     
                       
Figure 4.8 ILs used in collaboration with Celtic Catalyst 
 
After that, experiments with organic co-solvents and with four more challenging substrates 
57, 58, 59 and 60 were performed (Figure 4.10). Experiments with achiral catalyst, Rh-
DPPE, to investigate the possibility of an asymmetric induction by an IL were also carried 
out. Final part of the study involved large scale experiments.  
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[(R,R)-DiPAMP-Rh(cod)]BF4                                    [(S,S)-DiPAMP-Rh(cod)]BF4 
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P
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[DPPE-Rh(cod)]BF4 
Figure 4.9 Catalysts used during studies with Celtic Catalyst. 
 
CO2MeAcHN
     
CO2MeAcHN           CO2MeBocHN  
                     54                      57                       58 
 
 
CO2MeAcHN
                   
CO2MeAcHN
 
                       59                                              60 
Figure 4.10 Substrates used in collaboration with Celtic Catalyst 
 
All of the hydrogenation reactions were run for 10 hours and 0.5 mol% of catalyst loading 
was used. Progress of the reduction was monitored by hydrogen uptake which usually 
allows the determination of the reaction end point, however for experiments performed in 
ILs that was possible only in some cases due to the kinetics of the reaction. In organic 
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solvents reactions are fast and show very distinct end-point in hydrogen uptake, as oppose 
to ILs were reaction rate and hydrogen uptake are slow resulting in steadily declining rate 
and lack of sharp end-point indicating the completion of the reaction. Few other problems 
are associated with the accuracy of the end point determination, one of them being that 
pressure head is prone to minor leaks and other is due to the fact that monitoring process 
starts after vessel purges, where significant reaction could have taken place already. 
Product 55 was extracted from ILs with toluene, NMR spectra were recorded and 
conversion was determined. HPLC Analysis of the crude extract was performed. Crude 
product 55 from selected experiments was also purified at DCU and isolated yields values 
were calculated. Product of hydrogenation of 58 was purified before HPLC analysis in our 
laboratory.  
 
4.4.1 Achiral ILs as solvents 
The first objective of the screening was to determine the optimum temperature and pressure 
conditions for Rh-(R,R)-DiPAMP catalyzed hydrogenation reactions run in ILs. For that 
purpose achiral IL 44c with an ether side chain was selected and three various temperature 
(30 oC, 60 oC, 80 oC) and three pressure conditions (15 psi, 50 psi, 200 psi) were applied to 
investigate their impact on the reaction rate and ee of the product 55. (Table 4.2, entry 1-8) 
The highest ee value of 91.7 % was achieved when highest temperature and lowest 
hydrogen pressure were applied (80 oC, 15 psi), however only partial conversion (31 %) 
was reached after 10 hours (Table 4.2, entry 6). An additional experiment with double 
catalyst loading of 1 mol% was run, but conversion increased only up to 60 % (Table 4.2, 
entry 7). Reaction carried out in methanol at the same conditions (80 oC, 15 psi) went to 
completion within 1.5 hour with the product being formed with 95.2 % ee (Table 4.2, entry 
12). Complete conversion, but lower selectivity of 88.6 % ee, was achieved when high 
temperature and moderate hydrogen pressure (80 oC, 50 psi) was applied (Table 4.2, entry 
8). Lower temperature and the same pressure (60 oC, 50 psi) gave second best result where 
complete conversions and 87.0 % ee was reached (Table 4.2, entry 4).  
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Table 4.2 Optimization of hydrogenation conditions 
No IL Structure 
Temp. oC, P 
psi 
H2 uptake Conv. % 
Product 55 
ee % 
 
1. 
OBu
O
O
O
NN
NTf2  
44c 
30 °C, 50 psi ~6.5 h >95% 33.4 % (S) 
2. 
30 °C, 200 
psi 
nd >95% 15.6% (S) 
3. 60 °C, 15 psi ~10 h 43% 89.6% (S) 
4. 60 °C, 50 psi nd >95% 87.0% (S) 
5. 
60 °C, 
200psi 
~1.5 h >95% 77.2% (S) 
6. 80 °C, 15 psi ~ 10 h 31% 91.7% (S) 
7. 
80 °C, 15 
psia 
~10 h 60% 92.0% (S) 
8. 80 °C, 50 psi ~ 3h >95% 88.6% (S) 
9. 
O
O
NN
NTf2
 
43c 
80 °C, 50 psi ~3.5 h >95% 88.0% (S) 
10. 
MeOH 
60 °C, 15 psi ~0.5 h >95% 96.2 % (S) 
11. 60 °C, 50 psi ~0.5 h >95% 96.3 % (S) 
12. 80 °C, 15 psi ~1.5 h >95% 95.2 % (S) 
a using 1 mol% catalyst, nd (not determined) 
 
Further lowering the temperature to 30 oC had detrimental effect on selectivity of the 
hydrogenation reaction and 33.4 % and 15.6 % ee were obtained at 50 and 200 psi 
respectively, however with complete conversions in both cases (Table 4.2, entry 1, 2). 
Applying pressure of at least 50 psi was necessary to ensure the completion of the reaction 
within 10 hours at all of temperatures tested. From the above results conditions of 80 oC 
and 50 psi have emerged as the most optimal, where ee of 88.6 % with complete conversion 
can be reached within 3 hours, and those conditions were applied to majority of the 
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reactions (Table 4.2, entry 8). Another IL, 43c was tested under those conditions and 
similar results as for IL 44c were obtained with ee of 88 % and complete conversions 
(Table 4.2, entry 9). The best conditions for the hydrogenation reaction carried out in 
methanol were low pressure and moderate temperature (60 oC, 15 psi), where 96.2 % ee 
and complete conversion were recorded (Table 4.2, entry 10).  
 
4.4.1.1 Effect of temperature and pressure on enantioselectivity 
During optimisation of conditions for Rh-(R,R)-DiPAMP catalyzed hydrogenation reaction 
carried out in IL 44c, a correlation between temperature and selectivity as well as between 
pressure and selectivity was observed. At 50 psi of hydrogen pressure, with temperature 
increasing from 30 oC to 60 oC a significant improvement in the ee values from 33.4 % to 
87.0 % was found, followed by slight increase to 88.6 % ee at 80 oC (Figure 4.11). Higher 
temperature also improved the reaction rate. At 30 oC reaction was completed after 6.5 h as 
compared to 3 hour at 80 oC.   
 
Temperature and enantioselectivity dependence 
at 50 psi
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%
        
H2 pressure and enantioselectivity dependence 
at 60 oC
0
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100
0 50 100 150 200 250
H2 pressure psi
ee
 
%
 
Figure 4.11 Temp. vs. ee dependence                Figure 4.12 Pressure vs. ee dependence  
 
Correlation between hydrogen gas pressure and selectivity as well as reaction rate was 
observed at 60 oC. Increasing hydrogen pressure showed to have negative impact on the 
reaction enantioselectivity. At the lowest pressure tested (15 psi), the highest ee of 89.6 % 
was recorded and further pressure increase up to 50 psi lowered ee slightly to 87.0 % 
(Figure 4.12). At the highest pressure applied, 200 psi, a remarkable drop of ee to 77.2 % 
was observed. Increasing hydrogen gas pressure leaded to acceleration of the reduction 
process. At 15 psi, reaction was not completed even after 10 hours (43 % conversion) and 
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at 200 psi, reaction was finished in 1.5 hour. In methanol, at 15 psi and 50 psi, identical 
results were obtained at 60 oC, with ee of 96.2 % and 96.3 % respectively. Slightly lower ee 
of 95.2 % and longer reaction time of 1.5 hour were found in the experiment run at 80 oC, 
15 psi (Table 4.2, entry 10-12).  
Similar temperature and pressure effects on the enantioselectivity have been 
observed previously in the hydrogenation reactions carried out in the organic solvents 
catalyzed by chiral rhodium diphosphines. In 1980 Ojima et al. have shown that pressure 
exerts a significant influence on the hydrogenation process, where increasing pressure has a 
detrimental effect on the enantioselectivities of the reaction.17 Unusual for asymmetric 
reactions, positive effect of high temperature on the ee values of the product was 
demonstrated for the first time, where hydrogenation of Z-α-benzamidocinnamic acid with 
Rh-BPPM, Rh-DIOP and Rh-DiPAMP resulted in slightly higher enantioselectivities at 50 
oC than at 25 oC (Figure 4.13).17 Later, Landis and Halpern, who studied thermodynamic 
and kinetic aspects of Rh-DiPAMP catalyzed hydrogenation of methyl-(Z)-α-
acetamidocinnamate, have shown that with the temperature increase from 0 oC to 37 oC, ee 
values of the product have improved from 73 % to 89 %.20 Sinou investigated 
hydrogenation of the same substrate, methyl-(Z)-α-acetamidocinnamate, catalyzed by Rh-
DIOP and Rh-DIOXOP in wider range of temperatures (0 oC to 100 oC) and he showed that 
presence of such linear correlation between temperature and ee is not universal and depends 
on the ligand structure (Figure 4.13).21 In case of Rh-DIOXOP ee values were increasing 
from 0 % to 60 % with the temperature changing from 0 oC to 100 oC. However it was not 
the case with Rh-DIOP as catalyst, where temperature changing from 0 oC to 25 oC caused 
ee increase from 57 % to 66 %, but further temperature growth resulted in decrease of the 
ee values.21 Similar effect, as in Rh-DIOP catalyzed reaction, was observed in 
hydrogenation of Z-α-acetamidocinnamic acid in [bmim]BF4/isopropanol biphasic system 
with Rh-DiPAMP as catalyst.5 While increasing the temperature from 20 oC to 70 oC 
initially improvement of the enantioselectivity was observed, however above 55 oC 
decrease of the ee values was recorded.5 
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Figure 4.13 Common bidenate phosphine ligands 
 
Negative effect of the high hydrogen pressure on the reaction enantioselectivities have also 
been observed previously in the rhodium diphosphine catalyzed hydrogenation carried out 
in organic solvents. Ojima et al. have shown that during reduction of Z-α-
benzamidocinnamic acid increase of the hydrogen pressure from 1 atm to 20 atm caused 
drop of the ee value from 83.8 % to 21.2 % and further pressure increase caused appearing 
of excess of the opposite enantiomer of the product.17 Landis and Halpern in Rh-DiPAMP 
catalyzed reduction of methyl-(Z)-α-acetamidocinnamate also showed decrease of the 
enantioselectivities with increasing hydrogen pressure, where ee has dropped from 93.8 % 
at 1.5 psi to 82.3 % at 8.6 psi.20 Similar pressure vs. enantioselectivity correlation was 
observed in hydrogenation of methyl-(Z)-α-acetamidocinnamate, catalyzed by Rh-Me-
DuPHOS in [bmim][BF4] as solvent, where at 20 bar of H2 pressure ee of 91.9 % was 
achieved, followed by  ee 56.2 % at 50 bar (Figure 4.13).6 A detailed explanation for 
observed temperature and pressure dependence has emerged from thorough study of 
hydrogenation mechanism carried out by Halpern and Halpern and Landis.22, 20 In 1983 
Halpern published his groundbreaking work elucidating the mechanism of asymmetric 
hydrogenation by rhodium diphosphine catalysts. According to his findings hydrogenation 
occurs via “unsaturated route”, where hydrogen reacts with preformed Rh-substrate 
complex and not via the “dihydride route” observed in case of Wilkinsons catalyst, where 
olefin coordinates to the performed Rh-dihydride complex.22,23 It has been shown that the 
enantioselectivity in Rh-DiPAMP catalyzed reaction and other similar systems is emerging 
not from preferred initial binding of the prochiral substrate to the chiral catalyst, but rather 
from the differences in the rates of reaction of the two substrate-catalyst diastereomers with 
H2.22 As oppose to other catalytic systems, where the predominant diastereomer gives 
respective enantiomer as the major product, in this case the minor diastereomer 
(thermodynamically unfavorable and of higher initial free energy) reacts faster with H2 
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resulting in stereochemistry opposite to the one expected from the relative concentrations of 
the two substrate-catalyst complexes.22,19 High enantioselection depends upon rapid 
interconversion of two diastereomers compared with the rates of their reaction with H2. 
Substrate-catalyst complex dissociation leading to interconversion has typically much 
higher activation enthalpy, then its reaction with H2 (i.e. in case of achiral Rh-DPPE (also 
called Rh-DIPHOS) 18.3 and 6 kcal/mol respectively) therefore performing reaction at 
lower temperature should “freeze out” interconversion process, thus decreasing 
enantioselectivity.22 This interconversion process is also reduced at sufficiently high 
hydrogen pressure (hydrogen concentration), where the rate of subsequent step, oxidative 
H2 addition is increased. That mechanistic description explains the enantioselectivity 
decrease and even possible inversion in the chirality of the product.22 
The temperature and pressure vs. enantioselectivity dependence in the reaction carried out 
in IL 44c with Rh-(R,R)-DiPAMP as catalyst follows the same pattern as described by 
Halpern et al. and therefore we may assume that hydrogenation process in ionic liquid 
proceeds via “unsaturated route” as in case of organic solvents.   
 
4.4.2 Chiral ILs as solvents 
In the next stage chiral IL 40c derivative of S methyl mandelate and IL 41c derivative R 
methyl mandelate, were applied and possibility of asymmetric induction from those 
solvents was investigated. Hydrogenation reaction catalyzed by Rh-(R,R)-DiPAMP carried 
out in the presence of IL 40c resulted in product 55 with ee of 85.4 % (S) with complete 
conversion and in case of IL 41c ee  of 89.2 % (S) and 95 % conversion were reached 
(Table 4.3, entry 1,3). Experiments with the opposite enantiomer of catalyst, [(S, S)-
DiPAMP-Rh(cod)]BF4 were also performed, to establish if any match/mismatch effect can 
be observed. With Rh-(S,S)-DiPAMP product 55 in IL 40c was obtained with 84.8 % ee (R) 
and in IL 41c 88.8 % ee (R) were reached. 
In IL 40c product 55 with ee of 85.4 % (S) was formed in the reduction catalyzed by Rh-
(R,R)-DiPAMP and in the reduction with Rh-(S,S)-DiPAMP, the opposite enantiomer (R), 
but the same ee value was found. Similar pattern was observed in case of IL 41c where 
values of 89.2 % (S) and 88.8 % (R) ee were found. Although enantioselectivities are higher 
in IL 41c, above data show lack of match/mismatch effect, which is expected to be present 
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if solvent is inducing chirality to the product. In such instance ee values of the product 
should have been enhanced or decreased upon using opposite enantiomer of catalyst. 
Following those results, experiments with IL 40c and 41c and a achiral catalyst Rh-DPPE-
Rh(cod)]BF4, a close analogue of Rh-DiPAMP, were performed to finally established if the 
solvent alone would induce stereoselectivity. No chiral induction was observed, where 
recorded ee values were lower then 1 % (Table 4.4, entry 1,2). Significant difference was 
observed in reaction rates, where in case of IL 41c only 50 % conversion was reached, as 
oppose to IL 40c where reaction went to completion. At this stage one more chiral IL 42c 
with amide side chain was applied as a solvent. No asymmetric induction was observed, 
however excellent reaction rate was noticed, where process was completed within 1.5 hour 
(Table 4.4, entry 3).  
 
Table 4.3 Chiral IL and chiral catalyst study 
No IL Structure 
Temp. oC, 
P psi 
Catalyst H2 uptake Conv. % 
Product 
55 ee % 
 
1. 
Ph
O
OMe
O
O
NN
NTf2
 
40c 
 
 
80 °C, 50 psi 
(R,R) 
DiPAMP 
~7 h >95% 
85.4% 
(S) 
2. 80 °C, 50 psi 
(S,S) 
DiPAMP 
nd >95% 
84.8% 
(R) 
3. 
Ph
O
OMe
O
O
NN
NTf2
 
41c 
80 °C, 50 psi 
(R,R) 
DiPAMP 
~10 h 95% 
89.2% 
(S) 
4. 80 °C, 50 psi 
(S,S) 
DiPAMP 
~10 h 95% 
88.8% 
(R) 
 
 
 
 
 
 
 267
Table 4.4 Hydrogenation with achiral catalyst and chiral ILs 
No IL Structure 
Temp. oC, 
P psi 
Catalyst H2 uptake Conv. % 
Product 
55 ee % 
 
1. Ph
O
OMe
O
O
NN
NTf2
 
40c 
 
80 °C, 50 psi Rh-DPPE ~10 h ~95% <1% 
2. Ph
O
OMe
O
O
NN
NTf2
 
41c 
80 °C, 50 psi Rh-DPPE ~10 h 50% <1% 
3. NTf2
N
N
O
N
 
42c 
 
80 °C, 50 psi Rh-DPPE ~1.5 h >95% <1% 
 
4.4.3 ILs and co-solvent study 
It has been reported that mixing ILs with organic solvents lead to a positive effect on rate 
and enantioselectivity in hydrogenation reactions, therefore tests with IL 40c and 44c with 
various co-solvents, such as methanol, THF, ethyl acetate, toluene and 2-isopropanol have 
been carried out. In the following experiments 0.5 mL of IL were mixed with 1.5 mL of co-
solvent. Hydrogenation of substrate 54 catalyzed by Rh-(R,R)-DiPAMP, carried out at 80 
oC and 15 psi in the mixture of IL 44c and methanol was completed in 1 hour and product 
55 with 94.8 % ee was obtained (Table 4.5). The same reaction time and ee value was 
obtained in the IL 44c/toluene mixture (Table 4.5, entry 2). In neat IL 44c product 55 with 
91.7 % ee and 31 % conversion after 10 hours was formed (Table 4.2, entry 6) and 
hydrogenation carried out in pure methanol was completed after 1.5 hour and 55 was 
obtained with 95.2 % ee (Table 4.2, entry 12). Results obtained in the mixture IL 
44c/methanol at 80 oC and 15 psi were the same as in pure methanol (Table 4.5, entry 1). 
At 60 oC and 50 psi, similar selectivity improvement was observed, where in the mixture of 
IL 44c and methanol, reduction was completed in 0.5 hour and 55 with 95.2 % ee was 
obtained (Table 4.5, entry 3). At those conditions in neat IL 44c product 55 with 87.0 % ee 
was formed (Table 4.2, entry 4) and hydrogenation carried out in pure methanol was 
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completed after 0.5 hour and 55 was obtained with 96.3 % ee (Table 4.2, entry 11). At 60 
oC and 50 psi, enantioselectivities and reaction rates achieved in the mixture of IL 44c and 
methanol were the same, within margin of error, as the values obtained in pure methanol. 
Impact of various organic co-solvents on enantioselectivities and reaction rates of Rh-
(R,R)-DiPAMP
 
catalyzed hydrogenation was also investigated at 60 oC, 50 psi. The highest 
ee values were achieved with methanol, THF and ethyl acetate as co-solvents, where 
product 55 with ee of 95.2 %, 94.0 % and 93.6 % respectively was formed (Table 4.8, entry 
3-5). Isopropanol and toluene proved to be slightly less effective as co-solvents and product 
55 with 93.2 % and 91.4 % ee respectively was obtained (Table 4.8, entry 6, 7). 
Hydrogenation of substrate 54 with chiral IL 40c and co-solvents were also carried out at 
two sets of conditions 60 oC, 15 psi and 80 oC, 15 psi. At 60 oC, 15 psi, reduction of 54 in 
the mixture of IL 40c and methanol resulted in 55 with 96.4 % ee after 1 hour (Table 4.5, 
entry 8). The same enantioselectivity of 96.2 % ee was obtained in pure methanol at 60 oC, 
15 psi where the process was completed within 0.5 hour (Table 4.2, entry 10). At 80 oC, 15 
psi 54 was reduced in the mixture IL 40c/methanol and IL 40c/toluene and 
enantioselectivities of 95.2 % ee and 94.2 % ee were obtained after 2 hours (Table 4.5, 
entry 9 and 10). The same selectivity of 95.2 % ee was found in pure methanol, where 
reduction was completed in 1.5 hours (Table 4.2, entry 12). Hydrogenation of substrate 54, 
with achiral catalyst Rh-DPPE, in a mixture IL 40c/methanol or IL 40c/toluene was carried 
out at 80 oC, 15 psi (Table 4.6, entry 1, 2). No asymmetric induction have been observed 
and racemic product 55 with ee less than 1 % was obtained after 1.5 hours in toluene-IL 
40c mixture and after 3.0 hours in methanol-IL 40c mixture.  
In all of the hydrogenation experiments catalyzed by Rh-(R,R)-DiPAMP with IL-organic 
solvent mixture significant improvement of the reaction rates and enantioselectivities was 
evident as compared with tests in neat IL 40c and 44c. However all of the results including 
ee values, conversions and reaction times in IL/methanol mixture were identical or very 
similar to the results obtained in pure methanol. That suggest IL 40c and 44c might not be 
participating in the reduction process if organic solvent present.  
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Table 4.5 IL-co-solvent study 
No IL Structure 
Co-
solvent 
Temp. 
oC, 
P psi 
H2 
uptake Conv. % 
Product 
55 ee % 
 
1. 
OBu
O
O
O
NN
NTf2  
44c 
 
MeOH 
80 °C, 
15 psi 
~1h >95% 
94.8% 
(S) 
2. Toluene 
80 °C, 
15 psi 
~ 1h >95% 
94.0% 
(S) 
3. MeOH 
60 °C, 
50 psi 
<0.5 h >95% 
95.2% 
(S) 
4. THF 
60 °C, 
50 psi 
<1 h >95% 
94.0% 
(S) 
5. Et. Ac. 
60 °C, 
50 psi 
<0.5 h >95% 
93.6% 
(S) 
6. Toluene 
60 °C, 
50 psi 
<0.5 h >95% 
91.4% 
(S) 
7. IPA 
60 °C, 
50 psi 
<0.5 h >95% 
93.2% 
(S) 
8. 
Ph
O
OMe
O
O
NN
NTf2
 
40c 
 
MeOH 
60 °C, 
15 psi 
<1 h >95% 
96.4% 
(S) 
9. MeOH 
80 °C, 
15 psi 
~ 2h >95% 
95.2% 
(S) 
10. Toluene 
80 °C, 
15 psi 
~ 2h >95% 
94.2% 
(S) 
 
To confirm that further tests with ILs having more pronounced effect on the reaction 
outcome would be recommendable. Hydrogenation reactions in ILs/organic solvent mixture 
are very important, since upon careful choice of conditions, there is possibility of forming a 
biphasic system. In the ideal system IL would be miscible with organic solvent during the 
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reaction and would become immiscible upon reaction completion. Such biphasic systems 
offer several advantages such as ease of product separation, prevention of catalyst leaching 
to the product, by its immobilization in the IL layer and reaction rates, as efficient as in the 
organic solvents. In our test 0.5 mL and 1.5 mL of organic solvent was used but even 
further reduction of the IL amount may be possible. 
 
Table 4.6 IL-co-solvent and achiral catalyst, Rh-DPPE study 
No IL Structure 
Temp.oC, 
P psi 
Co-
solvent 
H2 
uptake 
Conv. 
% 
Product 
55 ee % 
 
1. 
Ph
O
OMe
O
O
NN
NTf2
 
40c 
 
80 °C, 15 
psi 
MeOH ~3 h >95% <1% 
2. 
80 °C, 15 
psi 
Toluene ~1.5 h >95% <1% 
 
4.4.4 Isolated yields 
Hydrogenation of 54 carried out in methanol as a solvent is a very clean process, which 
rapidly goes to completion and no by-products are formed. Therefore only removing of Rh 
catalyst by filtration or Rh-scavenging is necessary. Product recrystallisation may be 
carried out occasionally if ee enhancement is required. However in case of reactions 
performed in ILs, separation of the product from IL is usually needed. In our experiments, 
after completion of the hydrogenation reaction, product was extracted with toluene, but 
various amounts of ILs were still present in the extract, depending on the miscibility of the 
ILs with toluene. In order to obtain the isolated yield values, selected experiments were 
repeated, product 55 was extracted and then purified by column chromatography. The best 
result was obtained for IL 61 where 96 % of the product was isolated (Table 4.7, entry 4). 
Yields over 80 % were found in case of IL 62, 63 and 64 (Table 4.7, entry 5-7). Product 55 
extracted from IL 40c and 44c was isolated with 78 % yield in both cases (Table 4.7, entry 
2, 3). The lowest yield was found in case of product 55 isolated from IL 43c, where due to 
the similar Rf  values of IL and product 55, efficient separation of those two compounds 
proved to be difficult (Table 4.7, entry 1).  
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Table 4.7 Isolated yields 
No. Experiment Product 55 ee % Isolated Yields 
1. 
O
O
NN
NTf2
 
43c 
88.8% (S) 50 % 
2. 
Ph
O
OMe
O
O
NN
NTf2
 
40c 
87.1% (S) 78 % 
3. 
OBu
O
O
O
NN
NTf2  
44c 
88.7% (S) 78 % 
4. NN
N
O
O
O
NTf2
 
61a 
86.9% (S) 96 % 
5. NN
N
O NTf2
O
 
62a 
84.9 % (S) 88 % 
6. NN
N
O NTf2
 
63a 
90.5 % (S) 83 % 
7. 
O
OMe
O
O
NN
NTf2
 
64a 
85.9 % 
(S) 
84 % 
              a ILs prepared by other members of our group 
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4.4.5 Recycling Experiments 
Since recycling is one of the biggest advantages of ILs as solvents, an experiment was 
performed, where catalyst Rh-(R,R)-DiPAMP and an IL were reused in two consecutive 
cycles. In methanol a decomposition of Rh-(R,R)-DiPAMP catalyst is typically taking 
place, as can be seen due to the black rhodium residue present on the vial and stirring blade 
at the end of the process. Since the product is formed with high ee and very good reaction 
rates the decomposition may be taking place after completion of the reaction, where lack of 
substrate available to coordinate to the metal may result in formation of rhodium particles.  
Similar black residue was present in the reaction vial if IL 44c used as solvent.  
IL 63 with an amide bond has been shown to not cause the decomposition of the Rh-(R,R)-
DiPAMP catalyst during the hydrogenation reaction and therefore it was selected for the 
study. Toluene was used as a co-solvent and a biphasic system was formed upon its 
addition to IL 63. Hydrogenation reaction was run at 60 °C and 50 psi and 1 mmol of 
substrate 54 was dissolved in the mixture of 0.5 g of IL 63 and 2 mL of toluene. Upon 
completion of the hydrogenation process, reaction mixture was cooled to 35 °C, flushed 
with N2 and 2 mL of toluene were added to extract 55. After that fresh portion of substrate 
54 and toluene were added and second hydrogenation cycle was run at the same conditions. 
Extraction procedure was carried out after which another portion of substrate 54 and 
toluene was added and the second recycle was performed. Upon recycling of the catalyst - 
IL mixture a decrease of the catalyst activity was observed, as expressed by drop of ee 
values and an elongation of the reaction time. The first experiment was completed in 45 
min and product 55 with 94.2 % was formed. Upon first recycle 91.2 % ee was achieved 
within 55 min. Recycling of the catalyst – IL mixture for the second time resulted in 
product 55 with 86.2 % and 2 hours were necessary to complete the process (Table 4.8, 
entry 1-3).      
Successful recycling of Rh-(R,R)-DiPAMP in IL 63 was achieved during 
hydrogenation of 54 in the biphasic system with toluene as co-solvent. However only the 
first recycle, with ee value of the product 55 above 90 %, could be industrially useful. 
Drawbacks of this system include partial miscibility of IL 63 and toluene, resulting in 
presence of IL traces in toluene layer and a need for product 55 purification. Also two 
toluene extractions were not sufficient to entirely remove the product 55 from the reaction 
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mixture. Further research on the described system towards identifying better solvent-IL 
ratio or alternative co-solvent would be recommendable. The level of catalyst leaching to 
the product should also be determined.    
 
Table 4.8 Recycling Experiments 
 
No IL Structure Co-
solvent 
Temp.oC, 
P psi 
H2 uptake Conv. % 
Product 55 
ee % 
1. 
NN
N
O NTf2
 
63 
toluene 60 °C, 50 psi 
~45 min >95% 94.2% (S) 
2. ~55 min >95% 91.2% (S) 
3. ~ 2 h >95% 86.2% (S) 
 
 
4.4.6 Non-standard hydrogenation substrates 
Our next objective was to expand the number of compounds tested to determine whether 
the results obtained so far would generalize across similar substrates. Also the question 
arouse whether ionic liquids would facilitate Rh-(R,R)-DiPAMP catalyzed hydrogenation 
of more difficult substrates.  
CO2MeAcHN *
      
CO2MeBocHN *
     
CO2MeAcHN *
       
CO2MeAcHN *
 
          65                            66                               67                                           68  
Figure 4.14 Products of reduction of more challenging substrates 
 
Discussions with Celtic Catalyst to determine which non-natural amino acid compounds 
were of commercial interest lead us to choose 57, 58, 59 and 60 as substrates (Figure 4.10). 
Their respective reduced products 65 – 68 are pictured in the Figure 4.14. IL 40c, 41c and 
44c were used in the study at high temperature and moderate pressure conditions (80 oC, 50 
psi). Firstly substrate 57 structurally similar to compound 54 was reduced in the presence of 
IL 41c (Table 4.9). Reaction rate was surprisingly high, as compared with previous tests in 
neat ILs, with the reduction process being finished in less than 30 min. Product 65 with 
93.2 % ee was formed, which was the same as the value obtained in methanol, 92.4 % 
(Table 4.9, entry 1 and 3). In case of IL 44c reaction time of 30 min, but lower ee of 
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82.0 %, was observed (Table 4.9). However both of the reaction mixtures, with IL 41c and 
44c, at the end of the process contained a rubbery, brown, viscous material, insoluble in 
organic solvents, possibly product of polymerization of the substrate 57. Next, another 
structurally similar, substrate 60 was reduced to yield product 68 in the presence of IL 40c 
and 44c as solvents (Table 4.9, entry 4, 5). Product 68 with 88.2 % ee and 65 % conversion 
was formed in the reaction carried out in IL 44c (Table 4.9, entry 4). Complete conversion 
within 2 hours and with 88.0 % ee was obtained in IL 40c as solvent (Table 4.9, entry 5). 
Both ILs 40c and 44c were inferior to methanol, where reduction of 60 was completed in 
less then 30 min and product 68 with 95.2 % ee was formed (Table 4.9, entry 6). 
 
Table 4.9 Various substrates study. 
No Substrate 
 
IL Temp. oC, P psi H2 uptake Conv. % ee % 
1. 
CO2MeAcHN  
 
57 
41c 80 °C, 50 psi <0.5 h >95% 93.2% (S) 
2. 44c 80 °C, 50 psi <0.5 h >95% 82.0% (S) 
3. MeOH 80 °C, 50 psi <0.5 h >95% 92.4% (S) 
4. 
CO2MeAcHN
 
60 
44c 80 °C, 50 psi 
 
nd 65% 88.2% (S) 
5. 40c 80 °C, 50 psi ~2 h >95% 88.0% (S) 
6. MeOH 80 °C, 50 psi <0.5 h >95% 95.2% (S) 
7. 
CO2MeBocHN  
 
58 
44c 80 °C, 50 psi ~ 10 h <5% - 
8. 44c/MeOH 80 °C, 50 psi <1 h >95% 88.5% 
9. 41c/MeOH 80 °C, 50 psi <0.5 h >95% 89.5% 
10. MeOH 80 °C, 50 psi <0.5 h >95% 89.2% 
11. 
CO2MeAcHN
 
59 
44c 80 °C, 50 psi nd <5% - 
12. 44c/MeOH 80 °C, 50 psi nd <5% - 
13. 41c/MeOH 80 °C, 50 psi nd <5% - 
14. Methanol - 80 °C, 50 psi nd 38% 50.4% 
nd (not determined) 
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Until recently mostly N-acetyl or N-benzoyl protected amines were used routinely in the 
hydrogenation reactions.15 However removal of those protecting groups requires harsh 
acidic conditions, which may cause product racemisation, therefore need for alternative 
protecting groups applicable in hydrogenation reactions exist. Considering that, Boc 
protected substrate 58 was selected for the study as one of non-standard substrate. In the 
presence of IL 44c reduction rate was very slow, with conversion less then 5 % after 10 
hours. Upon co-solvent addition rapid reduction of substrate 58 took place, resulting in 
product 66 with 88.5 % ee in less then 1 hour. Reduction of substrate 58 in IL 41c/methanol 
mixture also required 1 hour to complete and product 66 with ee of 89.5 % was formed 
(Table 4.9, entry 9). In pure methanol product 66 with 89.2 % ee, in less than 30 min was 
obtained (Table 4.9, entry 10). Prior to ee determination product 66 was purified in our lab 
with column chromatography to remove traces of ILs present, which in case of this weakly 
UV-active compound were interfering with the analysis. Isolated yields values were 
calculated for 66 purified from IL 41c, 44c, 69 and 63. Very low yields of 11 % and 10 % 
were obtained in case of IL 44c and 69 respectively and low values of 23 % and 22 % were 
achieved in case of IL 41c and 63 (Table 4.10, entry 1-4). Poor isolation efficiency may be 
due to partial removal of the Boc group. Such deprotection could have occurred while 
adsorbing the crude product on the silica, where temperature of 50 °C was used for solvent 
evaporation. Low sensitivity in product detection, where anisaldehyde was used to visualize 
it on the silca plate might have also been the reason for low yields achieved.  
As the next starting material, substrate 59 with tetra-substituted double bond was chosen. 
Compounds with this substitution pattern are known to be difficult substrates for 
hydrogenation reactions, probably due to steric hindrance preventing efficient coordination 
of double bond and acetamido group to the metal of the catalyst. Reduction of substrate 59 
was attempted in the presence of IL 44c, however conversion of less then 5 % was found 
and even adding methanol as a co-solvent to IL 41c and 44c did not improve the results 
(Table 4.9, entry 11-13). Only reaction carried out in pure methanol resulted in product 67 
with 50.4 % ee and 38 % conversion (Table 4.9, entry 14). 
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Table 4.10 Product 66 isolated yields 
No IL Structure 
Isolated 
Yields % 
1. 
Ph
O
OMe
O
O
NN
NTf2
 
41c 
23 % 
2. 
OBu
O
O
O
NN
NTf2  
44c 
11 % 
3. NN
N
O NTf2
 
63a 
22 % 
4. 
O
OMe
O
O
NN
NTf2
 
69 
10 % 
 
4.4.7 Large scale hydrogenation experiments 
Following the experiments on the small scale, selected experiments were repeated on the 
large scale to test possibility of future application of the ILs in industrial processes.  
Reaction was carried out in 50 mL vessel of the Parr 4592 apparatus and 30 mL of IL 44c, 
3.3 g (15 mmol) of substrate and 56.73 mg of catalyst (0.5 mol%) were used.  
High temperature and moderate pressure (80 oC and 50 psi) originally chosen as optimal 
conditions for IL 44c, were applied. In Argonaut, the apparatus previously used for the 
small scale experiments constant pressure is maintained throughout the process via 
computer-controlled valve. However in case of large scale apparatus, Parr 4592, due to the 
safety considerations, vessel is pressurized up to desired value and then isolated. That 
procedure is repeated few times manually whenever the pressure drops significantly. With 
IL 44c as solvent, substrate 54 was reduced with complete conversion and ee of 91.1 % 
within 6 to 16 hours time frame (Table 4.11, entry 1). Enantiomeric excess value was 
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higher than in small scale experiment (88.6% ee, Table 4.2, entry 8), and hydrogenation 
reaction took longer to complete (3 hours). Both of those differences can be explain by the 
fact of the pressure drop (down to 15-30 psi) occurring during the process. As observed in 
the first part of the screening lower hydrogen pressure improves the selectivity of the 
reaction and reduces the rate of the process carried out in IL. With IL 40c as solvent, 
reduction of substrate 54 was completed within 6 to 26 hours and 89.1 % ee was reached 
(Table 4.11, entry 3). Similarly as in case of IL 44c enantiomeric excess values were 
slightly higher than in case of small scale experiment (85.4 % ee, Table 4.3, entry 1).  
Experiment with IL 44c and methanol as a co-solvent (1:3 mixture) was also carried out at 
60 oC and 50 psi. Reaction was completed in approximately 30 min and 95.5 % ee was 
achieved (Table 4.11, entry 2). Reaction in pure methanol was completed after 30 min and 
95.8 % ee was achieved (Table 4.11, entry 4). 
 
Table 4.11 Large scale experimentsa 
 
No 
Solvent 
Co-
solvent 
H2 uptake 
Conv. 
% 
Product 55 ee % 
1. 
OBu
O
O
O
NN
NTf2
44c 
- 6 h -16 h >95% 91.1 % (S) 
2. 
OBu
O
O
O
NN
NTf2
44c 
MeOH <1 h >95% 95.5 % (S) 
3. 
Ph
O
OMe
O
O
NN
NTf2
 
40c 
- 6 h - 26 h >95% 89.1 % (S) 
4. MeOH - <1 h >95% 95.8 % (S) 
aConditions: 80 oC, 50 psi 
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4.5 Hydrogenation study with the novel class of ILs as solvents 
4.5.1 Hydrogenation of methyl 2-acetamidoacrylate 
Substrate 57 has drawn our attention during the hydrogenation study carried out in 
collaboration with Celtic Catalyst, due to high ee values obtained and a short reaction time. 
Compound 57 reduced in the presence of IL 41c, gave product 65 with the same efficiency 
in terms of ee (93.2 %) and reaction time as reaction carried out in methanol (92.4 %) 
(Table 4.9, entry 1,3). There was however a problem associated with 57, that we propose is 
due to polymerization of the starting material. We decided that further study should be 
carried out in order to identify ILs and conditions in which that process is suppressed.  
CO2MeAcHN
5 mol% DiPamp
 H2, IL
CO2MeAcHN *
 
   57              65 
Figure 4.15 Hydrogenation of methyl 2-acetamidoacrylate (57) 
 
A novel class of ionic liquids, derivatives of 3,4-dimethoxy- and 3,4-methylendioxy- 
mandelic acid, has been applied as solvents in the hydrogenation reaction of 57 (Figure 
4.15). Three 1-methylimidazoilum ILs, 1c, 3c, 5c and pyridinium IL 6c, were tested. 
Reduction of 57 was catalyzed by 5 mol% Rh-(R,R)-DiPAMP and 1:1 molar ratio of 
substrate to IL was used. Hydrogen gas pressure of 1 atm was applied and reactions were 
run for 24 hours. Impact of various temperature conditions (60 oC, 80 oC, 100 oC) on the 
enantioselectivity of the process and on the polymerization was investigated across four ILs 
(Table 4.12).  
 
 
 
 
 
 
 
 
 
 
 279
Table 4.12 Reduction of methyl 2-acetamidoacrylate (57) in the presence of 5 mol%Rh-
(R,R)-DiPAMP catalyst 
No. Ionic Liquid Temp. oC Yield %a ee % 
1. 
N
O
OMe
N
OMe
MeO NTf2
 
1c 
60 oC 14 % 89 % (S) 
2. 80 oC 40 % 90 % (S) 
3. 100 oC 57 % 88 % (S) 
4. 
N
O
OBu
N
OMe
MeO NTf2
 
3c 
60 oC 37 % 88 % (S) 
5. 80 oC 37 % 89 % (S) 
6. 100 oC 66 % 82 % (S) 
7. RT 31 %b 63 % (S) 
8. 
N
O
OMe
N
NTf2O
O
 
5c 
60 oC 38 % 78 % (S) 
9. 80 oC 24 % 88 % (S) 
10. 100 oC 69 % 88 % (S) 
 
11. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 28 % 92 % (S) 
12. 80 oC 37 % 94 % (S) 
13. 100 oC 37 % 89 % (S) 
14. Methanol, 5 mL 
Methanol, 1 mL 
RT 
RTc 
  
81 % 
82 % 
85 % (S) 
97 % (S) 
a
 At 100 % conversions. b Partial conversion of 72 % was reached. c At 1 mol% 
catalyst 
 280
Out of four ILs 1c, 3c, 5c and 6c tested in the hydrogenation of 57, the highest 
enantioselectivity was achieved when IL 6c was applied as a solvent (Table 4.12). Across 
three temperatures tested 65 with the highest ee of 94 % was obtained at 80 oC. 65 with 
moderate ee value of 92 % was obtained in hydrogenation reaction carried out at 60 oC and 
the lowest ee of 89 % was found at 100 oC (Table 4.12, entry 11-13). The second best 
results in terms of enantioselectivity were obtained when IL 1c was used as a solvent. In IL 
1c product 65 with the highest ee of 90 % was obtained at 80 oC and the lowest ee of 88 oC 
was found at 100 oC (Table 4.12, entry 1-3). Hydrogenation reaction run in IL 5c gave 65 
with the highest ee of 88 % at both 80 oC and 100 oC and lowest ee of 78 % was found at 
60 oC (Table 4.12, entry 8-10). In the reduction in the presence of IL 3c product 65 with ee 
of 89 % at 80 oC was obtained and the lowest ee of 82 % was recorded at 100 oC (Table 
4.12, entry 4-6). An additional reaction at 20 oC was carried out in this IL, since IL 3c is a 
liquid at room temperature and even lower ee of 63 % was recorded (Table 4.12, entry 7). 
The highest ee value of 94 % in this hydrogenation reaction was achieved when IL 6c 
applied as a solvent and it is the same, within experimental error, as value reported in the 
literature for methanol (95 %).24 
 
4.5.1.1 Temperature and enantioselectivity correlation 
Enantioselectivity and temperature correlation was observed in the study. In three of the ILs 
tested 1c, 3c and 6c, the highest selectivities were obtained for the reactions carried out at 
80 oC (90 %, 89 %, 94 % respectively) and at 60 oC moderate results (89 %, 88 %, 92 %) 
were obtained. Hydrogenation carried out at 100 oC resulted in the lowest selectivities (88 
%, 82 %, 89 %). In IL 5c the same result of 88 % ee was obtained at 80 oC and 100 oC and 
lower value of 78 % ee was found at 60 oC.  
An improvement of selectivity with the temperature increase from 60 oC to 80 oC has been 
observed previously in the study with Celtic Catalyst, where at 50 psi and 200 psi, ee has 
increased by about 2 % when changing the temperature. Low enantioselectivity in the 
experiment in IL 3c at 20 oC is also consistent with the trend observed previously, where 
hydrogenation at 30 oC resulted in significantly lower ee, as compared with the experiments 
carried out at higher temperatures.  
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In the present study higher temperature was used and enantioselectivity improvement was 
observed initially when changing the temperature from 60 oC to 80 oC, however further 
increase up to 100 oC has slightly decreased ee values of 65.  
Such effect, where ee would start to decrease after certain temperature, has been predicted 
for Rh-DiPAMP catalyzed hydrogenation of methyl-(Z)-α-acetamidocinnamate, by Heller 
et al. in his theoretical study based on Halpern and Landis work.21,25 This trend has been 
observed by Sinou in experiments with Rh-DIOP catalyst and also in ILs by Frater, who 
studied Rh-DiPAMP catalyzed hydrogenation of (Z)-α-acetamidocinnamic acid in 
[bmim]/IPA biphasic system.5,24  
No correlation between temperature and conversion was observed within 60 oC-100 oC 
range and hydrogenation of 57 in all of the ILs tested 1c-6c, has occurred with complete 
conversions after 24 hours. Partial conversion of 72 % was found only in an additional 
experiment run at 20 oC with IL 3c as a solvent.  
 
4.5.1.2 Isolated yields of N-acetylalanine methyl ester 
In order to test the efficiency at which the amino acid derivative, 65 could be isolated from 
the ILs and also to estimate degree of polymerization occurring during the hydrogenation, 
the reaction mixtures were purified with use of column chromatography. Except experiment 
at 20 oC complete conversions were reached after 24 hours and no starting material was 
present in the reaction mixtures. In case of IL 1c column chromatography was not 
necessary due to the fact that product was efficiently extracted from the reaction mixture 
and no traces of IL were present. Isolated yields were low to moderate (14 % - 69 %) in all 
of the ILs tested (Table 4.12). Product 65 with the highest yield of 69 % was isolated from 
the reaction carried out in the presence of IL 5c at 100 oC and the lowest yield of 14 % was 
obtained in the reaction with IL 1c as solvent at 60 oC (Table 4.12, entry 10,1).  
Temperature and yield correlation was observed, where in all ILs tested the highest isolated 
yields were obtained in the hydrogenation carried out at the highest temperature, 100 oC. 
The lowest yields were recorded in reactions carried out at 60 oC, except IL 5c, where 
reaction at 80 oC resulted in the lowest yield. In case of IL 3c an additional experiment 
carried out at RT has resulted in yield even lower than at 60 oC.    
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Similarly as during Celtic Catalyst study, presence of insoluble yellow and brown viscous 
material was noticed at the end of the reactions, indicating polymerization taking place. 
Considering that complete conversions were reached, low isolated yields values at 60 oC 
suggest that the highest rate of polymerization occurs at that temperature in all IL tested, 
except IL 5c, where the lowest yield was recorded at 80 oC. The highest yields at 100 oC in 
all ILs tested, indicate low rate of polymerization at that temperature. This inversely 
proportional dependence between temperature and polymerization is present in IL 1c, 3c 
and 6c and it is independent on IL structure. The highest isolated yields were found for IL 
5c and IL 3c, which suggest that the lowest polymerization is taking place in those two ILs.  
However isolated yields values may depend not only on the amount of product present in 
the crude mixture, but also on the difficulty of the purification performed, determined by 
similarity of the Rf values between IL and the product. Therefore clear relationship between 
polymerization rate and IL structure is not known. Moderate to low isolated yields obtained 
in this part of the experiment may be also due to few other factors. Product 65 is not UV 
active and difficulty with visualizing of the product 65 on the TLC plate was encountered. 
None of the TLC dips tested was suitable and finally iodine was used for that purpose. 
Another problem was a small scale of the reactions, where 14 mg of the starting material 
was used and therefore an error associated with weighing of the final material may have 
been significant. In some cases performing the purification twice was necessary, which also 
may have resulted in lower yields. As mentioned earlier pyridinium IL 6c gave the best 
result in terms of selectivity and highest ee of 94 % was recorded at 80 oC, however the 
isolated yields obtained in the reaction was low, 37 %. The highest yield of 69 % was 
achieved in reaction carried out in 1-methylimidazolium IL 5c at 100 oC, where also good 
enantioselectivity of 88 % ee was recorded.    
 
4.5.2 Aromatic ring reduction study 
Since the beginning of 20th century, hydrogenation of aromatic compounds is a field of very 
active research both in academia and industry.26-30 Reduction of aromatic rings presents a 
valuable method to obtain cyclic compounds. First aromatic equivalents are constructed, 
based on robust and well known chemistry of aromatic compounds, and then the aromatic 
ring is reduced.31 Asymmetric reduction of aromatic rings and heterocycles presents 
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valuable method to obtain chiral cyclohexane derivatives.1 Arene hydrogenation is also a 
significant process in industry with benzene to cyclohexane reduction being currently one 
of the most important industrial processes.26,29,30 Extensive research is carried out in other 
areas of industrial interests such as partial benzene reduction and hydrogenation of aromatic 
rings present in petroleum and in polymers.26,30,32-34 Due to health and environmental 
concerns, there is a growing demand for lowering the aromatic content of petrol and 
hydrogenation my offer a suitable route to obtain cleaner fuels.34,35 In case of polymers it 
has been found that hydrogenation of aromatic rings greatly improves their thermal and 
oxidative stability, which could for example prevent yellowing of paper.26,36-38  
Hydrogenation of aromatic compounds can be carried out by a number of methods, 
including dissolving metal reductions, metal hydrides, heterogenoues and homogenous 
hydrogenation and ionic hydrogenations with TFA and silanes.39-41. Industrial 
hydrogenation is carried out typically with heterogeneous catalysts such as Rh/Al2O3 and 
Raney Nickel or metal sulfides.30 However usually harsh conditions where high hydrogen 
pressure and high temperature or high catalyst loading are applied, resulting often in low 
selectivities. 29,34,42,43 Hydrogenation reactions at mild conditions, with hydrogen pressure 
below 10 atm and even 1 atm, are also reported and those include reductions with “soluble 
heterogenoues catalyst” (metal nanoclusters, colloids, nanoparticles) and reactions with 
homogenous catalysts, however true nature of homogenous conditions is often subject of 
controversy.29 Nanosized metal particles and colloids are often generated in the presence of 
various stabilisers, such as surfactants, salts and polymers and hydrogenation reactions are 
often run in biphasic solutions. However it has been shown that those additives, as well as 
aqueous phase type can significantly affect catalytic ability of those systems and thus this 
area still requires a lot of work.30,44-47 
Hydrogenation on mild conditions might offer the chance to solve the selectivity problems 
such as chemoselectivity and even stereoselectivity in case of substituted arenes.30 
Our study of hydrogenation of methyl-(Z)-α-acetamidocinnamate (54), carried out in IL 40c 
and 41c as solvents and with Rh-(Rp,R)-Taniaphos SL-T001 as catalyst, has revealed 
presence not only the expected product, but also traces of a product 56 with reduced double 
bond and reduced aromatic ring in the reaction mixture (Figure 4.16). 
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CO2Me
NHAc 5 mol% Rh Catalyst
 H2, IL
∗ CO2Me
NHAc
* CO2Me
NHAc
+
 
  54                               55                      56 
Figure 4.16 Formation of product 55 and 56 in hydrogenation reaction. 
 
Product 56 due to its low quantity could not be observed in the NMR spectra, but it was 
detected with use of GCMS spectroscopy. That side reaction of aromatic ring reduction, 
upon optimization, could offer a valuable one step route to obtain an enantiomericly pure 
methyl 2-acetylamino-3-cyclohexylpropionate (56) at mild conditions of 1 atm. 
Hydrogenation of substrate 54 was investigated in order to find the conditions where 
content of 56 could be maximized and high ee values could be reached. A novel class of 
ionic liquids, derivatives of 3,4-dimethoxy- and 3,4-methylendioxy- mandelic acid, were 
applied as a solvent in this part of the study. Three temperature conditions were screened 
with various rhodium catalyst (Rh-(R,R)-DiPAMP, Rh-(Rp,R)-Taniaphos SL-T001 and Rh-
(Rp,R)-Taniaphos SL-T002 (Figure 4.17). Catalyst loading of 5 mol % and 1:1 ratio of 
substrate to IL were applied and initially all of the reactions were run for 24 hours.  
                        
Fe PPh2
N
PPh2
CH3H3C
BF4
Rh
                                        
Fe PCy2
N
PCy2
CH3H3C
BF4
Rh
 
        Cy - cyclohexyl 
Figure 4.17 (Rp,R)-Taniaphos SL-T001 (left) and Rh-(Rp,R)-Taniaphos SL-T002 (right) 
ligands with Rh(nbd)2BF4- metal complex 
 
4.5.2.1 Arene reduction in the hydrogenation of methyl (Z)-α-acetamidocinnamate  
Firstly pyridinium IL 6c was applied as solvent and set of three hydrogenation reactions at 
various temperatures, catalyzed by Rh-(Rp,R)-Taniaphos SL-T001 was run. Methyl (Z)-α-
acetamidocinnamate 54 was successfully hydrogenated and in all of the reaction mixtures 
product 56 was present. Product 56 was now in sufficient quantity to be observed in the 1H 
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NMR spectra (Figure 4.18) and 55 to 56 molar ratios have been determined based on the 
respective signal integration (Table 4.13, entry 1-3).  
 
Figure 4.18 NMR spectra of crude mixture of product 55 and 56 in 1:1.25 ratio 
 
Based on that ratio and conversions a percentage content of product 56 in the total reaction 
mixture was also estimated (Table 4.13). Across three temperatures tested in the presence 
of IL 6c, the best result with 55 to 56 molar ratio of 1:0.43 was obtained at 80 oC (Table 
4.13, entry 2). At 60 oC 55 to 56 ratio of 1:0.39 was found and the lowest ratio of 1:0.19 
was obtained at 100 oC (Table 4.13, entry 2,3). Those three experiments in IL 6c were 
repeated 48 hours later to determine reproducibility of the results. Unfortunately product 56 
was not present in any of the reaction mixtures, as shown by NMR spectra of the repeated 
reactions and only trace of 56 was detectable by analytical methods in the experiment 
carried out at 80 oC (Table 4.13, entry 4-6). Those reactions were repeated two more times 
and again product 56 was not observed in the NMR spectra. Since the same batch of IL 6c 
and substrate 54 was used, a stability of the Rh-(Rp,R)-Taniaphos SL-T001 catalyst and the 
catalytic species responsible for the ring reduction has been questioned. A new batch of 
catalyst has been bought and storing conditions has been changed with the catalyst being 
kept in the dessicator at RT under argon instead of being kept in the fridge. 
 
 286
Table 4.13 Reduction of methyl-(Z)-α-acetamidocinnamate (54) with Rh-(Rp,R)-Taniaphos 
SL-T001 catalyst 
No IL Structure Temp. oC Conversions % 
Product 56 
content % 
Product 55:56 
ratios 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 1 
1. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 61 % 17 % 1:0.39 
2. 80 oC 100 % 30 % 1:0.43 
3. 100 oC 100 % 16 % 1:0.19 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 1 Repeated 
4. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 66 % n/a ndc 
5. 80 oC 100 % n/a Trace 
6. 100 oC 
100 % 
 
n/a ndc 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 2 
7. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 86 % 16 % 1:0.23 
8. 80 oC 94 % 19 % 1:0.25 
9. 100 oC 93 % 15 % 1:0.19 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001-1 Batch 2  Repeated 
10. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 83 % 6 % 1:0.07 
11. 80 oC 88 % 21 % 1:0.32 
12. 100 oC 98 % 25 % 1:0.33 
13. Methanol RT 11 % nd nd 
c Product 56 not detected in the reaction mixture. 
 287
Experiments in IL 6c at three temperature conditions were repeated with the second batch 
of Rh-(Rp,R)-Taniaphos SL-T001 catalyst and this time product 56 was observed in NMR 
spectra of all of the reaction mixtures, however with slightly lower quantities in two of the 
cases. Similarly to the first set of reactions, the greatest ratio 55 to 56 of 1:0.25 was 
observed at 80 oC and the lowest ratio of 1:0.19 was found at 100 oC (Table 4.13, entry 7-
9). Those three reactions were repeated one more time resulting in similar 55 to 56 ratios of 
1:0.32 and 1:0.33 at 80 oC and 100 oC and the lowest ratio of 1:0.07 at 60 oC (Table 4.13, 
entry 10-12). 
Although product 55 to 56 ratios are not the same in the repeated tests, calculated 
percentage content of the product 56 does not vary significantly between the reactions and 
it is maintained within 11 % at each of the temperatures (Table 4.13, entry 1-3 and 7-12).   
Based on the NMR spectra, substrate 54 conversions to the products 55 and 56 were 
estimated. The greatest reaction rates were observed at higher temperatures of 80 oC and 
100 oC, where conversions between 88 % and 100 % were found. The lowest conversions, 
between 61 % and 86 %, were recorded at 60 oC (Table 4.13, entry 1-12).  
Next, IL 5c was used as a solvent in the reaction with Rh-(Rp,R)-Taniaphos SL-T001 as a 
catalyst. Inferior to IL 6c, 55 to 56 ratio of 1:0.18 was obtained with complete conversions 
(Table 4.13, entry 13-15).   
Catalyst Rh-(R,R)-DiPAMP was also applied in the reaction with IL 6c as a solvent, at 
three temperature conditions. The best result with 55 to 56 ratio of 1:0.26 was achieved in 
the reaction performed at 100 oC and ratio of 1:0.14 was obtained at 80 oC (Table 4.14, 
entry 2, 3). Product 56 was not formed at 60 oC (Table 4.14, entry 1). Conversions over 90 
% were recorded at 80 oC and 100 oC and only 32 % of substrate 54 has been reduced at 60 
oC (Table 4.14, entry 1-3). In terms of 55 to 56 ratio, results obtained with Rh-(R,R)-
DiPAMP catalyst were inferior to those recorded with Rh-(Rp,R)-Taniaphos SL-T001 and 
no further studies proceeded with Rh-(R,R)-DiPAMP.  
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Table 4.14 Reduction of methyl-(Z)-α-acetamidocinnamate (54) with Rh-(R,R)-DiPAMP 
 
IL Structure Temp. oC 
Conversions 
% 
Product 
56 content 
Product 
55:56 
ratios 
Catalyst: Rh-(R,R)-DiPAMP 
1. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 32 % n/ac n/a 
2. 
80 oC 91 % 11 % 1:0.14 
3. 
100 oC 92 % 19 % 1:0.26 
         c Product 56 not detected in the reaction mixture. 
 
Next, another catalyst, Rh-(Rp,R)-Taniaphos SL-T002, with cyclohexane substituents on the 
phosphorus atom was applied in reduction of substrate 54 in the presence of IL 6c as a 
solvent (Figure 4.17). Out of the three conditions screened, the best 55 to 56 ratio of 1:0.48 
was observed at the highest temperature, 100 oC (Table 4.15, entry 1-3). Second best result 
of 1:0.44 was recorded at 80 oC and the lowest ratio of 1:0.23 was found at 60 oC. 
Conversions were also increasing with temperature, starting with 69 % at 60 oC and 
reaching 100 % at 100 oC (Table 4.15, entry 1-3).  
Since the best results were obtained at 100 oC, in the next step four other ILs 1c, 3c, 5c and 
2c were screened at that temperature (Table 4.15, entry 16,9,7,10). The lowest ratio of 
1:0.08 was recorded for IL 3c, followed by 1:0.37 for IL 1c (Table 4.15, entry 9,16). IL 5c 
resulted in slightly better result of 1:0.57 and excellent result of 1:1.25 ratio, was achieved 
in pyridinium IL 2c (Table 4.15, entry 7,10) (Figure 4.18). Conversions of 91 % and 96 % 
were observed for IL 5c and 2c and complete conversions were found for the other two ILs 
1c and 3c (Table 4.15, entry 7,9,10,16). Following those findings, two additional 
experiments were carried out with IL 2c, one with three equivalents of IL 2c and another 
one where reaction time was extended up to 48 hours (Table 4.15, entry 12,13). Inferior 
result with ratio of 1:0.07 was obtained in case of reaction with excess of IL 2c. Reaction 
run for 48 hours proved to be very successful, resulting in 55 to 56 ratio of 1:3.40 (Table 
4.15, entry 13). The 48 hours experiment was repeated two more times with IL 2c resulting 
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in ratios of 1:5.26 and 1:10.5 (Table 4.15, entry 14,15). Although 55 to 56 ratios are not the 
same in these three experiments, percentage content of the product 56 varies within 
moderate range of 77 % to 91 %. The repeated experiments resulted in complete 
conversions (Table 4.15, entry 14,15). Experiments carried out with IL 5c and IL 6c as 
solvents were also run with extended reaction time of 48 hours. An improvement in 55 to 
56 ratio and complete conversions were achieved in both cases (Table 4.15, entry 5,8). 
Reaction carried out in IL 6c resulted in 1:1.39 ratio and IL 5c in ratio of 1:2.60.  
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Table 4.15 Reduction of methyl-(Z)-α-acetamidocinnamate (54) with Rh-(Rp,R)-Taniaphos 
SL-T002 catalyst 
 IL Structure Temp. oC 
Conversions 
% 
Product 56 
content 
Product 
55:56 ratio 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T002 
1. 
N
O
OMe
NTf2O
O
 
6c 
60oC 69 % 13 % 1:0.23 
2. 80oC 79 % 24 % 1:0.44 
3. 100oC 100 % 32 % 1:0.48 
4. 100oCd 100 % 28 % 1:0.39 
5. 100 oC 48h 100 % 58 % 1:1.39 
6. 100 oC 48hd 100 % 54 % 1:1.18 
7. 
N
O
OMe
N
NTf2O
O
 
5c 
100oC 91 % 33 % 1:0.57 
8. 100 oC 48 h 100 % 72 % 1:2.6 
9. 
N
O
OBu
N
OMe
MeO NTf2
 
3c 
100oC   H48 100 % 7 % 1:0.08 
10. 
N
O
OMe
NTf2MeO
OMe
 
2c 
100oC 96 % 54 % 1:1.25 
11. 100oC 100 % 38 % 1:0.6 
12. 100oC f 100 % 7 % 1:0.07 
13. 100oC  48 h 100 % 77 % 1:3.40 
14. 100oC 48 hd 100 % 91 % 1:10.5 
15. 100oC 48 hd 100 % 84 % 1:5.26 
         d
 Repeated experiment. f 1:3 substrate to IL ratio. 
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No. IL Structure Temp. oC 
Conversions 
% 
Product 56 
content 
Product 
55:56 ratio 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T002 
16. 
N
O
OMe
N
OMe
MeO NTf2
 
1c 
100oC 
 
100 % 
 
27 % 
 
 
 
1:0.37 
 
 
 
 
 
4.5.2.2 Enantiomeric excess determination for N-acetylphenylalanine methyl ester  
Enantiomeric excess of 55 obtained in the hydrogenation reactions was determined in the 
selected cases. In the Rh-(R,R)-DiPAMP catalyzed reactions with IL 6c as solvent, product 
55 with ee values over 80 % was obtained at all conditions tested (Table 4.16, entry 1-3). 
The highest ee of 86 % was recorded at 80 oC and slightly lower ee of 85 % was obtained at 
60 oC. Compound 55 with the lowest value of 82 % ee was found at 100 oC. In methanol 98 
% ee was obtained at 0.1 mol% of catalyst loading (Table 4.16, entry 4).       
The same temperature vs. enantioselectivity correlation was observed previously in Rh-
(R,R)-DiPAMP catalyzed hydrogenation of 54 and 57.   
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Table 4.16 Product 55 and 56 ee values 
 IL Structure Temp. oC 
Product 55 to 
56 ratio 
Product 
55 ee % 
Product 56 
ee % 
Catalyst: Rh-(R,R)-DiPAMP 
1. 
N
O
OMe
NTf2O
O
 
6c 
60 oC n/a 85 % (S) n/a 
2. 80 oC 1:0.14 86 % (S) 84 % (S) 
3. 100 oC 1:0.26 82 % (S) 89 % (S) 
4. methanol RT(1mol%) n/a 98 % (S) n/a 
 
 
Enantiomeric excess of 55 formed in the hydrogenation reactions catalyzed by Rh-(Rp,R)-
Taniaphos SL-T001, carried out in IL 6c was also determined. In the reactions with the first 
batch of catalyst, the same ee, within experimental error, of 82 % and 81 % were obtained 
at 60 oC and 80 oC (Table 4.17, entry 1, 2). The lowest ee of 73 % was found in the reaction 
at 100 oC (Table 4.17, entry 3). In the experiments with a second batch of Rh-(Rp,R)-
Taniaphos SL-T001 catalyst, 55 with 83 % ee was obtained at 60 oC and 80 oC and the 
lowest ee of 80 % was found at 100 oC (Table 4.17, entry 4-6). In the repeated reactions, 
product with ee of 83 % was formed at 80 oC, 79 % ee was recorded at 60 oC and the lowest 
enantioselectivity was found at 100 oC (Table 4.17, entry 7-9). Enantioselectivity vs. 
temperature correlation, similar to the one observed in Rh-(R,R)-DiPAMP catalyzed 
reactions is present, with the lowest ee found at 100 oC, however without a clear difference 
between 60 oC and 80 oC. Good reproducibility of the results, between three set of repeated 
reactions, within 4 % ee at lower temperatures and within 7 % at 100 oC was found. Across 
three sets of experiments conversions were improving with increasing temperature. Partial 
conversions were obtained at 60 oC and values over 90 % were reached at 100 oC. Product 
55 with 85 % ee and 11 % conversion was formed in the reaction carried out in methanol at 
5 mol% of catalyst loading (Table 4.17, entry 10), (Table 4.13, entry 13).  
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Table 4.17 Product 55 and 56 ee values 
 IL Structure Temp. oC 
Product 55 to 
56 ratio 
Product 
55 ee % 
Product 56 
ee % 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 1 
1. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 1:0.39 82 % (R) 56 % (R) 
2. 80 oC 1:0.43 81 % (R) 66 % (R) 
3. 100 oC 1:0.19 73 % (R) 78 % (R) 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 2 
4. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 1:0.23 83 % (R) 16 % (R) 
5. 80 oC 1:0.25 83 % (R) 73 % (R) 
6. 100 oC 1:0.19 80 % (R) 69 % (R) 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 2  Repeated 
7. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 1:0.07 79 % (R) n/a 
8. 80 oC 1:0.32 83 % (R) 70 % (R) 
9. 100 oC 1:0.33 73 % (R) 58 % (R) 
10. methanol RT n/a 85 % (R) n/a 
 
 
Enantioselectivity of hydrogenation reactions catalyzed by Rh-(Rp,R)-Taniaphos SL-T002 
was also determined in the selected cases. Unfortunately this catalyst is not a good choice 
for reducing substrate 54 and 55 with only 50 % ee can be achieved when reaction is run in 
methanol.19 Product 55 with 32 % ee was obtained in methanol at 0.2 mol% of catalyst 
loading (Table 4.18, entry 6). Reactions carried out in IL 6c with Rh-(Rp,R)-Taniaphos SL-
 294
T002 in three different temperatures showed ee and temperature correlation, although 
different than in the previously presented in cases of Rh-(R,R)-DiPAMP and Rh-(Rp,R)-
Taniaphos SL-T001. Product 55 with the highest ee of 20 % was recorded at 100 oC and 
very low values of 5 % and 3 % ee were found at 60 oC and 80 oC respectively (Table 4.18, 
entry 1-3). The same reaction run for 48 hours resulted in 55 with ee values of 16 % and 21 
% ee, upon repeating (Table 4.18, entry 4,5). Reduction of 54 in IL 5c resulted in 55 with 4 
% ee and the same value was found at the reaction time extended up to 48 hours (Table 
4.18, entry 7,8). During hydrogenation carried out in IL 2c, product 55 with 12 % ee was 
formed (Table 4.18, entry 9). Hydrogenation run IL 2c for 48 hours and repeated resulted in 
product with 8 % ee in both cases (Table 4.18, entry 10,11).   
Comparing three catalysts used in hydrogenation of substrate 54, product 55 with the 
highest ee values over 80 % was obtained in the reaction catalyzed by Rh-(R,R)-DiPAMP. 
Moderate enatioselectivity with ee within 73-83 % was achieved in Rh-(Rp,R)-Taniaphos 
SL-T001 catalyzed process. Rh-(Rp,R)-Taniaphos SL-T002 is not an efficient  catalyst for 
reduction of substrate 54 and low ee values 1-21 % were obtained. Although all ILs tested 
proved to be a suitable reaction media, where hydrogenation of 54 was proceeding, all of 
the ee values found for 55 were lower than in reactions carried out in methanol, where 98 % 
ee can be reached with Rh-(R,R)-DiPAMP, 97 % ee with Rh-(Rp,R)-Taniaphos SL-T001 
and 50 % ee with Rh-(Rp,R)-Taniaphos SL-T002.  
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Table 4.18 Product 55 and 56 ee values 
 IL Structure Temp. oC 
Product 55 
to 56 ratio 
Product 
55 ee % 
Product 56 
ee % 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T002 
1. 
N
O
OMe
NTf2O
O
 
6c 
60 oC 1:0.23 5 % (R) <1 % (R) 
2. 80 oC 1:0.44 3 % (R) 1 % (R) 
3. 100 oC 1:0.48 20 % (R) 20 % (R) 
4. 100 oC 48 h 1:1.39 16 % (R) ndg 
5. 100 oC 48 h 1:1.18 21 % (R) ndg 
6. Methanol RT n/a 32 % (R) n/a 
7. 
N
O
OMe
N
OMe
MeO NTf2
 
5c 
100 oC 1:0.57 4 % (R) 1 % (R) 
8. 100 oC 48 h 1:2.6 4 % (R) ndg 
10. 
N
O
OMe
NTf2MeO
OMe
 
2c 
100 oC 1:1.25 12 % (R) ndg 
11. 100 oC    48 h 1:3.40 8 % (R) <1 % (R) 
12. 100 oCd  48h 1:5.26 8 % (R) 16 % (R) 
              d
 Repeated experiment  g ee % not determined due to peaks coeluting. 
 
4.5.2.3 Enantiomeric excess determination for methyl 2-acetamido-3-
cyclohexylpropionate  
Enantiomeric excess values of 56 were acquired for selected reactions. The highest ee 
values, over 80 %, were achieved in the hydrogenation reaction catalyzed by Rh-(R,R)-
DiPAMP with IL 6c as a solvent. Product 56 with ee of 89 % was obtained at 100 oC and 
84 % ee were found at 80 oC (Table 4.16, entry 2, 3). At 60 oC 56 was not formed (Table 
4.16, entry 1). Enantiomeric excess of 56, formed in the reactions catalyzed by Rh-(Rp,R)-
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Taniaphos SL-T001 was also determined. Reactions carried out in IL 6c at 60 oC, 80 oC and 
100 oC were repeated twice. In the hydrogenation reactions with first batch of the catalyst, 
the highest ee value of 78 % was recorded at 100 oC and the lowest ee of 56 % at 60 oC 
(Table 4.17, entry 1-3). In the experiments with second batch of the Rh-(Rp,R)-Taniaphos 
SL-T001 catalyst the highest ee of 73 % at 80 oC and the lowest ee of 16 % at 60 oC were 
obtained (Table 4.17, entry 4-6). In the repeated reactions the highest ee value of 70 % at 
80 oC and the lowest ee of 58 % at 100 oC were found (Table 4.17, entry 7-9). At 60 oC ee 
value due to low product 56 concentration has not been determined. Across three set of 
reactions with Rh-(Rp,R)-Taniaphos SL-T001, a good reproducibility of ee values within 7 
% at 80 oC was observed, but a low repeatability at 60 oC and 100 oC was found.  
Enantioselectivity of hydrogenation reactions catalyzed by Rh-(Rp,R)-Taniaphos SL-T002 
was also determined. In the experiment carried out in IL 6c at three temperatures, 56 with 
the highest ee of 20 % was observed at 100 oC and negligible asymmetric induction was 
found at 60 oC and 80 oC (Table 4.18, entry 1-3). Reduction carried out in IL 5c was not 
enantioselective (Table 4.18, entry 7). Hydrogenation in IL 2c at extended 48 hours 
reaction time gave 56 with 16 % ee (Table 4.18, entry 12).  
Comparing the three catalysts used, the highest ee values of product 56, over 80 %, were 
achieved in Rh-(R,R)-DiPAMP catalyzed reaction and moderate enantioselectivity within 
56-78 % (and one result of 16 %) were found in Rh-(Rp,R)-Taniaphos SL-T001 catalyzed 
processes. Rh-(Rp,R)-Taniaphos SL-T002 proved to be not a suitable catalyst for the 
reaction tested and 56 with very low ee values of 1-20 % were obtained. In the 
hydrogenation processes catalyzed by Rh-(R,R)-DiPAMP and Rh-(Rp,R)-Taniaphos SL-
T002 very similar ee values for 55 and 56 were found, however in the Rh-(Rp,R)-Taniaphos 
SL-T001 catalyzed reactions 56 with ee values lower than for 55 was obtained, with the 
biggest discrepancies at 60 oC.  
 
4.5.2.4 Formation of methyl 2-acetamido-3-cyclohexylpropionate  
Formation of 56 occurs upon reduction of an aromatic ring of product 55, as suggested by 
the data recorded for the reactions run at 24 hours and 48 hours. It is the case in the 
experiments with IL 6c and Rh-(Rp,R)-Taniaphos SL-T002, where complete conversions 
were reached after 24 hours and content of product 56 nearly doubled after another 24 
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hours (Table 4.15, entry 3,5,6). An additional experiment catalyzed by Rh-(Rp,R)-
Taniaphos SL-T001, was also carried out with product 55 as a starting material and in this 
reaction 56 with 13 % conversion was formed, which confirms such pathway is operating 
(Table 4.19, entry 1). In such case ee values of 55 should match ee values of 56. However 
an alternative reaction pathway may also be plausible, where the aromatic ring is 
hydrogenated first, followed by C=C double bond reduction. An intermediate, methyl 2-
acetylamino-3-cyclohexylacrylate, with reduced aromatic ring have not been observed, but 
such pathway could be operating to some degree, especially in the reactions with IL 5c and 
2c where incomplete conversions were reached after 24 hours and substrate 54 and both 
products 55 and 56 are present in the reaction mixture. If the two pathways were operating 
at the same time, it could have explained the difference between ee values of 55 and 56 
found in some of the experiments, since hydrogenation of methyl 2-acetylamino-3-
cyclohexylacrylate would result in different ee values of the products, than hydrogenation 
of 54.   
 
Table 4.19 Reduction of with Rh-(Rp,R)-Taniaphos SL-T001 catalyst 
No IL Structure Temp. oC 
Conversions 
% 
Product 56 
content % 
Product 
55:56 
ratios 
Catalyst: Rh-(Rp,R)-Taniaphos SL-T001 Batch 2 
1. 
N
O
OMe
NTf2O
O
 
6c 
 
100 oCe 
 
13 %e 13 %e 1:0.15e 
       e Product  55 used as starting material. 
 
Reproducibility of the hydrogenation reaction of 54 in the presence of Rh-(Rp,R)-Taniaphos 
SL-T001 is an issue. Very likely a deficiency of the hydrogenation apparatus could have 
been a reason behind the variability of some of the results. In the apparatus available for the 
study, a balloon of hydrogen was used as a gas source and pressure applied was estimated 
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to be 1 atm, but the precise value and its reproducibility it is not known. Hydrogen leaks 
were also encountered frequently in that system.  
Even though such problems were present one of the goals of obtaining 56 as the major 
outcome of the reaction was successfully met. In the hydrogenation reaction carried out in 
IL 2c with Rh-(Rp,R)-Taniaphos SL-T002 as catalyst, 56 with reduced aromatic ring was 
present in the reaction mixture in 91 % (Table 4.15, entry 14). However the best result in 
terms of asymmetric synthesis was achieved in the reaction catalyzed by Rh-(R,R)-
DiPAMP, where 21 % of product 56 with 89 % ee was formed after 24 hours.      
 
4.5.2.5 Active catalyst in arene reduction 
Rhodium metal on solid supports such as Rh/C or Rh/Al2O3, operating under high 
hydrogen pressure, is very well known catalyst for aromatic ring reduction.29,34,43,48 
However homogeneous rhodium diphosphines catalysts are not effective for such 
purposes.49 Therefore a question about the nature of catalytic species causing aromatic ring 
reduction during hydrogenation of methyl-(Z)-α-acetamidocinnamate (54) has appeared. 
Rhodium diphosphine catalysts are known to be able to coordinate an aromatic ring to their 
metal center and complexes of that type have been characterized with their crystal structure 
reported. Some of the examples include [Rh(DIPHOS)(benzene)], 
[Rh(EtDuPHOS)(toluene)], [Rh(DIPHOS)(anthracene)], [Rh(DIPHOS)(naphthalene)] or 
arene bridged dimeric rhodium species.50-53 However with the homogeneous catalysts on 
the mild conditions only hydrogenation of polycyclic arenes to monoaromatic compounds 
is possible, as reported by Landis and Halpern for Rh-DIPHOS catalyzed anthracene and 
naphthalene reduction, but monocylic arenes cannot be reduced, due to higher loss of 
resonance stabilization energy upon such process.52, 54 In the remaining cases of Rh-arene 
complexes, deactivation of catalyst may occur, as shown for [Rh((S,S)-
(MeDuPHOS)(toluene)]BF4 or [Rh((R,R)-Et-DuPHOS(benzene)] BF4 or complex may not 
interfere with the catalytic cycle, as in case of arene bridged rhodium dimers.51,53 Yet 
another type of rhodium catalysts, rhodium trichloride or a dimer chloro(1,5-
hexadiene)rhodium operating on biphasic condition with quaternary ammonium salts have 
been reported as early as 1983 to be able to reduce monocyclic arenes at very mild 
conditions of 1 atmosphere of hydrogen.27,55 This area of research has remained very active 
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till today and after a very long period of misconception about true nature of those rhodium 
catalysts recently very strong evidence has been presented indicating that stabilized Rh(0) 
nanoclusters/colloids/nanoparticles are the active catalytic species in those systems.29,30,54,56 
Metal nanoclusters are very active under mild conditions due to their very large surface 
area.57 Since in our hydrogenation reactions right conditions for nanoclusters formation and 
stabilization are met, such as reductive environment, high temperature and ILs presence, 
therefore we postulate Rh(0) nanoclusters, stabilized by ILs, may be the catalytic species 
responsible for aromatic ring reduction and formation of methyl 2-acetylamino-3-
cyclohexylpropionate (56).43,54 The same catalytic species are probably also facilitating 
reduction of pyridinium ring of IL 6c and 2c.58 Presence of black material, very likely a 
rhodium metal, observed at the end of the reaction supports our hypothesis, since 
nanoclusters are the expected intermediates in the bulk metal formation process.56 
Obviously chiral rhodium catalysts are also present and are active during our experiments, 
as proved by high ee values of the product 55, but Rh(0) nanoclusters may be formed over 
the time in the reaction course, as the amount of substrate 54 able to coordinate to the 
catalyst is diminishing.  
 
4.6 ILs stability in hydrogenation reactions 
In general all of 1-methylimidazolium ILs tested were stable during the hydrogenation 
reactions at all of the temperature and pressure conditions. Both pyridinium ILs proved to 
be unstable and were undergoing reduction of pyridinium ring. The only exception between  
1-methylimidazolium ILs was IL 41c, which has decomposed during hydrogenation of the 
Boc protected substrate 58, but it has remained unchanged in all other experiments. 
Upon extraction of the reaction mixture after reduction of 58, instead of usual NMR spectra 
of product and IL, additional signals in the aromatic region and around 5.1 ppm were 
evident. Based on previous experience those additional signal have been assigned to 
methyl mandelate (49) and hydrolysis of an ester bond linking 1-methylimidazolium with 
the remaining part of molecule has been postulated. Of note IL 41c and its enantiomer IL 
40c were stable in all other experiments, including substrates 54, 59, 60, two catalysts and 
various conditions. That suggest the changes observed are specific to the substrate 58, 
containing an amine functionality protected with tert-butyloxycarbonyl group. As 
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carbamate, 58 is more basic than the other substrates 54, 59, 60 tested, which have an 
amide functionality. Thus in such environment and in the presence of water, hydrolysis of 
IL 41c might have occurred.    
Both of pyridinium ILs tested 6c and 2c proved to be unstable and were undergoing 
pyridine ring reduction, to a various degree, in nearly all of the hydrogenation experiments 
(Figures 4.19, 4.20). 
N
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Figure 4.19 Reduction of pyridinium ring during hydrogenation of substrate 54 
 
The more pronounced changes were taking place at higher temperatures and in few cases 
complete disappearance of the original IL was observed. It was the case during 
hydrogenation of 54 with Rh-(Rp,R)-Taniaphos SL-T001 and Rh-(Rp,R)-Taniaphos SL-
T002 at 100 oC and reduction of 57 with Rh-(R,R)-DiPAMP at 80 oC, where complete 
reduction of pyridinium ring of IL 6c was observed and a clean spectra of new piperidine 
based IL 70c was recorded (Figure 4.20). In all other cases mixtures of IL 6c, reduced IL 6c 
and possibly other decomposition products were observed. One exception is IL 6c in Rh-
(R,R)-DiPAMP catalyzed hydrogenation of 57 carried out at 60 oC, where IL 6c remained 
unchanged throughout the process. Similarly as for IL 6c, pyridinium IL 2c underwent the 
same reaction during hydrogenation of the substrate 54 with Rh-(Rp,R)-Taniaphos SL-T002 
as catalyst. Spectrum of respective piperidinium IL 71c has also been recorded (Figure 
4.21).    
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Figure 4.20 NMR spectra of IL 6c and IL 70c with reduced pyridinium ring 
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Figure 4.21 Reduction of pyridinium ring of IL 2c during hydrogenation of substrate 54 
 
 
4.7 Conclusions 
Preliminary study showed that all of ILs tested, IL 43c, 40c and 41c, are suitable 
media for hydrogenation reactions carried out in the presence of homogeneous rhodium 
catalysts. Substrate 54 was successfully reduced with Rh-(R,R)-DiPAMP catalyst, at the 
presence of IL 43c, 40c and 41c as solvents, with enantioselectivities over 90 %. Lower ee 
values within 85 %- 76 % range were achieved when Rh-(Rp,R)-Taniaphos SL-T001 was 
applied as catalyst. With that catalyst and in the presence of IL 40c and 41c, an unusual by-
product 56 with a reduced aromatic ring has been detected in the reaction mixture, which 
has been investigated in further studies. Although excellent enantioselectivities were 
obtained in the hydrogenation of 54 with ILs as solvents, very long reaction times were 
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necessary (20-120 hours) to complete the process, as compared with methanol (18 min), 
probably due to high viscosities and low hydrogen solubility in the ILs.59 Chiral IL 40c and 
its enantiomer IL 41c were tested as solvents in hydrogenation of substrate 54 to investigate 
possibility of solvent imposed chiral induction. Negligible difference of 1 % in ee values of 
the product 55 obtained with IL 40c and 41c implicated that chirality cannot be induced by 
the solvent at the conditions tested. 
Following the preliminary study collaboration with Celtic Catalyst was initiated and 
number of ILs were tested as solvents in hydrogenation reaction at various temperature and 
pressure conditions. Temperature and enantioselectivity correlation was observed and in the 
tested range (30–80 oC) the best ee values were found at the highest temperature. Pressure 
vs. enantioselectivity dependency was also evident and the highest ee values were obtained 
at the lowest hydrogen pressure (15 psi). However higher H2 pressure (50 psi) was 
necessary to ensure the completion of the reactions in less then 10 hours. Studies to 
investigate solvent induced chirality were also continued. Experiments with two 
enantiomers of the catalyst Rh-(R,R)-DiPAMP and Rh-(S,S)-DiPAMP as well as with 
achiral catalyst Rh-DPPE were carried out. Although initially 4 % difference in the ee 
values of product 55 obtained with IL 40c and 41c was found, further tests with opposite 
catalyst enantiomers showed lack of match/mismatch effect. Also in the reaction catalyzed 
by achiral Rh-DPPE racemic product 55 with ee less than 1 % was formed. Another chiral 
IL 42c was also applied and similarly racemic product 55 was formed in Rh-DPPE 
catalyzed process. Those tests finally proved chirality cannot be transferred from the 
solvent IL 40c, 41c or 42c to the product 55 in the hydrogenation reactions tested. 
In collaboration with Celtic Catalyst, hydrogenation reactions in the mixture of ILs and 
organic co-solvent, catalyzed by Rh-(R,R)-DiPAMP were also performed. Significant 
improvement of the reaction rates and ee values were observed and results as efficient as in 
pure organic solvents were obtained. Next, recycling of catalyst immobilized in ionic liquid 
was tested in the biphasic solvent system with organic co-solvent. Three runs were 
performed, however product 55 with ee values below 90 % was obtained upon second 
recycle of catalyst-IL phase, therefore only one recycle would be industrially applicable.  
In case of all reactions run in ILs final product was contaminated with traces of IL and 
purification by column chromatography was necessary. Efficiency of chromatographic 
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separation was therefore determined and isolated yields values were obtained. Depending 
on the IL structure, product 55 could have been recovered with 96 % to 50 % yield.  
Hydrogenation of more challenging substrates 57-60 was also tested in ILs and in all 
investigated cases, results were inferior to those obtained in methanol. In the last stage of 
the Celtic Catalyst collaboration, experiments on big scale with ILs as solvents were 
performed to investigate applicability of ILs in hydrogenation reactions on the industrial 
scale. Very good reproducibility of the previous results, obtained on the analytical scale 
was presented.  
In the last stage of studies regarding applicability of ILs in the hydrogenation 
reactions, a novel class of ILs 1c, 3c, 5c and 6c derivatives of 3,4-dimethoxy- and 3,4-
methylendioxy- mandelic acids, of low toxicity and promising biodegradation abilities was 
used. Study of hydrogenation of 57 catalyzed by Rh-(R,R)-DiPAMP in the presence of ILs 
1c, 3c, 5c and 6c to identify conditions where polymerization would be suppressed was 
carried out. All of ILs tested proved to be suitable solvents for reduction of 57, where 
complete conversions with high enantioselectivities, up to 94 % ee, similar to methanol of 
95 % ee, were obtained. However only moderate to low isolated yields of product 65 were 
found, suggesting that polymerization was taking place in all of ILs tested. The highest 
isolated yields were achieved in the reactions run at the highest temperature applied, 100 
oC, indicating the lowest degree of polymerization at that condition.  
The same class of ILs 1c, 2c, 3c, 5c and 6c derivatives of 3,4-dimethoxy- and 3,4-
methylendioxy- mandelic acids, was also applied as solvents in the investigation of an 
unexpected aromatic ring reduction occurring during hydrogenation of 54. Catalysts, such 
as Rh-(R,R)-DiPAMP, Rh-(Rp,R)-Taniaphos SL-T001 and Rh-(Rp,R)-Taniaphos SL-T002 
at various conditions were screened in order to maximize formation of product 56. That 
goal was successfully met and in the presence of IL 2c and Rh-(Rp,R)-Taniaphos SL-T002, 
product 56 was formed as 91 % of the final reaction mixture. Ee value could not be 
determined in that case, however low ee were found in general with Rh-(Rp,R)-Taniaphos 
SL-T002 catalyst. The most significant result, in terms of asymmetric synthesis was 
obtained with Rh-(R,R)-DiPAMP as catalyst in the presence of IL 6c, where 56 with ee of 
89 % was formed, at moderate content of 20 % of 56 in the final reaction mixture.  
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All of the ILs tested proved to be applicable in the hydrogenation reactions, where catalytic 
cycle with chiral rhodium phosphines was operating and reduction of the standard di- and 
tri-substituted enamides was possible. However in nearly all respects such as 
enantioselectivities, reaction time, need for chromatography purification of the product and 
hydrogenation of challenging substrates ILs tested were inferior to the organic solvents. 
One advantage ILs offer is possibility for biphasic reaction with organic co-solvent and 
catalyst immobilization and recycling, which may increase cost effectiveness of the 
process, minimize waste and reduce product contamination by catalyst traces. However in 
our study drop of ee value below 90 % was observed after second recycle and also product 
contamination by IL occurred, therefore further tests to identify better IL-catalyst-co-
solvent system are necessary. Another advantage of the ILs is that unusual reaction 
selectivities, other than in organic solvents, can be achieved. That was demonstrated during 
hydrogenation of substrate 54, where a reduction of an aromatic ring was possible at the 
very mild conditions and a one step route to optically enriched methyl 2-acetylamino-3-
cyclohexylpropionate (56) was developed. Of note very small amount of ILs was used in 
the study with 1:1 molar ratio of IL to substrate and more studies towards further decrease 
of ILs’ amount as well as catalyst loading would be recommendable.   
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4.8 Experimental section 
Materials and methods: 
Preliminary study: 
Substrate 54 was prepared from α-acetoamidocinnamic acid, bought from Sigma-Aldrich. 
ILs 40c, 41c and 43c were prepared as described in the Chapter 2.0 (Sections 2.6 and 2.8). 
[((R,R)-DiPAMP)Rh(cod)]BF4 was bought from Strem Chemicals. Taniaphos SL-T001-1 
and Rh(nbd)2BF4 were bought from Sigma-Aldrich. Product conversions were determined 
using 1H NMR spectra recorded on 400 MHz instrument. Enantiomeric excess values were 
determined with use of GCMS instrument equipped with Chirasil L-Val chiral column. 
Celtic Catalyst study: 
ILs: 40c, 41c, 42c, 43c, 44c and 63c were prepared according to the procedures described 
in the Chapter 2.0 (Sections 2.6 and 2.8). Reactions and product ee determination were 
carried out by Celtic Catalyst. Product conversions were determined using 1H NMR spectra 
recorded on 400 MHz instrument. Enantiomeric excess values were determined with use of 
HPLC equipped with chiral columns (Daicel Chiralpak IA, Daicel Chiralpak AS-H and 
Daicel Chiralcel OJ-H).  
Hydrogenation study with the novel class of ILs as solvents 
ILs 1c, 2c, 3c, 5c and 6c were prepared according to the procedures described in the in the 
Chapter 2.0 (Sections 2.2 and 2.8). Substrate 57 was bought from Sigma and substrate 54 
was received from Celtic Catalyst. Rh-DiPAMP was received from Celtic Catalyst, 
Rh(nbd)2 BF4, Taniaphos SL-T001-1 (batch 1), Taniaphos SL-T001-1 (batch 2) and 
Taniaphos SL-T002-1 was bought from Sigma-Aldrich. Product conversions were 
determined using 1H NMR spectra recorded on 400 MHz instrument. Enantiomeric excess 
values were determined with use of HPLC equipped with chiral column, Lux-2 (Cellulose 
tris(3-chloro-4-methylphenylcarbamate)).  
 
Preliminary study: 
Preparation of methyl (Z)-α-acetamidocinnamate (54)  
A solution of TMS-diazomethane (6 mL, 2M solution in diethyl ether) was stirred in a 
mixture of toluene (125 mL) and methanol (25 mL) under nitrogen atmosphere for 5 h. A 
solution of α-acetoamidocinnamic acid (1.246 g, 6.07 mmol) in methanol (6 mL) was 
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added. After sting for 30 min at ambient temperature during which period there was 
nitrogen evolution and gradual dissipation of a colour the reaction mixture was diluted with 
diethyl ether (120 mL) and 10 % solution of acetic acid (60 mL) was added. The aqueous 
phase was extracted with diethyl ether (4 × 30 mL) and the combined organic extractions 
were washed with saturated sodium carbonate solution, dried over anhydrous MgSO4, 
filtered and volatiles were removed under reduced pressure to give the title compound as a 
white solid in 76 % yield (1.013 g, 4.62 mmol).   
Product characterization:   
1H NMR (400 MHz, CDCl3, δ): 7.38-7.18 (m, 6H), 6.84 (s, 1H), 3.73 (s, 3H), 2.20 (s, 3H) 
EI-MS m/z: 219.2, 207.1, 177.2, 117.2 
1HNMR in agreement with literature60  
 
Hydrogenation experiments: 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4 (4.0 mg, 5.30 µmol) was weighed into a dry 2-
neck round bottom flask followed by IL: 40c, 41c or 43c (Table 1) and substrate: methyl 
(Z)-α-acetamidocinnamate (54) addition. 3 Ar cycles were performed, hydrogen was 
introduced via a balloon and reaction mixture was heated up to 86-100 oC. The progress of 
the reaction was monitored by 1H NMR. Upon termination of the reaction, the product was 
extracted using hexane (10 x 3 mL) and ees were determined using GC chiral column. 
Conversion of the starting material to the N-acetyl-phenylalanine methyl ester (55) was 
determined by 1H NMR. Enantiomeric excess values were obtained with use of Chirasil L-
Val chiral column and following conditions: Column temperature: 150 oC isocratic, Flow: 
2.0 mL/min, Injector temp.: 280 oC, Detector temp.: 260 oC, Split ratio: 200:1. Retention 
times: 7.6 min (R), 8.3 min (S). 
Product 55 characterization:   
1H NMR (400 MHz, CDCl3, δ): 7.25-7.17 (m, 3H), 7.04-7.00 (m, 2H), 5.87-5.79 (m, 1H), 
4.79-4.87 (m, 1H), 3.67 (s, 3H), 3.12-3.00 (m, 2H), 1.92 (s, 3H) 
EI-MS m/z: 162.2, 131.2, 120.2, 91.2 88.2 
1HNMR and EI-MS in agreement with literature61,62 
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Table 1 
No IL 
No. 
Temp. Time Catalyst IL Substrate 54 
1. 43c 86 oC 120 h 4.0 mg 
5.30 µmol 
0.75 mL 0.178 g 
0.815 mmol 
2. 40c 100 oC 24 h 3.08 mg 
4.10 µmol 
91.50 mg 
0.16 mmol 
43.60 mg 
0.2 mmol 
3. 41c 100 oC 24 h 3.15 mg 
4.2 µmol 
91.52 mg 
0.16 mmol 
43.75 mg 
0.2 mmol 
 
Catalyst: Taniaphos SL-T001-1 and Rh(nbd)2BF4 (Table 2) was weighed into a dry 2-neck 
round bottom flask followed by IL: 40c, 41c or 43c and substrate: methyl (Z)-α-
acetamidocinnamate  (54) addition. 3 Ar cycles were performed, hydrogen was introduced 
via a balloon and reaction mixture was heated up to 68-95 oC. The progress of the reaction 
was monitored by 1H NMR. Upon termination of the reaction, the product was extracted 
using hexane (10 x 3 mL) and ees were determined using GC chiral column. Conversion of 
the starting material to the N-acetyl-phenylalanine methyl ester was determined by 1H 
NMR. Enantiomeric excess values were obtained with use of Chirasil L-Val chiral column 
and following conditions: Column temperature: 150 oC isocratic, Flow: 2.0 mL/min, 
Injector temp.: 280 oC, Detector temp.: 260 oC, Split ratio: 200:1. Retention times: 7.6 min 
(R), 8.3 min (S). 
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Table 2 
 
No 
 
IL 
 
Temp. 
 
Time 
 
Rh(nbd)2BF4 
Taniaphos 
SL-T001-1 
 
IL 
 
Substrate 54 
1. 43c 86
 oC 120 h 
2.0 mg 
5.35 µmol 
4 mg 
6.25 µmol 
0.75 mL 
0.163 g 
0.75 mmol 
2. 40c 68
 oC 42 h 
2.2 mg 
5.88 mmol 
4.2 mg 
6.1mmol 
0.208 g 
0.37 
mmol 
0.074 g 
0.34 mmol 
3. 41c 95 
oC 20 h 
3.3 mg 
8.82 mmol 
5.4 mg 
7.85 mmol 
0.43 g 
0.76 
mmol 
0.10 g 
0.40 mmol 
 
Celtic Catalyst Study: 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4 (3.8 mg, 5 µmol), [((S,S)-DiPAMP)Rh(cod)]BF4 
(3.8 mg, 5 µmol) or [(DPPE)Rh(cod)]BF4  (3.5 mg, 5 µmol) was weighed into a dry glass 
vial followed by addition of solvent (2.0 mL or 2.0 g): IL 40c, 41c, 42c, 43c, 44c or 
methanol and substrate: methyl (Z)-α-acetamidocinnamate (54) (0.205 g, 1.0 mmol). 3 N2 
cycles with stirring were performed, hydrogen was introduced and reaction mixture was 
heated up to required temperatures. The progress of the reaction was monitored by 
hydrogen uptake and 1H NMR. Upon termination of the reaction, the product was extracted 
with toluene (2.5 mL). Enantiomeric excess values of product 55 were obtained with use of 
HPLC equipped with chiral column (Daicel Chiralpak IA 5µm, 250 x 4.6 mm). Conditions: 
90:10 n-heptane/EtOH, wavelength: 254, 230, 210 nm (ee determined at 210 nm), retention 
times: 11.1 min (R), 12.2 min (S). 
 
Co-solvent study: 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4  (3.8 mg, 5 µmol) was weighed into a dry glass 
vial followed by addition of solvent (0.5 mL or 0.5 g): IL 40c or 44c and co-solvent (1.5 
mL) and substrate: methyl (Z)-α-acetamidocinnamate (54) (0.205 g, 1.0 mmol). 3 N2 cycles 
with stirring were performed, hydrogen was introduced and reaction mixture was heated up 
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to required temperatures. The progress of the reaction was monitored by hydrogen uptake 
and 1H NMR. Upon termination of the reaction, the product was extracted with toluene (2.5 
mL). Enantiomeric excess values were obtained with use of HPLC equipped with chiral 
column (Daicel Chiralpak IA 5µm, 250 x 4.6 mm). Conditions: 90:10 n-heptane/EtOH, 
wavelength: 254, 230, 210 nm (ee determined at 210 nm), retention times: 11.1 min (R), 
12.2 min (S). 
 
Recycling Experiments 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4 (3.8 mg, 5 µmol) was weighed into a dry glass vial 
followed by addition of solvent: IL 63 (0.5 g), toluene (2.0 mL) and substrate: methyl (Z)-
α-acetamidocinnamate (54) (0.205 g, 1.0 mmol). 3 N2 cycles with stirring were performed, 
hydrogen was introduced and reaction mixture was heated up to 60 oC. The progress of the 
reaction was monitored by hydrogen uptake and 1H NMR. Upon termination of the reaction 
the apparatus was left to cool to approx. 35 °C and three N2 purges were performed. The 
vial was then removed, and stirred under a N2 blanket for 30 seconds. Toluene (2 mL) was 
added, and the biphasic mixture was stirred for approx. 5 min, then left to settle for approx. 
15 min. The upper (toluene) layer was removed using a syringe, and the extraction 
procedure repeated a second time. Further substrate (1.0 mmol) and toluene (2.0 mL) was 
then added, and the hydrogenation and workup procedure repeated a second and third time. 
Enantiomeric excess values were obtained with use of HPLC equipped with chiral column 
(Daicel Chiralpak IA 5µm, 250 x 4.6 mm). Conditions: 90:10 n-heptane/EtOH, wavelength: 
254, 230, 210 nm (ee determined at 210 nm), retention times: 11.1 min (R), 12.2 min (S). 
 
Non-standard hydrogenation substrates 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4  (3.8 mg, 5 µmol) was weighed into a dry glass 
vial followed by addition of solvent (2.0 g or 0.5 g for experiments with 1.5 mL of co-
solvent): IL 41c, 44c or methanol and substrate 57-60 (1.0 mmol). 3 N2 cycles with stirring 
were performed, hydrogen was introduced and reaction mixture was heated up to required 
temperatures. The progress of the reaction was monitored by hydrogen uptake and 1H 
NMR. Upon termination of the reaction, product was extracted with toluene (2.5 mL). 
Enantiomeric excess values were obtained with use of HPLC equipped with chiral column. 
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Product 65: Column: Daicel Chiralpak IA 5µm, 250 x 4.6 mm. Conditions: 80:20 n-
heptane/EtOH, wavelength: 254, 230, 210 nm (ee determined at 210 nm), Retention times: 
5.1 min (R), 6.4 min (S) 
Product 66: Product 66 was purified by column chromatography priori to HPLC analysis.  
Column: Daicel Chiralpak AS-H 5µm, 250 x 4.6 mm. Conditions: 99:01 n-heptane/EtOH 
Wavelength: 254, 230, 210 nm (ee determined at 210 nm), Retention times: 10.2 min (S), 
15.2 min (R) 
Product 67: Column: Daicel Chiralcel OJ-H 5µm, 250 x 4.6 mm. Conditions: 95:05 n-
heptane/EtOH, Wavelength: 254, 230, 210 nm (ee determined at 210 nm) 
Retention times: 24.7 min (probably R), 44.6 min (probably S) 
Product 68: Column: Daicel Chiralpak IA 5µm, 250 x 4.6 mm 
Conditions: 80:20 n-heptane/EtOH, Wavelength: 254, 230, 210 nm (ee determined at 210 
nm), Retention times: 7.6 min (R), 10.4 min (S) 
 
Large scale hydrogenation experiments: 
The substrate 54 (3.3 g, 15 mmol), catalyst (57 mg, 0.5 mol%) and solvent (30 mL): IL 40c, 
44c or methanol were placed in a Parr 50 mL vessel (316 SS). The pressure head was 
assembled and the mixture purged three times with N2 and H2. The pressure was released. 
The vessel was heated to the target temperature, then re-pressurized to 50 psi H2 and 
stirring commenced (600 rpm). The vessel was re-pressurized when the internal pressure 
had reached 1 bar (2 bar for slow reactions), but no more than every 5 min when reactions 
were at their most rapid. For rapid reactions, the apparatus was left to stir at pressure for 30 
min – 1 h after no more H2 uptake was measurable; slower reactions were filled repeatedly 
during 6 h, then left to stir at pressure overnight. Heating was discontinued and the vessel 
cooled before purging with N2. The pressure head was removed and the reaction mixture 
decanted into a bottle, washing in to a standard volume with MeOH. A sample (1%) was 
taken for NMR and HPLC analysis. Column: Daicel Chiralpak IA 5µm, 250 x 4.6 mm. 
Conditions: 90:10 n-heptane/EtOH, wavelength: 254, 230, 210 nm (ee determined at 210 
nm), retention times: 11.1 min (R), 12.2 min (S). 
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Hydrogenation study with the novel class of ILs as solvents 
Hydrogenation of methyl 2-acetamidoacrylate (57) 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4 (5.0 µmol) (Table 3) was weighed into a dry 2-
neck round bottom flask followed by solvent (0.1 mmol): IL 1c, 3c, 5c, 6c or methanol and 
substrate: methyl α-acetoamidoacrylate (57) (0.1 mmol) addition. 3 N2 flush cycles were 
performed, hydrogen was introduced via a balloon and reaction mixture was heated up to 
60 oC, 80 oC or 100 oC. Reactions were stirred over 24 h. Upon termination of the reaction, 
the product was extracted using diethyl ether:cyclohexane (15 x 5 mL) and ees were 
determined using HPLC with chiral column. Conversion of the substrate 57 to the N-acetyl-
alanine methyl ester (65) was determined. Chiral column: Lux-2; mobile phase: 
Hexane:IPA; 80:20, flow: 1 mL/min, wavenlenght: 210 nm, retention times: 8.0 min (S), 
10.8 min (R). 
Table 3 
No IL No. Temp. Catalyst 
(5.0 µmol) 
IL 
(0.1 mmol) 
Substrate 57 
(0.1 mmol) 
1. 1c 60 oC 4.09 mg 57.73 mg 14.47 mg 
2. 1c 80 oC 3.96 mg 57.86 mg 14.76 mg 
3. 1c 100 oC 4.00 mg 57.42 mg 14.16 mg 
4. 3c 60 oC 4.10 mg 63.30 mg 14.41 mg 
5. 3c 80 oC 3.99 mg 61.35 mg 14.68 mg 
6. 3c 100 oC 3.99 mg 62.20 mg 14.41 mg 
7. 3c RT 4.06 mg 62.04 mg 14.56 mg 
8. 5c 60 oC 3.96 mg 55.53 mg 14.45 mg 
9. 5c 80 oC 4.15 mg 55.26 mg 14.00 mg 
10. 5c 100 oC 4.15 mg 55.65 mg 14.14 mg 
11. 6c 60 oC 4.08 mg 55.35 mg 14.42 mg 
12. 6c 80 oC 4.14 mg 55.65 mg 14.41 mg 
13. 6c 100 oC 4.17 mg 55.51 mg 14.58 mg 
14 MeOH RT 
RT 
4.00 mg 
5.49 mg 
5.0 mL 
1.0 mL  
14.06 
101.00 mg 
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Hydrogenation of methyl (Z)-α-acetamidocinnamate (54) 
Catalyst Rh(nbd)2BF4 (5.0 µmol) (Table 4) and ligand (Rp,R) Rh-Taniaphos SL-T001-1 (5.0 
µmol) and was weighed into a dry 2-neck round bottom flask followed by solvent: IL 6c 
(0.1 mmol) or methanol and substrate: methyl α-acetoamidocinnamate (54) (0.1 mmol) 
addition. 3 N2 flush cycles were performed, hydrogen was introduced via a balloon and 
reaction mixture was heated up to 60 oC, 80 oC or 100 oC. Reactions were stirred over 24 h. 
Upon termination of the reaction, the product was extracted using diethyl ether:cyclohexane 
(15 x 5 mL) and ees were determined using HPLC with chiral column. Conversion of the 
substrate 54 to the N-acetyl-phenylalanine methyl ester 55 and 2- acetylamino-3-
cyclohexyl-propionic acid methyl ester 56 was determined.  
Chiral column: Lux-2; mobile phase: Hexane:IPA; 80:20, flow: 1 mL/min, wavenlenght: 
210 nm. Product 55: retention times: 11.9 min (S), Rt. 19.9 (R) min. Product 56: retention 
times: 6.8 min (S), Rt. 9.4 (R) min. 
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Table 4 
No IL Temp. Rh(nbd)2BF4 
(5.0 µmol) 
Taniaphos 
SL-T001-1 
(5.0 µmol) 
IL 
(0.1 
mmol) 
Substrate 54 
(0.1 mmol) 
1. 6ca 60 oC 1.83 mg 3.20 mg 55.67 mg 21.65 mg 
2. 6ca 80 oC 1.85 mg 3.27 mg 55.70 mg 21.4 mg 
3. 6ca 100 oC 1.85 mg 3.20 mg 55.90 mg 21.7 mg 
4. 6cb 60 oC 1.89 mg 3.20 mg 55.80 mg 22.2 mg 
5. 6cb 80 oC 2.02 mg 3.16 mg 55.81 mg 21.7 mg 
6. 6cb 100 oC 2.05 mg 3.40 mg 55.30 mg 22.3 mg 
7. 6cc 60 oC 1.95 mg 3.47 mg 55.95 mg 22.23 mg 
8. 6cc 80 oC 2.04 mg 3.60 mg 55.66 mg 21.98 mg 
9. 6cc 100 oC 1.87 mg 3.58 mg 55.61 mg 22.07 mg 
10. 6cd 60 oC 1.92 mg 3.61 mg 55.89 mg 21.99 mg 
11. 6cd 80 oC 2.01 mg 3.56 mg 56.67 mg 21.96 mg 
12. 6cd 100 oC 1.87 mg 3.44 mg 55.64 mg 21.93 mg 
13. MeOH RT 5 
mol% 
2.02 mg 3.87 mg 3.0 mL 21.16 mg 
a Taniaphos SL-T001-1 Batch 1, b Taniaphos SL-T001-1 Batch 1 repeated, c Taniaphos SL-
T001-1 Batch 2, d Taniaphos SL-T001-1 Batch 2 repeated. 
 
Hydrogenation of methyl (Z)-α-acetamidocinnamate (54) 
Catalyst Rh(nbd)2BF4 (5.0 µmol) (Table 5) and ligand (Rp,R) Rh-Taniaphos SL-T002 (5.0 
µmol) and was weighed into a dry 2-neck round bottom flask followed by IL 6c (0.1 mmol) 
and substrate: methyl α-acetoamidocinnamate 54 (0.1 mmol) addition. 3 N2 flush cycles 
were performed, hydrogen was introduced via a balloon and reaction mixture was heated up 
to 60 oC, 80 oC or 100 oC. Reactions were stirred over 24 or 48 h. Upon termination of the 
reaction, the product was extracted using diethyl ether:cyclohexane (15 x 5 mL) and ees 
were determined using HPLC with chiral column. Conversion of the substrate 54 to the N-
acetyl-phenylalanine methyl ester 55 and 2- acetylamino-3-cyclohexyl-propionic acid 
methyl ester 56 was determined.  
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Chiral column: Lux-2; mobile phase: Hexane:IPA; 80:20, flow: 1 mL/min, wavenlenght: 
210 nm. Product 55: retention times: 11.9 min (S), Rt. 19.9 (R) min. Product 56: retention 
times: 6.8 min (S), Rt. 9.4 (R) min. 
Table 5 
No IL Temp. Rh(nbd)2BF4 
(0.1 mmol) 
Taniaphos 
SL-T002-1 
(0.1 
mmol) 
IL 
(0.1 
mmol) 
Substrate 54 
(0.1 mmol) 
1. 6c 60 oC 2.00 mg 3.86 mg 55.95 mg 22.04 mg 
2. 6c 80 oC 2.25 mg 3.98 mg 55.66 mg 21.90 mg 
3. 6c 100 oC 2.25 mg 3.93 mg 55.61 mg 21.92 mg 
4. 6c 100 oC 2.10 mg 3.80 mg 55.44 mg 22.11 mg 
5. 6c 100 oC  
48 h 
1.98 mg 3.60 mg 56.70 mg 21.20 mg 
6. 6c 100 oC 48 
hd 
2.02 mg 3.93 mg 56.80 mg 21.80 mg 
7. 5c 100 oC  1.96 mg 3.74 mg 56.25 mg 21.82 mg 
8. 5c 100 oC  
48 h 
1.92 mg 3.99 mg 55.59 mg 21.60 mg 
9. 3c 100 oC 1.92 mg 3.60 mg 61.20 mg 21.92 mg 
10. 2c 100 oC 1.90 mg 3.84 mg 56.55 mg 21.78 mg 
11. 2c 100 oCd 2.00 mg 3.55 mg 56.95 mg 21.96 mg 
12. 2c 100 oCf 2.03 mg 3.61 mg 170.59 
mg 
22.15 mg 
13. 2c 100 oC  
48 h 
2.06 mg 3.64 mg 56.88 mg 21.88 mg 
14. 2c 100 oC 48 
hd 
2.15 mg 3.80 mg 57.22 mg 22.44 mg 
15. 2c 100 oC 48 
hd 
1.87 mg 3.81 mg 57.20 mg 22.10 mg 
16. 1c 100 oC 2.20 mg 3.57 mg 58.15 mg 21.68 mg 
          d
 Repeated experiment. f 1:3 substrate to IL ratio. 
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Hydrogenation of methyl (Z)-α-acetamidocinnamate (54) 
Catalyst: [((R,R)-DiPAMP)Rh(cod)]BF4 (5.0 µmol) (Table 6) was weighed into a dry 2-
neck round bottom flask followed by IL 6c (0.1 mmol) and substrate: methyl (Z)-α-
acetamidocinnamate (54) (0.1 mmol) addition. 3 N2 flush cycles were performed, hydrogen 
was introduced via a balloon and reaction mixture was heated up to 60 oC, 80 oC or 100 oC. 
Reactions were stirred over 24 h. Upon termination of the reaction, the product was 
extracted using diethyl ether:cyclohexane (15 x 5 mL) and ees were determined using 
HPLC with chiral column. Conversion of the substrate 54 to the N-acetyl-phenylalanine 
methyl ester (55) and 2- acetylamino-3-cyclohexyl-propionic acid methyl ester 56 was 
determined.  
Chiral column: Lux-2; mobile phase: Hexane:IPA; 80:20, flow: 1 mL/min, wavenlenght: 
210 nm. Product 55: retention times: 11.9 min (S), Rt. 19.9 (R) min. Product 56: retention 
times: 6.8 min (S), Rt. 9.4 (R) min. 
Table 6 
No IL No. Temp. Catalyst 
(5.0 µmol) 
IL 
(0.1 mmol) 
Substrate 54 
(0.1 mmol) 
1. 6c 60 oC 3.96 mg 55.01 mg 22.39 mg 
2. 6c 80 oC 3.84 mg 55.30 mg 22.32 mg 
3. 6c 100 oC 3.81 mg 55.46 mg 22.30 mg 
4. MeOH RT 3.82 mg 7.5 mL 108.80 mg 
 
Hydrogenation of N-acetyl-phenylalanine methyl ester (55) 
Catalyst Rh(nbd)2BF4 (5.0 µmol, 1.90 mg) and ligand (Rp,R) Rh-Taniaphos SL-T001-1 (5.0 
µmol, 3.60 mg) was weighed into a dry 2-neck round bottom flask followed by solvent: IL 
6c (0.1 mmol, 54.96 mg) and substrate: methyl α-acetoamidocinnamate (55) (0.1 mmol, 
22.70 mg) addition. 3 N2 flush cycles were performed, hydrogen was introduced via a 
balloon and reaction mixture was heated up to 100 oC. Reactions were stirred over 24 h. 
Upon termination of the reaction, the product was extracted using diethyl ether:cyclohexane 
(15 x 5 mL) and ees were determined using HPLC with chiral column. Conversion of the 
substrate 55 to the 2- acetylamino-3-cyclohexyl-propionic acid methyl ester (56) was 
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determined. Chiral column: Lux-2; mobile phase: Hexane:IPA; 80:20, flow: 1 mL/min, 
wavenlenght: 210 nm. Product 56: retention times: 6.8 min (S), Rt. 9.4 (R) min. 
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Chapter 5.0  
Thesis conclusions and future work 
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5.1 Thesis conclusions and future work 
Novel methylimidazolium and pyridinium ILs derived from disubstituted mandelic acids 
(3,4-dimethoxy, 3,4-methylenedioxy- and 3,4-dihydroxymandelic acid) with three types of 
counteranion (halide, OctOSO3−, NTf2−) were prepared in a simple 3-5 synthetic steps. Two 
classes of IL were synthesised, one with a cationic heterocycle linked directly to the chiral 
centre, and another with a corresponding acetoxy linker (Figures 2.1, 2.2). However, the 
latter class of IL with an acetoxy linker was unstable to hydrolysis, leading to IL 
degradation. All of the prepared novel ILs were chiral, but were prepared as racemic 
mixtures and various routes were attempted to obtain ILs in the optically pure form. With 
use of a chiral auxiliary approach, IL 38c with 20 % de was obtained. Further research 
needs to be carried out, since unexpected racemisation of the respective halide IL 38a 
occurred upon evaporation from water.  
Another part of the synthetic work involved preparation of known achiral and chiral, 
optically pure ILs on a large scale (up to 120 g). Chiral ILs were prepared starting from 
optically pure (S)- and (R)-mandelic acids, after a predeccesing racemisation test of two 
available synthetic methods. Optically pure ILs were prepared in a 3-4 step synthesis, 
without need for chromatographic purification. Achiral IL derivatives of pentanol and 
di(ethylene glycol) n-butyl ether were similarly prepared on large scale in a 2-3 step 
synthesis, without chromatographic purification. Those chiral and achiral ILs were 
subsequently used as solvents in asymmetric hydrogenation reactions. 
Once the ILs had been synthesized, they were tested regarding their potential 
environmental impact. IL toxicity tests on certain fungi and bacteria, along with 
biodegradation studies were carried out in collaborations with the Faculty of Pharmacy at 
Charles University, the School of Biotechnology at DCU and the Department of Chemical 
Technology at Gdansk University of Technology. Most of the prepared ILs, except 7a, 8a, 
24a, 4b, 5c were shown to be non-toxic at the highest concentration tested (2.0 mM). IL 5a 
was shown to be of relatively high toxicity (0.5-2.0 mM) to both types of microorganisms. 
ILs 24a, 4b exhibited moderate toxic effects towards fungi and IL 7a, 5c towards bacteria. 
Halide ILs were further tested at higher concentration (up to 200 mM) against different sets 
of bacteria strains. Two ILs 1a, 2a exhibited remarkably low toxicity and did not show 
inhibitory effect towards bacteria, with the exception of one strain, at concentration of 200 
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mM. Remaining halide ILs, except 8a, also proved to be of very low toxicities, with the 
lowest IC50 values within 25-100 mM.   
Biodegradation testing was carried out on halide ILs and none of the ILs were completely 
recalcitrant to biodegradation.  One of the ILs, 6d underwent 66 % degradation over a 28 
day period and was classified as a biodegradable compound. The remaining ILs were 
biodegraded to various degrees (13 % - 52 %). Upon extending the test time frame up to 56 
days, two ILs, 6a and 1a, improved their biodegradation to 79 % and 57 % respectively. 
Metabolite analysis was attempted, however isolation from activated sludge was not 
successful and only ILs with hydrolysed ester bonds were detected in the post-
biodegradation samples.  
Prepared ILs were subsequently used in hydrogenation reactions of various enamides. The 
optically pure ILs, derivatives of (S)- and (R)-mandelic acids and several achiral ILs, upon 
initial tests carried out in DCU, were further screened in collaboration with Celtic Catalysts 
company and a novel class of ILs, derivatives of substituted mandelic acids, were tested in 
DCU. Prepared ILs proved to be suitable solvents for hydrogenation reactions with 
asymmetric homogenous catalysts, where good ee values (85-92 %) of product 55 could be 
achieved. However much longer reaction times as compared with methanol, and a need for 
chromatographic separation of the product from ILs are the drawbacks of hydrogenation 
reactions in the presence of neat ILs.  
Reactions carried out in mixture of organic solvent and IL, resulted in product 55 with 
excellent ee values and reaction rates. Moreover, in such biphasic systems recycling of 
catalyst was possible, although sufficient ee values were only maintained after one recycle. 
Optimised biphasic systems, with multiple catalyst recycling would be an good alternative 
for use of organic solvents in the hydrogenation reactions on the industrial scale. 
Experiments with racemic catalyst and with opposite enantiomers of enantiomerically pure 
catalyst demonstrated that chirality could not be transferred from the enantiomericaly pure 
solvents, IL 40c, 41c or 42c to the product 55.  
During preliminary screening of the ILs, an unusual by-product 56 of substrate 54 
hydrogenation, with a reduced aromatic ring, was detected in the reaction mixture. This 
reaction was further optimised to maximise yield of 56. As a result, with IL 2c as solvent 
and Rh-(Rp,R)-Taniaphos SL-T002 as catalyst, 56 was obtained as 91 % of the final 
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reaction mixture, however low ee values were obtained. The most significant result, in 
terms of asymmetric synthesis was obtained with Rh-(R,R)-DiPAMP and IL 6c, where 20 
% of  56 in the final reaction mixture was formed with 89 % ee. Formation of Rh(0) 
nanoclusters was postulated to be responsible for the ring reduction process occurring at the 
very mild conditions used in the reaction. Novel class of ILs, derivatives of 3,4-
disubstituted mandelic acids proved to be suitable solvents for hydrogenation reactions, 
where good ee values and interesting selectivity could be achieved, however pyridinium 
ILs were shown to be not stable under tested conditions and undergoing reduction of the 
pyridinium heterocycle.     
 
Future work 
A key finding worthwhile to pursue is arene and heterocycle reduction at very mild 
conditions in the presence of rhodium diphosphine catalysts and ILs derived from 
disubstituted mandelic acids. Studies regarding hydrogenation reaction reproducibility, 
catalyst stability and nature of catalytic species need to be carried out.  
Investigation of enamides hydrogenation with catalyst recycling in biphasic system with the 
goal of further application on industrial scale as a continues-flow process should be 
completed. 
Continuation of biodegradation and toxicity studies including structure and activity 
relationship and ILs metabolite analysis may be a significant contribution into 
understanding of ILs environmental fate. Optimization of the synthetic methods for ILs 
preparation, with emphasis on green chemistry aspects such as atom economy, selection of 
solvents and reagent with reduced toxicity, by-product elimination as well as energy 
minimization, is of utmost importance.   
Further work regarding preparation of enantiomerically pure ILs would be also interesting 
to pursue. In continuation of work in this thesis involving chiral resolution, various chiral 
auxiliaries, such as chiral methylbenzylamine or pantolactone could be applied for the 
synthesis of optically pure ILs. Although challenging the use of a chiral anion to form a 
mixture of diasteromeric salts could lead to separation of the ionic liquids, especially of one 
isomer has a solid and the other a liquid at RT.  
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Considering that prepared ILs may easily undergo racemisation, as in the case of IL 38a, 
fluorination of the benzylic position of the ILs would be recommendable. Fluorination 
could be carried out asymmetrically and in this way enantiomerically pure, stable to 
racemisation ILs could be prepared. Another more convenient approach would be to use 
enantiomerically pure material for chiral IL synthesis. Work involving conversion of the 
amino group of chiral (−)-norepinephrine into a pyridinium ring with use of pyrylium salt 
has been attempted, however it was not pursued in detail due to time constraints. Such an 
IL could be applied as a catalyst for various asymmetric reactions, such as Baylis-Hillman 
or Michael reaction.  
 
 
 
